Sentence,class,file
"7, 1177 –1194 http://dx.doi.org/10.1080/19420862.2016.1212149",Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
MAbs 2015; 7:9-14; PMID:25529996; http://dx.doi.org/10.4161/19420862.2015.989042 3.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Methods 2005; 36:3-10; PMID:15848070; http://dx.doi.org/10.1016/j.ymeth.2005.01.001 6.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Adv Drug Deliv Rev 2006; 58:640- 56; PMID:16904789; http://dx.doi.org/10.1016/j.addr.2006.01.026 7.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
J Clin Immunol 1992; 12:116-21;PMID:1373150; http://dx.doi.org/10.1007/BF00918141 9.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Meth Enzymol 1991; 203:99-121; PMID:1762576; http://dx.doi.org/10.1016/0076-6879(91)03007-4 10.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
N Engl J Med 1998; 338:161-5; PMID:9428817; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Arthritis Rheum 1995; 38:1589-94; PMID:7488279; http://dx.doi.org/10.1002/art.1780381110 15.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Bio- chem Biophys Res Commun 2013; 441:1011-7; PMID:24239549;http://dx.doi.org/10.1016/j.bbrc.2013.11.014 16.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Nature 2009; 458:636-40; PMID:19287373; http://dx.doi.org/10.1038/nature07930 17.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Nat Biotechnol 1996; 14:845-51; PMID:9631008; http://dx.doi.org/10.1038/nbt0796-845 18.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Cloning Stem Cells 2002; 4:91-102; PMID:12006160; http://dx.doi.org/10.1089/153623002753632084 19.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Curr Opin Biotechnol 1995; 6:561-6; PMID:7579668; http://dx.doi.org/10.1016/0958-1669(95)80093-X 20.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Int Rev Immunol 1995; 13:65-93; PMID:7494109; http://dx.doi.org/ 10.3109/08830189509061738 21.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
J Immunol Methods 2013; 400 – 401:78-86; PMID:24184135; http://dx.doi.org/10.1016/j.jim.2013.10.007 22.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Nat Rev Drug Discov2010; 9:767-74; PMID:20811384; http://dx.doi.org/10.1038/nrd3229 23.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Science 1985; 228:1315-7; PMID:4001944; http://dx.doi.org/10.1126/science.4001944 24.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Gene 1988; 73:305-18; PMID:3149606; http://dx.doi.org/10.1016/0378-1119(88)90495-7 25.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Science 1988; 240:1038-41; PMID:3285470; http://dx.doi.org/10.1126/science.3285470 27.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Gene 1991; 104:147-53;PMID:1916287; http://dx.doi.org/10.1016/0378-1119(91)90244-6 28.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Nature 1991; 352:624-8; PMID:1907718; http://dx.doi.org/10.1038/352624a0 29.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Nature 1990; 348:552-4; PMID:2247164; http://dx.doi.org/10.1038/348552a0 30.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Nat Biotechnol2001; 19:75-8; PMID:11135557; http://dx.doi.org/10.1038/835671188 A. FRENZEL ET AL.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
J Biotechnol 2007; 127:626-37; PMID:16996161;http://dx.doi.org/10.1016/j.jbiotec.2006.08.015 34.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
J Mol Biol 2000; 296:57-86; PMID:10656818; http://dx.doi.org/10.1006/jmbi.1999.3444 35.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
FEBS J 2010; 277:2291-303; PMID:20423457; http://dx.doi.org/10.1111/ j.1742-4658.2010.07645.x 37.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
J Biotechnol 2011; 152:159-70; PMID:20883731; http://dx.doi.org/10.1016/j.jbiotec.2010.09.945 38.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Genome Biol 2007; 8:R254; PMID:18047641;http://dx.doi.org/10.1186/gb-2007-8-11-r254 39.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
"Nat Biotechnol 1996; 14:309-14; PMID:9630891; http://dx.doi.org/10.1038/nbt0396-309 40. de Haard HJ, van Neer N, Reurs A, Hufton SE, Roovers RC, Henderikx P, de Bru €ıne AP, Arends JW, Hoogenboom HR.",OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
J Biol Chem 1999; 274:18218- 30; PMID:10373423; http://dx.doi.org/10.1074/jbc.274.26.18218 41.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Nat Biotechnol 2005;23:344-8; PMID:15723048; http://dx.doi.org/10.1038/nbt1067 42.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Trends Biotechnol 2003; 21:484-90;PMID:14573361; http://dx.doi.org/10.1016/j.tibtech.2003.08.007 43.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
J Biotechnol 2001; 74:277-302; PMID:11526908; http://dx.doi.org/10.1016/S1389-0352(01)00021-6 44.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Vet ImmunolImmunopathol 2009; 128:178-83; PMID:19026455; http://dx.doi.org/10.1016/j.vetimm.2008.10.299 45.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
"D €ubel S, Stoevesandt O, Taussig MJ, Hust M. Generating recom- binant antibodies to the complet eh u m a np r o t e o m e .T r e n d sB i o - technol 2010; 28:333-9; PMID:20538360; http://dx.doi.org/10.1016/j.tibtech.2010.05.001 46.",OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Nat Biotechnol 2011; 29:245-54; PMID:21390033; http://dx.doi.org/10.1038/nbt.1791 47.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
BMC Biotechnol 2015; 15:10; PMID:25888378; http://dx.doi.org/ 10.1186/s12896-015-0125-0 48.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
PLoS ONE 2014; 9:e97478; PMID:24828352; http://dx.doi.org/10.1371/journal.pone.009747849.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
J Antivir Antiretrovir 2009; 1:36-42; PMID:20505850; http://dx.doi.org/10.4172/jaa.1000005 50.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
PLoS ONE 2011; 6:e15921; PMID:21264246; http://dx.doi.org/10.1371/journal.pone.0015921 51.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
MAbs 2014; 6:717-26; http://dx.doi.org/10.4161/mabs.28170 52.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
MAbs 2014; 6:446-59; PMID:24492304; http://dx.doi.org/10.4161/mabs.27773 53.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin E. PLoS ONE 2015; 10:e0139905; PMID:26440796; http://dx.doi.org/10.1371/journal.pone.0139905 54.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Development ofhuman-like scFv-Fc antibodies neutralizing Botulinum toxin sero-type B. MAbs 2015; 7:1161-77; PMID:26381852; http://dx.doi.org/ 10.1080/19420862.2015.1082016 55.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
PLoS ONE 2012; 7:e37242; PMID:22666347; http://dx.doi.or g/10.1371/journal.pone.0037242 56.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Mini Rev Med Chem 2009; 9:1633-8; PMID:20105119; http://dx.doi.org/10.2174/138955709791012283 57.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
MAbs 2014; 6:1425-38;PMID:25484064; http://dx.doi.org/10.4161/mabs.34376 58.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Annu Rev Immunol1994; 12:433-55; PMID:8011287; http://dx.doi.org/10.1146/ annurev.iy.12.040194.002245 59.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
J Immunol Methods 2013; 391:60-71; PMID:23454004; http://dx.doi.org/10.1016/j.jim.2013.02.010 60.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
MAbs 2014; 6:204-18; PMID:24262918; http://dx.doi.org/10.4161/mabs.27227 61.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Protein Eng Des Sel 2009; 22:159-68;PMID:18974080; http://dx.doi.org/10.1093/protein/gzn058 62.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
"The Journal of Biologic al Chemistry 1998; 273:21769-76; PMID:9705314; http://dx.doi.org/10.1074/jbc.273.34.21769 64. de Wildt RM, Mundy CR, Gorick BD, Tomlinson IM.",OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Nat Biotechnol 2000; 18:989-94; PMID:10973222; http://dx.doi.org/10.1038/79494 65.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Nat Biotechnol 2000; 18:852-6;PMID:10932154; http://dx.doi.org/10.1038/78458 66.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
J Mol Biol 2011; 413:261- 78; PMID:21856311; http://dx.doi.org/10.1016/j.jmb.2011.08.012 6 7 .,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
J Mol Biol 2008; 376:1182- 200; PMID:18191144; http://dx.doi.org/10.1016/j.jmb.2007.12.018 68.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
MAbs 2013; 5:445-70; PMID:23571156; http://dx.doi.org/10.4161/mabs.24218 6 9 .,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Methods 2005; 36:61-8; PMID:15848075; http://dx.doi.org/10.1016/j.ymeth.2005.01.006 71.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
J Immunol Methods 2003; 280:139-55; PMID:12972195;http://dx.doi.org/10.1016/S0022-1759(03)00109-1 72.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
J Virol Methods 2002; 106:225-33;PMID:12393153; http://dx.doi.org/10.1016/S0166-0934(02)00166-0 73.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
PLoS ONE 2009; 4:e6625; PMID:19675673; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Eur JImmunol 2013; 43:499-509; PMID:23180650; http://dx.doi.org/10.1002/eji.201242974 7 5 .,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
BMC Biotechnol 2015; 15:57;PMID:26084577; http://dx.do i.org/10.1186/s12896-015-0146-8 76.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
"Nizak C, Monier S, del Nery E, Moutel S, Goud B, Perez F. Recombi- nant antibodies to the small GTPase Rab6 as conformation sensors.Science 2003; 300:984-7; PMID:12738866; http://dx.doi.org/10.1126/ science.1083911 77.",OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
J Biol Chem 2006; 281:951-61;PMID:16278208; http://dx.doi.org/10.1074/jbc.M508199200 78.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Methods Mol Biol 2014; 1060:215-43; PMID:24037844;http://dx.doi.org/10.1007/978-1-62703-586-6_1279.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Appl Microbiol Bio- technol 2007; 74:723-9; PMID:17225094; http://dx.doi.org/10.1007/s00253-006-0810-y 80.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
BMC Biotechnol2013; 13:52; PMID:23802841; http://dx.doi.org/10.1186/1472-6750- 13-52 81.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
MAbs 2013; 5:1-4; PMID:23254906; http://dx.doi.org/10.4161/mabs.22976 83.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
MAbs 2014; 6:5-14; PMID:24284914; http://dx.doi.org/10.4161/mabs.27333 84.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
MAbs 2015; 7:1-8; PMID:25484055; http://dx.doi.org/10.4161/19420862.2015.988944 85.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
MAbs 2016; 8:197-204; PMID:26651519; http://dx.doi.org/10.1080/19420862.2015.1125583 86.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
MAbs 2014; 6:73- 85; PMID:24262785; http://dx.doi.org/10.4161/mabs.27240 87.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Clin Immu-nol 2009; 131:308-16; PMID:19188093; http://dx.doi.org/10.1016/j.clim.2009.01.002 88.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
N Engl J Med 1996; 334:1717-25; PMID:8637518; http://dx.doi.org/10.1056/NEJM199606273342607 89.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Lancet 1989; 2:244-7;PMID:2569055; http://dx.doi.org/10.1016/S0140-6736(89)90430-3 90.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Crit Care Med 2004; 32:2173-82; PMID:15640628; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
"Ann Rheum Dis 1999; 58 Suppl 1:I70-72; PMID:10577977; http://dx.doi.org/10.1136/ard.58.2008.i70 92. van de Putte LBA, Atkins C, Malaise M, Sany J, Russell AS, van Riel PLCM, Settas L, Bijlsma JW, Todesco S, Dougados M, et al.",OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Ann Rheum Dis 2004; 63:508-16; PMID:15082480; http://dx.doi.org/10.1136/ard.2003.013052 93.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Arthritis Rheum2003; 48:35-45; PMID:12528101; http://dx.doi.org/10.1002/art.10697 94.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Clin Ther 2003; 25:1700-21;PMID:12860493; http://dx.doi.org/10.1016/S0149-2918(03)80164-9 95.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Expert Opin Biol Ther 2010; 10:301-7; http://dx.doi.org/10.1517/147125909035306331190 A. FRENZEL ET AL.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Joint Bone Spine 2014; 81:352-9; PMID:24721422; http://dx.doi.org/10.1016/j.jbspin.2014.02.014 97.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Ann Rheum Dis 2013; 72:517-24; PMID:22562972; http://dx.doi.org/10.1136/annrheumdis-2011- 201244 98.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Rheumatology (Oxford) 2007; 46:327-34; PMID:16880188; http://dx.doi.or g/10.1093/rheumatology/kel236 100.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Ann Rheum Dis 2006; 65:889-94;PMID:16439435; http://dx.doi.org/10.1136/ard.2005.043166 101.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Science 1999; 285:260-3; PMID:10398604; http://dx.doi.org/ 10.1126/science.285.5425.260 102.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
J Exp Med 1999; 189:1747-56; PMID:10359578; http://dx.doi.org/10.1084/jem.189.11.1747 103.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Arthritis Rheum 2001; 44:1313-9;PMID:11407690; http://dx.doi.org/10.1002/1529-0131(200106)44:6%3c1313::AID-ART223%3e3.0.CO;2-S 104.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
J Immunol 2001; 166:6-10; PMID:11123269; http://dx.doi.org/10.4049/jimmunol.166.1.6 105.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Arthritis Res Ther 2011; 13:228; PMID:21745419; http://dx.doi.org/10.1186/ar3349 106.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Autoimmun Rev 2014; 13:1094-101; PMID:25149393; http://dx.doi.org/10.1016/j.autrev.2014.08.020 107.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Lancet 2014; 384:1878-88; PMID:24881804; http://dx.doi.org/ 10.1016/S0140-6736(14)60128-8 108.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
J Immunol 2009; 182:2532-41; PMID:19201910; http://dx.doi.org/10.4049/jimmunol.0802948 109.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
J Immunol 2005; 174:5537-44; PMID:15843552; http://dx.doi.org/10.4049/jimmunol.174.9.5537 110.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
J Immunol 2009; 183:3160-9; PMID:19657089;http://dx.doi.org/10.4049/jimmunol.0900385 111.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Arthritis Rheum 2003; 48:3253-65; PMID:14613291; http://dx.doi.org/10.1002/art.11299 112.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Toxicol Sci 2006; 91:586-99; PMID:16517838; http://dx.doi.org/10.1093/toxsci/kfj148 113.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
J Rheumatol 2013; 40:579-89;PMID:23547209; http://dx.doi.org/10.3899/jrheum.120886 114.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
"A phase II, ran- domized, double-blind, placebo-controlled, dose-ranging study ofbelimumab in patients with active systemic lupus erythematosus.Arthritis Rheum 2009; 61:1168-78; PMID:19714604; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Nat Biotechnol 2012; 30:69-77; PMID:22231104; http://dx.doi.org/10.1038/nbt.2076 116.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Lancet 2011; 377:721-31; PMID:21296403; http://dx.doi.org/10.1016/S0140-6736(10)61354-2 117.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
RMD Open 2015; 1:e000037; PMID:26535134; http://dx.doi.org/10.1136/rmdopen-2014-000037 118.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Allergy Asthma Clin Immunol 2010; 6:15;PMID:20667118; http://dx.doi.org/10.1186/1710-1492-6-15 119.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Ann Allergy AsthmaImmunol 2014; 113:460-466.e2; PMID:24980392; http://dx.doi.org/ 10.1016/j.anai.2014.05.028 120.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
J Blood Med 2015; 6:115-23;PMID:25931832; http://dx.doi.org/10.2147/JBM.S66825 122.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Expert Opin Biol Ther 2008; 8:1187-99;PMID:18613770; http://dx.doi.org/10.1517/14712598.8.8.1187 123.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Nat Rev Drug Discov 2010; 9:189-90; PMID:20190785; http://dx.doi.org/10.1038/nrd3125 124.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
J Biol Chem 2014; 289:23596-608; PMID:24970892;http://dx.doi.org/10.1074/jbc.M114.569061 125.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Clin Transl Oncol 2011; 13:839-47; PMID:22126726; http://dx.doi.org/10.1007/s12094-011-0744-4 126.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
2005; 92:1430-41; PMID:15846298; http://dx.doi.org/10.1038/sj.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Clin Cancer Res 2008; 14:3450-5;PMID:18519776; http://dx.doi.org/10.1158/1078-0432.CCR-07-1416 128.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Clin Cancer Res 2009; 15:5584-90; PMID:19690193; http://dx.doi.org/ 10.1158/1078-0432.CCR-09-0996 129.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
J Clin Oncol2007; 25:1390-5; PMID:17416859; http://dx.doi.org/10.1200/ JCO.2006.08.8898 130.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
"Trarbach T, Moehler M, Heinemann V, K €ohne C-H, Przyborek M, Schulz C, Sneller V, Gallant G, Kanzler S. Phase II trial of mapatu- mumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligandreceptor-1 (TRAIL-R1), in patients with refractory colorectal cancer.Br J Cancer 2010; 102:506-12; PMID:20068564; http://dx.doi.org/ 10.1038/sj.bjc.6605507 131.",Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Lung Cancer 2008; 61:82-90; PMID:18255187; http://dx.doi.org/10.1016/j.lungcan.2007.12.011 132.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Agents Actions 1988; 23:300-3;PMID:2456001; http://dx.doi.org/10.1007/BF02142570 133.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Semin Hematol 2012; 49:228-42; PMID:22726546; http://dx.doi.org/ 10.1053/j.seminhematol.2012.04.010 135.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
PLoS ONE 2012; 7:e45492; http://dx.doi.org/10.1371/journal.pone.0045492 136.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Cell Death Differ2008; 15:751-61; PMID:18219321; http://dx.doi.org/10.1038/sj.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Clin Cancer Res 2010; 16:1256-63; PMID:20145186; http://dx.doi.org/10.1158/1078-0432.CCR-09-1267 139.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Am J Hematol 2014; 89:1037-42; PMID:25092564; http://dx.doi.org/10.1002/ajh.23822 140.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
J Clin Oncol 2011; 29:4442- 51; PMID:22010015; http://dx.doi.org/10.1200/JCO.2011.37.2623 141.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Nat Rev Immunol 2008; 8:533-44; PMID:18551128;http://dx.doi.org/10.1038/nri2356 142.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Ann Rheum Dis 1997; 56:364-8; PMID:9227165;http://dx.doi.org/10.1136/ard.56.6.364 143.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Arthritis Res Ther 2012; 14:R199; PMID:22995428;http://dx.doi.org/10.1186/ar4037 144.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
J Immunol 2001; 166:2090-9; PMID:11160260; http://dx.doi.org/10.4049/jimmunol.166.3.2090 145.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Immunopharmacol Immunotoxicol 1998; 20:373-82; PMID:9736442; http://dx.doi.org/10.3109/08923979809034820 146.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
J Exp Med 2001; 194:873-82; PMID:11581310; http://dx.doi.org/10.1084/jem.194.7.873 147.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
NucleicAcids Res 1994; 22:5600-7; http://dx.doi.org/10.1093/nar/22.25.5600 148.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Mol Immunol 2008; 46:135-44; PMID:18722015; http://dx.doi.org/10.1016/j.molimm.2008.07.013 149.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Ann RheumDis 2015; 74:1058-64; PMID:24534756; http://dx.doi.org/10.1136/ annrheumdis-2013-204816 150.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Neurol Neuroimmunol Neu- roinﬂamm 2015; 2:e117; PMID:26185773; http://dx.doi.org/10.1212/ NXI.0000000000000117 151.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Protein Eng Des Sel 2006; 19:461-70; PMID:16868004; http://dx.doi.org/10.1093/protein/gzl031 152.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Mol Immunol 2007; 44:916-25; PMID:16697465; http://dx.doi.org/10.1016/j.molimm.2006.03.020 153.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Ann Rheum Dis 2011; 70:1542-9; PMID:21613310; http://dx.doi.org/ 10.1136/ard.2010.146225 155.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Cancer 2008; 112:1114-21; PMID:18219661; http://dx.doi.org/10.1002/cncr.23282 156.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Curr Drug Targets 2005; 6:243-57;PMID:15857286; http://dx.doi.org/10.2174/1389450053765879 159.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Clin Cancer Res 2006; 12:5268-72; PMID:17000658; http://dx.doi.org/10.1158/1078-0432.CCR-05-1554 160.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Structure 2008; 16:216-27; PMID:18275813; http://dx.doi.org/10.1016/j.str.2007.11.009 161.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Exp Cell Res 2009; 315:659-70; PMID:18992239; http://dx.doi.org/10.1016/j.yexcr.2008.10.008 162.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Drugs 2016; 76:283-9; PMID:26729188; http://dx.doi.org/10.1007/s40265-015-0537-0 164.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Br J Cancer 2016; 114 (4):372-80; PMID:26766738; http://dx.doi.org/10.1038/bjc.2015.480 165.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Science 1987; 235:442- 7; PMID:2432664; http://dx.doi.org/10.1126/science.2432664 166.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Nat Med 1995; 1:27-31; PMID:7584949; http://dx.doi.org/ 10.1038/nm0195-27 168.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
J Mol Biol 1999; 293:865-81; PMID:10543973; http://dx.doi.org/10.1006/jmbi.1999.3192 171.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Structure 1998; 6:1153-67;PMID:9753694; http://dx.doi.org/10.1016/S0969-2126(98)00116-6 172.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
N Engl J Med 2011; 364:1897-908;PMID:21526923; http://dx.doi.org/10.1056/NEJMicm1005605 173.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Crit Rev Oncol Hematol 2007; 62:179-213; PMID:17324579; http://dx.doi.org/10.1016/j.critrevonc.2007.01.006 174.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
"Biochem Biophys Res Commun 1992; 187:1579-86;PMID:1417831; http://dx.doi.org/10.1016/0006-291X(92)90483-2 178. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT.",OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Science 1992; 255:989-91; PMID:1312256; http://dx.doi.org/10.1126/science.1312256 179.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Endocr Rev 2004; 25:581-611; PMID:15294883; http://dx.doi.org/10.1210/er.2003-0027 180.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Cell Signal 2007; 19:2003-12;PMID:17658244; http://dx.doi.org/10.1016/j.cellsig.2007.05.013 181.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Int J Biochem Cell Biol 2001; 33:315-24; PMID:11312102;http://dx.doi.org/10.1016/S1357-2725(01)00019-X 182.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
J Biol Chem 2005; 280:9904-12;PMID:15637071; http://dx.doi.org/10.1074/jbc.M412017200 183.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
BioDrugs 2009; 23:289-304; PMID:19754219; http://dx.doi.org/10.2165/11317600-000000000-00000 184.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Int J Cancer 2002; 97:393-9; PMID:11774295; http://dx.doi.org/10.1002/ ijc.1634 186.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
2003; 278:43496-507; PMID:12917408; http://dx.doi.org/10.1074/ jbc.M307742200 187.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Biochem Biophys Res Commun 2006; 345:438-45;PMID:16682007; http://dx.doi.org/10.1016/j.bbrc.2006.04.119 188.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Drugs 2013; 73:2003-15; PMID:24277700;http://dx.doi.org/10.1007/s40265-013-0154-8 189.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
J Clin Oncol 2010; 28:780-7; PMID:20048182; http://dx.doi.org/10.1200/JCO.2009.23.7537 190.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Lancet 2014; 383:31-9; PMID:24094768; http://dx.doi.org/10.1016/S0140- 6736(13)61719-5 191.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
MAbs 2011; 3:517-27; PMID:22123065; http://dx.doi.org/10.4161/ mabs.3.6.17621 192.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Trends Microbiol 2014; 22:317-25;PMID:24684968; http://dx.doi.org/10.1016/j.tim.2014.02.012 193.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Infect Drug Resist 2014; 7:101-9; PMID:24812521; http://dx.doi.org/10.2147/IDR.S47305 195.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
MAbs 2009; 1:531-8; PMID:20068396; http://dx.doi.org/10.4161/mabs.1.6.10195 196.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Antimicrob Agents Chemother 2007; 51:2758-64; PMID:17517846; http://dx.doi.org/10.1128/AAC.01528-06197.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Curr Opin Virol 2012; 2:309-14; PMID:22503445; http://dx.doi.org/10.1016/j.coviro.2012.03.007 198.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
BMJ 2015; 350:g7827; PMID:25589091; http://dx.doi.org/ 10.1136/bmj.g7827 199.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
J Infect Dis 2006; 193:796-801; PMID:16479514; http://dx.doi.org/10.1086/500470 200.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Eur J Immunol 2005; 35:2131-45; PMID:15971273; http://dx.doi.org/10.1002/eji.200526134 201.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
J Virol 2005; 79:9062-8; PMID:15994800; http://dx.doi.org/10.1128/JVI.79.14.9062-9068.2005 202.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Vaccine 2008; 26:5922-7; PMID:18804136; http://dx.doi.org/10.1016/j.vaccine.2008.08.050 204.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Haemophilia 2010; 16:717-25;PMID:20041957; http://dx.doi.org/10.1111/j.1365-2516.2009.02160.x 205.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
Cancer Cell 2004; 6:507-16;PMID:15542434; http://dx.doi.org/10.1016/j.ccr.2004.09.030 206.,OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
J Immunol Methods 2004; 289:65-80; PMID:15251413; http://dx.doi.org/10.1016/j.jim.2004.03.014 207.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
"Proteomics Clin Appl 2016;; PMID:27198131, http://dx.doi.org/10.1002/prca.2016000021194 A. FRENZEL ET AL.",OADS,/arxiv_data1/oa_pdf/5d/e1/kmab-08-07-1212149.PMC5058633.pdf
"Primers and RT- PCR conditions can be found in the online supplement (see Table S1, Supple- mental Digital Content 1, at http://links.lww.com/SHK/A387).",Non-OADS,/arxiv_data1/oa_pdf/29/49/shk-46-566.PMC5058638.pdf
"Sample harvesting, determination of bacterial growth, and assays are described in the online supplement (see supplementary data, Supplemental Digital Content 2, at http://links.lww.com/SHK/A388).",OADS,/arxiv_data1/oa_pdf/29/49/shk-46-566.PMC5058638.pdf
"S1, Supplemental Digital Content 3, at http://links.lww.com/SHK/A389).",Non-OADS,/arxiv_data1/oa_pdf/29/49/shk-46-566.PMC5058638.pdf
"S2, Supplemental Digital Content 4, at http://links.lww.com/SHK/A390).",Non-OADS,/arxiv_data1/oa_pdf/29/49/shk-46-566.PMC5058638.pdf
"S3, Supplemental Digital Content 5, at http://links.lww.com/SHK/A391).",Non-OADS,/arxiv_data1/oa_pdf/29/49/shk-46-566.PMC5058638.pdf
Clinical Trial Registration—URL: http://pre-empt.cfri.ca/.,Non-OADS,/arxiv_data1/oa_pdf/95/29/hyp-68-1153.PMC5058640.pdf
*A list of all CHIPS Study Group participants is given in Table S1 in the online-only Data Supplement.The online-only Data Supplement is available with this article at http://hyper.ahajournals.org/lookup/suppl/doi:10.1161/HYPERTENSIONAHA.,Non-OADS,/arxiv_data1/oa_pdf/95/29/hyp-68-1153.PMC5058640.pdf
"Laura A. Magee, Peter von Dadelszen, Joel Singer, Terry Lee, Evelyne Rey, Susan Ross,   Elizabeth Asztalos, Kellie E. Murphy, Jennifer Menzies, Johanna Sanchez, Amiram Gafni,   Michael Helewa, Eileen Hutton, Gideon Koren, Shoo K. Lee, Alexander G. Logan,   Wessel Ganzevoort, Ross Welch, Jim G. Thornton, Jean-Marie Moutquin; for the CHIPS Study Group* Hypertension is available at http://hyper.ahajournals.org DOI: 10.1161/HYPERTENSIONAHA.116.07862 Clinical Trial: CHIPS",Non-OADS,/arxiv_data1/oa_pdf/95/29/hyp-68-1153.PMC5058640.pdf
"Methods In brief, CHIPS was an open pragmatic international multicenter trial  (ISRCTN 71416914, NCT01192412, http://pre-empt.cfri.ca/CHIPS)  that was approved by the Research Ethics Board at the University of British Columbia as the Coordinating Center (H08-00882) and at  all study sites.",Non-OADS,/arxiv_data1/oa_pdf/95/29/hyp-68-1153.PMC5058640.pdf
Medicine (2016) 95:27(e3826)Received: 21 September 2015 / Received in ﬁnal form: 27 April 2016 / Accepted: 10 May 2016 http://dx.doi.org/10.1097/MD.0000000000003826Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/c1/5a/medi-95-e3826.PMC5058790.pdf
Available at: https://nces.ed.gov/programs/statereform/tab5_1.asp.,OADS,/arxiv_data1/oa_pdf/c1/5a/medi-95-e3826.PMC5058790.pdf
Available at: http://www.healthypeople.gov/2020/topics-objectives/topic/cancer/objectives.,Non-OADS,/arxiv_data1/oa_pdf/c1/5a/medi-95-e3826.PMC5058790.pdf
Medicine (2016) 95:27(e3852)Received: 22 July 2015 / Received in ﬁnal form: 9 May 2016 / Accepted: 11 May 2016 http://dx.doi.org/10.1097/MD.0000000000003852Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/c9/ba/medi-95-e3852.PMC5058792.pdf
"A structured questionnaire was developed by an expert group, and trained personnel employed by a professional Korean research company conducted all interviews (http://links.lww.com/MD/B78).",OADS,/arxiv_data1/oa_pdf/c9/ba/medi-95-e3852.PMC5058792.pdf
http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/c9/ba/medi-95-e3852.PMC5058792.pdf
1997. http://laws-lois.justice.,Non-OADS,/arxiv_data1/oa_pdf/c9/ba/medi-95-e3852.PMC5058792.pdf
New Zealand: Ministry of Health Epidemiology and Toxicology Group; 2000. http://www.health.govt.nz/system/ ﬁles/documents/publications/chemicalcomponentscigarettesprior ities.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c9/ba/medi-95-e3852.PMC5058792.pdf
"INCA, Prevention and Surveillance Coordination Tobacco and Other CancerRisk Factors Control Division; 2003. http://www.inca.gov.br/english/tobacco/programstate.pdf.",Non-OADS,/arxiv_data1/oa_pdf/c9/ba/medi-95-e3852.PMC5058792.pdf
Medicine (2016) 95:27(e3854)Received: 5 November 2015 / Received in ﬁnal form: 9 May 2016 / Accepted: 12 May 2016 http://dx.doi.org/10.1097/MD.0000000000003854Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/3f/e9/medi-95-e3854.PMC5058793.pdf
http://apps.who.int/classi ﬁcations/icd10/browse/2010/en.,OADS,/arxiv_data1/oa_pdf/3f/e9/medi-95-e3854.PMC5058793.pdf
2010. http://goldcopd.org/gold-reports/.,OADS,/arxiv_data1/oa_pdf/3f/e9/medi-95-e3854.PMC5058793.pdf
2011. http://ginasthma.org/gina-reports/.,Non-OADS,/arxiv_data1/oa_pdf/3f/e9/medi-95-e3854.PMC5058793.pdf
Medicine (2016) 95:27(e3930)Received: 8 February 2016 / Received in ﬁnal form: 8 May 2016 / Accepted: 20 May 2016 http://dx.doi.org/10.1097/MD.0000000000003930Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/04/c9/medi-95-e3930.PMC5058795.pdf
"1, http://links.lww.com/MD/B82).",Non-OADS,/arxiv_data1/oa_pdf/04/c9/medi-95-e3930.PMC5058795.pdf
"2, http://links.lww.com/MD/B82).3.4.",Non-OADS,/arxiv_data1/oa_pdf/04/c9/medi-95-e3930.PMC5058795.pdf
Medicine (2016) 95:27(e3942) Received: 27 December 2015 / Received in ﬁnal form: 17 May 2016 / Accepted: 24 May 2016 http://dx.doi.org/10.1097/MD.0000000000003942Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/40/ca/medi-95-e3942.PMC5058796.pdf
"After propensity score matching to correct selection bias for surgical resection oflocally recurrent cancer, surgical treatment was associated withsigniﬁcantly better survival (Supplementary Table 1 and Figure 1, http://links.lww.com/MD/B108).",Non-OADS,/arxiv_data1/oa_pdf/40/ca/medi-95-e3942.PMC5058796.pdf
Medicine (2016) 95:27(e3952)Received: 25 November 2015 / Received in ﬁnal form: 20 May 2016 / Accepted: 24 May 2016 http://dx.doi.org/10.1097/MD.0000000000003952Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ba/52/medi-95-e3952.PMC5058797.pdf
Medicine (2016) 95:27(e3957)Received: 22 December 2015 / Received in ﬁnal form: 20 May 2016 / Accepted: 25 May 2016 http://dx.doi.org/10.1097/MD.0000000000003957Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/56/fd/medi-95-e3957.PMC5058798.pdf
Medicine (2016) 95:27(e3975)Received: 15 April 2016 / Received in ﬁnal form: 23 May 2016 / Accepted: 26 May 2016 http://dx.doi.org/10.1097/MD.0000000000003975Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/8b/36/medi-95-e3975.PMC5058801.pdf
Medicine (2016) 95:27(e3986)Received: 29 March 2016 / Received in ﬁnal form: 23 May 2016 / Accepted: 28 May 2016 http://dx.doi.org/10.1097/MD.0000000000003986Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/75/e8/medi-95-e3986.PMC5058802.pdf
"[19]If the mean and SD were not reported directly, these data were extracted from published ﬁgures using Engauge Digitizer version 4.1 (http://digitizer.sourceforge.net/) to calculate the means and SDs.",OADS,/arxiv_data1/oa_pdf/75/e8/medi-95-e3986.PMC5058802.pdf
"[20] The quality of evidence of each study was assessed (WL and JG) according to the guidelines of the GRADE Working Group(http://www.gradeworkinggroup.org/index.htm), using theGRADE pro ﬁler (version 3.6.1, http://ims.cochrane.org/rev man/gradepro) and GRADE Handbook to determine the quality of evidence and strength of recommendation.",OADS,/arxiv_data1/oa_pdf/75/e8/medi-95-e3986.PMC5058802.pdf
"The main characteristics of the included trials,including risk study quality, are summarized in online Supple- mentary Table 1, http://links.lww.com/MD/B92.",Non-OADS,/arxiv_data1/oa_pdf/75/e8/medi-95-e3986.PMC5058802.pdf
"[24]Excluding the data from this trial yielded a similar but more signi ﬁcant between-group difference (SMD =/C00.70; 95% CI: /C01.01 to /C00.39; P< 0.0001), with no signi ﬁcant heterogeneity ( x2=4.37; I2=31%; P=0.22; online Supplementary Figure 1, http://links.lww.com/ MD/B93).",OADS,/arxiv_data1/oa_pdf/75/e8/medi-95-e3986.PMC5058802.pdf
"However, we found no signi ﬁcant difference in blood albumin, C- reactive protein, interleukin 6 level, forced expiratory volume in 1second, and forced vital capacity (see online Supplementary Table 2, http://links.lww.com/MD/B92).",Non-OADS,/arxiv_data1/oa_pdf/75/e8/medi-95-e3986.PMC5058802.pdf
"Further, existing meta-analyses includedmixed RCTs and non-RCTs publications (online Supplementary Table 3a,3b, http://links.lww.com/MD/B92).",OADS,/arxiv_data1/oa_pdf/75/e8/medi-95-e3986.PMC5058802.pdf
Medicine (2016) 95:27(e3987)Received: 24 February 2016 / Received in ﬁnal form: 18 May 2016 / Accepted: 29 May 2016 http://dx.doi.org/10.1097/MD.0000000000003987Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/1c/dd/medi-95-e3987.PMC5058803.pdf
Medicine (2016) 95:27(e3992)Received: 11 January 2016 / Received in ﬁnal form: 21 May 2016 / Accepted: 28 May 2016 http://dx.doi.org/10.1097/MD.0000000000003992Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/27/dc/medi-95-e3992.PMC5058804.pdf
Medicine (2016) 95:27(e4001)Received: 13 March 2016 / Received in ﬁnal form: 2 May 2016 / Accepted: 1 June 2016 http://dx.doi.org/10.1097/MD.0000000000004001Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/87/6b/medi-95-e4001.PMC5058805.pdf
"WHO,UNAIDS, UNICEF 2011. http://www.who.int/hiv/pub/progress_report2011/en/index.html (accessed August 21, 2014).",Non-OADS,/arxiv_data1/oa_pdf/87/6b/medi-95-e4001.PMC5058805.pdf
Medicine (2016) 95:27(e4005)Received: 11 March 2016 / Received in ﬁnal form: 13 May 2016 / Accepted: 27 May 2016 http://dx.doi.org/10.1097/MD.0000000000004005Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/98/19/medi-95-e4005.PMC5058806.pdf
"1, http://links.lww.com/MD/B99).",Non-OADS,/arxiv_data1/oa_pdf/98/19/medi-95-e4005.PMC5058806.pdf
"Furthermore, the levels of EBV DNA within the former group were signi ﬁcantly higher (median: 2.54 log 10copies/mL; IQR: 2.02 –4.10) than in the latter group (median: 2.12 log 10copies/mL; IQR: 1.50 –2.81; P=0.01; Supplementary Figure 2A, http://links.lww.com/MD/B99).",Non-OADS,/arxiv_data1/oa_pdf/98/19/medi-95-e4005.PMC5058806.pdf
"Within this group, 12 of 15 mothers presented with ahigher EBV DNA load (median: 2.36 log 10copies/mL; IQR: 1.91 –3.07) in the breast milk samples with higher human cell-free DNA as compared with contralateral breast milk samples(median: 1.03 log 10copies/mL; IQR: 0.0 –2.42; P=0.012; Supplementary Figure 2B, http://links.lww.com/MD/B99).",Non-OADS,/arxiv_data1/oa_pdf/98/19/medi-95-e4005.PMC5058806.pdf
http://www.who.int/hiv/pub/guidelines/arv2013/download/en/.,Non-OADS,/arxiv_data1/oa_pdf/98/19/medi-95-e4005.PMC5058806.pdf
Medicine (2016) 95:27(e4007)Received: 7 December 2015 / Received in ﬁnal form: 28 April 2016 / Accepted: 31 May 2016 http://dx.doi.org/10.1097/MD.0000000000004007Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/0f/86/medi-95-e4007.PMC5058807.pdf
"1, Supplemental Content, http://links.lww.com/MD/B102).",Non-OADS,/arxiv_data1/oa_pdf/0f/86/medi-95-e4007.PMC5058807.pdf
"In the Table 4, Supplemental Content, http://links.lww.com/ MD/B102, we have reported the baseline clinical features of 2175 (8.1%) patients who develop a reduction of eGFR >30% from baseline value.",Non-OADS,/arxiv_data1/oa_pdf/0f/86/medi-95-e4007.PMC5058807.pdf
"2 and Table 5, Supplemental Content, http://links.lww.com/MD/B102).",Non-OADS,/arxiv_data1/oa_pdf/0f/86/medi-95-e4007.PMC5058807.pdf
"3 and Table 6, Supplemental Content, http://links.lww.com/MD/B102).",Non-OADS,/arxiv_data1/oa_pdf/0f/86/medi-95-e4007.PMC5058807.pdf
"6th ed.2013;Brussels, Belgium:International Diabetes Federation, http://www.idf.org/diabetesatlashttp://www.idf.org/diabete satlas.",Non-OADS,/arxiv_data1/oa_pdf/0f/86/medi-95-e4007.PMC5058807.pdf
Available at: http://www.usrds.org/adr.,Non-OADS,/arxiv_data1/oa_pdf/0f/86/medi-95-e4007.PMC5058807.pdf
Medicine (2016) 95:27(e4012)Received: 7 March 2016 / Received in ﬁnal form: 12 May 2016 / Accepted: 28 May 2016 http://dx.doi.org/10.1097/MD.0000000000004012Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/2b/cc/medi-95-e4012.PMC5058810.pdf
2014; http://www.cdc.gov/cancer/cervical/statistics/screening.htm.,Non-OADS,/arxiv_data1/oa_pdf/2b/cc/medi-95-e4012.PMC5058810.pdf
2014; http://www.va.gov/oig/pubs/VAOIG-14–02198 –284.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2b/cc/medi-95-e4012.PMC5058810.pdf
Medicine (2016) 95:27(e4018)Received: 9 December 2015 / Received in ﬁnal form: 26 May 2016 / Accepted: 1 June 2016 http://dx.doi.org/10.1097/MD.0000000000004018Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/35/b0/medi-95-e4018.PMC5058811.pdf
"Antidiabetic drugs dispensed in the pharmacy during the study period in Korea consisted of seven classes (i.e., SU, biguanide,alpha-glucosidase inhibitor, TZD, DPP-4 inhibitors, meglitinide, and insulin; Supplement Table S1, http://links.lww.com/MD/ B80).",Non-OADS,/arxiv_data1/oa_pdf/35/b0/medi-95-e4018.PMC5058811.pdf
"2, Supplementary Table S3, http://links.lww.com/MD/B80).",Non-OADS,/arxiv_data1/oa_pdf/35/b0/medi-95-e4018.PMC5058811.pdf
Available from: http://kostat.go.kr/portal/korea/ index.action.,Non-OADS,/arxiv_data1/oa_pdf/35/b0/medi-95-e4018.PMC5058811.pdf
Available at: http://www.mhlw.go.jp/bunya/kenkou/dl/kenkounippon21_02.pdf.,Non-OADS,/arxiv_data1/oa_pdf/35/b0/medi-95-e4018.PMC5058811.pdf
Medicine (2016) 95:27(e4030)Received: 3 November 2015 / Received in ﬁnal form: 20 May 2016 / Accepted: 24 May 2016 http://dx.doi.org/10.1097/MD.0000000000004030Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/15/28/medi-95-e4030.PMC5058815.pdf
"The detailed characteristics ofthe genotype distributions in case and control groups in this meta- analysis are presented in the Table 1 and Supplemental Table 1, http://links.lww.com/MD/B89.",OADS,/arxiv_data1/oa_pdf/15/28/medi-95-e4030.PMC5058815.pdf
"1, http://links.lww.com/MD/B89).",Non-OADS,/arxiv_data1/oa_pdf/15/28/medi-95-e4030.PMC5058815.pdf
Medicine (2016) 95:27(e4051)Received: 20 October 2015 / Received in ﬁnal form: 4 May 2016 / Accepted: 2 June 2016 http://dx.doi.org/10.1097/MD.0000000000004051Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/da/0a/medi-95-e4051.PMC5058816.pdf
"[18] http://www.gdwst.gov.cn/a/yiqingxx/2014121512665.html, accessed Feb 29th, 2016.",Non-OADS,/arxiv_data1/oa_pdf/da/0a/medi-95-e4051.PMC5058816.pdf
Medicine (2016) 95:27(e4052)Received: 1 December 2015 / Received in ﬁnal form: 13 May 2016 / Accepted: 2 June 2016 http://dx.doi.org/10.1097/MD.0000000000004052Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/31/4d/medi-95-e4052.PMC5058817.pdf
"Discussion Although SRCC has long been regarded as an adverse prognostic factor of gastric cancer, the ﬁndings of existing studies on this issue are inconsistent (see Appendix 1 in the “Supplementary Appendix 1.docx, ”http://links.lww.com/MD/B94).",Non-OADS,/arxiv_data1/oa_pdf/31/4d/medi-95-e4052.PMC5058817.pdf
2015. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.,Non-OADS,/arxiv_data1/oa_pdf/31/4d/medi-95-e4052.PMC5058817.pdf
Medicine (2016) 95:27(e4054)Received: 20 November 2015 / Received in ﬁnal form: 14 May 2016 / Accepted: 2 June 2016 http://dx.doi.org/10.1097/MD.0000000000004054 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/9f/b7/medi-95-e4054.PMC5058818.pdf
Medicine (2016) 95:27(e4066)Received: 14 January 2016 / Received in ﬁnal form: 29 May 2016 / Accepted: 3 June 2016 http://dx.doi.org/10.1097/MD.0000000000004066Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/d9/3e/medi-95-e4066.PMC5058821.pdf
"Genetic analyses of localized prostate cancer The relative frequencies of the SNPs in patients and their corresponding HRs (95% CI) are shown in Table 2 and Supplementary Table S1, http://links.lww.com/MD/B109.",Non-OADS,/arxiv_data1/oa_pdf/d9/3e/medi-95-e4066.PMC5058821.pdf
Medicine (2016) 95:27(e4077)Received: 21 March 2016 / Received in ﬁnal form: 7 June 2016 / Accepted: 7 June 2016 http://dx.doi.org/10.1097/MD.0000000000004077Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/4e/65/medi-95-e4077.PMC5058824.pdf
German procedure classi ﬁcation OPS [Internet] abailable from http://www.dimdi.,Non-OADS,/arxiv_data1/oa_pdf/4e/65/medi-95-e4077.PMC5058824.pdf
Medicine (2016) 95:27(e4083)Received: 7 April 2016 / Received in ﬁnal form: 15 May 2016 / Accepted: 6 June 2016 http://dx.doi.org/10.1097/MD.0000000000004083Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/57/3e/medi-95-e4083.PMC5058826.pdf
Resulting statistical FC maps were thresholded at P<0.05 (combined threshold of P<0.05) by using the AlphaSim program in the REST software (http://resting-fmri.sourceforge.net).,OADS,/arxiv_data1/oa_pdf/57/3e/medi-95-e4083.PMC5058826.pdf
Medicine (2016) 95:27(e4086)Received: 1 February 2016 / Received in ﬁnal form: 1 June 2016 / Accepted: 6 June 2016 http://dx.doi.org/10.1097/MD.0000000000004086Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/2f/b4/medi-95-e4086.PMC5058829.pdf
Medicine (2016) 95:27(e4089)Received: 3 August 2015 / Received in ﬁnal form: 7 June 2016 / Accepted: 7 June 2016 http://dx.doi.org/10.1097/MD.0000000000004089Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/24/9d/medi-95-e4089.PMC5058831.pdf
"Furthermore, this compulsory single- payer healthcare system covers more than 99% of the 23 million Taiwan residents and has contracts with >97% of medical care facilities nationwide (http://www.nhi.gov.tw/english/index.",Non-OADS,/arxiv_data1/oa_pdf/24/9d/medi-95-e4089.PMC5058831.pdf
"The National Health Research Institutes (NHRI) (http://nhird.nhri.org.tw) is in charge of maintaining the data security obtained from the NHIRD (http://w3.nhri.org.tw/nhird//date_01.html) and all data were deposited in a public repository.Each encrypted patient ’s unique personal identi ﬁcation number was crossly linked in the datasets of NHIRD to obtain each patient ’s longitudinal medical history, and the researchers can access the database after approval for research purpose.",OADS,/arxiv_data1/oa_pdf/24/9d/medi-95-e4089.PMC5058831.pdf
"Taiwan, http://nhird.nhri.org.tw/en/ (cited 2015).",Non-OADS,/arxiv_data1/oa_pdf/24/9d/medi-95-e4089.PMC5058831.pdf
Medicine (2016) 95:27(e4098)Received: 2 April 2016 / Received in ﬁnal form: 25 May 2016 / Accepted: 9 June 2016 http://dx.doi.org/10.1097/MD.0000000000004098Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/11/e9/medi-95-e4098.PMC5058834.pdf
"Washington, DC:National Academies Press (US); 2009;http://www.ncbi.nlm.nih.gov/books/NBK32813/http://www.ncbi.nlm.nih.gov/books/NBK32813/.",Non-OADS,/arxiv_data1/oa_pdf/11/e9/medi-95-e4098.PMC5058834.pdf
http://www.euro.who.int/__data/assets/pdf_ ﬁle/0014/243320/Roma nia- WHO-Country-Pro ﬁle.pdf?ua=1.,OADS,/arxiv_data1/oa_pdf/11/e9/medi-95-e4098.PMC5058834.pdf
Medicine (2016) 95:27(e4099) Received: 14 April 2016 / Received in ﬁnal form: 24 May 2016 / Accepted: 7 June 2016 http://dx.doi.org/10.1097/MD.0000000000004099Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/38/45/medi-95-e4099.PMC5058835.pdf
"Data collection Data on hospital and ICU infrastructure and resources, and patient data were collected using a standardized case record form(CRF; see Supplementary information, http://links.lww.com/MD/B128).",OADS,/arxiv_data1/oa_pdf/38/45/medi-95-e4099.PMC5058835.pdf
Medicine (2016) 95:27(e4100)Received: 18 January 2016 / Received in ﬁnal form: 4 June 2016 / Accepted: 9 June 2016 http://dx.doi.org/10.1097/MD.0000000000004100Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/89/29/medi-95-e4100.PMC5058836.pdf
Disponível em: <http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/89/29/medi-95-e4100.PMC5058836.pdf
ISSN 1344- 4964.Disponívelem: <http://www.ncbi.nlm.nih.gov/pubmed/14529160 >.,Non-OADS,/arxiv_data1/oa_pdf/89/29/medi-95-e4100.PMC5058836.pdf
Disponível em: <http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/89/29/medi-95-e4100.PMC5058836.pdf
Disponível em:<http://www.ncbi.nlm.nih.gov/pubmed/2665534 >.,Non-OADS,/arxiv_data1/oa_pdf/89/29/medi-95-e4100.PMC5058836.pdf
Disponível em: <http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/89/29/medi-95-e4100.PMC5058836.pdf
Disponível em: <http://www.ncbi.nlm.nih.gov/pubmed/ 11899221 >.,Non-OADS,/arxiv_data1/oa_pdf/89/29/medi-95-e4100.PMC5058836.pdf
Disponível em: <http://www.ncbi.nlm.nih.gov/ pubmed/25366271 >.,Non-OADS,/arxiv_data1/oa_pdf/89/29/medi-95-e4100.PMC5058836.pdf
Disponível em: <http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/89/29/medi-95-e4100.PMC5058836.pdf
Medicine (2016) 95:27(e4105)Received: 31 March 2016 / Received in ﬁnal form: 4 June 2016 / Accepted: 8 June 2016 http://dx.doi.org/10.1097/MD.0000000000004105Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ab/0d/medi-95-e4105.PMC5058840.pdf
"Primers and probes are presented in Supplementary Table 1, http://links.lww.com/MD/B104.",OADS,/arxiv_data1/oa_pdf/ab/0d/medi-95-e4105.PMC5058840.pdf
"The distribution of genotype frequency wassimilar across ischemic and nonischemic heart failure and differed signiﬁcantly from the controls (Table 3 and Supplementary Tables 2 and 3, http://links.lww.com/MD/B104).",Non-OADS,/arxiv_data1/oa_pdf/ab/0d/medi-95-e4105.PMC5058840.pdf
"No signi ﬁcant differences were noted between the investigated SNPs and all-cause mortality (Supplementary Figure 1, http://links.lww.com/MD/B104).",Non-OADS,/arxiv_data1/oa_pdf/ab/0d/medi-95-e4105.PMC5058840.pdf
"However, no signi ﬁcant association was detected in rehospitalization for heart failure for any of the SNPs tested, except that rs4819554 exhibited a modest trend toward higher rate of hospitalization for heart failure(Supplementary Table 4, http://links.lww.com/MD/B104).",Non-OADS,/arxiv_data1/oa_pdf/ab/0d/medi-95-e4105.PMC5058840.pdf
"Plasma IL- 17A levels did not differ between three genotypes of rs2275913(Supplementary Figure 2, http://links.lww.com/MD/B104).",Non-OADS,/arxiv_data1/oa_pdf/ab/0d/medi-95-e4105.PMC5058840.pdf
Medicine (2016) 95:27(e4106)Received: 6 May 2016 / Received in ﬁnal form: 1 June 2016 / Accepted: 8 June 2016 http://dx.doi.org/10.1097/MD.0000000000004106Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/b0/28/medi-95-e4106.PMC5058841.pdf
Medicine (2016) 95:27(e4109)Received: 13 October 2015 / Received in ﬁnal form: 7 May 2016 / Accepted: 9 June 2016 http://dx.doi.org/10.1097/MD.0000000000004109Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ec/89/medi-95-e4109.PMC5058842.pdf
"The mainstay of survival analysiswas the Cox proportional hazards model using R 3.0.1 (Vienna, Austria; http://www.R-project.org/) and Pvalue<0.05 was deemed statistically signi ﬁcant.",OADS,/arxiv_data1/oa_pdf/ec/89/medi-95-e4109.PMC5058842.pdf
"To do downstream analyses, including segmentation and calculation of the copy number for each gene, we used the ngCGH python package (version 0.4.4, http://github.com/seandavi/ngCGH), which is a tool for producing aCGH-like of next-generation sequencing data.",OADS,/arxiv_data1/oa_pdf/ec/89/medi-95-e4109.PMC5058842.pdf
"Other clinical parameters such as age, performance status, and extent of resection were not signi ﬁcantly different between the groups (Table 1) (S1 Fig., http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/ec/89/medi-95-e4109.PMC5058842.pdf
"[17]By importing the complete list of upregulated genes in LMD or non-LMD into the KEGGpathway and GO categories, we found that highly expressed genes in the LMD group were related to membrane part such as“anchored to plasma membrane (GO:0046658) ”and “HSA04360_AXON_GUIDANCE ”(Supplemental Table 1A, http://links.lww.com/MD/B86).",OADS,/arxiv_data1/oa_pdf/ec/89/medi-95-e4109.PMC5058842.pdf
"We mapped the above-mentioned reference genes onto the 5molecular subgroups de ﬁned by the TCGA network in non-LMD group (S2 Fig., http://links.lww.com/MD/B86).",OADS,/arxiv_data1/oa_pdf/ec/89/medi-95-e4109.PMC5058842.pdf
Medicine (2016) 95:27(e4113)Received: 10 December 2015 / Received in ﬁnal form: 4 January 2016 / Accepted: 10 June 2016 http://dx.doi.org/10.1097/MD.0000000000004113Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ae/b6/medi-95-e4113.PMC5058843.pdf
Medicine (2016) 95:27(e4115)Received: 5 April 2016 / Received in ﬁnal form: 6 June 2016 / Accepted: 10 June 2016 http://dx.doi.org/10.1097/MD.0000000000004115Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/10/3e/medi-95-e4115.PMC5058845.pdf
Available from: http://www.nhi.gov.tw/webdata/webdata.aspx?menu= 17&menu_id= 659&webdata_id=3513&WD_ID=664.,OADS,/arxiv_data1/oa_pdf/10/3e/medi-95-e4115.PMC5058845.pdf
Available from: http://www.nhi.gov.tw/webdata/webdata.aspx?menu=Yeh et al.,OADS,/arxiv_data1/oa_pdf/10/3e/medi-95-e4115.PMC5058845.pdf
Available from: http://www.hpa.gov.tw/Bhpnet/Web/HealthTopic/Topic.aspx?id=20071225003020.,Non-OADS,/arxiv_data1/oa_pdf/10/3e/medi-95-e4115.PMC5058845.pdf
Available from: https://www.cms.gov/medicare-coverage-database/stat icpages/icd-9-code-lookup.aspx.,OADS,/arxiv_data1/oa_pdf/10/3e/medi-95-e4115.PMC5058845.pdf
Medicine (2016) 95:27(e4122)Received: 13 March 2016 / Received in ﬁnal form: 21 May 2016 / Accepted: 25 May 2016 http://dx.doi.org/10.1097/MD.0000000000004122Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/b6/90/medi-95-e4122.PMC5058850.pdf
"Data extraction Data were extracted with a collection form designed by 2 investigators independently (See Collection Form, Supplemental Collection Form, http://links.lww.com/MD/B103).",OADS,/arxiv_data1/oa_pdf/b6/90/medi-95-e4122.PMC5058850.pdf
Medicine (2016) 95:27(e4127)Received: 2 March 2016 / Received in ﬁnal form: 9 June 2016 / Accepted: 10 June 2016 http://dx.doi.org/10.1097/MD.0000000000004127Quality Improvement Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/1a/df/medi-95-e4127.PMC5058852.pdf
Medicine (2016) 95:27(e4141)Received: 20 February 2016 / Received in ﬁnal form: 10 June 2016 / Accepted: 13 June 2016 http://dx.doi.org/10.1097/MD.0000000000004141Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/6a/c3/medi-95-e4141.PMC5058859.pdf
Medicine (2016) 95:27(e4153)Received: 25 April 2016 / Received in ﬁnal form: 7 June 2016 / Accepted: 13 June 2016 http://dx.doi.org/10.1097/MD.0000000000004153Diagnostic Accuracy Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ba/b2/medi-95-e4153.PMC5058863.pdf
Medicine (2016) 95:27(e4164)Received: 18 November 2015 / Received in ﬁnal form: 4 June 2016 / Accepted: 15 June 2016 http://dx.doi.org/10.1097/MD.0000000000004164Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/d8/c3/medi-95-e4164.PMC5058866.pdf
Medicine (2016) 95:27(e4168)Received: 9 May 2016 / Received in ﬁnal form: 10 June 2016 / Accepted: 14 June 2016 http://dx.doi.org/10.1097/MD.0000000000004168Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/12/c5/medi-95-e4168.PMC5058867.pdf
Medicine (2016) 95:27(e4170)Received: 22 March 2016 / Received in ﬁnal form: 4 May 2016 / Accepted: 3 June 2016 http://dx.doi.org/10.1097/MD.0000000000004170Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/4b/9d/medi-95-e4170.PMC5058868.pdf
"Thephantom study procedure and data are described elsewhere [4] and in the supplemental material (see Text, SupplementalContent, which describes the phantom study procedure, http://links.lww.com/MD/B111).",Non-OADS,/arxiv_data1/oa_pdf/4b/9d/medi-95-e4170.PMC5058868.pdf
"S1, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/4b/9d/medi-95-e4170.PMC5058868.pdf
"S2, http://links.lww.com/MD/B111, which demonstrates theTUS and the SPECT/CT).",Non-OADS,/arxiv_data1/oa_pdf/4b/9d/medi-95-e4170.PMC5058868.pdf
"S2, http://links.lww.com/MD/ B111).",Non-OADS,/arxiv_data1/oa_pdf/4b/9d/medi-95-e4170.PMC5058868.pdf
Medicine (2016) 95:27(e4197)Received: 21 December 2015 / Received in ﬁnal form: 17 June 2016 / Accepted: 17 June 2016 http://dx.doi.org/10.1097/MD.0000000000004197Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/e9/6c/medi-95-e4197.PMC5058873.pdf
"In each visit, implemented structured care is clearlydeﬁned in initial enrollment visit, continuing care visits, and annual evaluation visit, respectively (Tables 1-1, 1-2 and 1-3 in the Supplementary Appendix, http://links.lww.com/MD/B125).",Non-OADS,/arxiv_data1/oa_pdf/e9/6c/medi-95-e4197.PMC5058873.pdf
"Both fees are included in the New Taiwan Dollar (NTD) 1845, (NTD 32.1 =USD 1.0 in 2009) for initial enrollment visit (Supplementary Appendix:Table 1-1: package P1401C, http://links.lww.com/MD/B125), NTD 875 for continuing care visit (Table 1-2: package P1402C, http://links.lww.com/MD/B125), and NTD 2245 for annualevaluation visit (Table 1-3: package P1403C, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/e9/6c/medi-95-e4197.PMC5058873.pdf
"The CDE physician who ranks in the top 25percentile ofallthe candidates will be rewarded by annual incentive (please see Supplementary Appendix, http://links.lww.com/MD/ B125).",Non-OADS,/arxiv_data1/oa_pdf/e9/6c/medi-95-e4197.PMC5058873.pdf
"Introduction to the National Health Insurance Research Database (NHIRD), Taiwan Secondary Introduction to the NationalHealth Insurance Research Database (NHIRD), Taiwan; 2013. http://nhird.nhri.org.tw/en/index.html.Chen et al.",Non-OADS,/arxiv_data1/oa_pdf/e9/6c/medi-95-e4197.PMC5058873.pdf
Secondary Diabetes health educator certi ﬁcation Scheme; 2011. https://www.tade.org.tw/en/.,Non-OADS,/arxiv_data1/oa_pdf/e9/6c/medi-95-e4197.PMC5058873.pdf
"2001 [in Chinese] http://www.nhi.gov.tw/Resource/webdata/19248_2_%E7%B3%96%E5%B0%BF%E7%97%85%E9%86%AB%E7%99%82%E7%B5%A6%E4%BB%98%E6%94%B9%E5% 96%84%E6%96%B9%E6%A1%88.pdf (accessed January 1, 2001).",Non-OADS,/arxiv_data1/oa_pdf/e9/6c/medi-95-e4197.PMC5058873.pdf
2010. http://www.cdc.gov/nchs/nhanes/nhanes2005–2006/VID_D.htm.,OADS,/arxiv_data1/oa_pdf/cb/e8/medi-94-e1799.PMC5058880.pdf
http://www.pnlg.it/en_method.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/medi-94-e2045.PMC5058886.pdf
Available at: http://www.sign.ac.uk/.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/medi-94-e2045.PMC5058886.pdf
"It was demonstrated inSupplementary Table 1, http://links.lww.com/MD/A567 that all the 14 items were replied in each included article.",Non-OADS,/arxiv_data1/oa_pdf/e2/fd/medi-94-e2123.PMC5058891.pdf
http://links.lww.com/MD/A566).,Non-OADS,/arxiv_data1/oa_pdf/e2/fd/medi-94-e2123.PMC5058891.pdf
"The pooled results for sensitivity, specificity, LRP, and LRN were 0.76, 0.86, 3.85, and 0.34, respectively (Supple-mentary Figure 3, http://links.lww.com/MD/A566).",OADS,/arxiv_data1/oa_pdf/e2/fd/medi-94-e2123.PMC5058891.pdf
"The AUC was 0.89 (95% CI ¼0.80–0.91) which indicated the circulating miR-21 may have the adequate power either to confirm or toexclude cancer (Supplementary Figure 4, http://links.lww.com/MD/A566).",Non-OADS,/arxiv_data1/oa_pdf/e2/fd/medi-94-e2123.PMC5058891.pdf
"This system awards a scoreof 0–2 points for each of 12 items according to whether the item was reported or not and whether it was treated adequately or not (see Supplemental Table, Supplemental Content, http://links.lww.com/MD/A557, which provides a detailed descrip-tion of the Jadad and Minors scales).",Non-OADS,/arxiv_data1/oa_pdf/88/04/medi-94-e2126.PMC5058892.pdf
"(Supplemental Table 1, http://links.lww.com/MD/A561).",Non-OADS,/arxiv_data1/oa_pdf/e2/44/medi-94-e2127.PMC5058893.pdf
"To date, more than 200SLC26A4 mutations have been identified in patients with non- syndromic EVA or PS (http://www.healthcare.uiowa.edu/labs/ pendredandbor), including missense, frame-shift, splice-site,nonsense, and small-deletion mutations.",Non-OADS,/arxiv_data1/oa_pdf/3c/e8/medi-94-e2248.PMC5058913.pdf
"30 Score35 were considered to be of high quality (Table S1, http://links.lww.com/MD/A555).",Non-OADS,/arxiv_data1/oa_pdf/3c/e8/medi-94-e2248.PMC5058913.pdf
"Of the studies, 272 SLC26A4 variations were found in deafness with EVA (Table S2, http://links.lww.com/MD/A556).",Non-OADS,/arxiv_data1/oa_pdf/3c/e8/medi-94-e2248.PMC5058913.pdf
"The Distribution of Different SLC26A4 Mutations in the Multiethnic This study, 26 kinds of mutations, at the top of 10% mutation rate (Table S2, http://links.lww.com/MD/A556), in SLC26A4 were gathered by 24 studies on the EVA patients (Fig.",OADS,/arxiv_data1/oa_pdf/3c/e8/medi-94-e2248.PMC5058913.pdf
"http://www.ohri.ca/programs/clinical-epidemiol-ogy/oxford.htm (cited October 19, 2009).31.",Non-OADS,/arxiv_data1/oa_pdf/3c/e8/medi-94-e2248.PMC5058913.pdf
Available from: http://www.cochrane-hand-book.org.,Non-OADS,/arxiv_data1/oa_pdf/40/46/medi-94-e2254.PMC5058915.pdf
"R Foundation for Statistical Computing, Vienna, Austria2014 Available at: http://www.R-project.org/ 15.",Non-OADS,/arxiv_data1/oa_pdf/8e/3a/medi-94-e2258.PMC5058918.pdf
Available at: http://www.nccn.org/professionals/physician_gls/pdf/colon.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1c/f5/medi-94-e2260.PMC5058919.pdf
Available at: http://www.nccn.org/professionals/physician_gls/pdf/rectal.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1c/f5/medi-94-e2260.PMC5058919.pdf
"Taiwan, http://nhird.nhri.org.tw/en/index.html.",Non-OADS,/arxiv_data1/oa_pdf/e5/19/medi-94-e2276.PMC5058925.pdf
Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.,Non-OADS,/arxiv_data1/oa_pdf/38/32/medi-94-e2281.PMC5058928.pdf
"METHODS Data Source The National Health Insuran ce (NHI) program, launched by the Taiwan government in 1995, provides comprehensive health care coverage for 99% of the residents in Taiwan(registered in NHIRD, Taiwan; http://nhird.nhri.org.tw/en/ Background.html).",OADS,/arxiv_data1/oa_pdf/e2/53/medi-94-e2284.PMC5058929.pdf
"Compared with relatively soft tumors, relatively hard tumors (Supplemental Figure 1, http://links.lww.com/MD/A562) had significant correlationswith the frequency of axillary lymph node metastasis (hard tumors: 40.5% vs soft tumors: 24.3%, P<0.0001 in univariate logistic regression model), large tumor size (hard tumors:57.1% vs soft tumors: 46.2% of larger tumor occupancy,P¼0.0141 in univariate logistic regression model), and high body mass index (BMI) index of patients (hard tumors: 9.1% vs soft tumors: 4.4% of BMI /C2130,P¼0.0323 in univariate logistic regression model).",Non-OADS,/arxiv_data1/oa_pdf/87/54/medi-94-e2290.PMC5058935.pdf
"In the subgroup ofpatients with histologically IDC who underwent primary surgery,independent factors influencing tumor stiffness were lymph node metastasis (OR: 1.80, 95% CI: 1.02–3.24, P¼0.0426) and tumor size (OR: 1.81, 95% CI: 1.10–2.99, P¼0.0184; Supplemental Table 1, http://links.lww.com/MD/A562).",Non-OADS,/arxiv_data1/oa_pdf/87/54/medi-94-e2290.PMC5058935.pdf
"In contrast, multivariate analysis of factors influencing axillary lymph node involvement indicated clinical tumor stiff- ness (OR: 2.07, 95% CI: 1.37–3.15, P¼0.0005), tumor size (OR: 3.51, 95% CI: 2.30–5.42, P/C200.0001), and Ki67 labeling index (OR: 2.17, 95% CI: 1.43–3.30, P¼0.0003) as indepen- dent predictors (Supplemental Table 2, http://links.lww.com/ MD/A562).",Non-OADS,/arxiv_data1/oa_pdf/87/54/medi-94-e2290.PMC5058935.pdf
"Focusing on nodal staging, there were significant differ- ences in percentages of pathological lymph node stage (pN)according to clinical tumor stiffness (pN0: 150/503, 29.8%; pN1: 75/503, 14.9%; pN2: 19/503, 3.8%; and pN3: 8/503, 1.6% in hard tumors vs pN0: 190/503, 37.8%; pN1: 45/503, 9.0%;pN2: 10/503, 2.0%; and pN3: 6/503, 1.2% in soft tumors;P¼0.0016; Supplemental Figure 2A, http://links.lww.com/ MD/A562).",Non-OADS,/arxiv_data1/oa_pdf/87/54/medi-94-e2290.PMC5058935.pdf
"In addition, Strain Ratio as a continuous variable was also significant with respect to each pN stage (median valueof 7.0 in pN0, 13.18 in pN1, 13.89 in pN2, and 16.43 in pN3;P¼0.0015; Supplemental Figure 2B, http://links.lww.com/ MD/A562).",OADS,/arxiv_data1/oa_pdf/87/54/medi-94-e2290.PMC5058935.pdf
"Multi- variate logistic regression model of factors influencing clinicaltumor stiffness in the GEA group indicated LOX mRNA expression (OR: 3.48, 95% CI: 1.74–7.24, P¼0.0004), and body mass index (OR: 2.29, 95% CI: 1.09–4.99, P¼0.0290) as independent factors (Supplemental Table 4, http://links.lww.-com/MD/A562).",Non-OADS,/arxiv_data1/oa_pdf/87/54/medi-94-e2290.PMC5058935.pdf
"Cytotoxicagents, bortezomib, thalidomide or lenalidomide, and bispho- sphonates were not independent predictors of early mortality (Supplemental Table 1, http://links.lww.com/MD/A568).",Non-OADS,/arxiv_data1/oa_pdf/81/de/medi-94-e2305.PMC5058940.pdf
"Being male (adjusted OR 4.49, 95% CI 1.17–17.28) and LDH /C21250 U/L (adjusted OR 3.83, 95% CI 1.52–9.62) remained significant predictors for 30-day mortalityin the multivariate analysis (Supplemental Table 2, http://links.lww.com/MD/A568).",Non-OADS,/arxiv_data1/oa_pdf/81/de/medi-94-e2305.PMC5058940.pdf
"Scoliosis Research Society, SRS Terminology Committee and Work- ing Group on Spinal Classification Revised Glossary of Terms,Working Group on 3-D Classification (Chair Larry Lenke, MD),and the Terminology Committee, March 2000. http://www.srs.org/professionals/resources/sagittal_plane_white_paper.pdf [Access May12, 2011] 17.",Non-OADS,/arxiv_data1/oa_pdf/68/da/medi-94-e1841.PMC5058949.pdf
"Appendix shows the detailed search strategies, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/c0/c5/medi-94-e1893.PMC5058954.pdf
Available at: http://www.atlasbrasil.org.br/2013.,Non-OADS,/arxiv_data1/oa_pdf/7d/19/medi-94-e1924.PMC5058957.pdf
Available at: http://bvsms.saude.gov.br/bvs/publicacoes/abcad17.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7d/19/medi-94-e1924.PMC5058957.pdf
Available at: http://www.R-project.org.,Non-OADS,/arxiv_data1/oa_pdf/7d/19/medi-94-e1924.PMC5058957.pdf
"The International Classification of Diseases codeversion 9 (ICD-9) codes for the diseases are listed in theAppendix, http://links.lww.com/MD/A517.",Non-OADS,/arxiv_data1/oa_pdf/6a/0b/medi-94-e1960.PMC5058959.pdf
"The inclusion/ exclusion of patients was shown in supplementary Figure, http://links.lww.com/MD/A517.",Non-OADS,/arxiv_data1/oa_pdf/6a/0b/medi-94-e1960.PMC5058959.pdf
"2014. http://www.who.int/mediacentre/factsheets/fs310/en/Updated MayAccessed May, 2015 2.",Non-OADS,/arxiv_data1/oa_pdf/22/57/medi-94-e1980.PMC5058961.pdf
"Population and Housing Census 1991, 1991. http://www.ine.es/jaxi/ menu.do?type ¼pcaxis&path ¼%2Ft20%2Fe243&file ¼inebase&L ¼0\ Updated January, 1991.",OADS,/arxiv_data1/oa_pdf/22/57/medi-94-e1980.PMC5058961.pdf
"SNP Selection and Genotyping Single nucleotide polymorphisms in IL-1A, IL-1R1, IL-1RN, IL-1F5, and IL-18RA were selected based on Chinese population data in the HapMap database (http://www.hapma-p.org), then we used Haploview software, bioinformatics soft-ware packages such as TargetScan Human 6.2 (http:// www.targetscan.org/), miRanda (http://microrna.org/), and Patrocles (http://www.patrocles.org/) to select SNPs of themicroRNA-binding sites in 3 0UTR region of these genes.",OADS,/arxiv_data1/oa_pdf/67/51/medi-94-e1982.PMC5058962.pdf
Online SHEsis (http://analysis.bio- x.cn/myAnalysis.php) was app lied for haplotype prediction and analysis.,OADS,/arxiv_data1/oa_pdf/67/51/medi-94-e1982.PMC5058962.pdf
"IL-1F5 Might Be the Target Gene of miR-197 by Bioinformatics Prediction The present study found rs2472188 SNP in IL-1F5 might have an association with GC; by further forecast analysis through MirSNP (http://cmbi.bjmu.edu.cn/mirsnp)23and miR- NASNP (http://www.bioguo.org/miRNASNP)22software, it was found that rs2472188 in IL-1F5 might exist the target binding site with miR-197 ( DDG¼6.33 kJ/mol).",OADS,/arxiv_data1/oa_pdf/67/51/medi-94-e1982.PMC5058962.pdf
"For an estimation of the evolutionary conservation of the amino acid sequence, we referred to GERP þþ score in UCSC genome browser (http://genome.ucsc.edu/).",OADS,/arxiv_data1/oa_pdf/2f/fb/medi-94-e1996.PMC5058964.pdf
"Secondly, for the well-covered regions, we searched for split or discordant readings that supported structural variations or breakpoints, for not only exons, but also introns in OTOF by IGV (Integrative Genomic Viewer, http://www.broadinstitu-te.org/igv/home).",Non-OADS,/arxiv_data1/oa_pdf/2f/fb/medi-94-e1996.PMC5058964.pdf
"1, Table 1, and Supplementary TableS1, http://links.lww.com/MD/A518).",Non-OADS,/arxiv_data1/oa_pdf/2f/fb/medi-94-e1996.PMC5058964.pdf
"Through this second phase of TRS-134 data analyses, we identified that the exon 48, the last exon of OTOF , was notably poorly covered except in SH81–185 (Supple-mentary Table S2, http://links.lww.com/MD/A518).",OADS,/arxiv_data1/oa_pdf/2f/fb/medi-94-e1996.PMC5058964.pdf
the Taiwan National Health Insurance Research Database (NHIRD) (http://nhird.nhri.org.tw/en/Background.html) and analyzed for all patients who were admitted to hospitals from1997 through 2012 for primary bone-grafting treatment.,OADS,/arxiv_data1/oa_pdf/18/47/medi-94-e2034.PMC5058972.pdf
23 million) participate in the National Health Insurance program(http://www.nhi.gov.tw/English/Index.aspx?menu ¼13&menu_id ¼486&WD_ID ¼486).,Non-OADS,/arxiv_data1/oa_pdf/18/47/medi-94-e2034.PMC5058972.pdf
The established categories of expenditure were provided in inpatient expendi-ture by admission (DD files) (http://nhird.nhri.org.tw/date_01.html).,Non-OADS,/arxiv_data1/oa_pdf/18/47/medi-94-e2034.PMC5058972.pdf
"According to the chapter II, laws ofmedical care act, Ministry of Health and Welfare in Taiwan(http://law.moj.gov.tw/Eng/LawClass/LawContent.aspx?PCODE ¼L0020021), medical care institutions with wards for the inpa- tient care of patients shall be referred to as hospitals; those withonly out-patient facilities shall be referred to as clinics.",Non-OADS,/arxiv_data1/oa_pdf/18/47/medi-94-e2034.PMC5058972.pdf
"Taiwan, http://nhird.nhri.org.tw/en/Background.html (cited in 2015).",Non-OADS,/arxiv_data1/oa_pdf/49/59/medi-94-e2042.PMC5058974.pdf
"20All calculations were performed using the SPSS 23.0 statistical package for Windows (SPSS Inc.,Chicago, IL), the R software (Version 3.2.2; R Foundationfor Statistical Computing, http://www.r-project.org/), and GraphPad Prism 6.0 for Windows (GraphPad Software, Inc., San Diego, CA).",OADS,/arxiv_data1/oa_pdf/b2/79/medi-94-e2069.PMC5058981.pdf
Available at: http://globocan.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/b2/79/medi-94-e2069.PMC5058981.pdf
"Health Promotion Administration, Taiwan Ministry of Health and Welfare: Taiwan cancer registry annual report (2004, 2010, 2011).Available at: http://www.hpa.gov.tw/.",Non-OADS,/arxiv_data1/oa_pdf/b2/79/medi-94-e2069.PMC5058981.pdf
"Taiwan, http://nhird.nhri.org.tw/en/Background.html (cited in 2015).",Non-OADS,/arxiv_data1/oa_pdf/ba/8d/medi-94-e2086.PMC5058989.pdf
"METHODS Data Source The National Health Insurance (NHI) program was launched in Taiwan on March 1, 1995, and it consists of detailedhealthcare data from >23 million enrollees, representing >99% of the population of Taiwan (http://www.nhi.gov.tw/english/ index.aspx).",OADS,/arxiv_data1/oa_pdf/e1/35/medi-94-e2107.PMC5058997.pdf
2014:122. http://www.nhi.gov.tw/Resource/webdata/13767_1_NHI2014-2015%20Annual%20 Report%20 (bilingual)_141230.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ff/06/medi-94-e2113.PMC5058999.pdf
2011;http://www.nhi.gov.tw/English/webdata/webdata.aspx?menu ¼11&menu_id ¼295&WD_ID ¼295&webdata_id- ¼295&webdata_id ¼2431.,Non-OADS,/arxiv_data1/oa_pdf/ff/06/medi-94-e2113.PMC5058999.pdf
"For a certiﬁcate, please see:http://www.textcheck.com/certiﬁcate/HN4GQ8.",Non-OADS,/arxiv_data1/oa_pdf/42/49/medi-94-e2141.PMC5059009.pdf
http://nhird.nhri.org.tw/en/Background.html.,Non-OADS,/arxiv_data1/oa_pdf/45/f5/medi-94-e2142.PMC5059010.pdf
"Required by NHI Administration, the insurance system also records all patients with 30 categories of catastrophic illness such as malignant neoplasm, uremia, and chronic psy- chotic disorders that include dementia (International Classifi-cation of Diseases, Ninth Revision [ICD-9], code number 290.x), to become 1 NHI catastrophic illness registry file (eTable 1, http://links.lww.com/MD/A531).",Non-OADS,/arxiv_data1/oa_pdf/0a/0e/medi-94-e2143.PMC5059011.pdf
"Then, we used propensity-score-matched strategy to match the covariates, listed in Table 1 and eTable 2, http://links.lww.com/MD/A531, as 1:1 by using a ‘‘greedy’’ match-ing algorithm, with a maximum c aliper of 0.1, for analysis.",Non-OADS,/arxiv_data1/oa_pdf/0a/0e/medi-94-e2143.PMC5059011.pdf
"Potential Confounders Information about age, gender, income, and co-morbid- ities, including hypertension, d iabetes, cardiac dysrhythmia, congestive heart failure (CHF ), peripheral artery disease (PAD), peptic ulcer, ischemic stroke, and ischemic heartdisease (IHD), were a lso collected (eTable 2, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/0a/0e/medi-94-e2143.PMC5059011.pdf
"All covariates were comparableafter matching (Table 1; eTable 3, http://links.lww.com/MD/ A531).",OADS,/arxiv_data1/oa_pdf/0a/0e/medi-94-e2143.PMC5059011.pdf
"The percent of daily statin use in 719 mild-to-moderate AD patients with early statin use was /C243–4% before the index date and, after the index date, the percent of daily statin use in719 mild-to-moderate AD patients with early statin use started to approach that of patients without early statin use (eFigure 1, http://links.lww.com/MD/A531).",Non-OADS,/arxiv_data1/oa_pdf/0a/0e/medi-94-e2143.PMC5059011.pdf
"Even excluding 46 patients pre-scribed both lipophilic and hydrophilic statins during theexposure period, all covariates were still comparable between AD patients with early statin use and without early statin use (eTable 4, http://links.lww.com/MD/A531).Cumulative survival probability of AD progression was statistically lower in mild-to-moderate AD patients with earlystatin use than those without early statin use ( P¼0.00054; Figure 2A).",Non-OADS,/arxiv_data1/oa_pdf/0a/0e/medi-94-e2143.PMC5059011.pdf
"After adjusting for age, sex, hypertension, and diabetes, mild-to-moderate AD patients with early statin use exhibited a 0.86-risk (95% CI ¼0.77–0.96) to have AD progression than those without early statin use ( P¼0.0099, Table 2, eTable 5, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/0a/0e/medi-94-e2143.PMC5059011.pdf
http://nhird.nhri.,Non-OADS,/arxiv_data1/oa_pdf/0a/0e/medi-94-e2143.PMC5059011.pdf
"International Classification of diseases, Ninth Revision (ICD-9).http://www.cdc.gov/nchs/icd/icd9.htm 2014.",Non-OADS,/arxiv_data1/oa_pdf/0a/0e/medi-94-e2143.PMC5059011.pdf
"The relationships of BP to all-cause survival probability (Supplementary Figure 1, http://links.lww.com/MD /A532) were similar to their relationships to expanded-CV D survival probability.",OADS,/arxiv_data1/oa_pdf/92/2a/medi-94-e2160.PMC5059018.pdf
"The characteristics of the participants with expanded-CVD mortality after stratification by hypertension stage are shown in Supplementary Table 1,http://links.lww.com/MD/A532.",Non-OADS,/arxiv_data1/oa_pdf/92/2a/medi-94-e2160.PMC5059018.pdf
"The relationships of SBP and DBP to all-cause mortality were mainly monotonic and positive (SupplementaryFigure 2A and B, http://links.lww.com/MD/A532), with little orno relationships seen in the lower parts of the distributions.",OADS,/arxiv_data1/oa_pdf/92/2a/medi-94-e2160.PMC5059018.pdf
"The relationships of SBP and DBP to CVD mortality (Supple- mentary Figure 3A and B, http://links.lww.com/MD/A532) FIGURE 2.",Non-OADS,/arxiv_data1/oa_pdf/92/2a/medi-94-e2160.PMC5059018.pdf
Taiwan: Centers for Disease Control; 2015. https://www.cdc.gov.tw/uploads/files/201407/103228a0-fadd-47b0-b056-8dedda9fce1d.pdf.,Non-OADS,/arxiv_data1/oa_pdf/67/ea/medi-94-e2163.PMC5059020.pdf
"World Health Organization: Globocan 2012 Stomach Cancer: Estimated Incidence, Mortality and Prevalence Worldwide in 2012.http://globocan.iarc.fr/old/FactSheets/cancers/stomach-new.asp.Accessed October 14, 2014.",Non-OADS,/arxiv_data1/oa_pdf/67/ea/medi-94-e2163.PMC5059020.pdf
http://www.ncbi.nlm.nih.gov/ pubmed/25994939.,Non-OADS,/arxiv_data1/oa_pdf/89/95/medi-94-e2180.PMC5059022.pdf
"Trial Registration: http://www.anzctr.org.au/, ANZCTR No.",Non-OADS,/arxiv_data1/oa_pdf/77/81/medi-94-e2181.PMC5059023.pdf
Medicine (2016) 95:40(e4519)Received: 11 June 2016 / Received in ﬁnal form: 10 July 2016 / Accepted: 13 July 2016 http://dx.doi.org/10.1097/MD.0000000000004519Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/8d/b8/medi-95-e4519.PMC5059027.pdf
Medicine (2016) 95:40(e4629)Received: 17 March 2016 / Received in ﬁnal form: 27 June 2016 / Accepted: 22 July 2016 http://dx.doi.org/10.1097/MD.0000000000004629Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/72/a3/medi-95-e4629.PMC5059029.pdf
"[44]Additional informa- tion on the IPAQ is provided in Appendix 1, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/72/a3/medi-95-e4629.PMC5059029.pdf
WHO 2016Available from: URL: http://www.who.int/dietphysicalactivity/publications/9789241599979/en/.,Non-OADS,/arxiv_data1/oa_pdf/72/a3/medi-95-e4629.PMC5059029.pdf
[49] INSEE (National Institute of Statistics and Economic Studies) 2015 MarchAvailable from: URL: http://www.insee.fr/en/themes/.,Non-OADS,/arxiv_data1/oa_pdf/72/a3/medi-95-e4629.PMC5059029.pdf
Medicine (2016) 95:40(e4657)Received: 1 March 2016 / Received in ﬁnal form: 22 July 2016 / Accepted: 22 July 2016 http://dx.doi.org/10.1097/MD.0000000000004657Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/3e/73/medi-95-e4657.PMC5059030.pdf
Medicine (2016) 95:40(e4739)Received: 14 October 2015 / Received in ﬁnal form: 23 June 2016 / Accepted: 6 August 2016 http://dx.doi.org/10.1097/MD.0000000000004739Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/53/ab/medi-95-e4739.PMC5059032.pdf
Medicine (2016) 95:40(e4785)Received: 3 August 2016 / Received in ﬁnal form: 10 August 2016 / Accepted: 12 August 2016 http://dx.doi.org/10.1097/MD.0000000000004785Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/25/5b/medi-95-e4785.PMC5059033.pdf
Medicine (2016) 95:40(e4805)Received: 3 June 2016 / Received in ﬁnal form: 8 August 2016 / Accepted: 11 August 2016 http://dx.doi.org/10.1097/MD.0000000000004805Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/2d/50/medi-95-e4805.PMC5059034.pdf
Medicine (2016) 95:40(e4810)Received: 28 July 2016 / Received in ﬁnal form: 16 August 2016 / Accepted: 16 August 2016 http://dx.doi.org/10.1097/MD.0000000000004810Meta-Analysis of Observational Studies in Epidemiology Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/e5/50/medi-95-e4810.PMC5059035.pdf
The Newcastle –Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses.http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.,Non-OADS,/arxiv_data1/oa_pdf/e5/50/medi-95-e4810.PMC5059035.pdf
Medicine (2016) 95:40(e4818)Received: 15 March 2016 / Received in ﬁnal form: 2 August 2016 / Accepted: 17 August 2016 http://dx.doi.org/10.1097/MD.0000000000004818Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ec/2e/medi-95-e4818.PMC5059036.pdf
Medicine (2016) 95:40(e4819)Received: 20 March 2016 / Received in ﬁnal form: 17 August 2016 / Accepted: 17 August 2016 http://dx.doi.org/10.1097/MD.0000000000004819Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/2d/ee/medi-95-e4819.PMC5059037.pdf
Medicine (2016) 95:40(e4831)Received: 25 March 2016 / Received in ﬁnal form: 2 August 2016 / Accepted: 15 August 2016 http://dx.doi.org/10.1097/MD.0000000000004831Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/96/03/medi-95-e4831.PMC5059038.pdf
2015 Available: https://www.nccn.org/store/login/login.aspx?,Non-OADS,/arxiv_data1/oa_pdf/96/03/medi-95-e4831.PMC5059038.pdf
"ReturnURL= http://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf.Accessed August 26, 2015.",Non-OADS,/arxiv_data1/oa_pdf/96/03/medi-95-e4831.PMC5059038.pdf
Medicine (2016) 95:40(e4847)Received: 11 November 2015 / Received in ﬁnal form: 14 July 2016 / Accepted: 17 August 2016 http://dx.doi.org/10.1097/MD.0000000000004847Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/a2/92/medi-95-e4847.PMC5059039.pdf
Medicine (2016) 95:40(e4860)Received: 13 May 2016 / Received in ﬁnal form: 18 August 2016 / Accepted: 22 August 2016 http://dx.doi.org/10.1097/MD.0000000000004860Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/62/c0/medi-95-e4860.PMC5059041.pdf
Medicine (2016) 95:40(e4868)Received: 24 March 2016 / Received in ﬁnal form: 9 August 2016 / Accepted: 23 August 2016 http://dx.doi.org/10.1097/MD.0000000000004868Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/88/14/medi-95-e4868.PMC5059042.pdf
Medicine (2016) 95:40(e4870)Received: 21 May 2016 / Received in ﬁnal form: 19 August 2016 / Accepted: 23 August 2016 http://dx.doi.org/10.1097/MD.0000000000004870Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/b1/ba/medi-95-e4870.PMC5059043.pdf
Medicine (2016) 95:40(e4879)Received: 17 June 2016 / Received in ﬁnal form: 13 August 2016 / Accepted: 24 August 2016 http://dx.doi.org/10.1097/MD.0000000000004879Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/7d/c4/medi-95-e4879.PMC5059044.pdf
"London, UK: Global Initiative for Chronic Obstructive Lung Disease; 2013. http://www.goldcopd.org.",Non-OADS,/arxiv_data1/oa_pdf/7d/c4/medi-95-e4879.PMC5059044.pdf
Medicine (2016) 95:40(e4880)Received: 28 March 2016 / Received in ﬁnal form: 23 August 2016 / Accepted: 24 August 2016 http://dx.doi.org/10.1097/MD.0000000000004880Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/31/1d/medi-95-e4880.PMC5059045.pdf
"clinics (Supplementary table 1, http://links.lww.com/MD/B319) for the other variables.",Non-OADS,/arxiv_data1/oa_pdf/31/1d/medi-95-e4880.PMC5059045.pdf
Medicine (2016) 95:40(e4883)Received: 22 July 2016 / Received in ﬁnal form: 24 August 2016 / Accepted: 24 August 2016 http://dx.doi.org/10.1097/MD.0000000000004883Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/f6/48/medi-95-e4883.PMC5059046.pdf
Available at: http://globocan.iarc.fr/Pages/fact_sheets_population.aspx.,Non-OADS,/arxiv_data1/oa_pdf/f6/48/medi-95-e4883.PMC5059046.pdf
Available at: https://http://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/PS/Envejecimiento-demogra ﬁco-Colombia- 1951 –2020.pdf [Published April 2013].,Non-OADS,/arxiv_data1/oa_pdf/f6/48/medi-95-e4883.PMC5059046.pdf
Available at: http://www.cancer.gov.co/content/estadisticas.,Non-OADS,/arxiv_data1/oa_pdf/f6/48/medi-95-e4883.PMC5059046.pdf
Medicine (2016) 95:40(e4888)Received: 10 February 2016 / Received in ﬁnal form: 4 July 2016 / Accepted: 24 August 2016 http://dx.doi.org/10.1097/MD.0000000000004888Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/de/50/medi-95-e4888.PMC5059048.pdf
"A video showing the different steps of the procedure is attached, http://links.lww.com/MD/B311.",Non-OADS,/arxiv_data1/oa_pdf/de/50/medi-95-e4888.PMC5059048.pdf
"Indeed, characteristics of these patients were comparable to the 59 patients who did perform therecommended tests (see online tables, http://links.lww.com/MD/ B312).",Non-OADS,/arxiv_data1/oa_pdf/de/50/medi-95-e4888.PMC5059048.pdf
"2010;https://www.ncbi.nlm.nih.gov/pubmed/?term=Sleep+apnea+syndrome%3A+Clinical+practice+guidelines+housset [20] Amann M, Romer LM, Subudhi AW, et al.",Non-OADS,/arxiv_data1/oa_pdf/de/50/medi-95-e4888.PMC5059048.pdf
Medicine (2016) 95:40(e4904)Received: 2 April 2016 / Received in ﬁnal form: 13 August 2016 / Accepted: 25 August 2016 http://dx.doi.org/10.1097/MD.0000000000004904Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/6b/05/medi-95-e4904.PMC5059049.pdf
Available at: http://epub.cnki.net/kns/brief/default_result.aspx.Li et al.,OADS,/arxiv_data1/oa_pdf/6b/05/medi-95-e4904.PMC5059049.pdf
Medicine (2016) 95:40(e4940)Received: 28 March 2016 / Received in ﬁnal form: 17 August 2016 / Accepted: 18 August 2016 http://dx.doi.org/10.1097/MD.0000000000004940Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/fc/41/medi-95-e4940.PMC5059051.pdf
"7 and SupplementalVideo, http://links.lww.com/MD/B340).",Non-OADS,/arxiv_data1/oa_pdf/fc/41/medi-95-e4940.PMC5059051.pdf
Medicine (2016) 95:40(e4957)Received: 9 June 2016 / Received in ﬁnal form: 27 August 2016 / Accepted: 2 September 2016 http://dx.doi.org/10.1097/MD.0000000000004957Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/cd/37/medi-95-e4957.PMC5059053.pdf
Medicine (2016) 95:40(e4975)Received: 14 June 2016 / Received in ﬁnal form: 1 September 2016 / Accepted: 2 September 2016 http://dx.doi.org/10.1097/MD.0000000000004975Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/a8/cd/medi-95-e4975.PMC5059054.pdf
"Methods Literature search, study design, and data analysis were performed following PRISMA (Preferred Reporting Items for SystematicReviews and Meta-Analyses) guidelines (see Supplemental Contents —PRISMA checklist, http://links.lww.com/MD/ B316).",OADS,/arxiv_data1/oa_pdf/a8/cd/medi-95-e4975.PMC5059054.pdf
"The PICOS (Population, Intervention, Comparison, Outcome) worksheet was used to identify the main question of the meta-analysis anddeﬁne the targets of the search strategy (see in Supplemental Contents –PICOS worksheet, which describes type of population, intervention, type of comparison, and outcomes considered in the meta-analysis, http://links.lww.com/MD/B315).",OADS,/arxiv_data1/oa_pdf/a8/cd/medi-95-e4975.PMC5059054.pdf
"For each included study, we retrieved the following information: type of genetic test, type of biospecimen used to perform the genetic test (blood/paraf ﬁn blocks of primary tumor), number of the BRCA -positive patients, number of the reference group patients (sporadic orBRCA -negative), median age of patients in the study and reference groups, Ashkenazi Jewish ancestry (yes/no), triplenegative subtype (yes/no), pathological stage of the breast cancer, HRs and their 95% con ﬁdence interval (CI), factors considered in multivariate analysis (see Supplemental Contents –Master data- base, which reports the PUBMED identi ﬁcation number to retrieve the studies involved in the meta-analysis, and data for each study, http://links.lww.com/MD/B317).",Non-OADS,/arxiv_data1/oa_pdf/a8/cd/medi-95-e4975.PMC5059054.pdf
"However, the pooled estimates and heterogeneity analysis according to univariate and multivariate analyses are available(see Supplemental Contents —Table S1, http://links.lww.com/ MD/B313, which reports pooled estimates and heterogeneity analysis according to univariate and multivariate analyses).",Non-OADS,/arxiv_data1/oa_pdf/a8/cd/medi-95-e4975.PMC5059054.pdf
"After abstract reading, 82 articles were retrieved for full text evaluation, which led to 60 articles that met all inclusion criteria and represented the data source for the followingqualitative and quantitative analyses (see Supplemental Contents — Master database, which reports the PUBMED identi ﬁcation number to retrieve the studies involved in the meta-analysis, anddata for each study, http://links.lww.com/MD/B317).",Non-OADS,/arxiv_data1/oa_pdf/a8/cd/medi-95-e4975.PMC5059054.pdf
"See Supplemental Contents — Figure S1, http://links.lww.com/MD/B313, which illustrates the relationship between HRs of DMFS for BRCA1 mutationalstatus and publication years).",Non-OADS,/arxiv_data1/oa_pdf/a8/cd/medi-95-e4975.PMC5059054.pdf
"Publication bias We found no evidence of publication bias in the 9 meta-analyses including at least 10 studies (See Supplemental Contents — Figures S2 –S5, http://links.lww.com/MD/B313, which show funnel plots for publication bias).",Non-OADS,/arxiv_data1/oa_pdf/a8/cd/medi-95-e4975.PMC5059054.pdf
Medicine (2016) 95:40(e4977)Received: 3 June 2016 / Received in ﬁnal form: 19 August 2016 / Accepted: 5 September 2016 http://dx.doi.org/10.1097/MD.0000000000004977Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/bc/29/medi-95-e4977.PMC5059055.pdf
Medicine (2016) 95:40(e4993)Received: 26 June 2016 / Received in ﬁnal form: 1 September 2016 / Accepted: 7 September 2016 http://dx.doi.org/10.1097/MD.0000000000004993Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/07/fb/medi-95-e4993.PMC5059059.pdf
The grade of toxicity was assessed according to the Common Toxicity Criteria v2.0 of the National Cancer Institute (http://ctep.cancer.gov/reporting/ctc.html).,Non-OADS,/arxiv_data1/oa_pdf/07/fb/medi-95-e4993.PMC5059059.pdf
The Newcastle –Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses.Available at: http://www.ohri.ca/programs/clinical_epidemiology/ox ford.asp.,Non-OADS,/arxiv_data1/oa_pdf/07/fb/medi-95-e4993.PMC5059059.pdf
Medicine (2016) 95:40(e4995)Received: 24 January 2016 / Received in ﬁnal form: 29 August 2016 / Accepted: 7 September 2016 http://dx.doi.org/10.1097/MD.0000000000004995Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ae/80/medi-95-e4995.PMC5059060.pdf
Medicine (2016) 95:40(e4996)Received: 6 April 2016 / Received in ﬁnal form: 6 September 2016 / Accepted: 6 September 2016 http://dx.doi.org/10.1097/MD.0000000000004996Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/fd/54/medi-95-e4996.PMC5059061.pdf
"Laboratory data revealed a low plateletcount of 117 /C210 3/mL (Supplementary Table 1, http://links.lww.",OADS,/arxiv_data1/oa_pdf/67/68/medi-95-e4997.PMC5059062.pdf
Medicine (2016) 95:40(e4997)Received: 24 April 2016 / Received in ﬁnal form: 29 August 2016 / Accepted: 30 August 2016 http://dx.doi.org/10.1097/MD.0000000000004997Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/67/68/medi-95-e4997.PMC5059062.pdf
"1, http://links.lww.com/MD/B343).",Non-OADS,/arxiv_data1/oa_pdf/67/68/medi-95-e4997.PMC5059062.pdf
"2 –4, http://links.lww.com/MD/B343).",Non-OADS,/arxiv_data1/oa_pdf/67/68/medi-95-e4997.PMC5059062.pdf
"5 –9, http://links.lww.com/MD/B343).",Non-OADS,/arxiv_data1/oa_pdf/67/68/medi-95-e4997.PMC5059062.pdf
Medicine (2016) 95:40(e5020)Received: 1 July 2016 / Received in ﬁnal form: 31 August 2016 / Accepted: 3 September 2016 http://dx.doi.org/10.1097/MD.0000000000005020Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/89/da/medi-95-e5020.PMC5059063.pdf
Available at:http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm355128.pdf.,Non-OADS,/arxiv_data1/oa_pdf/89/da/medi-95-e5020.PMC5059063.pdf
Medicine (2016) 95:40(e5024)Received: 24 July 2016 / Received in ﬁnal form: 7 September 2016 / Accepted: 8 September 2016 http://dx.doi.org/10.1097/MD.0000000000005024Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/03/c5/medi-95-e5024.PMC5059064.pdf
Medicine (2016) 95:40(e5026)Received: 18 May 2016 / Received in ﬁnal form: 1 September 2016 / Accepted: 4 September 2016 http://dx.doi.org/10.1097/MD.0000000000005026Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/31/29/medi-95-e5026.PMC5059065.pdf
Medicine (2016) 95:40(e5036)Received: 2 March 2016 / Received in ﬁnal form: 30 July 2016 / Accepted: 9 September 2016 http://dx.doi.org/10.1097/MD.0000000000005036Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/eb/0b/medi-95-e5036.PMC5059067.pdf
Medicine (2016) 95:40(e5037)Received: 2 May 2016 / Received in ﬁnal form: 30 August 2016 / Accepted: 9 September 2016 http://dx.doi.org/10.1097/MD.0000000000005037Diagnostic Accuracy Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/6d/81/medi-95-e5037.PMC5059068.pdf
Medicine (2016) 95:40(e5045)Received: 9 June 2016 / Received in ﬁnal form: 8 September 2016 / Accepted: 9 September 2016 http://dx.doi.org/10.1097/MD.0000000000005045Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/c1/20/medi-95-e5045.PMC5059071.pdf
Medicine (2016) 95:40(e5053)Received: 6 September 2016 / Received in ﬁnal form: 12 September 2016 / Accepted: 13 September 2016 http://dx.doi.org/10.1097/MD.0000000000005053Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/a2/36/medi-95-e5053.PMC5059073.pdf
Medicine (2016) 95:40(e5054)Received: 25 August 2016 / Received in ﬁnal form: 8 September 2016 / Accepted: 9 September 2016 http://dx.doi.org/10.1097/MD.0000000000005054Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/7f/85/medi-95-e5054.PMC5059074.pdf
Medicine (2016) 95:40(e5057)Received: 20 July 2016 / Received in ﬁnal form: 8 September 2016 / Accepted: 10 September 2016 http://dx.doi.org/10.1097/MD.0000000000005057Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/b6/d0/medi-95-e5057.PMC5059075.pdf
Global status report on noncommunicable diseases 2014. http://www.who.int/nmh/publications/ncd-status-report- 2014/en/.,Non-OADS,/arxiv_data1/oa_pdf/b6/d0/medi-95-e5057.PMC5059075.pdf
2016. http://www.euro.who.,Non-OADS,/arxiv_data1/oa_pdf/b6/d0/medi-95-e5057.PMC5059075.pdf
"1986. http://www.euro.who.int/de/publications/policy-documents/ottawa-charter-for-health-promotion,-1986.",Non-OADS,/arxiv_data1/oa_pdf/b6/d0/medi-95-e5057.PMC5059075.pdf
2009. http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/b6/d0/medi-95-e5057.PMC5059075.pdf
2004. http://www.who.int/dietphysicalactivity/strategy/eb11344/strategy_english_web.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b6/d0/medi-95-e5057.PMC5059075.pdf
Medicine (2016) 95:40(e5059)Received: 29 January 2016 / Received in ﬁnal form: 17 June 2016 / Accepted: 13 September 2016 http://dx.doi.org/10.1097/MD.0000000000005059Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/e4/00/medi-95-e5059.PMC5059076.pdf
Medicine (2016) 95:40(e5067)Received: 6 April 2016 / Received in ﬁnal form: 11 September 2016 / Accepted: 11 September 2016 http://dx.doi.org/10.1097/MD.0000000000005067Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/84/ce/medi-95-e5067.PMC5059077.pdf
Medicine (2016) 95:40(e5069)Received: 18 May 2016 / Received in ﬁnal form: 4 August 2016 / Accepted: 10 September 2016 http://dx.doi.org/10.1097/MD.0000000000005069Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/24/ba/medi-95-e5069.PMC5059078.pdf
Medicine (2016) 95:40(e5070)Received: 1 June 2016 / Received in ﬁnal form: 18 August 2016 / Accepted: 10 September 2016 http://dx.doi.org/10.1097/MD.0000000000005070Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/31/16/medi-95-e5070.PMC5059079.pdf
Medicine (2016) 95:40(e5071)Received: 28 April 2016 / Received in ﬁnal form: 27 August 2016 / Accepted: 10 September 2016 http://dx.doi.org/10.1097/MD.0000000000005071Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/e7/e4/medi-95-e5071.PMC5059080.pdf
Medicine (2016) 95:40(e5072)Received: 5 June 2016 / Received in ﬁnal form: 8 September 2016 / Accepted: 10 September 2016 http://dx.doi.org/10.1097/MD.0000000000005072Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/53/b1/medi-95-e5072.PMC5059081.pdf
"Based on the UN ’sd eﬁnition and methodolo- gy, detailed GII data of Taiwan can be obtained on the Internet website.2015; http://eng.stat.gov.tw/ct.asp?xItem=25280&ctNode=6032&mp=5.",OADS,/arxiv_data1/oa_pdf/53/b1/medi-95-e5072.PMC5059081.pdf
Medicine (2016) 95:40(e5076)Received: 4 July 2016 / Received in ﬁnal form: 9 September 2016 / Accepted: 12 September 2016 http://dx.doi.org/10.1097/MD.0000000000005076Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/81/b1/medi-95-e5076.PMC5059082.pdf
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000406/human_med_000808.jsp&mid=WC0b01ac058001d124.,Non-OADS,/arxiv_data1/oa_pdf/81/b1/medi-95-e5076.PMC5059082.pdf
http://ansm.sante.fr/Dossiers/Interactions-medicamenteuses/ Interactions-medicamenteuses/(offset)/0.,OADS,/arxiv_data1/oa_pdf/81/b1/medi-95-e5076.PMC5059082.pdf
http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/81/b1/medi-95-e5076.PMC5059082.pdf
Medicine (2016) 95:40(e5077)Received: 2 March 2016 / Received in ﬁnal form: 9 September 2016 / Accepted: 12 September 2016 http://dx.doi.org/10.1097/MD.0000000000005077Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/fe/fb/medi-95-e5077.PMC5059083.pdf
Medicine (2016) 95:40(e5079)Received: 14 August 2016 / Received in ﬁnal form: 13 September 2016 / Accepted: 14 September 2016 http://dx.doi.org/10.1097/MD.0000000000005079Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/62/c8/medi-95-e5079.PMC5059084.pdf
Medicine (2016) 95:40(e5081)Received: 12 January 2016 / Received in ﬁnal form: 27 August 2016 / Accepted: 14 September 2016 http://dx.doi.org/10.1097/MD.0000000000005081Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/be/30/medi-95-e5081.PMC5059085.pdf
"All exons of NFKB2 were polymerase chain reaction (PCR) ampli ﬁed with DNA extracted from peripheral blood (see Table, Supplement Content, in which sequence of all primer pairs used are listed, http://links.lww.com/MD/B322).",Non-OADS,/arxiv_data1/oa_pdf/be/30/medi-95-e5081.PMC5059085.pdf
"Variation at this position has not been previously identi ﬁed in medical literature, the Exome Aggregation Consortium (http://exac.broadinstitute.org/), or the 1000 genomes (http://www.1000genomes.org/) database.",OADS,/arxiv_data1/oa_pdf/be/30/medi-95-e5081.PMC5059085.pdf
Medicine (2016) 95:40(e5083)Received: 17 June 2016 / Received in ﬁnal form: 11 September 2016 / Accepted: 15 September 2016 http://dx.doi.org/10.1097/MD.0000000000005083Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ce/d7/medi-95-e5083.PMC5059086.pdf
"Methods The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA, http://links.lww.com/MD/B324) wasutilized in the completion of this review (see Table, http://links.",Non-OADS,/arxiv_data1/oa_pdf/ce/d7/medi-95-e5083.PMC5059086.pdf
"Figure 1 outlines the study selection process.Baseline study characteristics are outlined in Supplemental Digital Content 3, http://links.lww.com/MD/B327 and 4, http://links.lww.com/MD/B328 (Tables), while Table 1 summa-rizes preservation and perfusion parameters for all studies.",Non-OADS,/arxiv_data1/oa_pdf/ce/d7/medi-95-e5083.PMC5059086.pdf
"Forest plots of selected meta-analyses are shown in Figure 2, with all results tabulated in Supplemental Digital Content 5, http://links.lww.com/MD/B329.",OADS,/arxiv_data1/oa_pdf/ce/d7/medi-95-e5083.PMC5059086.pdf
"Study heterogeneity was low for a majority of parameters (see Table, Supplemental Digital Content 5, http://links.lww.com/MD/B229).",OADS,/arxiv_data1/oa_pdf/ce/d7/medi-95-e5083.PMC5059086.pdf
"The risk of bias assessment of cohort studies is summarized in Supplemental Digital Content 7, http://links.lww.com/MD/B331(Figure).",Non-OADS,/arxiv_data1/oa_pdf/ce/d7/medi-95-e5083.PMC5059086.pdf
"Supplemental Digital Content 8, http://links.lww.com/MD/B332 (Table) displays the risk of bias assessment for the included RCTs upon utilization of the CochraneTable 1 Summary human and animal study perfusion and preservation characteristics‡.",Non-OADS,/arxiv_data1/oa_pdf/ce/d7/medi-95-e5083.PMC5059086.pdf
"Furthermore, WP, including subnormo- thermic MP, was used in 14 (36.8%) of the included animal studies (see Table, Supplemental Digital Content 4, http://links.lww.com/MD/B328).",OADS,/arxiv_data1/oa_pdf/ce/d7/medi-95-e5083.PMC5059086.pdf
"Meta-analysis publication bias and heterogeneity (WP studies) Analysis of funnel plots did not display signi ﬁcant asymmetry when comparing peak creatinine between WP and the HMP orCS groups (see Figure, Supplemental Digital Content 10, for funnel plots, http://links.lww.com/MD/B334).",Non-OADS,/arxiv_data1/oa_pdf/ce/d7/medi-95-e5083.PMC5059086.pdf
"Study heterogene- ity was high for most parameters (see Table, Supplemental DigitalContent 9, http://links.lww.com/MD/B333).",OADS,/arxiv_data1/oa_pdf/ce/d7/medi-95-e5083.PMC5059086.pdf
"Risk of bias assessment (all studies) Animal study bias assessment was performed using SYRCLE assessment tool [25]and is summarized in Supplemental Digital Content 11, http://links.lww.com/MD/B335 (Figure).",Non-OADS,/arxiv_data1/oa_pdf/ce/d7/medi-95-e5083.PMC5059086.pdf
"3; also see Table, Supplemen-tal Digital Content 9, http://links.lww.com/MD/B333).",Non-OADS,/arxiv_data1/oa_pdf/ce/d7/medi-95-e5083.PMC5059086.pdf
"Its use was much more prevalent in animal studies, with comparisons showing signi ﬁcantly lower FeNa in the oxygenated HMP compared to nonoxygenated HMP group(see Table, Supplemental Digital Content 9, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/ce/d7/medi-95-e5083.PMC5059086.pdf
"This was largely due to the fact that CIT for human MP kidneys was higherthan that for CS kidneys (see Table, Supplemental DigitalContent 3, http://links.lww.com/MD/B327), which is not surprising given that MP is often used as a means to extend the period of preservation.",Non-OADS,/arxiv_data1/oa_pdf/ce/d7/medi-95-e5083.PMC5059086.pdf
Availableat: http://www.crd.york.ac.uk/prospero/prospero.asp.,Non-OADS,/arxiv_data1/oa_pdf/ce/d7/medi-95-e5083.PMC5059086.pdf
Available at: http://www.campbellcollaboration.org/escalc/html/EffectSizeCalculator-Home.php.,Non-OADS,/arxiv_data1/oa_pdf/ce/d7/medi-95-e5083.PMC5059086.pdf
2014.Available at: http://www.ohri.ca/programs/clinical_epidemiology/ox ford.asp.,Non-OADS,/arxiv_data1/oa_pdf/ce/d7/medi-95-e5083.PMC5059086.pdf
Available at: http://www.bridgetolife.com/belzer-uw-cold-storage-so lution-instructions/.,Non-OADS,/arxiv_data1/oa_pdf/ce/d7/medi-95-e5083.PMC5059086.pdf
Medicine (2016) 95:40(e5085)Received: 4 August 2016 / Received in ﬁnal form: 13 September 2016 / Accepted: 14 September 2016 http://dx.doi.org/10.1097/MD.0000000000005085Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/2b/e3/medi-95-e5085.PMC5059087.pdf
"1, http://links.lww.com/MD/ B318).",Non-OADS,/arxiv_data1/oa_pdf/2b/e3/medi-95-e5085.PMC5059087.pdf
"2, http://links.lww.com/MD/B318).",Non-OADS,/arxiv_data1/oa_pdf/2b/e3/medi-95-e5085.PMC5059087.pdf
"3, http://links.lww.com/MD/B318).",Non-OADS,/arxiv_data1/oa_pdf/2b/e3/medi-95-e5085.PMC5059087.pdf
"Real-time PCR for ADAM28 was performed to con ﬁrm ADAM28 siRNA-mediated knock down of ADAM28 mRNA (Supplementary Fig 4C, http://links.lww.com/MD/B318).",OADS,/arxiv_data1/oa_pdf/2b/e3/medi-95-e5085.PMC5059087.pdf
Medicine (2016) 95:40(e5093)Received: 23 April 2016 / Received in ﬁnal form: 13 September 2016 / Accepted: 16 September 2016 http://dx.doi.org/10.1097/MD.0000000000005093Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/e1/4d/medi-95-e5093.PMC5059089.pdf
Medicine (2016) 95:40(e5095)Received: 7 January 2016 / Received in ﬁnal form: 16 August 2016 / Accepted: 15 September 2016 http://dx.doi.org/10.1097/MD.0000000000005095Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/a5/23/medi-95-e5095.PMC5059090.pdf
"Global strategy for the diagnosis, management, and prevention of chronic obstructive obstructive pulmonary disease(updated 2016), http://goldcopd.org/2016.2.",Non-OADS,/arxiv_data1/oa_pdf/a5/23/medi-95-e5095.PMC5059090.pdf
Medicine (2016) 95:40(e5096)Received: 24 May 2016 / Received in ﬁnal form: 15 September 2016 / Accepted: 16 September 2016 http://dx.doi.org/10.1097/MD.0000000000005096Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/e2/95/medi-95-e5096.PMC5059091.pdf
"ANCA titre (OR 10.60, 95% CI 4.61 –24.34) and more affected organ systems (OR 6.07, 95% CI 2.58 –14.26) were still independently related with AAV (see Table 5 –12 in the supplemental content for detailed information about these modelsand the sensitivity analysis, http://links.lww.com/MD/B359).",Non-OADS,/arxiv_data1/oa_pdf/e2/95/medi-95-e5096.PMC5059091.pdf
Medicine (2016) 95:40(e5097)Received: 21 March 2016 / Received in ﬁnal form: 17 August 2016 / Accepted: 16 September 2016 http://dx.doi.org/10.1097/MD.0000000000005097Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/1f/60/medi-95-e5097.PMC5059092.pdf
Medicine (2016) 95:40(e5110)Received: 31 March 2016 / Received in ﬁnal form: 26 July 2016 / Accepted: 18 September 2016 http://dx.doi.org/10.1097/MD.0000000000005110Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/4b/a3/medi-95-e5110.PMC5059096.pdf
Medicine (2016) 95:40(e5117)Received: 5 June 2016 / Received in ﬁnal form: 27 August 2016 / Accepted: 20 September 2016 http://dx.doi.org/10.1097/MD.0000000000005117Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/30/0d/medi-95-e5117.PMC5059098.pdf
2016; http://m.nhic.,Non-OADS,/arxiv_data1/oa_pdf/30/0d/medi-95-e5117.PMC5059098.pdf
2000; http://iris.wpro.who.int/bitstream/handle/ 10665.1/5379/0957708211_eng.pdf.,OADS,/arxiv_data1/oa_pdf/30/0d/medi-95-e5117.PMC5059098.pdf
Clinical Research Center for Rheumatoid Arthritis; 2015. http://kiis.konect.or.kr/jsp/guidelines/download/1-3.pdf.,Non-OADS,/arxiv_data1/oa_pdf/30/0d/medi-95-e5117.PMC5059098.pdf
Medicine (2016) 95:40(e5130)Received: 4 September 2016 / Received in ﬁnal form: 18 September 2016 / Accepted: 22 September 2016 http://dx.doi.org/10.1097/MD.0000000000005130Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/96/4b/medi-95-e5130.PMC5059099.pdf
The risk of hemorrhage de-Korean J Thorac Cardiovasc Surg 2016;49:329-336 □ CLINICAL RESEARCH □ http://dx.doi.or g/10.5090/k jtcs.2016.49.5.329,Non-OADS,/arxiv_data1/oa_pdf/a4/10/kjtcv-49-329.PMC5059117.pdf
We performed this retrospective study over a 16-year  period at a single institution to evaluate mid-term  mortality and morbidity outcomes among patients who underwent TAPVR repair with an in situ  approach  via mild to moderate cardioplegic hypothermia with-Korean J Thorac Cardiovasc Surg 2016;49:337-343 □ CLINICAL RESEARCH □ http://dx.doi.or g/10.5090/k jtcs.2016.49.5.337,Non-OADS,/arxiv_data1/oa_pdf/42/11/kjtcv-49-337.PMC5059118.pdf
"In order to eliminate acute and chronic volume  overload, some experts have advocated monocusp Korean J Thorac Cardiovasc Surg 2016;49:344-349 □ CLINICAL RESEARCH □ http://dx.doi.or g/10.5090/k jtcs.2016.49.5.344",Non-OADS,/arxiv_data1/oa_pdf/05/95/kjtcv-49-344.PMC5059119.pdf
"However, patients with MS who  have LV dysfunction are frequently encountered in Korean J Thorac Cardiovasc Surg 2016;49:350-355 □ CLINICAL RESEARCH □ http://dx.doi.or g/10.5090/k jtcs.2016.49.5.350",Non-OADS,/arxiv_data1/oa_pdf/a7/e3/kjtcv-49-350.PMC5059120.pdf
"I n  t h e  p r e s e n t  s t u d y ,  w e  r e p o r t  t h e  c l i n i c a l  r e s u l t s  o f  a  s i n g l e -c e n t e r   comparison between the median sternotomy approach  and the right minithoracotomy approach in treating cardiac myxoma.Korean J Thorac Cardiovasc Surg 2016;49:356-360 □ CLINICAL RESEARCH □ http://dx.doi.or g/10.5090/k jtcs.2016.49.5.356",Non-OADS,/arxiv_data1/oa_pdf/fc/20/kjtcv-49-356.PMC5059121.pdf
"Morbidity and mor- tality from sternal fractures are both directly related  t o  t h e  d e g r e e  o f  c o - i n j u r y ,  a n d  h a v e  n o  c l e a r  r e l a t i o n  Korean J Thorac Cardiovasc Surg 2016;49:361-365 □ CLINICAL RESEARCH □ http://dx.doi.or g/10.5090/k jtcs.2016.49.5.361",Non-OADS,/arxiv_data1/oa_pdf/2d/4b/kjtcv-49-361.PMC5059122.pdf
"When multiple bone fractures occur, a simple rewiring of-Korean J Thorac Cardiovasc Surg 2016;49:366-373 □ CLINICAL RESEARCH □ http://dx.doi.or g/10.5090/k jtcs.2016.49.5.366",Non-OADS,/arxiv_data1/oa_pdf/0b/1b/kjtcv-49-366.PMC5059123.pdf
"At 5 months of age, a follow-up angiography and  CT scan revealed that the left pulmonary artery had grown to a sufficient size with normal arborization Korean J Thorac Cardiovasc Surg 2016;49:374-378 □ CASE REPORT □ http://dx.doi.or g/10.5090/k jtcs.2016.49.5.374",Non-OADS,/arxiv_data1/oa_pdf/c9/32/kjtcv-49-374.PMC5059124.pdf
"On the 15th day after admission, the patient’s oxygen saturation level start- ed to decrease gradually while pulmonary infiltration Korean J Thorac Cardiovasc Surg 2016;49:379-382 □ CASE REPORT □ http://dx.doi.or g/10.5090/k jtcs.2016.49.5.379",Non-OADS,/arxiv_data1/oa_pdf/f0/4d/kjtcv-49-379.PMC5059125.pdf
"After aortic cross clamping, cardioplegia was given Korean J Thorac Cardiovasc Surg 2016;49:383-386 □ CASE REPORT □ http://dx.doi.or g/10.5090/k jtcs.2016.49.5.383",Non-OADS,/arxiv_data1/oa_pdf/65/52/kjtcv-49-383.PMC5059126.pdf
The patient’s white blood cell (WBC) Korean J Thorac Cardiovasc Surg 2016;49:387-391 □ CASE REPORT □ http://dx.doi.or g/10.5090/k jtcs.2016.49.5.387,Non-OADS,/arxiv_data1/oa_pdf/51/29/kjtcv-49-387.PMC5059127.pdf
"Tissue plasminogen activator (t-PA) was ad- ministered promptly (within 90 minutes after symp- tom occurrence), and magnetic resonance angiography (MRA) was conducted while intravenous thrombol-Korean J Thorac Cardiovasc Surg 2016;49:392-396 □ CASE REPORT □ http://dx.doi.or g/10.5090/k jtcs.2016.49.5.392",Non-OADS,/arxiv_data1/oa_pdf/85/07/kjtcv-49-392.PMC5059128.pdf
Distal anastomosis of the right  and left arteries was performed on the common iliac Korean J Thorac Cardiovasc Surg 2016;49:397-400 □ CASE REPORT □ http://dx.doi.or g/10.5090/k jtcs.2016.49.5.397,Non-OADS,/arxiv_data1/oa_pdf/b6/53/kjtcv-49-397.PMC5059129.pdf
Under the impression of Korean J Thorac Cardiovasc Surg 2016;49:401-404 □ CASE REPORT □ http://dx.doi.or g/10.5090/k jtcs.2016.49.5.401,Non-OADS,/arxiv_data1/oa_pdf/52/b1/kjtcv-49-401.PMC5059130.pdf
Since she considered it to be irrelevant to the thy-Korean J Thorac Cardiovasc Surg 2016;49:405-407 □ CASE REPORT □ http://dx.doi.or g/10.5090/k jtcs.2016.49.5.405,Non-OADS,/arxiv_data1/oa_pdf/90/9b/kjtcv-49-405.PMC5059131.pdf
"Brain magnetic resonance imaging revealed a sub- arachnoid hemorrhage in the frontal and right occipi- tal lobes, as well as multifocal microhemorrhages in  the bilateral cerebellum and the left occipital, left pa-Korean J Thorac Cardiovasc Surg 2016;49:408-412 □ CASE REPORT □ http://dx.doi.or g/10.5090/k jtcs.2016.49.5.408",Non-OADS,/arxiv_data1/oa_pdf/34/8f/kjtcv-49-408.PMC5059132.pdf
e-mail: iyamane@affrc.go.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/af/1b/jvms-78-1385.PMC5059364.pdf
Available: http://www.cvm.umn.edu/sdec/SwineDiseases/pedv/SHMP_14/index.htm.,Non-OADS,/arxiv_data1/oa_pdf/af/1b/jvms-78-1385.PMC5059364.pdf
Ministry of Agriculture Forestry and Fisheries 2014. available from http://www.maff.go.jp/j/syouan/douei/ped/ped.html.,Non-OADS,/arxiv_data1/oa_pdf/af/1b/jvms-78-1385.PMC5059364.pdf
e-mail:ahorimo@mail.ecc.u-tokyo.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/83/1f/jvms-78-1391.PMC5059365.pdf
e-mail: zawaniisa@yahoo.com ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/d7/de/jvms-78-1399.PMC5059366.pdf
e-mail: imaiku@obihiro.ac.jp ©2016	The	Japanese	Society	of	 Veterinary	Science This	is	an	open-access	 article	distributed 	under	the	terms	of	the	Creative	 Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/6f/03/jvms-78-1405.PMC5059367.pdf
Available	online	 at	http://www.who.int/csr/resources/publications/influenza/who 	 cdscsrncs20025rev.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6f/03/jvms-78-1405.PMC5059367.pdf
Available	 online	at	http://www.who.int/influenza/hu- man_animal_interface/H5N1_cumulative_table_archives/en/.,OADS,/arxiv_data1/oa_pdf/6f/03/jvms-78-1405.PMC5059367.pdf
e-mail: nobsasa@vmas.kitasato-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/d4/a4/jvms-78-1413.PMC5059368.pdf
hCas9 mRNA  from pX330 (https://www.addgene.org/42230/) was synthe- sized using the mMESSAGE mMACHINE T7 kit (Thermo  Fisher Scientific) and was polyadenylated with the Poly (A)  Tailing kit (Thermo Fisher Scientific).,Non-OADS,/arxiv_data1/oa_pdf/d4/a4/jvms-78-1413.PMC5059368.pdf
CBB-stained  urinary albumin was quantified using the image analysis  program ImageJ (http://rsb.info.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/d4/a4/jvms-78-1413.PMC5059368.pdf
©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/66/67/jvms-78-1421.PMC5059369.pdf
The ASCII files were imported into  “R” software (http://cran.r-project.org/) and aligned using an  open-access software package.,OADS,/arxiv_data1/oa_pdf/66/67/jvms-78-1421.PMC5059369.pdf
"The identi- fied metabolites were defined based on data from a previous  study and public databases, e.g., the Human Metabolome  database (HMdB, http://www.hmdb.ca) and the Biologi-cal Magnetic Resonance data Bank (BMRB, www.bmrb.",OADS,/arxiv_data1/oa_pdf/66/67/jvms-78-1421.PMC5059369.pdf
"Based on the Kyoto Encyclopedia  of Genes and Genomes (KEGG, http://www.kegg.jp), the  impact factor of the topology analyses of metabolic path- ways was graphically presented using metabolomics data  analysis software (Metaboanalyst 2.0, www.metaboanalyst.",OADS,/arxiv_data1/oa_pdf/66/67/jvms-78-1421.PMC5059369.pdf
e-mail:	kanai@vmas.kitasato-u.ac.jp ©2016	The	Japanese	Society	of	 Veterinary	Science This	is	an	open-access	 article	distributed 	under	the	terms	of	the	Creative	 Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/2d/b9/jvms-78-1429.PMC5059370.pdf
e-mail: nmgtl1986@yahoo.co.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/6d/27/jvms-78-1439.PMC5059371.pdf
e-mail: hohdatsu@vmas.kitasato-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/09/2b/jvms-78-1447.PMC5059372.pdf
"We report the distribution of anti-bodies against Brucella	 in	large	Pacific	whales	and	propose	 a hypothesis on the transmission and maintenance of this  *Corresponden Ce to: Ohishi , K., Present address: Tokyo Polytech- nic University, Iiyama 1583, Atsugi, Kanagawa 243–0297, Japan,  e-mail: cie20910@syd.odn.ne.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/2b/5d/jvms-78-1457.PMC5059373.pdf
©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/23/d9/jvms-78-1465.PMC5059374.pdf
e-mail: Fumiaki_Mizobe@jra.go.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/4f/cc/jvms-78-1475.PMC5059375.pdf
e-mail: skazuaki@cc.tuat.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/46/b2/jvms-78-1481.PMC5059376.pdf
e-mail: pengjian@mail.hzau.edu.cn ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/c0/2d/jvms-78-1487.PMC5059377.pdf
"e-mail: anuwat.wir@mahidol.edu, neoart23026@gmail.com ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/5e/90/jvms-78-1495.PMC5059378.pdf
Online available at: http://www.boe.moph.go.th/ (cited: 2015 June 15).,Non-OADS,/arxiv_data1/oa_pdf/5e/90/jvms-78-1495.PMC5059378.pdf
Online available at: http://ict.dld.go.th/ (cited: 2015 June  15).,OADS,/arxiv_data1/oa_pdf/5e/90/jvms-78-1495.PMC5059378.pdf
e-mail: osawa@cc.miyazaki-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/a2/92/jvms-78-1501.PMC5059379.pdf
e-mail: hayatomo@affrc.go.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/88/74/jvms-78-1505.PMC5059380.pdf
e-mail: alejandro.perez.ecija@uco.es ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/16/c5/jvms-78-1511.PMC5059381.pdf
e-mail: ayone@mail.ecc.u-tokyo.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/10/da/jvms-78-1515.PMC5059382.pdf
e-mail: aksugiur@mail.ecc.u-tokyo.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/07/50/jvms-78-1521.PMC5059383.pdf
http://www.anicom-page.com/hakusho/book/pdf/ book_201411.pdf.,Non-OADS,/arxiv_data1/oa_pdf/07/50/jvms-78-1521.PMC5059383.pdf
http://www.petfood.or.jp/data/chart2014/index.html.,Non-OADS,/arxiv_data1/oa_pdf/07/50/jvms-78-1521.PMC5059383.pdf
e-mail: baku@vmas.kitasato-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/cc/61/jvms-78-1525.PMC5059384.pdf
e-mail: itagaki@iwate-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/f6/6e/jvms-78-1529.PMC5059385.pdf
e-mail:	khk1329@kribb.re.kr ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/35/13/jvms-78-1533.PMC5059386.pdf
e-mail: yoohs@snu.ac.kr © The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/87/74/jvms-78-1537.PMC5059387.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Lui, S. K. Y.",Non-OADS,/arxiv_data1/oa_pdf/c5/f4/ncomms13020.PMC5059473.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ rThe Author(s) 2016NATURE COMMUNICATIONS | DOI: 10.1038/ncomms13020 ARTICLE NATURE COMMUNICATIONS | 7:13020 | DOI: 10.1038/ncomms13020 | www.nature.com/naturecommunications 7",Non-OADS,/arxiv_data1/oa_pdf/c5/f4/ncomms13020.PMC5059473.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-nd/4.0/      © Th e Author(s) 2016",Non-OADS,/arxiv_data1/oa_pdf/12/ea/ajg2016439a.PMC5059698.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016 Supplementary Information accompanies this paper on Gene Therapy website (http://www.nature.com/gt)Delivery of therapeutic proteins via mRNA F DeRosa et al 707 Gene Therapy (2016) 699 –707",Non-OADS,/arxiv_data1/oa_pdf/cf/c7/gt201646a.PMC5059749.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 625 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.03.019 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/97/cf/main.PMC5059821.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/cf/main.PMC5059821.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/25/main.PMC5059822.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 560–562 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.03.014 1319-0164 ª2015 The Author.",Non-OADS,/arxiv_data1/oa_pdf/ea/25/main.PMC5059822.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/25/main.PMC5059822.pdf
http://dx.doi.org/10.5144/0256-4947.2012.492 .,Non-OADS,/arxiv_data1/oa_pdf/ea/25/main.PMC5059822.pdf
http://dx.doi.org/ 10.4103/1817-1737.109823 .,Non-OADS,/arxiv_data1/oa_pdf/ea/25/main.PMC5059822.pdf
"< http://www.fda.gov/ohrms/dockets/ac/02/brieﬁng/ 3861OPH1_07_Winckler.PDF >, (Retrieved 12.10.13).",Non-OADS,/arxiv_data1/oa_pdf/ea/25/main.PMC5059822.pdf
http://dx.doi.org/10.1001/ archderm.142.6.712 .,Non-OADS,/arxiv_data1/oa_pdf/ea/25/main.PMC5059822.pdf
http://dx.doi.org/10.1016/j.amjopharm.2011.02.007 .,OADS,/arxiv_data1/oa_pdf/ea/25/main.PMC5059822.pdf
http://dx.doi.org/10.1089/tmj.2010.0003 .,OADS,/arxiv_data1/oa_pdf/ea/25/main.PMC5059822.pdf
http://dx.doi.org/10.1111/dsu.12344 .,Non-OADS,/arxiv_data1/oa_pdf/ea/25/main.PMC5059822.pdf
http://dx.doi.org/10.1016/j.cgh.2013.04.024 .,OADS,/arxiv_data1/oa_pdf/ea/25/main.PMC5059822.pdf
http://dx.doi.org/ 10.1016/j.ejheart.2005.01.002 .,OADS,/arxiv_data1/oa_pdf/ea/25/main.PMC5059822.pdf
http://dx.doi.org/10.1177/ 1741826711430926 .,Non-OADS,/arxiv_data1/oa_pdf/ea/25/main.PMC5059822.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8e/05/main.PMC5059823.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 515–524 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.02.015 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/8e/05/main.PMC5059823.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8e/05/main.PMC5059823.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 571–578 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.03.006 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/e7/1b/main.PMC5059824.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e7/1b/main.PMC5059824.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e7/1b/main.PMC5059824.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/0a/main.PMC5059825.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 507–514 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.01.020 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/eb/0a/main.PMC5059825.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/0a/main.PMC5059825.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/39/28/main.PMC5059826.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 600–604 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.03.021 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/39/28/main.PMC5059826.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/39/28/main.PMC5059826.pdf
http://dx.doi.org/10.4103/ 0976-500X.120941 .,Non-OADS,/arxiv_data1/oa_pdf/39/28/main.PMC5059826.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 605–610 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.03.016 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/3a/99/main.PMC5059827.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/99/main.PMC5059827.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/99/main.PMC5059827.pdf
< http://www.nhlbisupport.com/bmi/bmi-m.htm >.,Non-OADS,/arxiv_data1/oa_pdf/3a/99/main.PMC5059827.pdf
< http://pewinternet.org/Reports/2011/Social-Networking- Sites.aspx >.,Non-OADS,/arxiv_data1/oa_pdf/3a/99/main.PMC5059827.pdf
http://www.pewinternet.org/2010/03/24/health-information/ .610 A.I.,Non-OADS,/arxiv_data1/oa_pdf/3a/99/main.PMC5059827.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7e/3b/main.PMC5059828.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 525–536 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.02.025 1319-0164 ª2015 The Author.",Non-OADS,/arxiv_data1/oa_pdf/7e/3b/main.PMC5059828.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7e/3b/main.PMC5059828.pdf
Rep. 4.http://dx.doi.org/10.1038/srep04723 .,Non-OADS,/arxiv_data1/oa_pdf/7e/3b/main.PMC5059828.pdf
http://dx.doi.org/10.1155/2013/340315 .,Non-OADS,/arxiv_data1/oa_pdf/7e/3b/main.PMC5059828.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bb/30/main.PMC5059829.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 547–553 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.03.013 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/bb/30/main.PMC5059829.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bb/30/main.PMC5059829.pdf
< http://dx.doi.org/10.5772/57282 >.,Non-OADS,/arxiv_data1/oa_pdf/bb/30/main.PMC5059829.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 563–570 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.03.023 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c7/51/main.PMC5059830.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c7/51/main.PMC5059830.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c7/51/main.PMC5059830.pdf
"< http://www.haad.ae/HAAD/LinkClick.aspx?ﬁleticket= 8YIa2Sz8nDE%3d&tabid=207 >, (accessed 26.04.13).",Non-OADS,/arxiv_data1/oa_pdf/c7/51/main.PMC5059830.pdf
< http://www.haad.,Non-OADS,/arxiv_data1/oa_pdf/c7/51/main.PMC5059830.pdf
"< http://www.accp.com/- docs/positions/misc/Improvin g_Patient_and_Health_System_ Outcomes.pdf >, (accessed 22.02.13).",Non-OADS,/arxiv_data1/oa_pdf/c7/51/main.PMC5059830.pdf
"< http://www.accp.com/docs/positions/ misc/Improving_Patient_and_ Health_System_Outcomes.pdf >, (accessed 22.02.13).",Non-OADS,/arxiv_data1/oa_pdf/c7/51/main.PMC5059830.pdf
"< http://gmcajman.net/newsroom/?p=1312 >, (accessed 05.06.11).",Non-OADS,/arxiv_data1/oa_pdf/c7/51/main.PMC5059830.pdf
"< http://www.haad.ae/haad/Portals/0/ Reporting%20Adverse%20Reactions-updated24-june%20.pdf >, (accessed 12.11.12).",Non-OADS,/arxiv_data1/oa_pdf/c7/51/main.PMC5059830.pdf
"< http://www.haad.ae/haad/Portals/ 0/Reporting%20Medictaion% 20Errors-updated24-june.pdf >, (accessed on: 19.05.13).",Non-OADS,/arxiv_data1/oa_pdf/c7/51/main.PMC5059830.pdf
"< http://www.haad.ae/ CME/LinkClick.aspx?ﬁleticket=FiwfHufqE3Q%3d&tabid=47 >, (accessed 25.09.12).",Non-OADS,/arxiv_data1/oa_pdf/c7/51/main.PMC5059830.pdf
"< http://www.haad.ae/ HAAD/LinkClick.aspx?ﬁleticket=jgNyCFiAttg%3d&tabid=933 >, (accessed 18.01.11).",Non-OADS,/arxiv_data1/oa_pdf/c7/51/main.PMC5059830.pdf
"< http://www.haad.ae/haad/Portals/0/Health %20Regulation%20Laws/Book2_E n/ﬁles/assets/downloads/ publication.pdf >, (accessed 15.03.13).",Non-OADS,/arxiv_data1/oa_pdf/c7/51/main.PMC5059830.pdf
"< http://www.haad.ae/ HAAD/LinkClick.aspx?ﬁleticket=hOnNXZIep3M%3d&tabid=976>, (accessed 02.02.13).",Non-OADS,/arxiv_data1/oa_pdf/c7/51/main.PMC5059830.pdf
< http://www.haad.ae/HAAD/LinkClick.,Non-OADS,/arxiv_data1/oa_pdf/c7/51/main.PMC5059830.pdf
< http://www.haad.ae/cme/ CMECPCNews/tabid/107/ctl/Details/Mid/447/ItemID/2/Default.,Non-OADS,/arxiv_data1/oa_pdf/c7/51/main.PMC5059830.pdf
"< http://www.haad.ae/haad/tabid/58/ctl/Details/Mid/417/ ItemID/186/Default.aspx >, (accessed 08.06.11).",Non-OADS,/arxiv_data1/oa_pdf/c7/51/main.PMC5059830.pdf
"Abu Dhabi, UAE: HAAD < http://www.haad.ae/haad/tabid/58/ctl/Details/Mid/417/ ItemID/170/Default.aspx >, (accessed 08.06.11).",Non-OADS,/arxiv_data1/oa_pdf/c7/51/main.PMC5059830.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/a6/main.PMC5059831.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 537–546 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.02.024 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/0b/a6/main.PMC5059831.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/a6/main.PMC5059831.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fc/3a/main.PMC5059832.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 554–559 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.03.022 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/fc/3a/main.PMC5059832.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fc/3a/main.PMC5059832.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/88/main.PMC5059833.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 611–615 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.03.025 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/eb/88/main.PMC5059833.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/88/main.PMC5059833.pdf
< http://www.cdc.gov/gets- mart/community/index.html > (accessed 19.02.15).,Non-OADS,/arxiv_data1/oa_pdf/eb/88/main.PMC5059833.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 588–599 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.03.020 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/37/aa/main.PMC5059834.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/aa/main.PMC5059834.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/aa/main.PMC5059834.pdf
http://www.ncbi.nlm.nih.gov/pubmed/20722498 Pharm.,Non-OADS,/arxiv_data1/oa_pdf/37/aa/main.PMC5059834.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/82/main.PMC5059835.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2016) 24, 579–587 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2015.03.007 1319-0164 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/4f/82/main.PMC5059835.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/82/main.PMC5059835.pdf
< http://www.ich.org/ﬁleadmin/Public_Web_Site/ ICH_Products/Guidelines/Quality/Q1C/Step4/Q1C_Guideline.pdf> (Accessed 5th June 2013).,Non-OADS,/arxiv_data1/oa_pdf/4f/82/main.PMC5059835.pdf
<http://ethesis.helsinki.ﬁ/julkaisut/mat/farma/vk/rashid/centrifu.,Non-OADS,/arxiv_data1/oa_pdf/4f/82/main.PMC5059835.pdf
Availlable at:http://mixedmethodsappraisaltoolpublic.pbworks.,Non-OADS,/arxiv_data1/oa_pdf/cf/14/HEX-18-0754.PMC5060808.pdf
"The majority of health professionals routinely ‘talk the talk’ of informed choice and patient-centred care, increasingly emphasizing ‘patient-important outcomes’ as promoted by the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) col- laboration 1and the newly established Patient- Centered Outcomes Research Institute (PCO- RI) (http://www.pcori.org) among many other individuals and groups.",Non-OADS,/arxiv_data1/oa_pdf/5d/2a/HEX-18-0689.PMC5060847.pdf
"18,19These range from implementations of a SMART (Simple Multi Attribute Rating System) in a simple spread- sheet, implementations using the analytic hierarchy process (AHP) as executed either in a spreadsheet template or a dedicated soft- ware package, notably Expert Choice, http://expertchoice.com/products-services/expert-choice- desktop/, to speciﬁc MCDA implementations such as V.I.S.A http://www.visadecisions.com, HiView http://www.catalyze.co.uk/index.php/soft ware/hiview3/, Web-Hipre http://hipre.aalto.ﬁ/ and Logical Decisions http://www.logicaldeci sions.com/.",Non-OADS,/arxiv_data1/oa_pdf/5d/2a/HEX-18-0689.PMC5060847.pdf
"Conﬂict of Interest Jack Dowie has a ﬁnancial interest in theAnnalisa software, but Annalisa and Elicia are ©Maldaba Ltd. (http://maldaba.co.uk/products/ annalisa) References 1 Guyatt GH, Oxman AD, Kunz R et al.",Non-OADS,/arxiv_data1/oa_pdf/5d/2a/HEX-18-0689.PMC5060847.pdf
"Patient Education and Counseling , 2012 [cited 2012 Nov 7]; Available from: http://www.ncbi.nlm.nih.gov/ pubmed/22854227.",Non-OADS,/arxiv_data1/oa_pdf/5d/2a/HEX-18-0689.PMC5060847.pdf
"Implementation Science , 2013; Available at http://ipdas.ohri.ca/IPDAS – Implementa.",OADS,/arxiv_data1/oa_pdf/5d/2a/HEX-18-0689.PMC5060847.pdf
"Available at: http://www.cma.ca/ privacy-conﬁdentiality, accessed 15 September 2011.",Non-OADS,/arxiv_data1/oa_pdf/d8/65/HEX-18-0727.PMC5060870.pdf
"Available at: http://www.hc-sc.gc.ca/hcs-sss/prim/about-apropos-eng.php, accessed 5 August 2011.",Non-OADS,/arxiv_data1/oa_pdf/d8/65/HEX-18-0727.PMC5060870.pdf
"Available at: http://www.camft.org/ ScriptContent/CAMFTarticles/Conﬁdentiality/ConﬁdentialityIssuesInAgency.htm, accessed 18 June2011.",Non-OADS,/arxiv_data1/oa_pdf/d8/65/HEX-18-0727.PMC5060870.pdf
Available at: http://laws-lois.justice.,Non-OADS,/arxiv_data1/oa_pdf/d8/65/HEX-18-0727.PMC5060870.pdf
"Ottawa, ON: Government of Canada, 2010.Available at: http://www.pre.ethics.gc.ca/eng/resources-ressources/news-nouvelles/nr-cp/2010-12- 07/, accessed 15 November 2013.",Non-OADS,/arxiv_data1/oa_pdf/d8/65/HEX-18-0727.PMC5060870.pdf
"Available at: http://www.pre.ethics.gc.ca/eng/policy-politique/initiatives/ tcps2-eptc2/Default/, accessed 7 February 2013.",Non-OADS,/arxiv_data1/oa_pdf/d8/65/HEX-18-0727.PMC5060870.pdf
"Available at: http://www.aho.no/en/ AHO/News-and-events/Service-Design/Program1/PapersAbstracts/, accessed 5 July 2013.",Non-OADS,/arxiv_data1/oa_pdf/d8/02/HEX-18-0676.PMC5060875.pdf
Available at: http://apps.who.int/trialsearch/trial.aspx?,Non-OADS,/arxiv_data1/oa_pdf/d8/02/HEX-18-0676.PMC5060875.pdf
"Available at: http://www.rcgp.org.uk/news/2013/December/~/ media/Files/Policy/A-Z-policy/RCGP-Social- Inclusion-Commissioning-Guide.ashx, accessed 14January 2014.",Non-OADS,/arxiv_data1/oa_pdf/7b/64/HEX-18-0784.PMC5060882.pdf
"Available at: https://www.gov.uk/government/publications/healthy-child-programme-pregnancy -and-the-ﬁrst-5-years-of-life, accessed 14 January 2014.",Non-OADS,/arxiv_data1/oa_pdf/7b/64/HEX-18-0784.PMC5060882.pdf
)Available at: http://www.ncbi.nlm.nih.gov/books/ NBK38337.,Non-OADS,/arxiv_data1/oa_pdf/7b/64/HEX-18-0784.PMC5060882.pdf
"Available at:http://www.leedsgate.co.uk/information/ publications-and-resources/, accessed 14 January 2014.",Non-OADS,/arxiv_data1/oa_pdf/7b/64/HEX-18-0784.PMC5060882.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/45/26/10.1177_2325967116667497.PMC5060903.pdf
http://www.ssb.no [accessed 20 October 2014].,Non-OADS,/arxiv_data1/oa_pdf/03/87/BJS-103-226.PMC5061026.pdf
RevisionoftheEuropean StandardPopulation:ReportofEurostat’sTaskForce ; 2013. http://ec.europa.eu/eurostat/documents/3859598/5926869/KS-RA-13-028-EN.PDF/e713fa79-1add-44e8-b23d-5e8fa0 9b3f8f [accessed 30 September 2015].,Non-OADS,/arxiv_data1/oa_pdf/03/87/BJS-103-226.PMC5061026.pdf
EpiTools:EpidemiologyTools.Rpackage version0.5-7 ; 2012. http://CRAN.R-project.org/ package =epitools [accessed 30 September 2015].,Non-OADS,/arxiv_data1/oa_pdf/03/87/BJS-103-226.PMC5061026.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/30/11/main.PMC5061058.pdf
Direct link to deposited data https://www.ncbi.nlm.nih.gov/nuccore/1069984307 2.,OADS,/arxiv_data1/oa_pdf/30/11/main.PMC5061058.pdf
http://dx.doi.org/10.1016/j.gdata.2016.10.001 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/30/11/main.PMC5061058.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/30/11/main.PMC5061058.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Hypertension Diagnosis Dietary Approaches to Stop Hypertension(DASH) dietNutrient intakeNational Health and Nutrition ExaminationSurvey (NHANES) 1.,Non-OADS,/arxiv_data1/oa_pdf/81/b7/main.PMC5061059.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.09.009 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/81/b7/main.PMC5061059.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/b7/main.PMC5061059.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/81/b7/main.PMC5061059.pdf
"As part of a larger project aimed at utilizing genomic data for forest disease diagnostics, pathogen detection and monitoring (TheTAIGA project: Tree Aggressors Identi ﬁcation using Genomic Approaches; http://taigaforesthealth.com /), we se- quenced the genomes of six important Phytophthora species that are important invasive pathogens of trees and a serious threat to the international trade of forest products.",Non-OADS,/arxiv_data1/oa_pdf/76/d4/main.PMC5061060.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Invasive species Oomycetes Forest health Speci ﬁcations Organism/cell line/tissue Six Phytophthora species, see Table 1 .",Non-OADS,/arxiv_data1/oa_pdf/76/d4/main.PMC5061060.pdf
http://dx.doi.org/10.1016/j.gdata.2016.09.013 2213-5960/Crown Copyright © 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/76/d4/main.PMC5061060.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/76/d4/main.PMC5061060.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c6/15/main.PMC5061062.pdf
http://dx.doi.org/10.1016/j.idcr.2016.09.015 2214-2509/ ã  2016  The  Authors.,OADS,/arxiv_data1/oa_pdf/c6/15/main.PMC5061062.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases  6  (2016)  68–71 Contents  lists  available  at  ScienceDirect IDCases journal  homepage:  www.elsevier.com/locat  e/idcr,Non-OADS,/arxiv_data1/oa_pdf/c6/15/main.PMC5061062.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: BovineIntervertebral disc Annulus ﬁbrosus Cell line In situ hybridization Resource table.,Non-OADS,/arxiv_data1/oa_pdf/47/b7/main.PMC5061063.pdf
http://dx.doi.org/10.1016/j.gdata.2016.09.012 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/47/b7/main.PMC5061063.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/b7/main.PMC5061063.pdf
"37 (2015) 1573 –1577, http://dx.doi.org/10.1007/s10529-015-1833-1 .",Non-OADS,/arxiv_data1/oa_pdf/47/b7/main.PMC5061063.pdf
"4 (2016) 1 –18,http://dx.doi.org/10.3390/ jdb4010003.",Non-OADS,/arxiv_data1/oa_pdf/47/b7/main.PMC5061063.pdf
"PLoS One 9 (2014), e91799, http://dx.doi.org/10.1371/journal.pone.0091799 .",Non-OADS,/arxiv_data1/oa_pdf/47/b7/main.PMC5061063.pdf
"12(2010) R22, http://dx.doi.org/10.1186/ar2929 .",Non-OADS,/arxiv_data1/oa_pdf/47/b7/main.PMC5061063.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/96/84/main.PMC5061065.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.05.020 390,OADS,/arxiv_data1/oa_pdf/96/84/main.PMC5061065.pdf
"Sinda Zarrouk-Mahjoub PhD Genomics Platform, Pasteur Institute of Tunis, Tunisia 3 October 2016Molecular Genetics and Metabolism Reports 9 (2016) 34 http://dx.doi.org/10.1016/j.ymgmr.2016.10.002 2214-4269/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c2/f0/main.PMC5061068.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c2/f0/main.PMC5061068.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e5/36/main.PMC5061071.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.10.002 2213-0071/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e5/36/main.PMC5061071.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 19 (2016) 143 e149,Non-OADS,/arxiv_data1/oa_pdf/e5/36/main.PMC5061071.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.09.005,Non-OADS,/arxiv_data1/oa_pdf/4d/a4/main.PMC5061073.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,6 9 –72 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/4d/a4/main.PMC5061073.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,6 9 –72 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/4d/a4/main.PMC5061073.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,6 9 –72 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/4d/a4/main.PMC5061073.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.09.004,Non-OADS,/arxiv_data1/oa_pdf/30/7e/main.PMC5061075.pdf
MALDI-TOF MS spectrum accession number The MALDI-TOF MS spectrum of this strain is available online (http://mediterranee-infection.com/article.php?laref=256&titre =urms-database ).,Non-OADS,/arxiv_data1/oa_pdf/30/7e/main.PMC5061075.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,6 7 –68 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/30/7e/main.PMC5061075.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/dc/main.PMC5061076.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.10.004 2213-0071/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/58/dc/main.PMC5061076.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 19 (2016) 155 e158,Non-OADS,/arxiv_data1/oa_pdf/58/dc/main.PMC5061076.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.09.002,Non-OADS,/arxiv_data1/oa_pdf/ab/06/main.PMC5061077.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,5 8–66 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ab/06/main.PMC5061077.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,5 8–66 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ab/06/main.PMC5061077.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,5 8–66 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ab/06/main.PMC5061077.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,5 8–66 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ab/06/main.PMC5061077.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,5 8–66 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ab/06/main.PMC5061077.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,5 8–66 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ab/06/main.PMC5061077.pdf
"A qualitative goal for limiting ﬂuoroquinolone prescribing in outpatient care in Swe- den was set in 2007, but none of the counties has reached the target set ( https://www.folkhalsomyndigheten.se/page ﬁles/ 24127/Swedres-Svarm-2015-15099.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/ab/06/main.PMC5061077.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,5 8–66 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ab/06/main.PMC5061077.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,5 8–66 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ab/06/main.PMC5061077.pdf
"1, 59–74 http://dx.doi.org/10.1080/10255842.2016.1198784 Computational model of mesenchymal migration in 3D under chemotaxis F. O. Ribeiroa,b, M. J. Gómez-Benitob, J. Folgadoa, P .",OADS,/arxiv_data1/oa_pdf/6b/fa/gcmb-20-059.PMC5061084.pdf
"this is an open access article distributed under the terms of the Creative Commons attribution-nonCommercial-nod erivatives license (http://creativecommons.org/licenses/by-nc- nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon  in any way.CONTACT J. m. g arcía- aznar  jmgaraz@unizar.es  the supplementary material for this paper is available online at http://dx.doi.org.10.1080/10255842.2016.1198784.",Non-OADS,/arxiv_data1/oa_pdf/6b/fa/gcmb-20-059.PMC5061084.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0e/0d/main.PMC5061085.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.09.006 2213-0071/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0e/0d/main.PMC5061085.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 19 (2016) 150 e154,Non-OADS,/arxiv_data1/oa_pdf/0e/0d/main.PMC5061085.pdf
http://www.Census.Gov/prod/ 2006pubs/p23-209.pdf 17.,OADS,/arxiv_data1/oa_pdf/d0/b3/EHF2-3-44.PMC5061087.pdf
24. http://www.learningace.com/doc/191199/ 51f25519884ce11938bfbe8f338a2018/mncode 25.,Non-OADS,/arxiv_data1/oa_pdf/d0/b3/EHF2-3-44.PMC5061087.pdf
"For the biological motion (BM) conditions of the mainexperiments and the Response and Attention Control Experiments, dots moved according to motion-tracking data (frame rate 60 Hz) recorded from the head, shoulders, elbows, wrists, hips, knees and ankles of human actors, obtained from: http://mocap.cs.cmu.edu/.",OADS,/arxiv_data1/oa_pdf/71/a4/HBM-37-203.PMC5061089.pdf
"Activation sites were projected (enclosing voxel projection) onto the PALS template [Van Essen, 2005, http://sumsdb.wustl.edu:8081/ sums/directory.do?id 5636032] using Caret software [Van Essen et al., 2001, http://brainvis.wustl.edu/caret].",OADS,/arxiv_data1/oa_pdf/71/a4/HBM-37-203.PMC5061089.pdf
"Retrieved May 8, 2013, from http://www.newsoxy.com/business/cdc-suicide-economy-22739.html.",Non-OADS,/arxiv_data1/oa_pdf/44/66/SLTB-46-352.PMC5061092.pdf
"28, 2015, from: http://wisqars.cdc.gov:8080/ costt/.",OADS,/arxiv_data1/oa_pdf/44/66/SLTB-46-352.PMC5061092.pdf
"Retrieved December 11, 2014, from: https://suicideinfo.ca/ LinkClick.aspx?",Non-OADS,/arxiv_data1/oa_pdf/44/66/SLTB-46-352.PMC5061092.pdf
"Retrieved January 26, 2015, from http://kff.org/other/state-indicator/health- spending-per-capita/.",Non-OADS,/arxiv_data1/oa_pdf/44/66/SLTB-46-352.PMC5061092.pdf
"Retrieved February 17, 2015, from http://www.pire.org/documents/WisqarsCostMeth-ods.pdf.",Non-OADS,/arxiv_data1/oa_pdf/44/66/SLTB-46-352.PMC5061092.pdf
"Retrieved January 2015, 20, from: http://www.samhsa.- gov/data/sites/default/ﬁles/2k12MH_Findings/2k12MH_Findings/NSDUHmhfr2012.htm.",OADS,/arxiv_data1/oa_pdf/44/66/SLTB-46-352.PMC5061092.pdf
"Retrieved January 28, 2015, from http://dataferrett.census.gov/.",OADS,/arxiv_data1/oa_pdf/44/66/SLTB-46-352.PMC5061092.pdf
"Retrieved February 11, 2015, from: http://en.wikipedia.org/ wiki/Demographics_of_ Scotland.",Non-OADS,/arxiv_data1/oa_pdf/44/66/SLTB-46-352.PMC5061092.pdf
"Retrieved February 12, 2015, from http://data.worldbank.org/indicator/ NY.GDP.PCAP.CD/countries?display=default.",OADS,/arxiv_data1/oa_pdf/44/66/SLTB-46-352.PMC5061092.pdf
"Retrieved February 12, 2015, from http://data.worldbank.org/indicator/SP.P OP.TOTL.",OADS,/arxiv_data1/oa_pdf/44/66/SLTB-46-352.PMC5061092.pdf
"Retrieved December 11, 2014, from http://www.xe.com/currencyconverter/.",Non-OADS,/arxiv_data1/oa_pdf/44/66/SLTB-46-352.PMC5061092.pdf
Available from URL: http://www.rcr.ac.uk/docs/oncology/pdf/ORF%20survey%202011%20oct%202011%20FINAL%2027%2010%2011.pdf 10.,Non-OADS,/arxiv_data1/oa_pdf/9f/32/JMIRO-59-717.PMC5061100.pdf
"’project, see http://www.uib.no/en/project/speakup), which followed a group of at-risk children and matched controls from they were 5 to 11 years old, when dyslexia was diagnosed and the collected data could be analysed retrospectively (Helland, Plante, & Hugdahl, 2011).",Non-OADS,/arxiv_data1/oa_pdf/d8/2d/DYS-22-3.PMC5061103.pdf
"(Avail- able from: http://www.nature.com/nature/journal/v461/n7266/suppinfo/nature08461_S1.html) Christensen, A.-L. (1985).",Non-OADS,/arxiv_data1/oa_pdf/d8/2d/DYS-22-3.PMC5061103.pdf
"Bergen, Norway: (Available from: http://www.vesttest.no).",Non-OADS,/arxiv_data1/oa_pdf/d8/2d/DYS-22-3.PMC5061103.pdf
(Available from http://www.regjeringen.no/en/dokumenter/ kindergarten-act/id115281/) Norwegian Directorate for Education and Training.,Non-OADS,/arxiv_data1/oa_pdf/d8/2d/DYS-22-3.PMC5061103.pdf
Oslo (Available from http://www.udir.no/kl06/ENG1-03) Norwegian Directorate for Education and Training.,Non-OADS,/arxiv_data1/oa_pdf/d8/2d/DYS-22-3.PMC5061103.pdf
"(Available from https://www.regjeringen.no/nb/dokumenter/meld-st-18-20102011/id639487/) Pancsofar, N., & Vernon-Feagans, L. (2006).",Non-OADS,/arxiv_data1/oa_pdf/d8/2d/DYS-22-3.PMC5061103.pdf
"British dyslexia associtation: De ﬁnition of dyslexia, (Available from: http://www.bdadyslexia.org.uk/about-dyslexia/faqs.html).",Non-OADS,/arxiv_data1/oa_pdf/d8/2d/DYS-22-3.PMC5061103.pdf
Available at http://www.oecd.org/els/health-systems/europeandiabetesleadershipforumedlfcopenhagen25-26april2012.htm Last accessed 2 October 2015.,Non-OADS,/arxiv_data1/oa_pdf/22/52/DME-33-877.PMC5061106.pdf
PROcedure SPECiﬁc postoperative pain menagemenT (PROSPECT) [www document] http://www.postoppain.org/ (accessed 15February 2013).,Non-OADS,/arxiv_data1/oa_pdf/ad/8b/AAS-60-289.PMC5061107.pdf
Available at: http://www.clinicalwebcasts.com/updates/index.htm.,Non-OADS,/arxiv_data1/oa_pdf/ad/8b/AAS-60-289.PMC5061107.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/98/4d/main.PMC5061111.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.09.038 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/98/4d/main.PMC5061111.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/c6/main.PMC5061114.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/c6/main.PMC5061114.pdf
http://dx.doi.org/10.1016/j.eucr.2016.09.001Urology Case Reports 9 (2016) 58 e61,Non-OADS,/arxiv_data1/oa_pdf/84/c6/main.PMC5061114.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f0/c5/main.PMC5061118.pdf
"When  vigorously  stim- ulated  with  touch  and  speech,  she  could  give  eye  contact  and http://dx.doi.org/10.1016/j.ijscr.2016.09.018 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/f0/c5/main.PMC5061118.pdf
"1https://www.nice.org.uk/guidance/cg132/chapter/ftn.footnote  1.Top-up  was  not  uncommonly  used  but  the  top-up  drug,  volume  and mixture  as  well  as  when/how  the  top-up  was  administered,  in  the labour  ward  or  after  transfer  to  the  operating  theatre  varied  con- siderable.",Non-OADS,/arxiv_data1/oa_pdf/f0/c5/main.PMC5061118.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/87/a7/main.PMC5061119.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.09.037 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/87/a7/main.PMC5061119.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/73/41/main.PMC5061120.pdf
http://dx.doi.org/10.1016/j.idcr.2016.09.013 2214-2509/ ã  2016  The  Authors.,OADS,/arxiv_data1/oa_pdf/73/41/main.PMC5061120.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases  6  (2016)  65–67 Contents  lists  available  at  ScienceDirect IDCases journal  homepage:  www.elsevier.com/locate/idcr,Non-OADS,/arxiv_data1/oa_pdf/73/41/main.PMC5061120.pdf
PR9 1 (2016) e574http://dx.doi.org/10.1097/PR9.0000000000000574 1 (2016) e574 www.painreportsonline.com 1,Non-OADS,/arxiv_data1/oa_pdf/e9/11/painreports-1-e574.PMC5061130.pdf
"The order of temperatures was randomized across participants, but the same order was used across the three blocks for a single participant.Stimulus presentation and response logging were controlled by MATLAB (R2015a; The MathWorks Inc, Natick, MA) using the Psychophysics Toolbox v3 (http://psychtoolbox.org/).",OADS,/arxiv_data1/oa_pdf/e9/11/painreports-1-e574.PMC5061130.pdf
"To disentangle opposing effects of the motivational challenge from the thirst and mood changes on pain, we used mediation analyses28implemented in the Multilevel Mediation and Moder- ation (M3) Toolbox for MATLAB (http://wagerlab.colorado.edu/tools 50).",OADS,/arxiv_data1/oa_pdf/e9/11/painreports-1-e574.PMC5061130.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c5/c9/main.PMC5061296.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.09.051 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/c5/c9/main.PMC5061296.pdf
"(2016),  http://dx.doi.org/10.1007/ s00464-016-4984-9 .",Non-OADS,/arxiv_data1/oa_pdf/c5/c9/main.PMC5061296.pdf
This  is  an  open access article under  the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ef/89/main.PMC5061297.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.09.046 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/ef/89/main.PMC5061297.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/4c/fe/main.PMC5061298.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.08.004 387,OADS,/arxiv_data1/oa_pdf/4c/fe/main.PMC5061298.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.08.001 377,OADS,/arxiv_data1/oa_pdf/e0/bd/main.PMC5061299.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fb/bb/main.PMC5061300.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.09.054 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/fb/bb/main.PMC5061300.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a1/cb/main.PMC5061301.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.06.001 380,OADS,/arxiv_data1/oa_pdf/a1/cb/main.PMC5061301.pdf
"Available at: http://ec.europa.eu/health/ scientific_committees/consumer_safety/docs/sccs_o_145.pdf .A c - cessed April 13, 2015.",Non-OADS,/arxiv_data1/oa_pdf/a1/cb/main.PMC5061301.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/57/19/main.PMC5061302.pdf
The  patient  had  disease  free http://dx.doi.org/10.1016/j.ijscr.2016.10.002 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/57/19/main.PMC5061302.pdf
"7  (2014)  1877–1880,  http://dx.doi.org/10.3892/ol.2014.1995 , PMC4049717.",Non-OADS,/arxiv_data1/oa_pdf/57/19/main.PMC5061302.pdf
"111  (2015)  546–552,  http://dx.doi.org/10.1002/jso.23843 .",Non-OADS,/arxiv_data1/oa_pdf/57/19/main.PMC5061302.pdf
"26  (2008) 5113–5118,  http://dx.doi.org/10.1200/JCO.2008.17.4631 .",Non-OADS,/arxiv_data1/oa_pdf/57/19/main.PMC5061302.pdf
"9  (2015)  1807–1812,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/57/19/main.PMC5061302.pdf
"38  (2014)  1235–1240,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/57/19/main.PMC5061302.pdf
"111  (2015)  604–614,  http://dx.doi.org/10.1002/jso.",Non-OADS,/arxiv_data1/oa_pdf/57/19/main.PMC5061302.pdf
"38  (2013)  818–820, http://dx.doi.org/10.1097/RLU.0b013e3182a20033 .",Non-OADS,/arxiv_data1/oa_pdf/57/19/main.PMC5061302.pdf
"3)  (2014),  http://dx.doi.org/10.1093/ annonc/mdu254 ,  iii102-12.",Non-OADS,/arxiv_data1/oa_pdf/57/19/main.PMC5061302.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5c/19/main.PMC5061303.pdf
The  Hepatobiliary Surgery  Group  and  the  Transplantation  Surgery  Group  evaluated http://dx.doi.org/10.1016/j.ijscr.2016.09.044 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/5c/19/main.PMC5061303.pdf
"41  (9)  (2015)  1137–1143,  http://dx.doi.org/10.1016/j.ejso.",Non-OADS,/arxiv_data1/oa_pdf/5c/19/main.PMC5061303.pdf
"Ishak,  Hepatic  angiosarcoma  associated with  androgenic-anabolic  steroids,  Lancet  314  (8152)  (1979)  1120–1123, http://dx.doi.org/10.1016/S0140-6736(79)92515-7  [Internet]  Available  from:.",Non-OADS,/arxiv_data1/oa_pdf/5c/19/main.PMC5061303.pdf
"6  (104)  (2008)  1–5,  http://dx.doi.org/10.1186/1477- 7819-6-104 [Internet]  Available  from:.",Non-OADS,/arxiv_data1/oa_pdf/5c/19/main.PMC5061303.pdf
"6 (1)  (2006)  392–397,  http://dx.doi.org/10.1111/j.1600-6143.2005.01179.x [Internet]  Available  from:.",Non-OADS,/arxiv_data1/oa_pdf/5c/19/main.PMC5061303.pdf
"21  (19)  (2015)  6088–6096,  http://dx.doi.org/10.3748/wjg.v21.",Non-OADS,/arxiv_data1/oa_pdf/5c/19/main.PMC5061303.pdf
"18  (4)  (2014)  E114–E119,  http://dx.doi.org/10.1111/petr.12245 [Internet] Available from:.",Non-OADS,/arxiv_data1/oa_pdf/5c/19/main.PMC5061303.pdf
"94  (19) (2015)  1–10,  http://dx.doi.org/10.1097/MD.0000000000000816  [Internet] Available from:.",Non-OADS,/arxiv_data1/oa_pdf/5c/19/main.PMC5061303.pdf
Rep.  16  (2015)  52–55  [Internet]  Surgical Associates  Ltd  Available  from:  http://linkinghub.elsevier.com/retrieve/pii/ S2210261215003971 .,Non-OADS,/arxiv_data1/oa_pdf/5c/19/main.PMC5061303.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/33/main.PMC5061304.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.10.003 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/33/main.PMC5061304.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/8e/main.PMC5061305.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.09.047 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/8e/main.PMC5061305.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/56/ed/main.PMC5061306.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.09.007 2213-0071/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/56/ed/main.PMC5061306.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 19 (2016) 140 e142,Non-OADS,/arxiv_data1/oa_pdf/56/ed/main.PMC5061306.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1e/97/main.PMC5061307.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.07.009 384,OADS,/arxiv_data1/oa_pdf/1e/97/main.PMC5061307.pdf
"For young adults (age < 60 years) and ﬁt elderly patients http://dx.doi.org/10.1016/j.lrr.2016.09.001 Received 20 July 2016; Accepted 30 September 2016⁎Correspondence to: Divisions of Hematology and Internal Medicine, Department of Medicine University Hospital Basel, Petersgraben 4, CH-4031 Basel, Switzerland.",Non-OADS,/arxiv_data1/oa_pdf/0b/81/main.PMC5061308.pdf
This is an open access article under the  CC BY-NC-ND license (http://creativecommons.org/licenses/by/4.0/).Available online 01 October 2016 crossmark,Non-OADS,/arxiv_data1/oa_pdf/0b/81/main.PMC5061308.pdf
http://dx.doi.org/10.1016/j.bbmt.2016.05.026 (Epub ahead of print).,OADS,/arxiv_data1/oa_pdf/0b/81/main.PMC5061308.pdf
http://dx.doi.org/10.1038/leu.2016.183 (Epub ahead of print).,Non-OADS,/arxiv_data1/oa_pdf/0b/81/main.PMC5061308.pdf
"The overall accuracy and quality of our approach was positively related to buffer distance, with accuracies ranging from 50 to 95% for buffer distances from 0 to 100 m. Our results alsoReceived: 15 April 2016 Revised: 30 August 2016 Accepted: 29 September 2016 Heliyon 2 (2016) e00174 http://dx.doi.org/10.1016/j.heliyon.2016.e00174 2405-8440/© 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
"However, due to the conversion of point to zonal data in the development of census data, census based maps have several limitations, including variable precision across space, and an increased likelihood of excluding isolated buildings and scattered low density development ( Bar-Massada et al., 2013 ;Clark et al., 2009 ;Platt, 2010 ).Theobald and Romme (2007) attempted to address some of these limitations through the use of daysemteric techniques which remove undeveloped land prior to calculating Article No~e00174 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00174 2405-8440/© 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
"These methods include both automated and semi-automated methods, and utilize remote sensing, Article No~e00174 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00174 2405-8440/© 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
We conclude with a discussion of Article No~e00174 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00174 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
Article No~e00174 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00174 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
After extracting building locations Article No~e00174 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00174 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
Article No~e00174 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00174 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
Article No~e00174 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00174 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
Article No~e00174 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00174 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
Article No~e00174 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00174 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
Article No~e00174 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00174 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
"However, errors associated with the built environment often persisted through the semi-automated results and were removed during the Article No~e00174 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00174 2405-8440/© 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
"Assuggested by Blaschke (2010) , these improvements might be achieved through Article No~e00174 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00174 2405-8440/© 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
The approach Article No~e00174 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00174 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
Article No~e00174 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00174 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
Article No~e00174 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00174 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
Article No~e00174 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00174 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
Article No~e00174 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00174 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
Article No~e00174 19 http://dx.doi.org/10.1016/j.heliyon.2016.e00174 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8c/89/main.PMC5061309.pdf
This  is  an  open access article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/4d/main.PMC5061310.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.09.055 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/50/4d/main.PMC5061310.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/bc/main.PMC5061311.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.10.001 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/1c/bc/main.PMC5061311.pdf
"[26]  D.  Haboubi,  A.  Thapar,  C.  Bhan,  A.  Oshowo,  Perforated  duodenal  diverticulae: importance for the surgeon  and  gastroenterologist,  BMJ  Case  Rep.  (2014), http://dx.doi.org/10.1136/bcr-2014-205859 .",Non-OADS,/arxiv_data1/oa_pdf/1c/bc/main.PMC5061311.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/98/main.PMC5061312.pdf
We  ﬁrst  observed  the  attribution  and  position  of  the  her- nia  oriﬁce  intraperitoneally  by  laparoscopic  exploration  from http://dx.doi.org/10.1016/j.ijscr.2016.09.053 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/6f/98/main.PMC5061312.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f0/90/main.PMC5061450.pdf
E-mail address: J.Elliott-King@lboro.ac.uk http://dx.doi.org/10.1016/j.dadm.2016.06.002 2352-8729/ /C2112016 Published by Elsevier Inc. on behalf of the Alzheimer’s Association.,Non-OADS,/arxiv_data1/oa_pdf/f0/90/main.PMC5061450.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/61/38/main.PMC5061465.pdf
E-mail address: thad-abrams@uiowa.edu http://dx.doi.org/10.1016/j.dadm.2016.08.004 2352-8729/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/61/38/main.PMC5061465.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/38/main.PMC5061465.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2016.08.004 .,OADS,/arxiv_data1/oa_pdf/61/38/main.PMC5061465.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/09/e9/main.PMC5061466.pdf
E-mail address: eero.vuoksimaa@helsinki.ﬁ http://dx.doi.org/10.1016/j.dadm.2016.08.003 2352-8729/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/09/e9/main.PMC5061466.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/e9/main.PMC5061466.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2016.08.003 .RESEARCH IN CONTEXT 1.,OADS,/arxiv_data1/oa_pdf/09/e9/main.PMC5061466.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ed/b0/main.PMC5061467.pdf
E-mail address: gsanchezb@fpmaragall.org http://dx.doi.org/10.1016/j.dadm.2016.07.001 2352-8729/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ed/b0/main.PMC5061467.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/b0/main.PMC5061467.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2016.07.001 .,OADS,/arxiv_data1/oa_pdf/ed/b0/main.PMC5061467.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Cytomegalovirus Communication AttitudesBirth defectsPrevention 1.,Non-OADS,/arxiv_data1/oa_pdf/b0/5e/main.PMC5061468.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.09.0082211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/5e/main.PMC5061468.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b0/5e/main.PMC5061468.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/b0/5e/main.PMC5061468.pdf
http://dx.doi.org/10.1097/01.AOG.0000466430.,Non-OADS,/arxiv_data1/oa_pdf/b0/5e/main.PMC5061468.pdf
73 –86http://dx.doi.org/10.1385/1592599656 .,Non-OADS,/arxiv_data1/oa_pdf/b0/5e/main.PMC5061468.pdf
http://dx.doi.org/10.1186/1471-2458- 5-70.,Non-OADS,/arxiv_data1/oa_pdf/b0/5e/main.PMC5061468.pdf
http://www.cdc.gov/ cmv/overview.html .,OADS,/arxiv_data1/oa_pdf/b0/5e/main.PMC5061468.pdf
1 –7http://dx.doi.org/ 10.1155/IDOG/2006/80383 .,OADS,/arxiv_data1/oa_pdf/b0/5e/main.PMC5061468.pdf
https://www.census.gov/quickfacts/table/PST045215/00 .,OADS,/arxiv_data1/oa_pdf/b0/5e/main.PMC5061468.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/73/db/main.PMC5061469.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Drugs and Drug Resistance journal homepage: www.elsevier.com/locate/ijpddr http://dx.doi.org/10.1016/j.ijpddr.2016.09.004 2211-3207/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/73/db/main.PMC5061469.pdf
"In silico physicochemical properties calculation Virtual Computational Chemistry Laboratory ( Tetko et al., 2005 ) (http://www.vcclab.org/ ) and Molinspiration online propertycalculation toolkit ( http://www.molinspiration.com/cgi-bin/ properties ) were used to calculate Topological Polar Surface Area (TPSA) ( Ertl et al., 2000 ), ALOGPs2.1, number of rotatable bonds and violations of Lipinski's rule of ﬁve (Lipinski et al., 1997 ).",OADS,/arxiv_data1/oa_pdf/73/db/main.PMC5061469.pdf
"Viruses were dislodged from the sediment using a physical-chemical procedure ( 50), and viral DNA, which was extracted and purified according to standard protocols,was sequenced on a 454 FLX Titaniu m platform (see the Supplementary Materials).SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/10/e1600492/DC1Supplementary Methodsfig.",Non-OADS,/arxiv_data1/oa_pdf/92/ef/1600492.PMC5061471.pdf
The Brazi lian Annual Statistics publica- tion organized by the IBGE is available at http://biblioteca.ibge.gov.br.,Non-OADS,/arxiv_data1/oa_pdf/dc/4e/1600936.PMC5061472.pdf
"We extracted a mask encompassing the states of Acre, Amazonas, Roraima, and Rondônia from a preclassified mosaic (wetland extant, vegetation cover, and inundation state) at a 100-m resolution of the Japanese Earth Resource Satellite (JERS-1), which is free for use and isavailable on the ORNL DAAC websit e at http://daac.ornl.gov/index.",OADS,/arxiv_data1/oa_pdf/dc/4e/1600936.PMC5061472.pdf
SUPPLEMENTARY MATERIAL Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/10/e1600936/DC1text S1.,Non-OADS,/arxiv_data1/oa_pdf/dc/4e/1600936.PMC5061472.pdf
"The IUCN Red List of Threatened Species 2015: e.T12304A21937379, http://dx.doi.org/10.2305/IUCN.UK.2015-2.RLTS.T12304A21937379.en (2015).",Non-OADS,/arxiv_data1/oa_pdf/dc/4e/1600936.PMC5061472.pdf
"QGIS Geographic Information System, http://qgis.osgeo.org (2015).",OADS,/arxiv_data1/oa_pdf/dc/4e/1600936.PMC5061472.pdf
"This is an open access article licensed under the terms  of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, noncommercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/58/JIE-5-320.PMC5061473.pdf
"This is an open access article licensed under the terms  of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, noncommercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/e6/JIE-5-331.PMC5061474.pdf
"This is an open access article licensed under the terms  of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, noncommercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/eb/1b/JIE-5-335.PMC5061475.pdf
Available  from: http://www.kew.org/science/tropamerica/neotropikey/families/glossary.htm#.,Non-OADS,/arxiv_data1/oa_pdf/e9/cc/JIE-5-343.PMC5061476.pdf
"This is an open access article licensed under the terms  of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, noncommercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e9/cc/JIE-5-343.PMC5061476.pdf
Available from: http://www.taconiccom/anmodels/spragued/sdheme.htm.,Non-OADS,/arxiv_data1/oa_pdf/2c/8f/JIE-5-350.PMC5061477.pdf
"This is an open access article licensed under the terms  of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, noncommercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/8f/JIE-5-350.PMC5061477.pdf
"This is an open access article licensed under the terms  of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, noncommercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/47/02/JIE-5-358.PMC5061478.pdf
"This is an open access article licensed under the terms  of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, noncommercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c2/dc/JIE-5-364.PMC5061479.pdf
"This is an open access article licensed under the terms  of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, noncommercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/54/JIE-5-372.PMC5061480.pdf
"All the collected plant materials were identified in the Department of Plant Resources, Nepal, and Voucher specimens are deposited in Pharmacognosy Unit of Department of Plant Resources, Thapathali, Kathmandu, Nepal (http://www.dpr.gov .np).",OADS,/arxiv_data1/oa_pdf/4e/76/JIE-5-383.PMC5061481.pdf
"This is an open access article licensed under the terms  of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, noncommercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4e/76/JIE-5-383.PMC5061481.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs366/en/.,Non-OADS,/arxiv_data1/oa_pdf/59/b1/JIE-5-390.PMC5061482.pdf
Available from: http://www.who.int/neglected_diseases/preventive_chemotherapy/sth/db/?units=minimal&region=all&country=ind&countries=ind&year=2014.,Non-OADS,/arxiv_data1/oa_pdf/59/b1/JIE-5-390.PMC5061482.pdf
"This is an open access article licensed under the terms  of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, noncommercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/59/b1/JIE-5-390.PMC5061482.pdf
Available from: http://www.dx.doi.org/10.1016/j.jfda.2015.06.008.,OADS,/arxiv_data1/oa_pdf/d8/95/JIE-5-396.PMC5061483.pdf
Available from: http://www.dx.doi.org/10.4061/2011/916310.,Non-OADS,/arxiv_data1/oa_pdf/d8/95/JIE-5-396.PMC5061483.pdf
"This is an open access article licensed under the terms  of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, noncommercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d8/95/JIE-5-396.PMC5061483.pdf
"This is an open access article licensed under the terms  of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, noncommercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5c/11/JIE-5-403.PMC5061484.pdf
"This is an open access article licensed under the terms  of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, noncommercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/04/JIE-5-408.PMC5061485.pdf
Available from: http://www.oecd.org/chemicalsafety/risk-assessment/1948378.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ee/e0/JIE-5-415.PMC5061486.pdf
"This is an open access article licensed under the terms  of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, noncommercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/e0/JIE-5-415.PMC5061486.pdf
"This is an open access article licensed under the terms  of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, noncommercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/3d/JIE-5-422.PMC5061487.pdf
"This is an open access article licensed under the terms  of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, noncommercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/99/ea/JIE-5-427.PMC5061488.pdf
"This is an open access article licensed under the terms  of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, noncommercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c3/14/JIE-5-434.PMC5061489.pdf
"This is an open access article licensed under the terms  of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, noncommercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/da/JIE-5-439.PMC5061490.pdf
dicksoni from Digimorph (http://digimorph.org).,Non-OADS,/arxiv_data1/oa_pdf/75/a1/1601329.PMC5061491.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/10/e1601329/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/75/a1/1601329.PMC5061491.pdf
METHODS First-principles MD simulations were performed in the Born-Oppenheimer approximation using the Qbox code (http://qboxcode.org/) ( 45).,Non-OADS,/arxiv_data1/oa_pdf/59/45/1601278.PMC5061492.pdf
"We used norm-conserving pseudo potentials (Pseudopotential Table, http://fpmd.ucdavis.edu/potentials) ( 48,49)w i t hak i n e t i cc u t o f fo f8 5R y , which was increased to 220 Ry for pressure calculations.",Non-OADS,/arxiv_data1/oa_pdf/59/45/1601278.PMC5061492.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/10/e1601278/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/59/45/1601278.PMC5061492.pdf
"Available at: http://www.whocc.no/atcddd/  (accessed September 24, 2014).",OADS,/arxiv_data1/oa_pdf/3a/77/pharmpract-14-717.PMC5061515.pdf
"https://www.pharmacy.texas.gov/infocist/continue.asp   (accessed on July 4, 2015 ).",Non-OADS,/arxiv_data1/oa_pdf/8e/a0/pharmpract-14-769.PMC5061518.pdf
"at:  http://texreg.sos.state.tx.us/public/readtac$ext.TacPage?sl=R&app=9&p_dir=&p_rloc=&p_tloc=&p_ploc=&pg=1&p_tac= &ti=22&pt=15&ch=295&rl=8  (accessed on October 28, 2015).",OADS,/arxiv_data1/oa_pdf/8e/a0/pharmpract-14-769.PMC5061518.pdf
"at:  http://allhealthcare.monster.com/training/articles/3 803-pharmacy -specialties  (accessed on September 28, 2015).",Non-OADS,/arxiv_data1/oa_pdf/8e/a0/pharmpract-14-769.PMC5061518.pdf
"at: http://www.acpe -accredit.org   (accessed on June 24, 2015).",Non-OADS,/arxiv_data1/oa_pdf/8e/a0/pharmpract-14-769.PMC5061518.pdf
"Bureau of Labor Statistics, U.S. Department of Labor, May 2014. at:  http://www.bls.gov/oes/current/oes291051.htm  (accessed on June 24, 2015).",OADS,/arxiv_data1/oa_pdf/8e/a0/pharmpract-14-769.PMC5061518.pdf
"at: https://www.acpe -accredit.org/ceproviders/CPD.asp   (accessed on October 28, 2015).",Non-OADS,/arxiv_data1/oa_pdf/8e/a0/pharmpract-14-769.PMC5061518.pdf
"2014. at: https://www.acpe -accredit.org/pdf/CPE_Standards_Final.pdf  (accessed on October 28, 2015) .",Non-OADS,/arxiv_data1/oa_pdf/8e/a0/pharmpract-14-769.PMC5061518.pdf
"at: https://www.surveymonkey.com/r/?sm=QX2MwSmfnbho3TgwGJ7hhc3sZdTjFJ3DuDzaXk7LXbk%3d   (accessed on September 27, 20 15).",Non-OADS,/arxiv_data1/oa_pdf/8e/a0/pharmpract-14-769.PMC5061518.pdf
"Department for Environment, Food & Rural Affairs, UK; https://www.gov.uk/government/collections/rural -urban - classification  (access  August 12, 2016 ).",Non-OADS,/arxiv_data1/oa_pdf/8c/08/pharmpract-14-774.PMC5061519.pdf
Available at: http://www.bemedwise.org/survey/final_survey.pdf  (accessed 8  December 2015).,Non-OADS,/arxiv_data1/oa_pdf/ce/1a/pharmpract-14-782.PMC5061520.pdf
Available at:  http://www.yourhealthathand.org/images/uploads/CHPA_OTC_Trust_Survey_White_Paper.pdf  (accessed 24 November  2015).,Non-OADS,/arxiv_data1/oa_pdf/ce/1a/pharmpract-14-782.PMC5061520.pdf
"http://www.ihi.org/topics/adesmedicationreconciliation/Pages/default.aspx  (accessed September 25, 2015 ).",Non-OADS,/arxiv_data1/oa_pdf/97/03/pharmpract-14-785.PMC5061521.pdf
"http://www.ashp.org/DocLibrary/BestPractices/OrgStPharmCare.aspx   (accessed September 7, 2015 ).",Non-OADS,/arxiv_data1/oa_pdf/97/03/pharmpract-14-785.PMC5061521.pdf
"Ärztliches Zentrum für Qualität in der Medizin (ÄZQ), Nationale VersorgungsLeitlinie (NVL) Asthma, 2nd e d:  http://www.asthma.versorgungsleitlinien.de/  (accessed 17 April 2016 ).",Non-OADS,/arxiv_data1/oa_pdf/ed/ed/pharmpract-14-786.PMC5061522.pdf
Available at:  http://www.ap ha.org/policies -and-advocacy/public -health -policy -statements/policy -database/2014/07/07/13/05/the -role- of-the-pharmacist -in-public -health  (accessed 2016 Feb 24).,Non-OADS,/arxiv_data1/oa_pdf/0b/34/pharmpract-14-792.PMC5061523.pdf
Available at: http://www.healthypeople.gov/   (accessed 2016 Feb 24).,Non-OADS,/arxiv_data1/oa_pdf/0b/34/pharmpract-14-792.PMC5061523.pdf
Available at:  http://www.nacds.or g/pdfs/pr/2012/rximpact -0312.pdf  (accessed 2016 Feb 24).,Non-OADS,/arxiv_data1/oa_pdf/0b/34/pharmpract-14-792.PMC5061523.pdf
Available at: http://www.nacds.org/pdfs/membership/payer_needs.pdf  (accessed 2016 Feb 24).,Non-OADS,/arxiv_data1/oa_pdf/0b/34/pharmpract-14-792.PMC5061523.pdf
Available at:  http://www.pharmacist.com/sites/default/files/files/core_elements_of_an_mtm_practice.pdf  (accessed 2016 Feb 2 4).,Non-OADS,/arxiv_data1/oa_pdf/0b/34/pharmpract-14-792.PMC5061523.pdf
Available at: https://www.cms.gov/Medicare/Prescription - Drug -Coverage/PrescriptionDrugCovContra/Downloads/Memo -Contract -Year -2016 -Medication -Thera py-Management - MTM -Program -Submission -v-040715.pdf  (accessed 2016 Feb 24).,Non-OADS,/arxiv_data1/oa_pdf/0b/34/pharmpract-14-792.PMC5061523.pdf
Available  at: https://www.pharmacist.com/node/677975?is_sso_called=1  (accessed 2016 Feb 24) .,Non-OADS,/arxiv_data1/oa_pdf/0b/34/pharmpract-14-792.PMC5061523.pdf
Available at: http://www.strategyand.pwc.com/media/file/The_Pharmacy_Solution.pdf  (accessed  2016 Feb 24).,Non-OADS,/arxiv_data1/oa_pdf/0b/34/pharmpract-14-792.PMC5061523.pdf
Available at: http://www.cdc.gov/dhdsp/programs/spha/docs/pharmacist_guide.pdf  (accessed 2016 Feb 24).,OADS,/arxiv_data1/oa_pdf/0b/34/pharmpract-14-792.PMC5061523.pdf
Available from:  http://drugtopics.modernmedicine.com/drug -topics/news/modernmedicine/modern -medicine -news/expanding - pharmacists -role-mtm-services?page=full  (accessed 2016 Feb 24).,Non-OADS,/arxiv_data1/oa_pdf/0b/34/pharmpract-14-792.PMC5061523.pdf
"Available at:  http://www.lowitja.org.au/sites/default/files/docs/Research_Partnerships.pdf  (accesed August 4, 2016).",OADS,/arxiv_data1/oa_pdf/e0/84/pharmpract-14-798.PMC5061524.pdf
"Available at:  http://rrh.deakin.edu.au  (accesed August 4, 2016).",Non-OADS,/arxiv_data1/oa_pdf/e0/84/pharmpract-14-798.PMC5061524.pdf
: 08000 116 016  or online at https://www.hilfetelefon.de ) or rape  crisis centres ( www.frauen -gegen -gewalt.de )  and medical care.,Non-OADS,/arxiv_data1/oa_pdf/33/52/pharmpract-14-828.PMC5061525.pdf
Quality assurance guideline – version as of 13 November 2013.  http://www.abda.de/themen/apotheke/qualitaets sicherung0/leitlinien/leitlinien0/  (accessed 19 June 2016 ).,Non-OADS,/arxiv_data1/oa_pdf/33/52/pharmpract-14-828.PMC5061525.pdf
http://www.abda.de/fileadmin/assets/Gesetze/ApBetrO_engl_ -_Stand_ -_2015 - 03.pdf   (accessed 19 June 2016 ).,OADS,/arxiv_data1/oa_pdf/33/52/pharmpract-14-828.PMC5061525.pdf
"75.03 -3822 -V-16018/601411/14, 5 November 2014.  http://www.bfarm.de/SharedDocs/Downloads/DE/Arzneimittel/Pharmakovigilanz/Risikoinformationen/RisikoBewVerf/g - l/levonorgestrel_bescheid.pdf?__blob=publicationFile&v=1  (accessed 19 June 2016 ).",Non-OADS,/arxiv_data1/oa_pdf/33/52/pharmpract-14-828.PMC5061525.pdf
"http://wokinfo.com/essays/journal -selection -process/   (accessed Sep 10, 2016).",Non-OADS,/arxiv_data1/oa_pdf/6c/35/pharmpract-14-842.PMC5061526.pdf
"Available at: http://www.ncbi.nlm.nih.gov/pmc/  (accessed Sep 10, 2016).",Non-OADS,/arxiv_data1/oa_pdf/6c/35/pharmpract-14-842.PMC5061526.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2016.19.3.153 Pediatr Gastroenterol Hepatol Nutr 2016 September 19(3):153-161PGHN Review Article  PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Received：June 24, 2016, Revised：August 22, 2016, Accepted：Augus t 31, 2016 Corresponding author: Yvan Vandenplas, Department of Pediatrics, Universitair Ziekenh uis Brussel, Vrije Universiteit Brussel, Laarbeeklaan 101 , 1090 Brussels, Belgium.",Non-OADS,/arxiv_data1/oa_pdf/88/42/pghn-19-153.PMC5061656.pdf
"Tel: +32-2-477-57-81, Fax: +32-2-477-57 -83, E-mail: yvan.vandenplas@uzbrussel.be Copyright ⓒ 2016 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.Middle East Consensus Stat ement on the Diagnosis and  Management of Functional Gastrointestinal Disorders in <12 Months Old Infants Yvan Vandenplas, Muath Abdurrahman Alturaiki *, Wafaa Al-Qabandi†, Fawaz AlRefaee‡,  Ziad Bassil§, Bassam Eidǁ, Ahmed El Beleidy¶, Ali Ibrahim Almehaidib **, Pierre Mouawad††, and  Maroun Sokhn§,††  Department of Pediatrics, Universita ir Ziekenhuis Brussel, Vr ije Universiteit Brussel, Brussels, Belgium, *Department o f  Pediatrics, King Salman Hospital, Riyadh, Saudi Arabia, †Faculty of Medicine, Kuwait Un iversity, Kuwait City, Kuwait,  ‡Department of Pediatrics, Al Adan Hospital, Kuwait City, Kuwait, §Department of Pediatric Gastroentrology, He patolog y and Pediatric Nutrition, St. Jose ph Hospital, Beirut, Lebanon, ǁDepartment of Pediatric Gastroenterology, Hotel Dieu d e France, Beirut, Lebanon, ¶Department of Pediatrics, Cairo University, Cairo, Egypt, **Department of Pediatric  Gastroenterology, King Faisal Specialist Hosp ital and Research Center, Ryiadh, Saudi Arabia, ††Department of Pediatric Gastroenterology, St. Georges Orthodox, Beirut, Lebanon This paper covers algorithms for the management of regurgitation, constipation and infantile colic in infants.",Non-OADS,/arxiv_data1/oa_pdf/88/42/pghn-19-153.PMC5061656.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2016.19.3.162 Pediatr Gastroenterol Hepatol Nutr 2016 September 19(3):162-167PGHN Original Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Socioeconomic Impacts of Gluten-Free Diet among Saudi  Children with Celiac Disease Ahmed Sarkhy *,†, Mohammad I. El Mouzan *,†, Elshazaly Saeed†, Aziz Alanazi‡,  Sharifa Alghamdi§, Shirin Anil∥, and Asaad Assiri *,† *Division of Gastroenterology, Department of Pediatrics, King Khalid University Hosp ital, King Saud University,  †Prince Abdullah Bin Khalid Celiac Disease Research Chair, College of Medicine, King Saud University, ‡Division of  Gastroenterology, Department of Pediat rics, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh,  §Division of Gastroenterology, Department of Pediatrics, King  Faisal Specialist Hospital and Research Center, Jeddah,  ∥Consultant Epidemiologist, Coll ege of Medicine, King Saud University, Riyadh, Saudi Arabia Purpose:  To determine the socio-economic impact of gluten fr ee diet (GFD) on Saudi children and their families  Methods:  A cross-sectional study was conducted in which an online questionnaire was sent to all families registered  in the Saudi celiac patients support group.",Non-OADS,/arxiv_data1/oa_pdf/ce/21/pghn-19-162.PMC5061657.pdf
"Tel: +966-11-4670807, Fax: +966-11-4679463, E-mail:   aalsarkhy@ksu.edu.sa Copyright ⓒ 2016 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ce/21/pghn-19-162.PMC5061657.pdf
Available from: http://wdi.worldbank.org/table/2.1.,Non-OADS,/arxiv_data1/oa_pdf/ce/21/pghn-19-162.PMC5061657.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2016.19.3.168 Pediatr Gastroenterol Hepatol Nutr 2016 September 19(3):168-174PGHN Original Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Factors Associated with Removal of Impactted Fishbone  in Children, Suspected Ingestion Chun Woo Lim *,†, Min Hwan Park *,†, Hyun Jeong Do *,†, Jung-Sook Yeom *,†, Ji Sook Park *,†,  Eun Sil Park *,†, Ji Hyun Seo *,†, Jung Je Park†,‡, Jae Young Lim *,†, Chan Hoo Park *,†,  Hyang-Ok Woo *,†, and Hee-Shang Youn *,† *Department of Pediatrics, †Institute of Health Science, and ‡Department of Otorhinolaryngology, Gyeongsang  National University Hospital, Jinju, Korea Purpose:  The management and clinical course in pediatric patients who had ingested foreign body were investigated  retrospectively to evaluate the frequency and factor associated with successful removal of fishbone foreign body.",Non-OADS,/arxiv_data1/oa_pdf/cf/cc/pghn-19-168.PMC5061658.pdf
"Tel: +82-55-750-8161, Fax: +82- 55-752-9339, E-mail: csassi@hanmail.net Copyright ⓒ 2016 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION Foreign body ingestion is one of the main prob- lems that causes young children to visit the emer-gent care unit or hospital frequently.",Non-OADS,/arxiv_data1/oa_pdf/cf/cc/pghn-19-168.PMC5061658.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2016.19.3.175 Pediatr Gastroenterol Hepatol Nutr 2016 September 19(3):175-185PGHN Original Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Henoch-Schonlein Purpura in Children Hospitalized  at a Tertiary Hospital during 2004-2015 in Korea: Epidemiology and Clinical Management  Yong Hee Lee, Yu Bin Kim, Ja Wook Koo, and Ju-Young Chung Department of Pediatrics, Sanggye Paik Hospital, In je University College of  Medicine, Seoul, Korea Purpose:  To investigate the epidemiology, clinical manifestations, investigations and management, and prognosis  of patients with Henoch-Schonlein purpura (HSP).Methods:  We performed a retrospective review of 212 HSP patients under the age of 18 years who were admitted  to Inje University Sanggye Paik Hospital between 2004 and 2015.",Non-OADS,/arxiv_data1/oa_pdf/a4/06/pghn-19-175.PMC5061659.pdf
"Tel: +82-2-950-1071, Fax: +82-2-9 51-1246, E-mail: c hungjy@paik.ac.kr Copyright ⓒ 2016 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION Henoch-Schonlein purpura (HSP) is the most  common type of vasculitis in children [1,2].",Non-OADS,/arxiv_data1/oa_pdf/a4/06/pghn-19-175.PMC5061659.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2016.19.3.186 Pediatr Gastroenterol Hepatol Nutr 2016 September 19(3):186-192PGHN Original Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Correlation between Colon Transi t Time Test Value and Initial  Maintenance Dose of Laxative in Children with Chronic Functional Constipation Mock Ryeon Kim, Hye Won Park, Jae Su ng Son, Ran Lee, and Sun Hwan Bae Department of Pediatrics, Konkuk Univer sity School of Medicine, Seoul, Korea Purpose:  To evaluate the correlation between colon transit ti me (CTT) test value and initial maintenance dose of  polyethylene glycol (PEG) 4000 or lactulose.Methods:  Of 415 children with chronic functional constipation, 190 were enrolled based on exclusion criteria using  the CTT test, defecation diary, and clinical chart.",Non-OADS,/arxiv_data1/oa_pdf/99/61/pghn-19-186.PMC5061660.pdf
"Tel: +82-2-2030-7554, Fax: +82-2-2030-7748, E-mai l: baedori@hanafos.com Copyright ⓒ 2016 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION Constipation is one of the most common symp- toms in children and is responsible for 7% of pedia-tric clinic visit.",Non-OADS,/arxiv_data1/oa_pdf/99/61/pghn-19-186.PMC5061660.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2016.19.3.193 Pediatr Gastroenterol Hepatol Nutr 2016 September 19(3):193-198PGHN Original Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Spontaneous Perforation of Colon in Previously Healthy Infants and Children: Its Clinical Implication Soo-Hong Kim, Yong-Hoon Cho, and Hae-Young Kim Department of Pediatric Surgery, Pusan National University Children’s Hospital, Yangsan, Korea Purpose:  Spontaneous colon perforations are usually encountered as necrotizing enterocolitis in the neonatal period,  but occur rarely in infants and children without pathological conditions.",Non-OADS,/arxiv_data1/oa_pdf/7a/95/pghn-19-193.PMC5061661.pdf
"Tel: +82-55-360-2124, Fax: +82-55-360-215 4, E-mail: choyh70@pusan.ac.kr  Copyright ⓒ 2016 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION Spontaneous bowel perforations not associated  with disease or blunt trauma, particularly a colon  perforation, are uncommon beyond the neonatal  period.",Non-OADS,/arxiv_data1/oa_pdf/7a/95/pghn-19-193.PMC5061661.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2016.19.3.199 Pediatr Gastroenterol Hepatol Nutr 2016 September 19(3):199-206PGHN Original Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Associations among the Degree of  Nonalcoholic Fatty Liver  Disease, Metabolic Syndrome, Degree of Obesity in Children, and Parental Obesity Min-Su Oh, Sorina Kim, Joon-Hyuck Jang, Jong Yoon Park, Hyun-Sik Kang, Mu Sook Lee *,  and Ki Soo Kang Departments of Pediatrics and *Radiology, Jeju National University  School of Medicine, Jeju, Korea Purpose:  To analyze the associations among the degrees of nonalcoholic fatty liver disease (NAFLD) by ultra- sonography and metabolic syndrome, degrees of obesit y in children, and degrees of parental obesity.",Non-OADS,/arxiv_data1/oa_pdf/8e/3d/pghn-19-199.PMC5061662.pdf
"Tel: +82 -64-754-8146, Fax: +82-64-717-1131, E -mail: kskang@jejunu.ac.kr Copyright ⓒ 2016 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION Obesity is newly emerged as a very important  health problem in children.",Non-OADS,/arxiv_data1/oa_pdf/8e/3d/pghn-19-199.PMC5061662.pdf
Available from: http://www.moe .go.kr/web/106888/ko/  board/view.do?bbsId=339&boardSeq=58466.,Non-OADS,/arxiv_data1/oa_pdf/8e/3d/pghn-19-199.PMC5061662.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2016.19.3.207 Pediatr Gastroenterol Hepatol Nutr 2016 September 19(3):207-209PGHN Case Report PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Corrosive Esophagitis with Benzalkonium Chloride in a Two  Days Old Neonate Hasret Ayyildiz Civan, Didem Gulcu, and Tulay Erkan Department of Pediatric Gastroenterology, Hepatology a nd Nutrition, Istanbul University Cerrahpasa Medical Facult y,  Istanbul, Turkey Benzalkonium chloride (BAC) is a caustic agent which is used in farms, homes and hospitals for cleaning skin and  wounds as an antiseptic solution.",Non-OADS,/arxiv_data1/oa_pdf/7d/30/pghn-19-207.PMC5061663.pdf
"Tel: +90-505-747 -97-65, Fax: +90-212-632-00-50, E-m ail: hasretayy ildiz@yahoo.co m Copyright ⓒ 2016 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION Caustic substance intake may lead to a wide varie- ty of complications as a result of tissue and organ damages [1].",Non-OADS,/arxiv_data1/oa_pdf/7d/30/pghn-19-207.PMC5061663.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2016.19.3.210 Pediatr Gastroenterol Hepatol Nutr 2016 September 19(3):210-213PGHN Case Report PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Oral Vancomycin Therapy in a Child with Primary Sclerosing  Cholangitis and Severe Ulcerative Colitis Cynthia Buness, Keith D. Lindor *,†, and Tamir Miloh‡ National Patient Advocate Foundation, Paradise Valley, *College of Health Solutions, Arizona State University,  †Department of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, AZ, ‡Department of Gastroenterology,  Hepatology and Nutrition, Texas Children's Hospital, Houston, TX, USA Primary sclerosing cholangitis (PSC), a rare progressive liver disease characterized by cholestasis and bile duct  fibrosis, has no accepted, effective therapy known to delay or arrest its progression.",Non-OADS,/arxiv_data1/oa_pdf/00/0c/pghn-19-210.PMC5061664.pdf
"Tel: +1-602-496-0789, Fax: +1-602-496-0544,  E-mail: Keith.Lindor@asu .edu Copyright ⓒ 2016 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION Primary sclerosing cholangitis (PSC) is a rare pro- gressive disease of the liver characterized by choles- tasis and bile duct fibrosis, leading to decreased qual- ity of life, cirrhosis, and the need for liver trans-plantation within an averag e of 12 years [1].",Non-OADS,/arxiv_data1/oa_pdf/00/0c/pghn-19-210.PMC5061664.pdf
SUPPLEMENTARY DATA Supplementary data can be found with this article  online at http://www.pghn.org and at http://dx.do- i.org/10.5223/pghn.2016.19.3.210.REFERENCES 1.,OADS,/arxiv_data1/oa_pdf/00/0c/pghn-19-210.PMC5061664.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2016.19.3.214 Pediatr Gastroenterol Hepatol Nutr 2016 September 19(3):214-220PGHN Case Report PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Failure of Fecal Microbiota Transplantation in a Three-Year-Old  Child with Severe Refrac tory Ulcerative Colitis Hideki Kumagai, Koji Yokoyama, Tomoyuki Imagawa, Shun Inoue, Janyerkye Tulyeu,  Mamoru Tanaka *, and Takanori Yamagata Department of Pediatrics, Jichi Medical University, Shimotsuke, *Miyarisan Pharmaceutical Co., Ltd., Tokyo, Japan Fecal microbiota transplantation (FMT) is a treatment desi gned to correct gut dysbiosis by administration of feces  from a healthy volunteer.",Non-OADS,/arxiv_data1/oa_pdf/40/0e/pghn-19-214.PMC5061665.pdf
"Tel: +81-285-58-7366, Fax: +81-285-44-6123, E-mail: h-ku magai@jichi.ac.jp Copyright ⓒ 2016 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION Fecal microbiota transplantation (FMT) is an in- vestigational treatment desi gned to correct dysbiosis  in the gut by administration  of feces from a healthy  volunteer.",Non-OADS,/arxiv_data1/oa_pdf/40/0e/pghn-19-214.PMC5061665.pdf
"Other inclusionTable of Links TARGETS Enzymes [2] GPCRs [3] ACE AT1-receptor This Table lists key protein targets in this article which are hyperlinked to corresponding entries in http://www.guidetopharmacology.org, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY [1] and are permanently archived in the Concise Guide to PHARMA-COLOGY 2015/16 [2, 3].",Non-OADS,/arxiv_data1/oa_pdf/6d/91/BCP-82-1351.PMC5061782.pdf
Competing Interests All authors have completed the Uni ﬁed Competing Interest form at http://www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organization for the submitted work;DdZ was a member of the advisory board of KeryxBiopharmaceuticals in the previous 3 years; no other relation-ships or activities that could appear to have in ﬂuenced the submitted work.,Non-OADS,/arxiv_data1/oa_pdf/6d/91/BCP-82-1351.PMC5061782.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/76/4f/hgv201634.PMC5061861.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2016Harts ﬁeld syndrome with a novel FGFR1 mutation M Takagi et al 4 Human Genome Variation (2016) 16034 Of ﬁcial journal of the Japan Society of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/76/4f/hgv201634.PMC5061861.pdf
"This variant has not been reported in the available public databases including ExAC browser (http://exac.broadinstitute.org/), Exome Variant Server (http://evs.gs.washington.edu/EVS/) or 1000 Genomes (http://browser.1000genomes.org/index.html) (all accessed on July29, 2016).",OADS,/arxiv_data1/oa_pdf/d3/b6/hgv201635.PMC5061862.pdf
This mutation may explain thevariable clinical expression of DA2B in this family.HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,Non-OADS,/arxiv_data1/oa_pdf/d3/b6/hgv201635.PMC5061862.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016Novel TNNI2 mutation causing distal arthrogryposis VČulićet al 4 Human Genome Variation (2016) 16035 Of ﬁcial journal of the Japan Society of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/d3/b6/hgv201635.PMC5061862.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Infection Ecology and Epidemiology 2016, 6: 32870 - http://dx.doi.org/10.3402/iee.v6.32870 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/63/70/IEE-6-32870.PMC5061866.pdf
"It is however the presence ofAnna Gillman 2 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 32870 - http://dx.doi.org/10.3402/iee.v6.32870",Non-OADS,/arxiv_data1/oa_pdf/63/70/IEE-6-32870.PMC5061866.pdf
"In addition, IA Vsare known to stay infectious for a long time in lake water(2); freezing of viruses in lakes at breeding areas withRisk of resistant avian influenza virus in wild waterfowl Citation: Infection Ecology and Epidemiology 2016, 6: 32870 - http://dx.doi.org/10.3402/iee.v6.32870 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/63/70/IEE-6-32870.PMC5061866.pdf
"The experimental results from OCexposure studies over the last couple of years (92 /C197) have contributed to the estimations of the ecologic risks related to the release of active NAIs to the environment.Anna Gillman 4 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 32870 - http://dx.doi.org/10.3402/iee.v6.32870",Non-OADS,/arxiv_data1/oa_pdf/63/70/IEE-6-32870.PMC5061866.pdf
"J Virol 1997; 71: 3385 /C190.Risk of resistant avian influenza virus in wild waterfowl Citation: Infection Ecology and Epidemiology 2016, 6: 32870 - http://dx.doi.org/10.3402/iee.v6.32870 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/63/70/IEE-6-32870.PMC5061866.pdf
Available from: http://www.fass.se/LIF/product?userType /C30 0&nplId /C3019990209 000018&docType /C303 [cited 18 January 2015].,Non-OADS,/arxiv_data1/oa_pdf/63/70/IEE-6-32870.PMC5061866.pdf
"Chemosphere 2013; 93: 1672/C17.Anna Gillman 6 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 32870 - http://dx.doi.org/10.3402/iee.v6.32870",Non-OADS,/arxiv_data1/oa_pdf/63/70/IEE-6-32870.PMC5061866.pdf
"Inﬂuenza A(H7N9) virus acquiresresistance-related neuramin idase I222T substitution whenRisk of resistant avian influenza virus in wild waterfowl Citation: Infection Ecology and Epidemiology 2016, 6: 32870 - http://dx.doi.org/10.3402/iee.v6.32870 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/63/70/IEE-6-32870.PMC5061866.pdf
"PLoS Pathog 2014; 10:e1004065.Anna Gillman 8 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 32870 - http://dx.doi.org/10.3402/iee.v6.32870",Non-OADS,/arxiv_data1/oa_pdf/63/70/IEE-6-32870.PMC5061866.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Pathobiology of Aging & Age-related Diseases 2016, 6: 32517 - http://dx.doi.org/10.3402/pba.v6.32517 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/03/a6/PBA-6-32517.PMC5061878.pdf
"2 (page number not for citation purpose)Citation: Pathobiology of Aging & Age-related Diseases 2016, 6: 32517 - http://dx.doi.org/10.3402/pba.v6.32517",Non-OADS,/arxiv_data1/oa_pdf/03/a6/PBA-6-32517.PMC5061878.pdf
"Transgenic overexpression of Kir6 dominant-negative subunits in the endothelium lead toCardiovascular K ATPchannels and aging Citation: Pathobiology of Aging & Age-related Diseases 2016, 6: 32517 - http://dx.doi.org/10.3402/pba.v6.32517 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/03/a6/PBA-6-32517.PMC5061878.pdf
"4 (page number not for citation purpose)Citation: Pathobiology of Aging & Age-related Diseases 2016, 6: 32517 - http://dx.doi.org/10.3402/pba.v6.32517",Non-OADS,/arxiv_data1/oa_pdf/03/a6/PBA-6-32517.PMC5061878.pdf
"The protective effects of preconditioning is absent inelderly patients undergoing coronary angioplasty; anCardiovascular K ATPchannels and aging Citation: Pathobiology of Aging & Age-related Diseases 2016, 6: 32517 - http://dx.doi.org/10.3402/pba.v6.32517 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/03/a6/PBA-6-32517.PMC5061878.pdf
"6 (page number not for citation purpose)Citation: Pathobiology of Aging & Age-related Diseases 2016, 6: 32517 - http://dx.doi.org/10.3402/pba.v6.32517",Non-OADS,/arxiv_data1/oa_pdf/03/a6/PBA-6-32517.PMC5061878.pdf
"1993;265:C1723 /C18.Cardiovascular K ATPchannels and aging Citation: Pathobiology of Aging & Age-related Diseases 2016, 6: 32517 - http://dx.doi.org/10.3402/pba.v6.32517 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/03/a6/PBA-6-32517.PMC5061878.pdf
"8 (page number not for citation purpose)Citation: Pathobiology of Aging & Age-related Diseases 2016, 6: 32517 - http://dx.doi.org/10.3402/pba.v6.32517",Non-OADS,/arxiv_data1/oa_pdf/03/a6/PBA-6-32517.PMC5061878.pdf
"2009;126(6):779 /C189.Cardiovascular K ATPchannels and aging Citation: Pathobiology of Aging & Age-related Diseases 2016, 6: 32517 - http://dx.doi.org/10.3402/pba.v6.32517 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/03/a6/PBA-6-32517.PMC5061878.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/03/a6/PBA-6-32517.PMC5061878.pdf
"10 (page number not for citation purpose)Citation: Pathobiology of Aging & Age-related Diseases 2016, 6: 32517 - http://dx.doi.org/10.3402/pba.v6.32517",Non-OADS,/arxiv_data1/oa_pdf/03/a6/PBA-6-32517.PMC5061878.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016 Supplementary Information accompanies the paper on the Neuropsychopharmacology website (http://www.nature.com/npp)PDE11A4 is required for social memories S Hegde et al 2931 Neuropsychopharmacology",Non-OADS,/arxiv_data1/oa_pdf/bf/c6/npp2016106a.PMC5061884.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)The combined endocrine receptor BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.206 973,Non-OADS,/arxiv_data1/oa_pdf/21/93/bjc2016206a.PMC5061898.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER MEK inhibition abrogates sunitinib resistance 928 www.bjcancer.com | DOI:10.1038/bjc.2016.263,Non-OADS,/arxiv_data1/oa_pdf/f3/f7/bjc2016263a.PMC5061902.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Persistence to hormonal therapy in France BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.276 919,Non-OADS,/arxiv_data1/oa_pdf/61/f3/bjc2016276a.PMC5061907.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Hypoxia and radiosensitisation by HDACi BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.278 939,Non-OADS,/arxiv_data1/oa_pdf/12/73/bjc2016278a.PMC5061908.pdf
"International Agency for Research on Cancer: Lyon, France (2013) Available at http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx (accessed on 24 March 2015).",Non-OADS,/arxiv_data1/oa_pdf/3b/cf/bjc2016293a.PMC5061911.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER C4BPA is a serum biomarker for pancreatic cancer 956 www.bjcancer.com | DOI:10.1038/bjc.2016.295,Non-OADS,/arxiv_data1/oa_pdf/5b/18/bjc2016295a.PMC5061912.pdf
"1,2Diagnosis of SGBS is based on the clinical ﬁndings, family history consistent with X-linked inheritance and molecular biological testing of the glypican-3 gene (GPC3 ; MIM #300037 [http://omim.org/]) that maps to Xq26.",Non-OADS,/arxiv_data1/oa_pdf/19/dc/hgv201633.PMC5061924.pdf
differences between female carriers appear to depend on the X-chromosome inactivation pattern.12 HGV DATABASE T h er e l e v a n td a t af r o mt h i sD a t aR e p o r ta r eh o s t e da tt h eH u m a n Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/19/dc/hgv201633.PMC5061924.pdf
"ﬁgshare.hgv.858, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/19/dc/hgv201633.PMC5061924.pdf
"ﬁgshare.hgv.861, http://dx.doi.org/10.6084/m9.",OADS,/arxiv_data1/oa_pdf/19/dc/hgv201633.PMC5061924.pdf
"ﬁgshare.hgv.864, http://dx.doi.org/ 10.6084/m9.",OADS,/arxiv_data1/oa_pdf/19/dc/hgv201633.PMC5061924.pdf
ﬁgshare.hgv.867 and http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/19/dc/hgv201633.PMC5061924.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2016 Supplementary Information for this article can be found on the Human Genome Variation website (http://www.nature.com/hgv) Figure 2.",Non-OADS,/arxiv_data1/oa_pdf/19/dc/hgv201633.PMC5061924.pdf
"Retrieved fromhttps://mmcp.dhmh.maryland.gov/SiteAssets/pages/Provider-Information/2016%20Physician%20Fee%20Schedule%20pdf.pdf Finney, J. W., Riley, A. W., & Cataldo, M. F. (1991).",OADS,/arxiv_data1/oa_pdf/52/f5/jsw063.PMC5061975.pdf
Retrieved from http://www.michigan.gov/documents/mdhhs/Non-Physician_BH-012016_514585_7.pdf Missouri Department of Social Services.,Non-OADS,/arxiv_data1/oa_pdf/52/f5/jsw063.PMC5061975.pdf
"Retrieved from https://dssapp3.dss.mo.gov/FeeSche dules/fsmain.aspx1142 Cederna-Meko, Ellens, Burrell, Perry, and Rafiq",Non-OADS,/arxiv_data1/oa_pdf/52/f5/jsw063.PMC5061975.pdf
"[9d] [a]Dr.T.Ichikawa, A.Okafuji, Prof. H.Ohno Depar tment ofBiote chnolog y TokyoUniv ersity ofAgricultur eandTechnolog y Nakacho ,Kogan ei,Tokyo 184-8588 (Japan) E-mail :t-ichi@cc .tuat.ac.jp ohnoh @cc.tua t.ac.jp [b]Dr.T.Ichikawa PRESTO, TheJapan Science and Techno logy Agency (JST) 4-1-8 Honch o,Kawa guchi 332-001 2(Japan ) [c]T.Kato Depar tment ofChem istry and Biotec hnology ,TheUnive rsity ofTokyo Hongo ,Bunkyo-ku ,Tokyo113-8656 (Japan) Supp orting Infor mati onand theORCID identificati onnumber (s)forthe autho r(s)ofthis article canbefoundunde rhttp://dx.doi.org/ 10.1002 / open.20160005 4.",Non-OADS,/arxiv_data1/oa_pdf/f8/a8/OPEN-5-439.PMC5062008.pdf
"[a]Dr.G.Mirri, Prof. I.Musˇevicˇ Conden sedMatt erPhysics Depar tment, JozˇefStefan Institute Jamova 39,1000 Ljubljana (Slov enia) E-mail :giorgio.m irri@ijs.si [b]Dr.G.Mirri, D.C.Scho enm akers, Dr.P.H.J.Kouwer Institute forMolecules and Mate rials, Radbou dUniversity Nijmegen Heyenda alseweg 135, 6525 AJNijme gen (The Netherla nds) E-mail :p.kouwer@scienc e.ru.nl [c]Prof. Dr.P.Veranic ˇ Institute ofCellBiolog y Faculty ofMedicine, Univ ersity ofLjubljan a Vrazov trg2,1000 Ljubljana (Slovenia) [d]Dr.B.Sˇtefan e Organic Chemi stryDepartment Faculty ofChemi stryand Chemica lTechnol ogy,Univers ityofLjubljana Vecˇnapot113,1000 Ljubljana (Slovenia) E-mail :bogda n.stefane@ fkkt.uni -lj.si Supp orting Infor mati onand theORCID identificati onnumber (s)forthe autho r(s)ofthis article canbefoundunde rhttp://dx.doi.org/ 10.1002 / open.20160006 7.",Non-OADS,/arxiv_data1/oa_pdf/4c/45/OPEN-5-450.PMC5062010.pdf
"Dr.U.Pyell Depar tment ofChem istry,University ofMarb urg Hans- Meerwein-Str aße, 35032 Marburg (Germ any) E-mail :pyellu@st aff.uni-ma rburg.de [b]Dr.A.A.Al-Ma ssaed h Depar tment ofChem istry,Faculty ofScience Alal-Ba ytUniv ersity,25113Mafraq (Jordan) [c]Dr.M.Schmidt, Dr.U.M.Reinscheid Depar tment ofNMR- based Struc turalBiolo gy Max-P lanck-Insti tute forBiophy sical Chem istry AmFassb erg11,37077 Gçttingen (Germany ) E-mail :ureinsc @nmr .mpibp c.mpg.de Supp orting Infor mati onand theORCID identificati onnumber (s)forthe autho r(s)ofthisarticle canbefoundunde rhttp://dx.doi.org/ 10.1002 / open.20160008 5.",Non-OADS,/arxiv_data1/oa_pdf/11/f4/OPEN-5-455.PMC5062011.pdf
Biolog icalChemis tryand Molecular Mode ling Instituto deQu/C237micaAvanzada deCata lunya (CSIC) C/Jord iGirona 18-26 08034 Barc elona (Spa in) E-mail :angel.m esseguer@ iqac.c sic.es [b]Dr.M.Orz/C181ez Laborator yofPeptid eandProtein Chem istry Centro deInves tigaciones Pr/C237ncipe Felipe C/Eduard oPrimo Yﬄfera 3 46012 Valencia (Spain) Supp orting Infor mati onand theORCID identificati onnumber (s)forthe autho r(s)ofthisarticle canbefoundunde rhttp://dx.doi.org/ 10.1002 / open.20160005 2.,Non-OADS,/arxiv_data1/oa_pdf/51/6e/OPEN-5-485.PMC5062015.pdf
"4, 347 –365 http://dx.doi.org/10.1080/14780887.2016.1219800 © 2016 Michelle Fine.",Non-OADS,/arxiv_data1/oa_pdf/c6/7a/uqrp-13-347.PMC5062036.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/c6/7a/uqrp-13-347.PMC5062036.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/32/1a/ycii-17-211.PMC5062039.pdf
http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/32/1a/ycii-17-211.PMC5062039.pdf
"Retrieved October 1, 2015, from http://www.pewresearch.org / fact-tank /2013/06/06/cell-phone-ownership-hits-91-of-adults /.",Non-OADS,/arxiv_data1/oa_pdf/32/1a/ycii-17-211.PMC5062039.pdf
"Retrieved October 1, 2015 from http://www.pewinternet.org /2015/04/01/us-smart phone-use-in-2015 /.",Non-OADS,/arxiv_data1/oa_pdf/32/1a/ycii-17-211.PMC5062039.pdf
"15 –16, 2604 –2611 http://dx.doi.org/10.1080/01496395.2016.1162809 Published with license by Taylor & Francis Group, LLC © Agata Jakóbik-Kolon, Andrzej K. Milewski, Krzysztof Karo ń, and Joanna Bok-Badura This is an Open Access article.",Non-OADS,/arxiv_data1/oa_pdf/45/cb/lsst-51-2604.PMC5062040.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivativesLicense ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduc- tion in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.Psychology & Health , 2016 Vol.",Non-OADS,/arxiv_data1/oa_pdf/a7/f2/gpsh-31-1481.PMC5062042.pdf
"12, 1481 –1497, http://dx.doi.org/10.1080/08870446.2016.1235166",Non-OADS,/arxiv_data1/oa_pdf/a7/f2/gpsh-31-1481.PMC5062042.pdf
"Published by Informa UK Limited, trading as Taylor & Francis Group This is an Open Access article distributed under the terms of the Creat ive Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distributi on, and reproduction in any medium, provided the original work is properly cited, and is not altered , transformed, or built upon in any way.INTERNATIONAL JOURNAL OF PEST MANAGEMENT, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/5b/43/ttpm-62-348.PMC5062043.pdf
"4, 348 /C0359 http://dx.doi.org/10.1080/09670874.2016.1206993",Non-OADS,/arxiv_data1/oa_pdf/5b/43/ttpm-62-348.PMC5062043.pdf
"In accordance with the standard protocol (ESA STAT Dust Working Group 2011 ), the working sam- ple was then placed in the rotating drum of a Heu- bach dustmeter (Type 1, Heubach GmbH, Langelsheim, Germany, http://www.heubachcolor.de/ ﬁleadmin/documents/downlo ads/Brochures/Dustmeter.",Non-OADS,/arxiv_data1/oa_pdf/5b/43/ttpm-62-348.PMC5062043.pdf
The European Seed Association also recommends cleaning the seeds after coating to produce seeds with low dust values [ESA ( http://esta.azurewebsites.net/Standard/Dust )].,Non-OADS,/arxiv_data1/oa_pdf/5b/43/ttpm-62-348.PMC5062043.pdf
Retrieved from http://esta.azurewebsites.net/Standard/Dust .,OADS,/arxiv_data1/oa_pdf/5b/43/ttpm-62-348.PMC5062043.pdf
"5, 689 –702 http://dx.doi.org/10.1080/01488376.2016.1212775",Non-OADS,/arxiv_data1/oa_pdf/91/57/wssr-42-689.PMC5062044.pdf
Retrieved from: http://www.unwomen.,Non-OADS,/arxiv_data1/oa_pdf/91/57/wssr-42-689.PMC5062044.pdf
Retrieved from http://www3.weforum.org/docs/ WEF_GenderGap_Report_2013.pdf702 A.,OADS,/arxiv_data1/oa_pdf/91/57/wssr-42-689.PMC5062044.pdf
"11, 1309–1318 http://dx.doi.org/10.1080/13691058.2016.1182213 SHORT REPORT Gay Xhosa men’s experiences of ulwaluko (traditional male  initiation) Anathi Ntozini and Hlonelwa Ngqangweni Department of Psychology, university of Fort Hare, east l ondon, South a frica ABSTRACT This paper explores the lives of gay men undergoing traditional  initiation in the Eastern Cape.",Non-OADS,/arxiv_data1/oa_pdf/fc/fc/tchs-18-1309.PMC5062045.pdf
"this is an Open a ccess article distributed under the terms of the Creative Commons a ttribution-NonCommercial-NoDerivatives license  (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium,  provided the original work is properly cited, and is not altered, transformed, or built upon in any way.KEYWORDS Beliefs; cultural practices; gay  men; South a frica; ulwalukoARTICLE HISTORY received 28 January 2015 accepted 20 april 2016 CONTACT anathi Ntozini  antozini@ufh.ac.za  Supplemental data for this article can be accessed here.",Non-OADS,/arxiv_data1/oa_pdf/fc/fc/tchs-18-1309.PMC5062045.pdf
"5, 383 –392 http://dx.doi.org/10.1080/10640266.2016.1192910 © 2016 Marisol Perez, Tara K. Ohrt, and Amanda B. Bruening.",Non-OADS,/arxiv_data1/oa_pdf/9e/77/uedi-24-383.PMC5062049.pdf
"Published by Taylor & Francis This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/9e/77/uedi-24-383.PMC5062049.pdf
ORCID Marisol Perez http://orcid.org/0000-0002-0915-2145390 M. PEREZ ET AL.,Non-OADS,/arxiv_data1/oa_pdf/9e/77/uedi-24-383.PMC5062049.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License(http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.CONTACT Siobhan Morse, MHSA Siobhan.morse@frnmail.com Foundations Recovery Network, 5409 Maryland Way, Suite 320, Brentwood, TN 37027.SOCIAL WORK IN PUBLIC HEALTH 2016, VOL.",Non-OADS,/arxiv_data1/oa_pdf/4d/44/whsp-31-678.PMC5062050.pdf
"7, 678 –687 http://dx.doi.org/10.1080/19371918.2016.1188738",Non-OADS,/arxiv_data1/oa_pdf/4d/44/whsp-31-678.PMC5062050.pdf
Retrieved from http://www.samhsa.gov/data/ Centers for Disease Control and Prevention.,OADS,/arxiv_data1/oa_pdf/4d/44/whsp-31-678.PMC5062050.pdf
Retrieved from Substance Abuse and Mental Health Services Administration website: http://www.samhsa.gov/data/sites/default/ ﬁles/DR006/DR006/nonmedical-pain-reliever-use- 2013.htm National Institute on Drug Abuse.,OADS,/arxiv_data1/oa_pdf/4d/44/whsp-31-678.PMC5062050.pdf
"Inter-laboratory optimization of protein extraction, separation, and ﬂuorescent detection of endogenous rice allergens Rie Satoh1, Reiko Teshima2, Kazumi Kitta1, Gang-Hua Lang1, Kathleen Schegg3, Kenneth Blumenthal4, Leslie Hicks5, Bénédicte Labory-Carcenac6, David Rouquié6, Rod A. Herman7, Corinne Herouet-Guicheney8, Gregory S. Ladics9, Scott McClain10, Lars K. Poulsen11, Laura Privalle12, Jason M. Ward13, Nancy Doerrer14and Jean-Baptiste Rascle6,* 1Food Research Institute, National Agriculture and Food Research Organization, Tsukuba, Japan;2Division of Novel Foods and Immunochemistry, National Institute of Health Sciences, Tokyo, Japan;3Nevada Proteomics Center, University of Nevada Reno, Reno, NV , USA;4Formerly at Department of Biochemistry, State University of New York at Buffalo, Buffalo, NY, USA;5Formerly at Proteomics & Mass Spectrometry Facility, Donald Danforth Plant Science Center, St. Louis, MI, USA;6Bayer S.A.S., Bayer CropScience, Sophia Antipolis, France;7Dow AgroSciences LLC, Indianapolis, IN, USA;8Formerly at Bayer S.A.S., Bayer CropScience, Sophia Antipolis, France; 9DuPont Haskell Global Centers for Health and Environmental Sciences, Newark, DE, USA;10Syngenta Crop Protection, LLC, Research Triangle Park, NC, USA;11Allergy Clinic, Copenhagen University Hospital at Gentofte, Copenhagen, Denmark;12Regulatory Science, Formerly at BASF Plant Science, Research Triangle Park, NC, USA; 13Regulatory Division, Product Characterization Center, Formerly at Monsanto Co., St. Louis, MO, USA;14Protein Allergenicity Technical Committee, ILSI Health and Environmental Sciences Institute (HESI), Washington, DC, USA Received March 8, 2016; accepted June 2, 2016 http://dx.doi.org/10.1080/09168451.2016.1206810 In rice, several allergens have been identi ﬁed such as the non-speci ﬁc lipid transfer protein-1, the α-amylase/trypsin-inhibitors, the α-globulin, the 33 kDa glyoxalase I (Gly I), the 52 –63 kDa globulin, and the granule-bound starch synthetase.",Non-OADS,/arxiv_data1/oa_pdf/39/d5/tbbb-80-2198.PMC5062055.pdf
Please see Corrigendum ( http://dx.doi/10.1080/09168451.2016.,Non-OADS,/arxiv_data1/oa_pdf/39/d5/tbbb-80-2198.PMC5062055.pdf
"This is an Open Access article distributed under the terms of the Creativ e Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not alter ed, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/39/d5/tbbb-80-2198.PMC5062055.pdf
"ORCID David Rouquié http://orcid.org/0000-0002-7796-7418 Jean-Baptiste Rascle http://orcid.org/0000-0001-6353-8869 References [1] James, C, 2014 .",Non-OADS,/arxiv_data1/oa_pdf/39/d5/tbbb-80-2198.PMC5062055.pdf
Available from: http://www.isaaa.org/resources/publications/briefs/46/default.asp [2] Codex.,Non-OADS,/arxiv_data1/oa_pdf/39/d5/tbbb-80-2198.PMC5062055.pdf
"Available from: http://www.codexalimentarius.net/down load/standards/10021/CXG_045e.pdf [3] Parrott W, Chassy B, Ligon J, et al.",Non-OADS,/arxiv_data1/oa_pdf/39/d5/tbbb-80-2198.PMC5062055.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/b1/55/JIPS-16-340.PMC5062136.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/b1/55/JIPS-16-340.PMC5062136.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/25/aa/JIPS-16-400.PMC5062137.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/45/ec/JIPS-16-352.PMC5062144.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/a5/18/JIPS-16-390.PMC5062152.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/a5/18/JIPS-16-390.PMC5062152.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/7a/msw141.PMC5062318.pdf
"The RNA sample (1 lg each) library synthesis was done using TruSeq RNA Sample Prep Kit, version 2(Illumina), polyA-unstranded, at the Functional Genomics Center Zurich (http://www.fgcz.ch).",OADS,/arxiv_data1/oa_pdf/9c/7a/msw141.PMC5062318.pdf
"We classified the reads to each parental ( H-origin orL-origin ) using HomeoRoq (http://seselab.org/homeoroq, last accessed July 14, 2016).",OADS,/arxiv_data1/oa_pdf/9c/7a/msw141.PMC5062318.pdf
HMA4 homoeolog alignments and Supplementary Files 5–7 can be downloaded from athttp://dx.doi.org/10 .5061/dryad.tr85d.,OADS,/arxiv_data1/oa_pdf/9c/7a/msw141.PMC5062318.pdf
Associate editor: Emma Teeling Sequencing data (bam ﬁles) are available for download from the Seque nce Read Archive repository (http://www.ncbi.nlm.nih.gov/sra) (accession no.,OADS,/arxiv_data1/oa_pdf/a7/12/msw144.PMC5062319.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/12/msw144.PMC5062319.pdf
The Wisent Demography Has Been More Fluctuating than the Bovine One during the Whole Pleistocene We further sought to characterize the genetic variability ofthe wisent population that has long been considered as athreatened species and is still classified as “vulnerable” bythe International Union for Conservation of Nature red list(http://www.iucnredlist.org/).,Non-OADS,/arxiv_data1/oa_pdf/a7/12/msw144.PMC5062319.pdf
The resulting bam files are available for download from the Sequence Read Archive re- pository (http://www.ncbi.nlm.nih.gov/sra) under the acces-sion number SRP070526.,OADS,/arxiv_data1/oa_pdf/a7/12/msw144.PMC5062319.pdf
It should be noted that mapping the wisent reads onto the preliminary Y-chromosome (BTAY) sequence from the BosTau7 assembly (available at http://www.genome.ucsc.edu/) lead to a high proportion of reads improperly paired and only approximately 12% of the BTAY s e q u e n c ew a sc o v e r e dw i t ha nu n e x p e c t e dh i g hr e a dcoverage ( >60X).,Non-OADS,/arxiv_data1/oa_pdf/a7/12/msw144.PMC5062319.pdf
"Segments mapping to the (bovine) X-chromosome or with more than 500,000 (5%) missing information (i.e., anuncalled base in either the BTA or BBO sequence) were further discarded leading to a total of 123 and 177 available segments for the BBO_3569 and BBO_3574 alignments, respectively.Maximum-likelihood inference was then carried out indepen- dently for each segment using the scripts isolation-model.py (version 1.1) for the I-model, and the initial-migration-model.py (version 1.2) for the IM-model, from the IMCoalHMM software package (https://github.com/mailund/IMCoalHMM).",OADS,/arxiv_data1/oa_pdf/a7/12/msw144.PMC5062319.pdf
ENSEMBL protein-coding sequences as defined in the UCSC genome database (http://genome.ucsc.edu/).,OADS,/arxiv_data1/oa_pdf/a7/12/msw144.PMC5062319.pdf
"A total of 405 of these transcripts were fur- ther identified as one to one orthologs between cattle andsheep, using Ensembl orthology information (http://www.ensembl.org/biomart/).",OADS,/arxiv_data1/oa_pdf/a7/12/msw144.PMC5062319.pdf
A network w a sc o n s i d e r e da ss i g n i f i c a n tw h e n S>3.Supplementary Material Supplementary figures S1–S7 and tables S1–S6 are available at Molecular Biology and Evolution online (http://www.mbe.,OADS,/arxiv_data1/oa_pdf/a7/12/msw144.PMC5062319.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c2/69/msw157.PMC5062320.pdf
"Sequence Read Archive (SRA) data were retrieved from GenBank (http://www.ncbi.nlm.nih.gov/sra/; last accessed August 5, 2016).",OADS,/arxiv_data1/oa_pdf/c2/69/msw157.PMC5062320.pdf
Corrected AIC criterion and mixed model of birth-death or Yule were implemented in the calculation.Supplementary Materials Supplementary figures S1–S6 and tables S1–S5 are available at Molecular Biology and Evolution online (http://www.mbe.,OADS,/arxiv_data1/oa_pdf/c2/69/msw157.PMC5062320.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dd/b0/msw163.PMC5062321.pdf
"These were blasted against the pKP33 plasmid reference using theGView web-server available at: https://server.gview.ca/, last accessed August 8, 2016.",OADS,/arxiv_data1/oa_pdf/dd/b0/msw163.PMC5062321.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f0/a7/msw166.PMC5062323.pdf
"Methods Data Sources and Assembly We obtained RNA-seq data for 19 of the MMETSP ciliate species from iMicrobe (http://data.imicrobe.us/), along with four sequence read archive (SRA) files from ( Feng et al.",OADS,/arxiv_data1/oa_pdf/f0/a7/msw166.PMC5062323.pdf
"Position Specific Codon Frequencies in Condylostoma Individual transcripts from MMETSP0210 Condylostoma magnum, strain COL2 from iMicrobe (http://data.imicrobe.us/) were searched using a collection of eukaryotic ortholo- gous groups, KOGs ( Tatusov et al.",OADS,/arxiv_data1/oa_pdf/f0/a7/msw166.PMC5062323.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/7b/msw170.PMC5062324.pdf
Supplementary Material Supplementary figures S1–S12 and tables S1–S11 are available atMolecular Biology and Evolution online (http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/a1/7b/msw170.PMC5062324.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/74/a3/msw173.PMC5062326.pdf
"arXiv:1506.06998, http://arxiv.org/abs/1506.06998.",Non-OADS,/arxiv_data1/oa_pdf/74/a3/msw173.PMC5062326.pdf
http://dx.doi.org/10.1080/10618600.2016.1159212.,Non-OADS,/arxiv_data1/oa_pdf/74/a3/msw173.PMC5062326.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/dc/msw174.PMC5062327.pdf
"Adapter clipping and quality trimming of rawreads were performed using fqtrim software (version 0.9.4, http://ccb.jhu.edu/software/fqtrim/) and PRINSEQ (version 0.20.4; Schmieder and Edwards 2011 ), by calculating the com- plexity using the DUST method with a maximum allowed score of 7.",OADS,/arxiv_data1/oa_pdf/6a/dc/msw174.PMC5062327.pdf
Available from: http://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/6a/dc/msw174.PMC5062327.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ae/10/msw175.PMC5062328.pdf
"Our approach is explained below and was implemented in Python 2.7 (scripts are available at https://github.com/anaflo/tomato, last accessed December 29, 2015).",OADS,/arxiv_data1/oa_pdf/ae/10/msw175.PMC5062328.pdf
Supplementary Material Supplementary tables S1–S3 and figures S1–S6 are available at Molecular Biology and Evolution online (http://www.mbe.,OADS,/arxiv_data1/oa_pdf/ae/10/msw175.PMC5062328.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/40/msw176.PMC5062329.pdf
"Specifically, we considered 44,078 SNP-trait associations from the Association Results Browser (http://www.ncbi.nlm.nih.",OADS,/arxiv_data1/oa_pdf/19/40/msw176.PMC5062329.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/13/msw182.PMC5062330.pdf
"2006 ) (http://www.abren.net/protherm/, last accessed 31 August 2016) 4,805 single buried site mutants from 180 proteins were available.About 1,667 mutants belonged to the aliphatic to aliphatic category, nearly half of them being mutations to alanine.",OADS,/arxiv_data1/oa_pdf/e3/13/msw182.PMC5062330.pdf
"Supplementary Material Supplementary figures S1–S6, tables S1–S9 ,C c d BM S seqdata (S1_Appendix.xlsx) and Materials and Methods are available atMolecular Biology and Evolution online (http://www.mbe.",OADS,/arxiv_data1/oa_pdf/e3/13/msw182.PMC5062330.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/c2/ddw058.PMC5062578.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/00/ddw061.PMC5062579.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b5/fc/ddw062.PMC5062580.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/86/35/ddw069.PMC5062586.pdf
"Consistent with the current recommendations for reporting GWAS ﬁndings, we have made available the entire set of single-marker association results for the six PCTS listed in ascending P-value order at: http://genomewide.net/public/aric/dental/complex_traits/pct#.",OADS,/arxiv_data1/oa_pdf/86/35/ddw069.PMC5062586.pdf
The full list of gene-centric association testing results is available at http://genomewide.net/public/aric/dental/ gene-centric/CP_PCT_Genes.xls.,OADS,/arxiv_data1/oa_pdf/86/35/ddw069.PMC5062586.pdf
Additional online resources included tools available at the National Center for Biotechnology Information (NCBI- http:// www.ncbi.nlm.nih.gov/) and the UCSF Genome browser v274 at (http://genome.ucsc.edu/).,OADS,/arxiv_data1/oa_pdf/86/35/ddw069.PMC5062586.pdf
Available from: http://www.cdc.gov/nhsn/PDFs /pscManual/4PSC_CLABScurrent.pdf  2.,OADS,/arxiv_data1/oa_pdf/fb/cf/idr-2016-3-6275.PMC5062625.pdf
Available from: http://www.cdc.gov/HAI/pdfs/progress- report/hai-progress-report.pdf  4.,OADS,/arxiv_data1/oa_pdf/fb/cf/idr-2016-3-6275.PMC5062625.pdf
Available from:https://www.cms.gov/Newsroom/MediaReleaseDatabase/Press-releases/2011-Press- releases-items/2011-04-12.html 10.,Non-OADS,/arxiv_data1/oa_pdf/fb/cf/idr-2016-3-6275.PMC5062625.pdf
Available from: http://www.infectioncontroltoday.com/arti- cles/2011/01/public-reporting-of-infec- tions-and-the-clabsi-mandate.aspx 13.,Non-OADS,/arxiv_data1/oa_pdf/fb/cf/idr-2016-3-6275.PMC5062625.pdf
Available from: http://www.cdc.gov/abcs/ reports-findings/survreports/hib11.pdf.,OADS,/arxiv_data1/oa_pdf/10/e3/idr-2016-3-6494.PMC5062627.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/ec/0b/CG-CGCR160004.PMC5062645.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/06/4b/CG-CGCR160046.PMC5062646.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/2c/b9/CG-CGCR160016.PMC5062647.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/62/45/CG-CGCR160026.PMC5062648.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/33/e0/CG-CGCR160025.PMC5062649.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/25/25/CG-CGCR160044.PMC5062650.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/c6/1e/CG-CGCR160011.PMC5062651.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/2e/4d/CG-CGCR160007.PMC5062652.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/0a/de/CG-CGCR160043.PMC5062653.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/5b/b3/CG-CGCR160021.PMC5062654.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/a7/42/CG-CGCR160010.PMC5062655.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/e3/79/CG-CGCR160027.PMC5062656.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/53/04/CG-CGCR160001.PMC5062657.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/ee/54/CG-CGCR160018.PMC5062658.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/e6/d1/CG-CGCR160047.PMC5062659.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/76/ce/CG-CGCR160009.PMC5062660.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/f6/8a/CG-CGCR160006.PMC5062661.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/ba/0d/CG-CGCR160008.PMC5062662.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/b4/89/CG-CGCR160023.PMC5062663.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/d1/52/CG-CGCR160022.PMC5062664.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/19/5d/CG-CGCR160029.PMC5062665.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/38/7e/CG-CGCR160030.PMC5062666.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/e7/74/CG-CGCR160002.PMC5062667.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/60/cd/CG-CGCR160017.PMC5062668.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/08/f6/CG-CGCR160005.PMC5062669.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/0d/a2/CG-CGCR160028.PMC5062670.pdf
http://www.uptodate.com/contents/ hypertriglyceridemia-induced-acute-pancreatitis .,Non-OADS,/arxiv_data1/oa_pdf/0d/a2/CG-CGCR160028.PMC5062670.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/f8/df/CG-CGCR160065.PMC5062671.pdf
http://www.nccn.org/professionals/physician_gls/pdf/occult.,Non-OADS,/arxiv_data1/oa_pdf/f8/df/CG-CGCR160065.PMC5062671.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/b7/3d/CG-CGCR160083.PMC5062672.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/e0/bf/CG-CGCR160076.PMC5062673.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/0b/85/CG-CGCR160064.PMC5062674.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/0e/79/CG-CGCR160062.PMC5062675.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/e1/bb/CG-CGCR160053.PMC5062676.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/d8/1d/CG-CGCR160068.PMC5062677.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/f7/23/CG-CGCR160055.PMC5062678.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/e1/09/CG-CGCR160061.PMC5062679.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/94/6e/CG-CGCR160057.PMC5062680.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/6d/0d/CG-CGCR160091.PMC5062681.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/54/95/CG-CGCR160069.PMC5062682.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/75/20/CG-CGCR160075.PMC5062683.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/6f/c4/CG-CGCR160031.PMC5062684.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/76/11/CG-CGCR160049.PMC5062685.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/0a/d0/CG-CGCR160067.PMC5062686.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/3d/ff/CG-CGCR160020.PMC5062687.pdf
Available from: http://www.census.gov/hhes/school/data/cps/2012/tables.html 8.,OADS,/arxiv_data1/oa_pdf/bb/74/jphr-2016-2-595.PMC5062751.pdf
Available from: http://www.cdc.gov/brfss 10.,OADS,/arxiv_data1/oa_pdf/bb/74/jphr-2016-2-595.PMC5062751.pdf
Available from: http://appliedresearch.cancer.gov/tus-cps/ 11.,Non-OADS,/arxiv_data1/oa_pdf/bb/74/jphr-2016-2-595.PMC5062751.pdf
Available from: http://www.die- bonn.de/esprid/dokumente/doc-2004/apel04_02.pdf 17.,Non-OADS,/arxiv_data1/oa_pdf/ff/ea/jphr-2016-2-621.PMC5062752.pdf
Available from: http://www.futuresearch.net.,Non-OADS,/arxiv_data1/oa_pdf/ff/ea/jphr-2016-2-621.PMC5062752.pdf
Available from: http://www.cancervic.org.au/research/registry-sta- tistics/vcr  10.,Non-OADS,/arxiv_data1/oa_pdf/ff/97/jphr-2016-2-678.PMC5062754.pdf
Available from: http://www.abs.gov.au/websitedbs/D3310114.nsf/home/Australian+ Statistical+Geography+Standard+%28ASGS%29  11.,Non-OADS,/arxiv_data1/oa_pdf/ff/97/jphr-2016-2-678.PMC5062754.pdf
Available from: http://www.abs.gov.au/ausstats/abs@.nsf/mf/2001.0  12.,Non-OADS,/arxiv_data1/oa_pdf/ff/97/jphr-2016-2-678.PMC5062754.pdf
Available from: http://agriculture.vic.gov.au/agriculture/food-and-fibre- industries/industry-profiles  14.,Non-OADS,/arxiv_data1/oa_pdf/ff/97/jphr-2016-2-678.PMC5062754.pdf
Available from: http://performance.health.,Non-OADS,/arxiv_data1/oa_pdf/ff/97/jphr-2016-2-678.PMC5062754.pdf
Available from: http://www.health.vic.gov.au/healthstatus/atlas/html/lga_by_aria_c ategory.html  18.,Non-OADS,/arxiv_data1/oa_pdf/ff/97/jphr-2016-2-678.PMC5062754.pdf
Available from: http://www.health.vic.gov.au/trauma/regional- services/regional-services-locations.htm 20.,Non-OADS,/arxiv_data1/oa_pdf/ff/97/jphr-2016-2-678.PMC5062754.pdf
Available from: http://www.ndss.com.au/ 23.,Non-OADS,/arxiv_data1/oa_pdf/ff/97/jphr-2016-2-678.PMC5062754.pdf
Available from: http://www.health.vic.gov.au/hdss/vaed/ 24.,Non-OADS,/arxiv_data1/oa_pdf/ff/97/jphr-2016-2-678.PMC5062754.pdf
Available from: http://www.health.vic.gov.au/hdss/vemd/ 25.,Non-OADS,/arxiv_data1/oa_pdf/ff/97/jphr-2016-2-678.PMC5062754.pdf
Available from: http://www.humanservices.gov.au/ corporate/statistical-information-and-data/medicare-statistics 26.,OADS,/arxiv_data1/oa_pdf/ff/97/jphr-2016-2-678.PMC5062754.pdf
Availablefrom: https://aoanjrr.dmac.adelaide.edu.au/ 27.,Non-OADS,/arxiv_data1/oa_pdf/ff/97/jphr-2016-2-678.PMC5062754.pdf
Available from: http://www.anzdata.org.au /v1/structure.html 28.,OADS,/arxiv_data1/oa_pdf/ff/97/jphr-2016-2-678.PMC5062754.pdf
Available from: http://www.humanservices.gov.au/customer/sub- jects/medicare-services 31.,Non-OADS,/arxiv_data1/oa_pdf/ff/97/jphr-2016-2-678.PMC5062754.pdf
Available from: https://www.abdn.ac.uk/iahs/content- images/Module_5.pdf 5.,Non-OADS,/arxiv_data1/oa_pdf/21/fc/jphr-2016-2-692.PMC5062756.pdf
Available from: http://www.un.org/millenniumgoals/ pdf/Goal_5_fs.pdf 6.,Non-OADS,/arxiv_data1/oa_pdf/21/fc/jphr-2016-2-692.PMC5062756.pdf
Available from: http://www.eluniverso.com/noticias/2015/10/08/nota/5172101/indic es-mortalidad-materna 7.,Non-OADS,/arxiv_data1/oa_pdf/21/fc/jphr-2016-2-692.PMC5062756.pdf
Available from: http://www.who.int/gho/mater- nal_health/mortality/maternal_mortality_text/en/ 9.,Non-OADS,/arxiv_data1/oa_pdf/21/fc/jphr-2016-2-692.PMC5062756.pdf
Available from: http://www.ecuadorencifras.gob.ec/ nacimientos-defunciones/  10.,Non-OADS,/arxiv_data1/oa_pdf/21/fc/jphr-2016-2-692.PMC5062756.pdf
Available from: http://www.salud.gob.ec/datos-de- hospitales/ 11.,Non-OADS,/arxiv_data1/oa_pdf/21/fc/jphr-2016-2-692.PMC5062756.pdf
Available from: https://www.k4health.org/sites/default/files/EONC%20Program%20 Implementation%20Guide%20v1.1.pdf  13.,Non-OADS,/arxiv_data1/oa_pdf/21/fc/jphr-2016-2-692.PMC5062756.pdf
Available f r o m : https://aplicaciones.msp.gob.ec/salud/publico/dniscg/geosalud/gui/ 15.,Non-OADS,/arxiv_data1/oa_pdf/21/fc/jphr-2016-2-692.PMC5062756.pdf
Available from: http://vizhub.healthdata.org/gbd-compare/” http://vizhub.healthda- ta.org/gbd-compare/ 16.,Non-OADS,/arxiv_data1/oa_pdf/21/fc/jphr-2016-2-692.PMC5062756.pdf
Available from: http://www.stat.fi/til/yskp/tau_en.html 9.,OADS,/arxiv_data1/oa_pdf/4a/7d/jphr-2016-2-705.PMC5062757.pdf
Available at: http://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/4a/7d/jphr-2016-2-705.PMC5062757.pdf
"Additional Information Supplementary information accompanies this paper at http://www.nature.com/srep Competing financial interests: The authors declare no competing financial interests.How to cite this article: Marcinkowska, U. M. et al.",Non-OADS,/arxiv_data1/oa_pdf/6e/80/srep33545.PMC5062761.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc/4.0/ Metadata associated with this  Data Descriptor is available at http://www.nature.com/sdata/ and is released under the CC0 waiver to maximize  reuse.",Non-OADS,/arxiv_data1/oa_pdf/6e/80/srep33545.PMC5062761.pdf
"A stringent scanning threshold of 10 bits wasused,ensuringalowfalsepositiverate.Tostudyconser-vation of the binding sites in other related species, we used 12 eutherian EPO alignments from the Ensembl website (http://www.ensembl.org/ ).The12speciesweredividedinto fivegroupsofrelatedspecies:(i)mouseandrat,(ii)human, chimpanzee, gorilla, marmoset, orangutan and macaque,(iii) cow and pig, (iv) dog and (v) horse.",Non-OADS,/arxiv_data1/oa_pdf/32/48/gkw512.PMC5062961.pdf
Non-coding LD SNPs (r2>0.8) to the daSNPs in IGR were identified using the CEPH population-based HapMap data ( ftp://ftp.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/a4/46/gkw519.PMC5062962.pdf
ICD-10 ( http://www.who.int/classifications/icd/en/ ) annotations were used to make disease names from differ- entsourcescomparable.DnaseIhypersensitivitysite(DHS) annotations were downloaded from the UCSC genomebrowser ( 30).,OADS,/arxiv_data1/oa_pdf/a4/46/gkw519.PMC5062962.pdf
The human eQTL /mQTL data sets used in this study were downloaded from the GEOdatabase( http://www.ncbi.nlm.nih.gov/geo );thesedatasets included all that became publicly available by the end of 2014 (the list of these data is shown in Supplementary Ta-ble S1).,OADS,/arxiv_data1/oa_pdf/a4/46/gkw519.PMC5062962.pdf
"The gene regions in the eQTL /mQTL data were converted to gene IDs used in this analysis if they overlapped with the regions of the geneIDsforatleast1bp.InMarch2016,wesearchedinthe ENCODE( 15)website( http://www.encodeproject.org )and found 72 samples of human Small RNA-seq data (20–200 nt,ribominus)inbamformat,correspondingtoatotalof17 humantissuesand15humancelllines.Wedownloadedandprocessedthesebamdata.ReadcountsforHREswerecal- culatedbyfeatureCounts( 32).Onlyuniquelymappedreads were used for the analysis.",OADS,/arxiv_data1/oa_pdf/a4/46/gkw519.PMC5062962.pdf
HICutilizedHi-CandChIA-PETdata topredictthetargetgenesforDREs.Hi-CdataandChIA- PET data of human cell lines generated from 8 studies (SupplementaryTableS2)weredownloadedfromtheGEOdatabase ( http://www.ncbi.nlm.nih.gov/gds ).,OADS,/arxiv_data1/oa_pdf/a4/46/gkw519.PMC5062962.pdf
The gene IDs used by that methodwereconvertedtotheIDsweusedinthisanalysisbasedon the annotations of RefSeq ( http://www.ncbi.nlm.nih.gov/ refseq).,OADS,/arxiv_data1/oa_pdf/a4/46/gkw519.PMC5062962.pdf
"We downloaded eight sets of eQTL /mQTL data from the GEO database ( http://www.ncbi.nlm.nih.gov/geo ), which included the eQTL / mQTL data from blood, liver, intes- tine and brain tissues of Caucasian or European popula-tions (Supplementary Table S1).",OADS,/arxiv_data1/oa_pdf/a4/46/gkw519.PMC5062962.pdf
The predicted target genes of IGR daSNPs can help to ex- plain their disease phenotypes We obtained disease gene annotations from GAD ( 29) (http://geneticassociationdb.nih.gov ).,OADS,/arxiv_data1/oa_pdf/a4/46/gkw519.PMC5062962.pdf
"NucleicAcidsResearch,2016,Vol.44,No.18 8657 Kaplan–Meier analyses Kaplan–Meiercurves( 38)weregeneratedusingtheGOBO tool (http://co.bmc.lu.se/gobo )(39) and the following gene set:KDM1A (LSD1) (Entrez Gene ID: 23028), HDAC1 (EntrezGeneID:3065), HDAC6(EntrezGeneID:10013), HSP90AB1 (Hsp90 /H9252)(EntrezGeneID:3326)and CARM1 (EntrezGeneID: 10498).",OADS,/arxiv_data1/oa_pdf/e8/6c/gkw522.PMC5062963.pdf
Database searching and interpretation of the tandem mass spectra Ariadne( 35)(http://ariadne.riken.jp/ )wasusedfordatabase searches and assignment of the tandem mass spectralpeaks in conjunction with the sequences in the Sc genome database ( http://www.yeastgenome.org/download- data/sequence ).,OADS,/arxiv_data1/oa_pdf/d3/77/gkw564.PMC5062969.pdf
The predicted internal loop at the base of an upper stem and the 12–19 nt upstream of an H or ACA boxwerecomparedwiththesequencearoundthetargetsite.The snoRNA with the greatest sequence identity was se- lectedastheresponsiblesnoRNA.RNAtertiarystructures definedbytheirPDBfileswerevisualizedandanalysedwiththeSwiss-PdbViewer( http://spdbv.vital-it.ch/ ).,OADS,/arxiv_data1/oa_pdf/d3/77/gkw564.PMC5062969.pdf
ACCESSION NUMBERS The 3D EM volume in this study has been deposited into EMDB(https://www.ebi.ac.uk/pdbe/emdb/ ).Theaccession ID is EMD-8146.,OADS,/arxiv_data1/oa_pdf/bb/97/gkw576.PMC5062973.pdf
"Integrity of each RNA sam- ple was determined using the 3’:5’ method in which qPCR of each cDNA was performed using two primer pairs, oneof which amplifies a sequence from the 5 /primeend of the ref- erence gene sigAand the other from the 3/primeend of the gene (21).All3/prime:5/primeratiosexceeded0.2,consistentwithintactnon- degradedRNA.PrimersforRT-qPCRweredesignedusing NCBI primer blast online tool ( http://www.ncbi.nlm.nih.",OADS,/arxiv_data1/oa_pdf/36/fd/gkw625.PMC5062980.pdf
"Us-ing the search pattern function of the Tuberculist website (http://genolist.pasteur.fr/Tuberculist ), we searched the M. tuberculosis H37Rvgenomesequenceforexactmatchesand for sequences that differed by up to five bases from the 20 bases of the protospacer sequence the plus the adjacent 3- base PAM sequence in the target gene (Supplementary Ta-ble S1).",OADS,/arxiv_data1/oa_pdf/36/fd/gkw625.PMC5062980.pdf
"Handbook ofMarkovChainMonteCarlo .V ol.2, http://www.mcmchandbook.net/HandbookChapter5.pdf .",Non-OADS,/arxiv_data1/oa_pdf/61/c5/gkw627.PMC5062982.pdf
"Applying this method to the cellular transcriptome, we found that it ap-propriatelyvalidatedannotatedcellulargeneswhilealsore- vealing novel splice variants, alternative transcription start sites and alternative polyadenylation sites (Figure 1Ea n d SupplementaryFigure S3).TRIMD scriptsare available athttps://github.com/flemingtonlab/public and can easily be used to assess transcript structures for other viral and even cellular genomes.",OADS,/arxiv_data1/oa_pdf/c6/bc/gkw629.PMC5062983.pdf
tionfilesfoundat https://github.com/flemingtonlab/public ).,Non-OADS,/arxiv_data1/oa_pdf/c6/bc/gkw629.PMC5062983.pdf
"2015,http://www.pacb.com/ .",Non-OADS,/arxiv_data1/oa_pdf/c6/bc/gkw629.PMC5062983.pdf
"The data were ex- ported in Fastq files, uploaded to the galaxy server and processed further ( https://galaxyproject.org/ ).",OADS,/arxiv_data1/oa_pdf/5f/37/gkw709.PMC5062988.pdf
"Analysis resulted in 244 significantly differen- tialexpressedgenes( P-value <0.005)whichweresubjected for further functional enrichment analysis using the PAN- THER classification platform of the Gene Ontology Con- sortium tool( http://geneontology.org/ )(31).RESULTS PNLDC1 is a phylogenetically distinct exonuclease with specificitytopolyadenylates The protein sequence alignment of PNLDC1 with PARN homologues from many representative organisms showed that share sequence similarities mainly in the nuclease (CAF1) domain that contains the characteristic DEDDmotif of the active site as expected (Figure 1A and Supple- mentaryFigureS1),buttheoverallidentityislow.Asurvey for the the detection of either PNLDC1 or PARN showedthateitheroneispresentinverylowmetazoa(i.e.PARNin Placozoa and PNLDC1 in Cnidaria) and both of them are presentinarthropods(including B.mori)andmainlyinam- niotic vertebrates.",OADS,/arxiv_data1/oa_pdf/5f/37/gkw709.PMC5062988.pdf
"Primers were designed using Primer3 specifications to limitoff-targetamplificationwithinthemurinegenome(es-pecially within nuclear mitochondrial segments, NUMTs, which are transpositions of mtDNA into the nucleus), and their specificity was confirmed using UCSC in silicoPCR (http://rohsdb.cmb.usc.edu/GBshape/cgi-bin/ hgPcr) and NCBI primer-BLAST ( 37).",OADS,/arxiv_data1/oa_pdf/3a/0d/gkw716.PMC5062989.pdf
"Primers weredesigned with the aid of NCBI’s primer-BLAST ( 37)a n d UCSCIn-SilicoPCR( http://rohsdb.cmb.usc.edu/GBshape/ cgi-bin/hgPcr ), as with the primer /probes used in ddPCR.",OADS,/arxiv_data1/oa_pdf/3a/0d/gkw716.PMC5062989.pdf
"OligoAnalyzer3.1IntegratedDNATechnology,Inc, https://sg.idtdna.com/calc/analyzer .",OADS,/arxiv_data1/oa_pdf/4b/be/gkw718.PMC5062990.pdf
"Currently, more than 100 PTM sites have been mapped on human and mouse DNMT1 (http://www.phosphosite.org )( F i g u r e 4).",OADS,/arxiv_data1/oa_pdf/93/c1/gkw723.PMC5062992.pdf
"Regulation of DNMT3A by phosphorylation The regulation of the DNMT3 enzymes by phosphoryla- tion has not been studied almost at all, despite the fact that more than 70 phosphorylation sites have been identi- fiedinDNMT3AandDNMT3Binglobalproteomicsstud-ies (http://www.phosphosite.org ).",Non-OADS,/arxiv_data1/oa_pdf/93/c1/gkw723.PMC5062992.pdf
R software was used for category enrichment analysis (http://www.r-project.org/ ).,OADS,/arxiv_data1/oa_pdf/58/b0/gkw732.PMC5062994.pdf
GO (http://www.yeastgenome.,Non-OADS,/arxiv_data1/oa_pdf/58/b0/gkw732.PMC5062994.pdf
Many subsequent genomesequenceshavebeenderivedfromothercyanobac- terial species and have been assembled and deposited in theNCBIsequencedatabase( http://www.ncbi.nlm.nih.gov/ genomes).,OADS,/arxiv_data1/oa_pdf/ca/cf/gkw737.PMC5062996.pdf
"The node-edge structure is provided as a .sif file (Supplementary Data File), that canbe viewed inCytoscape ( http://www.cytoscape.org/ ,(29)).",OADS,/arxiv_data1/oa_pdf/ca/cf/gkw737.PMC5062996.pdf
"8824NucleicAcidsResearch,2016,Vol.44,No.18 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc= GSE72691 .",OADS,/arxiv_data1/oa_pdf/ca/cf/gkw737.PMC5062996.pdf
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc= GSE72880 .,OADS,/arxiv_data1/oa_pdf/ca/cf/gkw737.PMC5062996.pdf
"Thebeadswereboiledafterextensivewashingandthepro-teins were detected by Western blotting, followed by quan- tificationusingImageJsoftware( http://rsb.info.nih.gov/ij ).",OADS,/arxiv_data1/oa_pdf/cc/7d/gkw748.PMC5062998.pdf
Colonies that were ≥200/H9262m in diameter were counted us- ing ImageJ software( https://imagej.nih.gov/ij/ ).,OADS,/arxiv_data1/oa_pdf/cc/7d/gkw748.PMC5062998.pdf
"Last, a database search of PhosphoSitePlus (http://www.phosphosite.org/ ) revealed that phosphoryla- tion atT236-SOX9 was previouslyreported( 65).",OADS,/arxiv_data1/oa_pdf/cc/7d/gkw748.PMC5062998.pdf
"Clearly,therequirementofaknownorpredictedsecondary structure might limit BEAM applicability, but we believethat this would not be a major hindrance thanks to recent technology advances that are quickly leading toward an era when high-quality RNA secondary structure informa-tionwillbeavailableforentiretranscriptomes( 41).BEAM sourcecodeisfreelyavailableat https://github.com/noise42/ beam.",Non-OADS,/arxiv_data1/oa_pdf/24/f1/gkw750.PMC5062999.pdf
Statistics Student’st-tests and Chi-square tests were performed by Prism 6(GraphPad Software).Dataaccess RNA-seq data reported in this paper have been submit- tedtoGeneExpressionOmnibus( http://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/a6/8f/gkw765.PMC5063002.pdf
"942 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/12/hyw091.PMC5063005.pdf
"http://www.who.int/fctc/guidelines/adopted/article_8/en/ (17 December 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/26/12/hyw091.PMC5063005.pdf
"http://www.who.int/tobacco/glo bal_report/2015/en/ (28 December 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/26/12/hyw091.PMC5063005.pdf
http://epi.ncc.,Non-OADS,/arxiv_data1/oa_pdf/26/12/hyw091.PMC5063005.pdf
http://www.R-project.org .,Non-OADS,/arxiv_data1/oa_pdf/26/12/hyw091.PMC5063005.pdf
"http://www.mhlw.go.jp/bunya/ken-kou/eiyou/h25-houkoku.html (17 December 2015, date last accessed) [in Japanese].",Non-OADS,/arxiv_data1/oa_pdf/26/12/hyw091.PMC5063005.pdf
"http://www.thecommunityguide.org/toba cco/index.html .Jpn J Clin Oncol, 2016 , Vol.",Non-OADS,/arxiv_data1/oa_pdf/26/12/hyw091.PMC5063005.pdf
"The chicken, bovine, and turkey isolates were obtained  from the Bundesinstitut für Risikobewertung (BfR, Feder-al Institute for Risk Assessment, http://www.bfr.bund.de/de/nationales_referenzlabor_fuer_campylobacter-8818.html) in Berlin, Germany.",Non-OADS,/arxiv_data1/oa_pdf/db/09/eujmi-06-162.PMC5063009.pdf
The C. jejuni  MLST website  (http://pubmlst.org/campylobacter/) was consulted for assignation of sequence types and clonal complexes [24].,OADS,/arxiv_data1/oa_pdf/db/09/eujmi-06-162.PMC5063009.pdf
Campylobacter jejuni  chemoreceptor distribution European Journal of Microbiology and Immunology167 Multiple sequence alignment of the tlp gene sequences  was performed using the Clustal Omega package (http://www.ebi.ac.uk/Tools/msa/clustalo/) [25] hosted at the EMBL-EBI bioinformatics web and programmatic tools framework website [26].,OADS,/arxiv_data1/oa_pdf/db/09/eujmi-06-162.PMC5063009.pdf
The multiple DNA sequence alignment was analyzed using Clustal Omega (http://www.ebi.ac.uk/Tools/msa/ clustalo/).,OADS,/arxiv_data1/oa_pdf/db/09/eujmi-06-162.PMC5063009.pdf
Depicted is a neighbor-joining tree without distance corrections (http://www.ebi.,Non-OADS,/arxiv_data1/oa_pdf/db/09/eujmi-06-162.PMC5063009.pdf
"S. sonnei is the dominating species, and the ma- jority of the cases are infected abroad (http://www.msis.no/).",Non-OADS,/arxiv_data1/oa_pdf/4f/cb/eujmi-06-197.PMC5063012.pdf
"Also, the Norwegian Act relating to control of communicable diseases (https://lovdata.no/dokument/NL/lov/1994-08-05-55?q=Smittevernloven) obliges the NIPH to monitor the Shigella  spp.",Non-OADS,/arxiv_data1/oa_pdf/4f/cb/eujmi-06-197.PMC5063012.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/ec/taw069.PMC5063019.pdf
"Hepatitis A Fact sheet 2016. http://www.who.int/media centre/factsheets/fs328/en/ (3 March 2016, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/50/ec/taw069.PMC5063019.pdf
"Hepatitis B Fact sheet 2016. http://www.who.int/media centre/factsheets/fs204/en/ (3 March 2016, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/50/ec/taw069.PMC5063019.pdf
"International Travel and Health, Vaccine-preventable dis- eases and vaccines, 2015. http://www.who.int/ith/ITH_chapter_6.",Non-OADS,/arxiv_data1/oa_pdf/50/ec/taw069.PMC5063019.pdf
"http://wwwnc.cdc.gov/travel/ (3 March 2016, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/50/ec/taw069.PMC5063019.pdf
"The pre-travel consultation, 2016. http://wwwnc.cdc.gov/travel/yellowbook/2016/the-pre-travel-consul tation/the-pre-travel-consultation (3 March 2016, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/50/ec/taw069.PMC5063019.pdf
2015. http://www.medscape.com/viewarticle/840585 4.,Non-OADS,/arxiv_data1/oa_pdf/23/a8/nihms820486.PMC5063047.pdf
http://www.fda.gov/Drugs/InformationOnDrugs/ ApprovedDrugs/ucm395386.htm 6.,Non-OADS,/arxiv_data1/oa_pdf/23/a8/nihms820486.PMC5063047.pdf
http://www.nccn.org/professionals/ physician_gls/pdf/nscl.pdf 18.,Non-OADS,/arxiv_data1/oa_pdf/23/a8/nihms820486.PMC5063047.pdf
"Thesignal intensity of the 12- to 15-kDa, 25-kDa, and 40-kDa bandsfrom each individual’s tear sample was quantiﬁed using ImageJ(http://imagej.nih.gov/ij: provided in the public domain by theNational Institutes of Health, Bethesda, MD, USA).",OADS,/arxiv_data1/oa_pdf/79/2a/i1552-5783-57-13-5237.PMC5063056.pdf
Available at: http://cran.r-project.org/web/packages/pROC/pROC.pdf.,Non-OADS,/arxiv_data1/oa_pdf/79/2a/i1552-5783-57-13-5237.PMC5063056.pdf
Cells Tissues Organs 2016; 201(5):342-353. http://dx.doi.org/10.1159/000444389 © 2016 Darrell Wiens.,Non-OADS,/arxiv_data1/oa_pdf/84/49/kngs-03-01-1230167.PMC5063060.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/49/kngs-03-01-1230167.PMC5063060.pdf
"1, e1230167 (5 pages)http://dx.doi.org/10.1080/23262133.2016.1230167",Non-OADS,/arxiv_data1/oa_pdf/84/49/kngs-03-01-1230167.PMC5063060.pdf
"Lancet 1980; 1:339-340;PMID:6101792; http://dx.doi.org/10.1016/S0140-6736(80)90886-7 [2] Smithells RW, Nevin NC, Seller MJ, Sheppard S, Harris R, Read AP, Fielding DW, Walker S, Schorah CJ, Wild J.Further experience of vitamin supplementation for pre-vention of neural tube defect recurrences.",OADS,/arxiv_data1/oa_pdf/84/49/kngs-03-01-1230167.PMC5063060.pdf
"Lancet 1983;1:1027-1031; PMID:6133069; http://dx.doi.org/10.1016/S0140-6736(83)92654-5 [3] Mulinare J, Cordero JF, Erickson JD, Berry RJ.",OADS,/arxiv_data1/oa_pdf/84/49/kngs-03-01-1230167.PMC5063060.pdf
"JAMA 1988; 260 (21):3141-3145; PMID:3184392; http://dx.doi.org/10.1001/jama.1988.03410210053035 [4] Milunsky A, Jick H, Jick SS, Bruell CL, MacLaughlin DS, Rothman KJ, Willett W. Multivitamin/folic acidsupplementation in early pregnancy reduces the prev-alence of neural tube defects.",Non-OADS,/arxiv_data1/oa_pdf/84/49/kngs-03-01-1230167.PMC5063060.pdf
"JAMA 1989; 262(20):2847-2852; PMID:24 78730; http://dx.doi.org/ 10.1001/jama.1989.03430200091032[5] Wald D, Bishop L, Wald NJ, Law M, Hennessy E, Weir D, McPartlin J, Scott J. Randomized trial of folic acidsupplementation and serum homocysteine levels.",OADS,/arxiv_data1/oa_pdf/84/49/kngs-03-01-1230167.PMC5063060.pdf
ArchIntern Med 2001; 161(5):695-700; PMID:11231701;http://dx.doi.org/10.1001/archinte.161.5.695 [6] Rogers EJ.,OADS,/arxiv_data1/oa_pdf/84/49/kngs-03-01-1230167.PMC5063060.pdf
"Med Hypotheses 2008; 71:406-410; PMID:18514430; http://dx.doi.org/10.1016/j.mehy.2008.04.013 [7] Leeming RJ, Lucock M. Autism: is there a folate connec- tion?",Non-OADS,/arxiv_data1/oa_pdf/84/49/kngs-03-01-1230167.PMC5063060.pdf
"J Inherit Metab Dis 2009; 32:400-402;PMID:19277892; http://dx.doi.org/10.1007/s10545-009-1093-0 [8] Lucock M, Leeming R. Autism, seasonality and the environmental perturbation of epigenome related vita- min levels.",OADS,/arxiv_data1/oa_pdf/84/49/kngs-03-01-1230167.PMC5063060.pdf
"Prev Nutr Food Sci 2014; 19(4):247-260PMID:25580388;http://dx.doi.org/10.3746/pnf.2014.19.4.247 [10] Beard CM, Panser LA, Katusic SK.",Non-OADS,/arxiv_data1/oa_pdf/84/49/kngs-03-01-1230167.PMC5063060.pdf
"Med Hypothe-ses 2011; 77(1):15-17; PMID:21454018; http://dx.doi.org/10.1016/j.mehy.2011.03.013 [11] DeSoto MC, Hitlan R. Synthetic folic acid supplementa- tion during pregnancy may increase the risk of develop-ing autism.",Non-OADS,/arxiv_data1/oa_pdf/84/49/kngs-03-01-1230167.PMC5063060.pdf
"Brain Dev-Jpn 2012; 34:64-71;http://dx.doi.org/10.1016/j.braindev.2011.01.002 [13] Wiens D, DeWitt A, Kosar M, Underriner C, Finsand M, Freese M. In ﬂuence of folic acid on neural connectivity during dorsal root ganglia neurogenesis.",OADS,/arxiv_data1/oa_pdf/84/49/kngs-03-01-1230167.PMC5063060.pdf
"Neuron 2012; 73(6):1068- 1081; PMID:22445336; http://dx.doi.org/10.1016/j.neuron.2012.03.005 [16] Lowery LA, Vactor DV.",OADS,/arxiv_data1/oa_pdf/84/49/kngs-03-01-1230167.PMC5063060.pdf
"Nat Rev Mol Cell Biol2009; 10(5):332-343; PMID:19373241; http://dx.doi.org/10.1038/nrm2679 [17] Corlew R, Wang Y, Ghermazien H, Erisir A, Philpot BD.",OADS,/arxiv_data1/oa_pdf/84/49/kngs-03-01-1230167.PMC5063060.pdf
J Neurosci 2007; 27:9835-9845; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/49/kngs-03-01-1230167.PMC5063060.pdf
"J Cell Sci 2015; 128(4):768-780;http://dx.doi.org/10.1242/jcs.162362 [19] Yang J, Woodhall GL, Jones RS.",OADS,/arxiv_data1/oa_pdf/84/49/kngs-03-01-1230167.PMC5063060.pdf
"J Neurosci 2006; 26:406-410; http://dx.doi.org/10.1523/JNEUROSCI.4413-05.2006 [20] Valenzuela CF, Partridge LD, Mameli M, Meyer DA.",OADS,/arxiv_data1/oa_pdf/84/49/kngs-03-01-1230167.PMC5063060.pdf
"Nature 2013;493(7432):327-337; PMID:23325215; http://dx.doi.org/ 10.1038/nature11860 [22] Gambrill AC, Barria A. NMDA receptor subunit composition controls synaptogenesis and synapsestabilization.",OADS,/arxiv_data1/oa_pdf/84/49/kngs-03-01-1230167.PMC5063060.pdf
"Dev Dyn 2013; 242:201-218;PMID:23335187; http://dx.doi.org/10.1002/dvdy.23922 [24] O ’Dell TJ, Christensen BN.",OADS,/arxiv_data1/oa_pdf/84/49/kngs-03-01-1230167.PMC5063060.pdf
"The sensitiv-ity rates in relation to the transgenes andtissues in which the techniques wereapplied and related sensitivity limitationsare thoroughly discussed in our 14and others publications.15While both PCR and ﬂow cytometry proved to reliably detect low numbers of chimeric cells withKeywords: fetal immune development, ﬂow cytometry, maternal microchimer- ism, mouse model © Maria Emilia Solano, Kristin Thiele, Ina Annelies Stelzer, Hans-Willi Mittr €ucker, and Petra Clara Arck *Correspondence to: Maria Emilia Solano; Email: e.solano@uke.de Submitted: 05/16/2014 Revised: 08/06/2014Accepted: 08/26/2014http://dx.doi.org/10.4161/19381956.2014.959827 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproductionin any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/a3/kchm-05-3-4-959827.PMC5063069.pdf
Lab Invest 2003; 83(5):673-81; PMID:12746477; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/c1/a3/kchm-05-3-4-959827.PMC5063069.pdf
J Reprod Immunol 2013; 97(1):27-35; PMID:23432869; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c1/a3/kchm-05-3-4-959827.PMC5063069.pdf
"Chimerism 2011; 2(1):6-10; PMID:21547029;http://dx.doi.org/10.4161/chim.15151 5.;stensen M, Villiger PM, F €orger F. Interaction of preg- nancy and autoimmune rheumatic disease.",OADS,/arxiv_data1/oa_pdf/c1/a3/kchm-05-3-4-959827.PMC5063069.pdf
Arthritis Rheum 2011;63(3):640-4; PMID:21360493; http://dx.doi.org/ 10.1002/art.30160 7.,Non-OADS,/arxiv_data1/oa_pdf/c1/a3/kchm-05-3-4-959827.PMC5063069.pdf
Nat Med 2013; 19(5):548-56; PMID: 23652115; http://dx.doi.org/10.1038/nm.3160 8.,OADS,/arxiv_data1/oa_pdf/c1/a3/kchm-05-3-4-959827.PMC5063069.pdf
J Immunol 2007; 179 (10):6749-61; PMID:17982065; http://dx.doi.org/ 10.4049/jimmunol.179.10.6749 9.,Non-OADS,/arxiv_data1/oa_pdf/c1/a3/kchm-05-3-4-959827.PMC5063069.pdf
J Autoimmun 2014; 50:51-8; PMID:24268809; http://dx.doi.org/10.1016/j.jaut.2013.10.005 10.,OADS,/arxiv_data1/oa_pdf/c1/a3/kchm-05-3-4-959827.PMC5063069.pdf
J Clin Invest 2011; 121(2):582-92; PMID: 21245575; http://dx.doi.org/10.1172/JCI44907 12.,Non-OADS,/arxiv_data1/oa_pdf/c1/a3/kchm-05-3-4-959827.PMC5063069.pdf
J Allergy Clin Immunol 2013; 132(1):39-44; PMID:23434286;http://dx.doi.org/10.1016/j.jaci.2012.12.1575 13.,Non-OADS,/arxiv_data1/oa_pdf/c1/a3/kchm-05-3-4-959827.PMC5063069.pdf
J Immu- nol Methods 2014; PMID:24657636; http://dx.doi.org/10.1016/j.jim.2014.03.009 15.,OADS,/arxiv_data1/oa_pdf/c1/a3/kchm-05-3-4-959827.PMC5063069.pdf
Biol Reprod 2009; 81(1):26-32; PMID:19279322; http://dx.doi.org/10.1095/biolreprod.,Non-OADS,/arxiv_data1/oa_pdf/c1/a3/kchm-05-3-4-959827.PMC5063069.pdf
Biol Reprod 2005; 72(2):460-9; PMID:15469995; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c1/a3/kchm-05-3-4-959827.PMC5063069.pdf
Dev Immunol 1991; 1(4):243-54; PMID:1822988; http://dx.doi.org/10.1155/1991/52686 18.,Non-OADS,/arxiv_data1/oa_pdf/c1/a3/kchm-05-3-4-959827.PMC5063069.pdf
Biol Reprod 2008; 78(5):883-7; PMID:18256332; http://dx.doi.org/ 10.1095/biolreprod.107.063305 20.,Non-OADS,/arxiv_data1/oa_pdf/c1/a3/kchm-05-3-4-959827.PMC5063069.pdf
J Autoimmun 2011; 36(3-4):253-62; PMID:21414756; http://dx.doi.org/10.1016/j.jaut.2011.02.003 23.,OADS,/arxiv_data1/oa_pdf/c1/a3/kchm-05-3-4-959827.PMC5063069.pdf
Biol Reprod 1996; 54(5):1103-10; PMID:8722632; http://dx.doi.org/ 10.1095/biolreprod54.5.1103 24.,Non-OADS,/arxiv_data1/oa_pdf/c1/a3/kchm-05-3-4-959827.PMC5063069.pdf
Placenta 2007;28(7):639-49; PMID:17116327; http://dx.doi.org/ 10.1016/j.placenta.2006.10.006 Figure 3.,OADS,/arxiv_data1/oa_pdf/c1/a3/kchm-05-3-4-959827.PMC5063069.pdf
"1 –2, 8 –20 http://dx.doi.org/10.1080/19381956.2015.1107253",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
Science 1945; 102:400-1; PMID:17755278; http://dx.doi.org/10.1126/science.102.2651.400 [2] Lillie FR.,Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Science 1916; 43:611-3; PMID:17756274; http://dx.doi.org/10.1126/science.43.1113.611 [3] Owen RD, Wood HR, Foord AG, Sturgeon P, Baldwin LG.",OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Science 1988; 241:1815-7; PMID:3051377; http://dx.doi.org/10.1126/science.3051377 [6] Burlingham WJ, Grailer AP, Heisey DM, Claas FH, Norman D, Mohanakumar T, Brennan DC, de Fijter H,van Gelder T, Pirsch JD, et al.",OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"N Engl J Med 1998; 339:1657-64; PMID:9834302; http://dx.doi.org/ 10.1056/NEJM199812033392302 [7] Eikmans M, van Halteren AG, van Besien K, van Rood JJ, Drabbels JJ, Claas FH.",OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Chimerism 2014; 5:24-39;PMID:24762743; http://dx.doi.org/10.4161/chim.28908 [8] Hirayama M, Azuma E, Komada Y. Tolerogenic effect of non-inherited maternal antigens in hematopoieticCHIMERISM 15",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
Front Immunol 2012; 3:135; PMID:22654885; http://dx.doi.org/10.3389/ ﬁmmu.,Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Blood 2004; 104:3821-8; PMID:15280193;http://dx.doi.org/10.1182/blood-2004-03-1212 [11] Kanda J, Ichinohe T, Shimazaki C, Hamaguchi M, Watanabe A, Ishida H, Yoshihara T, Morimoto A,Uoshima N, Adachi S, et al.",OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Bone Marrow Transplantation 2009; 44:327-9;PMID:19219076; http://dx.doi.org/10.1038/bmt.2009.18 [12] Okumura H, Yamaguchi M, Kotani T, Sugimori N, Sugimori C, Ozaki J, Kondo Y, Yamazaki H, Chuhjo T,Takami A, et al.",OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
Eur J Haematol 2007; 78:157-60; PMID:17313562; http://dx.doi.org/10.1111/j.1600-0609.2006.00797.x [13] Opelz G. The effect of tolerance to noninherited mater- nal HLA antigens on the survival of renal transplantsfrom sibling donors.,Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"N Eng J Med 1999; 340:1369-70;http://dx.doi.org/10.1056/NEJM199904293401715 [14] Andrassy J, Kusaka S, Jankowska-Gan E, Torrealba JR, Haynes LD, Marthaler BR, Tam RC, Illigens BM, Ano- sova N, Benichou G, et al.",OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"J Immunol 2003;171:5554-61; PMID:14607963 ; http://dx.doi.org/ 10.4049/jimmunol.171.10.5554 [15] Aoyama K, Koyama M, Matsuoka K, Hashimoto D, Ichinohe T, Harada M, Akashi K, Tanimoto M,Teshima T. Improved outcome of allogeneic bone mar- row transplantation due to breastfeeding-induced toler- ance to maternal antigens.",OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Blood 2009; 113:1829-33;PMID:19124834; http://dx.doi.org/10.1182/blood-2008-05-155283 [16] Campbell DA, Jr., Lorber MI, Sweeton JC, Turcotte JG, Niederhuber JE, Beer AE.",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Transplantation 1984; 37:340-4; PMID:6369661; http://dx.do i.org/10.1097/00007890- 198404000-00004[17] Dutta P, Molitor-Dart M, Bobadilla JL, Roenneburg DA, Yan Z, Torrealba JR, Burlingham WJ.",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Blood 2009; 114:3578-87;PMID:19700665; http://dx.doi.org/10.1182/blood-2009-03-213561 [18] Flomenberg N, Dupont B, O ’Reilly RJ, Hayward A, Pol- lack MS.",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Transplantation 1983; 36:733-5;PMID:6606881; http://dx.doi.org/10.1097/00007890-198336060-00031 [19] Geha RS, Reinherz E. Identi ﬁcation of circulating maternal T and B lymphocytes in uncomplicated severe combined immunode ﬁciency by HLA typing of subpopulations of T cells separated by the ﬂuores- cence-activated cell sorter and of Epstein Barr virus-derived B cell lines.",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"[20] Kadowaki J, Thompson RI, Zuelzer WW, Woolley PV, Jr., Brough AJ, Gruber D. XX-XY lymphoid chi-maerism in congenital immunological de ﬁciency syn- d r o m ew i t ht h y m i ca l y m p h o p l a s i a .L a n c e t1 9 6 5 ; 2:1152-6; PMID:4158909; http://dx.doi.org/10.1016/S0140-6736(65)92559-6 [21] Pollack MS, Kapoor N, Sorell M, Kim SJ, Christiansen FT, Silver DM, Dupont B, O ’Reilly RJ.",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"N Eng J Med 1982; 307:662-6; http://dx.doi.org/10.1056/NEJM198209093071106 [23] Thompson LF, O ’Connor RD, Bastian JF.",OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Blood 2001; 98:1847-51; PMID:11535520; http://dx.doi.org/10.1182/blood.V98.6.1847 [25] Alexander A, Samlowski WE, Grossman D, Bruggers CS, Harris RM, Zone JJ, Noyes RD, Bowen GM, Leach- man SA.",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"J Clin Oncol2003; 21:2179-86; PMID:12775744; http://dx.doi.org/10.1200/JCO.2003.12.149 [26] Isoda T, Ford AM, Tomizawa D, van Delft FW, De Cas- tro DG, Mitsuiki N, Score J, Taki T, Morio T, Takagi M, et al.",OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"2009; 106:17882-5; PMID:19822752; http://dx.doi.org/ 10.1073/pnas.0904658106 [27] Walker JW, Reinisch JF, Monforte HL.",OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"PediatrPathol Mol Med 2002; 21:57-69; PMID:11858176;http://dx.doi.org/10.1080/15227950252774174 [28] Lambert NC, Erickson TD, Yan Z, Pang JM, Guthrie KA, Furst DE, Nelson JL.",OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Arthritis Rheumatism 2004; 50:906-14; PMID:15022334; http://dx.doi.org/10.1002/art.20200 [29] Maloney S, Smith A, Furst DE, Myerson D, Rupert K, Evans PC, Nelson JL.",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"J Clin Invest 1999; 104:41-7;PMID:10393697; http://dx.doi.org/10.1172/JCI6611 [30] Spurgin LG, Richardson DS.",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Proc Biol Sci 2010; 277:979-88; PMID:20071384; http://dx.doi.org /10.1098/rspb.2009.2084 [31] Lo YM, Lau TK, Chan LY, Leung TN, Chang AM.",OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Immunol 2000; 101:570-80; http://dx.doi.org/10.1046/j.1365-2567.2000.00144.x [34] Mold JE, McCune JM.",OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Adv Immunol 2012; 115:73-111; PMID:22608256; http://dx.doi.org/ 10.1016/B978-0-12-394299-9.00003-5 [35] Mold JE, Michaelsson J, Burt TD, Muench MO, Becker- man KP, Busch MP, Lee TH, Nixon DF, McCune JM.Maternal alloantigens promote the development of tol-erogenic fetal regulatory T cells in utero.",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Science 2008;322:1562-5; PMID:19056990; http://dx.doi.org/10.1126/science.1164511 [36] Billingham RE, Brent L, Medawar PB.",OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
J Immunol 2007; 179:6749-61;PMID:17982065; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Curr Opin Organ Transplant 2011;16:359-65; PMID:21666480; http://dx.doi.org/10.1097/MOT.0b013e3283484b57 [40] Alhajjat AM, Lee AE, Strong BS, Shaaban AF.",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Front Pharmacol 2015; 6:51; PMID:25852555; http://dx.doi.org/10.3389/fphar.2015.00051 [41] Merianos D, Heaton T, Flake AW.",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Biol Blood Marrow Transplant2008; 14:729-40; PMID:18541191; http://dx.doi.org/10.1016/j.bbmt.2008.02.012 [42] Derderian SC, Jeanty C, Walters MC, Vichinsky E, MacKenzie TC.",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Blood2008; 112:5245-53; PMID:18796629; http://dx.doi.org/10.1182/blood-2007-12-128116 [45] Kroemer A, Edtinger K, Li XC.",OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"J Pediatr Surg 1999; 34:726-9; discus-sion 9-30; PMID:10359172; http://dx.doi.org/10.1016/S0022-3468(99)90364-0 [48] Kim HB, Shaaban AF, Yang EY, Liechty KW, Flake AW.",OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Curr Opin Pediatr 2014; 26:377-82;PMID:24759226; http://dx.doi.org/10.1097/MOP.0000000000000087 [51] Kinder JM, Jiang TT, Ertelt JM, Xin L, Strong BS, Shaa- ban AF, Way SS.",OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
Immunity 2007; 27:203-13;PMID:17707129; http://dx.do i.org/10.1016/j.immuni.,OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Chimerism 2014; 5:6-15; PMID:24451553; http://dx.doi.org/10.4161/chim.27778 [56] Shaaban AF, Kim HB, Gaur L, Liechty KW, Flake AW.",OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"J Immunol 2013; 190:3438-46; PMID:23467933 ; http://dx.doi.org/ 10.4049/jimmunol.1203140 [58] Rosenblum M, Gratz I, Paw J, Lee K, Marshak-Roth- stein A, Abbas A.",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"J Immunol2014; 192:1351-5; PMID:24442443; http://dx.doi.org/10.4049/jimmunol.1301777 [60] Sanchez AM, Zhu J, Huang X, Yang Y.",OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
J Immunol 2012; 189:2805-14;PMID:22855712; http://dx.do i.org/10.4049/jimmunol.,Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Nat Med 2001;7:913-9; PMID:11479623; http://dx.doi.org/10.1038/ 90950 [62] Nelson RW, McLachlan JB, Kurtz JR, Jenkins MK.",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"J Immunol 2013; 190:2828-34; PMID:23382562;http://dx.doi.org/10.4049/jimmunol.1202183 [63] Seder R, Ahmed R. Similarities and differences in CD4+ and CD8 effector and memory T cells generation.",OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"J Immunol 2001; 167:6967-74; PMID:11739516;http://dx.doi.org/10.4049/jimmunol.167.12.6967 [65] Williams MA, Holmes BJ, Sun JC, Bevan MJ.",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Immunol Rev 2006; 211:146-53; PMID:16824124;http://dx.doi.org/10.1111/j.0105-2896.2006.00389.x [66] Adkins B, Leclerc C, Marshall-Clarke S. Neonatal adap- tive immunity comes of age.",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
Nat Rev Immunol 2004;4:553-64; PMID:15229474; http://dx.doi.org/10.1038/nri1394 [67] Erlebacher A. Mechanisms of T cell tolerance towards the allogeneic fetus.,Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Nat Rev Immunol 2013; 13:23-33; PMID:23237963; http://dx.doi.org/10.1038/nri3361 [68] Munoz-Suano A, Hamilton AB, Betz AG.",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"ImmunolRev 2011; 241:20-38; PMID:21488887; http://dx.doi.org/10.1111/j.1600-065X.2011.01002.x [69] Samstein RM, Josefowicz SZ, Arvey A, Treuting PM, Rudensky AY.",OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
J Clin Invest 2015; 125:1713-25; PMID:25751061; http://dx.doi.org/10.1172/ JCI7857818 J. M. KINDER ET AL.,OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Cell HostMicrobe 2011; 10:54-64; PMID:21767812; http://dx.doi.org/10.1016/j.chom.2011.06.005 [72] Rowe JH, Ertelt JM, Xin L, Way SS.",OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"PLoS Pathog 2012; 8:e1002873;PMID:22916020; http://dx.doi.org/10.1371/journal.ppat.1002873 [73] Rowe JH, Ertelt JM, Xin L, Way SS.",OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
Pregnancy imprints regulatory memory that sustains anergy to fetal antigen.Nature 2012; 490:102-6; PMID:23023128; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"PLoSOne 2011; 6:e24101; PMID:21912617; http://dx.doi.org/10.1371/journal.pone.0024101 [75] Gammill HS, Stephenson MD, Aydelotte TM, Nelson JL.",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Chimerism 2014; 5:103-5; PMID:25779348;http://dx.doi.org/10.1080/19381956.2015.1017241 [77] Campbell D, MacGillivray I, Carr-Hill R. Pre-eclampsia in second pregnancy.",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Br J Obstet Gynaecol 1985; 92:131-40; PMID:3970893; http://dx.doi.org/10.1111/ j.1471-0528.1985.tb01064.x [78] Trupin L, Simon L, Eskenazi B.",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Epide-miol 1996; 7:240-4; http://dx.doi.org/10.1097/00001648-199605000-00004 [79] Kinder JM, Jiang TT, Clark DR, Chaturvedi V, Xin L, Ertelt JM, Way SS.",OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Pregnancy-induced maternal regula- tory T cells, bona ﬁde memory or maintenance by anti- genic reminder from fetal cell microchimerism?Chimerism 2014; 5:16-9; PMID:24553046; http://dx.doi.org/10.4161/chim.28241 [80] Bianchi D, Zickwolf G, Weil G, Sylvester S, DeMaria M. Male fetal progenitor cells persist in maternal blood foras long as 27 years postpartum.",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Nat Immunol 2006; 7:241-6;PMID:16482172; http://dx.doi.org/10.1038/ni1317 [82] Adams KM, Lambert NC, Heimfeld S, Tylee TS, Pang JM, Erickson TD, Nelson JL.",OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Blood2003; 102:3845-7; PMID:12869496; http://dx.doi.org/10.1182/blood-2003-05-1570 [83] O ’Donoghue K, Chan J, de la Fuente J, Kennea N, San- dison A, Anderson JR, Roberts IA, Fisk NM.Microchimerism in female bone marrow and bone dec- ades after fetal mesenchymal stem-cell traf ﬁcking in pregnancy.",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Lancet 2004; 364:179-82; PMID:15246731;http://dx.doi.org/10.1016/S0140-6736(04)16631-2 [84] Goulder PJ, Watkins DI.",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Nat Rev Immunol 2008; 8:619-30; PMID:18617886; http://dx.doi.org/10.1038/nri2357 [85] Oliver MK, Telfer S, Piertney SB.",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Proc Biol Sci 2009; 276:1119-28; PMID:19129114; http://dx.doi.org/10.1098/rspb.2008.1525 [86] Israeli M, Kristt D, Nardi Y, Klein T. Genetic Consider- ations in Human Sex-Mate Selection: Partners Share Human Leukocyte Antigen but not Short-Tandem-Repeat Identity Markers.",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Am J Reprod Immunol 2014;71:467-71; PMID:24589062; http://dx.doi.org/10.1111/aji.12213 [87] Chaix R, Cao C, Donnelly P. Is mate choice in humans MHC-dependent?",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"PLoS Genet 2008; 4:e1000184; PMID:18787687; http://dx.doi.org/10.1371/ journal.pgen.1000184 [88] Ober C, Weitkamp LR, Cox N, Dytch H, Kostyu D, Elias S. HLA and mate choice in humans.",OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
Am J HumGenet 1997; 61:497-504; PMID:9326314 http://dx.doi.org/10.1086/515511 [89] Nelson JL.,OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
Trends Immunol 2012; 33:421-7;PMID:22609148; http://dx.doi.org/; http://dx.doi.org/ 10.1016/j.it.2012.03.002 [90] Stevens AM.,OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Lupus2006; 15:820-6; PMID:17153857; http://dx.doi.org/10.1177/0961203306070068 [91] Nelson JL, Gillespie KM, Lambert NC, Stevens AM, Loubiere LS, Rutledge JC, Leisenring WM, EricksonTD, Yan Z, Mullarkey ME, et al.",OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
Arthritis Rheum 2009; 60:73-80; PMID:19117368; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Annal rheum Dis 1998; 57:672-5; http://dx.doi.org/10.1136/ard.57.11.672 [95] Wegorzewska M, Le T, Tang Q, MacKenzie TC.",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Increased maternal T cell microchimerism in the alloge-neic fetus during LPS-induced preterm labor in mice.Chimerism 2015:1-6; PMID:25779065; http://dx.doi.org/10.1080/19381956.2014.1002703 [96] Reed AM, Picornell YJ, Harwood A, Kredich DW.",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
Lan-cet 2000; 356:2156-7; PMID:11191546; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Lancet2000; 356:2155-6; PMID:11191545; http://dx.doi.org/10.1016/S0140-6736(00)03499-1 [98] Stevens AM, Hermes HM, Rutledge JC, Buyon JP, Nel- son JL.",OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Lancet 2003; 362:1617-23; PMID:14630442; http://dx.doi.org/10.1016/S0140-6736(03)14795-2 [99] Suskind DL, Rosenthal P, Heyman MB, Kong D, Magrane G, Baxter-Lowe LA, Muench MO.",OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"BMC Gastroenterol 2004; 4:14; PMID:15285784;http://dx.doi.org/10.1186/1471-230X-4-14 [100] Gammill H, Nelson J.",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Int J Dev Biol 2010; 54:531-43; PMID:19924635;http://dx.doi.org/10.1387/ijdb.082767hg [101] Nijagal A, Fleck S, Hills NK, Feng S, Tang Q, Kang SM, Rosenthal P, MacKenzie TC.",OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Am J Transplant 2012;12:409-19; PMID:22221561; http://dx.doi.org/ 10.1111/j.1600-6143.2011.03895.x [102] Dutta P, Dart M, Roenneburg DA, Torrealba JR, Burlingham WJ.",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"Am J Transplant 2011;11:1296-301; PMID:21449933; http://dx.doi.org/10.1111/j.1600-6143.2011.03484.x [103] Maurel MC, Kanellopoulos-Lan gevin C. Heredity-ventur- ing beyond genetics.",Non-OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
Biol Reprod 2008; 79:2-8; PMID:18401011; http://dx.doi.org/10.1095/biolreprod.107.,OADS,/arxiv_data1/oa_pdf/d1/2c/kchm-06-1-2-1107253.PMC5063085.pdf
"However, the  mechanism underlying SCF-induced endothelial hyperper - meability has not yet been fully elucidated, although our Molecular Vision  2016; 22:1213-1220 <http://www.molvis.org/molvis/v 22/1213 > Received 10 February 2016 | Accepted 11 October 2016 | Published 13 October 2016© 2016 Molecular Vision 1213Src tyrosine kinase regulates the stem cell factor–induced  breakdown of the blood–retinal barrier Ji-Eun Im, Sun-Hwa Song, Wonhee Suh College of Pharmacy, Chung-Ang University, Seoul, Korea Purpose:  Stem cell factor (SCF) has been recently acknowledged as a novel endothelial permeability factor.",Non-OADS,/arxiv_data1/oa_pdf/2c/bf/mv-v22-1213.PMC5063088.pdf
Molecular Vision  2016; 22:1213-1220 <http://www.molvis.org/molvis/v 22/1213 > © 2016 Molecular Vision  1214previous studies pointed to an important role of the endothe - lial nitric oxide synthase.,Non-OADS,/arxiv_data1/oa_pdf/2c/bf/mv-v22-1213.PMC5063088.pdf
"Molecular Vision  2016; 22:1213-1220 <http://www.molvis.org/molvis/v 22/1213 > © 2016 Molecular Vision  1215phospho-cKit (p-cKit; Cell Signaling Technology, Danvers,  MA) and cKit (R&D Systems), followed by incubation with  horseradish peroxidase-conjugated secondary IgGs (Vector  Laboratories, Burlingame, CA).",Non-OADS,/arxiv_data1/oa_pdf/2c/bf/mv-v22-1213.PMC5063088.pdf
"Molecular Vision  2016; 22:1213-1220 <http://www.molvis.org/molvis/v 22/1213 > © 2016 Molecular Vision  1216activation of Src contributes to SCF-mediated retinal vascular  hyperpermeability, we performed an in vitro endothelial  permeability assay with HRMECs that were pretreated  with the Src inhibitor, SU6656.",Non-OADS,/arxiv_data1/oa_pdf/2c/bf/mv-v22-1213.PMC5063088.pdf
Molecular Vision  2016; 22:1213-1220 <http://www.molvis.org/molvis/v 22/1213 > © 2016 Molecular Vision  1217 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/2c/bf/mv-v22-1213.PMC5063088.pdf
Molecular Vision  2016; 22:1213-1220 <http://www.molvis.org/molvis/v 22/1213 > © 2016 Molecular Vision  1218 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/2c/bf/mv-v22-1213.PMC5063088.pdf
Molecular Vision  2016; 22:1213-1220 <http://www.molvis.org/molvis/v 22/1213 > © 2016 Molecular Vision  1219and intermolecular interaction.,Non-OADS,/arxiv_data1/oa_pdf/2c/bf/mv-v22-1213.PMC5063088.pdf
Molecular Vision  2016; 22:1213-1220 <http://www.molvis.org/molvis/v 22/1213 > © 2016 Molecular Vision  12208.,Non-OADS,/arxiv_data1/oa_pdf/2c/bf/mv-v22-1213.PMC5063088.pdf
"Therefore, to understand  the effects of TTR on the development of DR microvascular  complications, human retinal microvascular endothelial cells Molecular Vision  2016; 22:1188-1197 <http://www.molvis.org/molvis/v 22/1188 > Received 28 June 2016 | Accepted 10 October 2016 | Published 12 October 2016© 2016 Molecular Vision 1188Transthyretin represses neovascularization in diabetic  retinopathy Jun Shao, Yong Yao Department of Ophthalmology, Wuxi People’ s Hospital affiliated to Nanjing Medical University, Wuxi, China Purpose:  The apoptosis of human umbilical vein endothelial cells has been reportedly induced by the protein trans - thyretin (TTR).",Non-OADS,/arxiv_data1/oa_pdf/b5/57/mv-v22-1188.PMC5063089.pdf
"Molecular Vision  2016; 22:1188-1197 <http://www.molvis.org/molvis/v 22/1188 > © 2016 Molecular Vision  1189(hRECs) were cultured with exogenous or endogenous TTR  in natural and simulated DR environments (hyperglycemia  and hypoxia); in addition, in vitro proliferation, migration,  and tube formation, together with the mRNA levels of associ - ated genes, were investigated.",Non-OADS,/arxiv_data1/oa_pdf/b5/57/mv-v22-1188.PMC5063089.pdf
"Molecular Vision  2016; 22:1188-1197 <http://www.molvis.org/molvis/v 22/1188 > © 2016 Molecular Vision  1190cultured in natural and experimental media for 72 h, and  the cell index was detected with xCELLigence RTCA MP  (Roche).",OADS,/arxiv_data1/oa_pdf/b5/57/mv-v22-1188.PMC5063089.pdf
"Molecular Vision  2016; 22:1188-1197 <http://www.molvis.org/molvis/v 22/1188 > © 2016 Molecular Vision  1191cells were cultured for 72 h, and each plate was scanned using  xCELLigence RTCA MP.",OADS,/arxiv_data1/oa_pdf/b5/57/mv-v22-1188.PMC5063089.pdf
"Molecular Vision  2016; 22:1188-1197 <http://www.molvis.org/molvis/v 22/1188 > © 2016 Molecular Vision  1192in Figure 2A, the TTR content of the overexpressed cells  (TTR-OE) was almost three times or higher than that in the  cells containing an empty plasmid (Control; *: p < 0.001, F  = 113.347 (24 h); p < 0.001, F = 55.084 (48 h); p < 0.001, F =  78.254 (72 h)).",Non-OADS,/arxiv_data1/oa_pdf/b5/57/mv-v22-1188.PMC5063089.pdf
"Molecular Vision  2016; 22:1188-1197 <http://www.molvis.org/molvis/v 22/1188 > © 2016 Molecular Vision  1193TTR affects the migration of hRECs:  The hRECs were  seeded in 96-well plates and grown to confluence, wounds  were created by scraping with a pipette tip, and the plates  were transferred to the IncuCyte after the medium had been  replaced with fresh media (natural and simulated DR environ - ments) with or without 4 μM TTR.",Non-OADS,/arxiv_data1/oa_pdf/b5/57/mv-v22-1188.PMC5063089.pdf
"Molecular Vision  2016; 22:1188-1197 <http://www.molvis.org/molvis/v 22/1188 > © 2016 Molecular Vision  1194(HG+Hypoxia and HG+Hypoxia+TTR), the tube formation  process of the hRECs was significantly decreased by TTR  (about 55%; ##: p < 0.001, F = 364.605).",Non-OADS,/arxiv_data1/oa_pdf/b5/57/mv-v22-1188.PMC5063089.pdf
"Molecular Vision  2016; 22:1188-1197 <http://www.molvis.org/molvis/v 22/1188 > © 2016 Molecular Vision  1195and Angpt1,  to 4.67-fold, whereas Angpt2  was downregulated  to 0.04-fold and VEGFR1  and VEGF2,  to 0.09- and 0.02 -fold,  respectively (Figure 5).",Non-OADS,/arxiv_data1/oa_pdf/b5/57/mv-v22-1188.PMC5063089.pdf
Molecular Vision  2016; 22:1188-1197 <http://www.molvis.org/molvis/v 22/1188 > © 2016 Molecular Vision  1196while Tie2 and Angpt1  were evidently enhanced.,Non-OADS,/arxiv_data1/oa_pdf/b5/57/mv-v22-1188.PMC5063089.pdf
Molecular Vision  2016; 22:1188-1197 <http://www.molvis.org/molvis/v 22/1188 > © 2016 Molecular Vision  1197growth factor.,Non-OADS,/arxiv_data1/oa_pdf/b5/57/mv-v22-1188.PMC5063089.pdf
"Consistent  with the absence of MAS activity in aralar-deficient mice,  cultures of cortical neurons from aralar-deficient mice have  a 12-fold increase in the lactate to pyruvate ratio [ 26] and Molecular Vision  2016; 22:1198-1212 <http://www.molvis.org/molvis/v 22/1198 > Received 27 January 2016 | Accepted 10 October 2016 | Published 12 October 2016© 2016 Molecular Vision 1198Deficient glucose and glutamine metabolism in Aralar/AGC1/ Slc25a12  knockout mice contributes to altered visual function Laura Contreras,1 Laura Ramirez,2 Jianhai Du,3,4 James B. Hurley,3,4 Jorgina Satrústegui,1 Pedro de la Villa2 1Centro de Biología Molecular Severo Ochoa CSIC-UAM, CI.B.E.R.",Non-OADS,/arxiv_data1/oa_pdf/6f/47/mv-v22-1198.PMC5063090.pdf
Molecular Vision  2016; 22:1198-1212 <http://www.molvis.org/molvis/v 22/1198 > © 2016 Molecular Vision  119946% slower glucose-fueled respiration [ 27] compared with  their control counterparts.,Non-OADS,/arxiv_data1/oa_pdf/6f/47/mv-v22-1198.PMC5063090.pdf
"Molecular Vision  2016; 22:1198-1212 <http://www.molvis.org/molvis/v 22/1198 > © 2016 Molecular Vision  1200with these observations, we have found that aspartate and  glutamine levels are diminished in aralar-deficient retinas  [33].",Non-OADS,/arxiv_data1/oa_pdf/6f/47/mv-v22-1198.PMC5063090.pdf
Molecular Vision  2016; 22:1198-1212 <http://www.molvis.org/molvis/v 22/1198 > © 2016 Molecular Vision  1201handling was performed under indirect dim red light (>620  nm) followed by 5 min in complete darkness before the  recordings.,Non-OADS,/arxiv_data1/oa_pdf/6f/47/mv-v22-1198.PMC5063090.pdf
Molecular Vision  2016; 22:1198-1212 <http://www.molvis.org/molvis/v 22/1198 > © 2016 Molecular Vision  1202 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/6f/47/mv-v22-1198.PMC5063090.pdf
Molecular Vision  2016; 22:1198-1212 <http://www.molvis.org/molvis/v 22/1198 > © 2016 Molecular Vision  1203 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/6f/47/mv-v22-1198.PMC5063090.pdf
Molecular Vision  2016; 22:1198-1212 <http://www.molvis.org/molvis/v 22/1198 > © 2016 Molecular Vision  1204 Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/6f/47/mv-v22-1198.PMC5063090.pdf
"Molecular Vision  2016; 22:1198-1212 <http://www.molvis.org/molvis/v 22/1198 > © 2016 Molecular Vision  1205in DSR; and significant decreases by 57±6.5%, b-scot;  42±5.43%, a-wave; 45±5.35%, b-wave; 44±7.17%, OP) at the  different light intensities (Figure 4B) when compared to that  of the control mice.",Non-OADS,/arxiv_data1/oa_pdf/6f/47/mv-v22-1198.PMC5063090.pdf
Molecular Vision  2016; 22:1198-1212 <http://www.molvis.org/molvis/v 22/1198 > © 2016 Molecular Vision  1206 Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/6f/47/mv-v22-1198.PMC5063090.pdf
Molecular Vision  2016; 22:1198-1212 <http://www.molvis.org/molvis/v 22/1198 > © 2016 Molecular Vision  1207 Figure 6.,Non-OADS,/arxiv_data1/oa_pdf/6f/47/mv-v22-1198.PMC5063090.pdf
Molecular Vision  2016; 22:1198-1212 <http://www.molvis.org/molvis/v 22/1198 > © 2016 Molecular Vision  1208in a second flash should show a further decrease in the aralar- deficient mice readily observable as a decrease in the b- to  a-wave ratios.,Non-OADS,/arxiv_data1/oa_pdf/6f/47/mv-v22-1198.PMC5063090.pdf
Molecular Vision  2016; 22:1198-1212 <http://www.molvis.org/molvis/v 22/1198 > © 2016 Molecular Vision  1209shortest time point in aralar-deficient retinas.,Non-OADS,/arxiv_data1/oa_pdf/6f/47/mv-v22-1198.PMC5063090.pdf
Molecular Vision  2016; 22:1198-1212 <http://www.molvis.org/molvis/v 22/1198 > © 2016 Molecular Vision  1210APPENDIX 4.,Non-OADS,/arxiv_data1/oa_pdf/6f/47/mv-v22-1198.PMC5063090.pdf
Molecular Vision  2016; 22:1198-1212 <http://www.molvis.org/molvis/v 22/1198 > © 2016 Molecular Vision  121123.,Non-OADS,/arxiv_data1/oa_pdf/6f/47/mv-v22-1198.PMC5063090.pdf
Molecular Vision  2016; 22:1198-1212 <http://www.molvis.org/molvis/v 22/1198 > © 2016 Molecular Vision  121247.,Non-OADS,/arxiv_data1/oa_pdf/6f/47/mv-v22-1198.PMC5063090.pdf
"The point mutation  T14484C exhibits some visual recovery in (58%) of patients Molecular Vision  2016; 22:1169-1175 <http://www.molvis.org/molvis/v 22/1169 > Received 12 May 2016 | Accepted 10 October 2016 | Published 12 October 2016© 2016 Molecular Vision 1169A real-time ARMS PCR/high-resolution melt curve assay for the  detection of the three primary mitochondrial mutations in Leber’s  hereditary optic neuropathy Siobhan Eustace Ryan,1 Fergus Ryan,2 Veronica O’Dwyer,1 Derek Neylan2 1National Optometry Centre, Dublin Institute of Technology, Dublin, Ireland; 2School of Biological Sciences, Dublin Institute of  Technology, Dublin, Ireland Purpose:  Approximately 95% of patients who are diagnosed with Leber’s hereditary optic neuropathy (LHON) have one  of three mitochondrial point mutations responsible for the disease, G3460A, G11778A, and T14484C.",Non-OADS,/arxiv_data1/oa_pdf/c8/e2/mv-v22-1169.PMC5063091.pdf
"Molecular Vision  2016; 22:1169-1175 <http://www.molvis.org/molvis/v 22/1169 > © 2016 Molecular Vision  1170with LHON, followed by the point mutation G3460A at 25%.",Non-OADS,/arxiv_data1/oa_pdf/c8/e2/mv-v22-1169.PMC5063091.pdf
"Molecular Vision  2016; 22:1169-1175 <http://www.molvis.org/molvis/v 22/1169 > © 2016 Molecular Vision  1171ABI 7500 Fast (Life Technologies, Carlsbad, CA) real-time  PCR instrument in a reaction containing 50 ng of genomic  DNA, 100 ng of the appropriate primer mix, and 7.5 μl of  PowerUp SYBR Green Master Mix (Life Technologies) in a  total volume of 15 μl.",Non-OADS,/arxiv_data1/oa_pdf/c8/e2/mv-v22-1169.PMC5063091.pdf
Molecular Vision  2016; 22:1169-1175 <http://www.molvis.org/molvis/v 22/1169 > © 2016 Molecular Vision  1172 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/c8/e2/mv-v22-1169.PMC5063091.pdf
"Molecular Vision  2016; 22:1169-1175 <http://www.molvis.org/molvis/v 22/1169 > © 2016 Molecular Vision  1173allele-specific products, this product was chosen for the  multiplex analysis.",Non-OADS,/arxiv_data1/oa_pdf/c8/e2/mv-v22-1169.PMC5063091.pdf
"Molecular Vision  2016; 22:1169-1175 <http://www.molvis.org/molvis/v 22/1169 > © 2016 Molecular Vision  1174As can be seen in Figure 1 and Figure 2, mutation identi - fication in subjects is clear and robust.",Non-OADS,/arxiv_data1/oa_pdf/c8/e2/mv-v22-1169.PMC5063091.pdf
Molecular Vision  2016; 22:1169-1175 <http://www.molvis.org/molvis/v 22/1169 > © 2016 Molecular Vision  1175mutation in six pedigrees.,Non-OADS,/arxiv_data1/oa_pdf/c8/e2/mv-v22-1169.PMC5063091.pdf
"We evaluated the  retinal structure and function, photoreceptor-specific gene  expression of mRNA and protein levels, and inflammatory Molecular Vision  2016; 22:1176-1187 <http://www.molvis.org/molvis/v 22/1176 > Received 9 June 2016 | Accepted 10 October 2016 | Published 12 October 2016© 2016 Molecular Vision 1176Non-toxic retention of nanoceria in murine eyes Xue Cai,1 Sudipta Seal,4 James F. McGinnis1,2,3 1Department of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, OK; 2Department of Cell  Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK; 3Oklahoma Neuroscience Center, University of  Oklahoma Health Sciences Center, Oklahoma City, OK; 4Advanced Materials Processing Analysis Center, Mechanical Materials  Aerospace Eng., Nanosci.",Non-OADS,/arxiv_data1/oa_pdf/b8/39/mv-v22-1176.PMC5063092.pdf
"Molecular Vision  2016; 22:1176-1187 <http://www.molvis.org/molvis/v 22/1176 > © 2016 Molecular Vision  1177responses, including the alteration of the vascular system and  cytokine expression.",Non-OADS,/arxiv_data1/oa_pdf/b8/39/mv-v22-1176.PMC5063092.pdf
Molecular Vision  2016; 22:1176-1187 <http://www.molvis.org/molvis/v 22/1176 > © 2016 Molecular Vision  1178the retina section starting from the ONH.,Non-OADS,/arxiv_data1/oa_pdf/b8/39/mv-v22-1176.PMC5063092.pdf
Molecular Vision  2016; 22:1176-1187 <http://www.molvis.org/molvis/v 22/1176 > © 2016 Molecular Vision  1179 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/b8/39/mv-v22-1176.PMC5063092.pdf
"Molecular Vision  2016; 22:1176-1187 <http://www.molvis.org/molvis/v 22/1176 > © 2016 Molecular Vision  1180cytokines, none of the concentrations of nanoceria induced  alterations in the expression of these cytokines compared to  the uninjected controls (Figure 4A-D).",Non-OADS,/arxiv_data1/oa_pdf/b8/39/mv-v22-1176.PMC5063092.pdf
Molecular Vision  2016; 22:1176-1187 <http://www.molvis.org/molvis/v 22/1176 > © 2016 Molecular Vision  1181not find any cells inside the vitreous of the eyes injected with  nanoceria or saline (Figure 6).,Non-OADS,/arxiv_data1/oa_pdf/b8/39/mv-v22-1176.PMC5063092.pdf
Molecular Vision  2016; 22:1176-1187 <http://www.molvis.org/molvis/v 22/1176 > © 2016 Molecular Vision  1182Table  1.,Non-OADS,/arxiv_data1/oa_pdf/b8/39/mv-v22-1176.PMC5063092.pdf
Molecular Vision  2016; 22:1176-1187 <http://www.molvis.org/molvis/v 22/1176 > © 2016 Molecular Vision  1183 Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/b8/39/mv-v22-1176.PMC5063092.pdf
Molecular Vision  2016; 22:1176-1187 <http://www.molvis.org/molvis/v 22/1176 > © 2016 Molecular Vision  1184 Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/b8/39/mv-v22-1176.PMC5063092.pdf
"Molecular Vision  2016; 22:1176-1187 <http://www.molvis.org/molvis/v 22/1176 > © 2016 Molecular Vision  1185tissues of CD1 mice via various means of administration and  do not cause overt toxicity or pathology, and no significant  immune response was detected [ 10].",Non-OADS,/arxiv_data1/oa_pdf/b8/39/mv-v22-1176.PMC5063092.pdf
Molecular Vision  2016; 22:1176-1187 <http://www.molvis.org/molvis/v 22/1176 > © 2016 Molecular Vision  11864.,Non-OADS,/arxiv_data1/oa_pdf/b8/39/mv-v22-1176.PMC5063092.pdf
Molecular Vision  2016; 22:1176-1187 <http://www.molvis.org/molvis/v 22/1176 > © 2016 Molecular Vision  1187of cerium oxide nanoparticles in a mouse hippocampal brain  slice model of ischemia.,Non-OADS,/arxiv_data1/oa_pdf/b8/39/mv-v22-1176.PMC5063092.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/68/61/10.1177_2325967116667717.PMC5063093.pdf
"A total of 818 patients were included in the triple therapy arm and 3,724 were included in the ETN-MTX arm (Table 1 and Supplementa- ry Tables 1, 2, 3, and 4, available on the Arthritis Care & Research web site at http://onlinelibrary.wiley.com/doi/10.",Non-OADS,/arxiv_data1/oa_pdf/8c/14/ACR-67-1656.PMC5063099.pdf
"Antibody characterization We used a mouse monoclonal anti-Neurofilament (165 kDa) antibody from Developmental Studies Hybrid- o m aB a n k( D S H B ,2 H 3 ,I o w aC i t y ,I A ) ,c a t a l o gn u m b e r http://dshb.biology.uiowa.edu/2H3, antibody registry AB_2314897, at a concentration of 1:50.",Non-OADS,/arxiv_data1/oa_pdf/da/bc/CNE-524-1424.PMC5063101.pdf
Antibodies Used for Immunohistochemistry Name of antibody Immunogen Manufacturer Catalog number RRID ClonalityHost species Concentration Neurofilament (165 kDa)Membrane preparations obtained fromE14-E15 rat spinal cord tissueDSHB (2H3) http://dshb.biology.,Non-OADS,/arxiv_data1/oa_pdf/da/bc/CNE-524-1424.PMC5063101.pdf
uiowa.edu/2H3AB_2314897 Monoclonal Mouse 1:50 Synaptic vesicle glycoprotein 2APurified synaptic vesiclesDSHB (SV2) http://dshb.biology.,Non-OADS,/arxiv_data1/oa_pdf/da/bc/CNE-524-1424.PMC5063101.pdf
[www document] Available at: http://www.glycotope.com/wp-content/uploads/documents/phagotst.pdf (accessed07 January 2012).,Non-OADS,/arxiv_data1/oa_pdf/52/05/AAS-60-502.PMC5063102.pdf
"Foster City, CA: Gilead Sciences; October, 2014.Available at https://www.gilead.com/~/media/Files/pdfs/ medicines/liver-disease/harvoni/harvoni_pi.pdf.",Non-OADS,/arxiv_data1/oa_pdf/e9/30/LIV-36-488.PMC5063106.pdf
Available at http://www.ibtimes.com/cost-cure-new-drugs-may-eradicate-hepati tis-c-are-they-worth-it-1570671.,Non-OADS,/arxiv_data1/oa_pdf/e9/30/LIV-36-488.PMC5063106.pdf
Available athttp://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021511s020lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e9/30/LIV-36-488.PMC5063106.pdf
Available athttp://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204671s000lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e9/30/LIV-36-488.PMC5063106.pdf
Available at http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204671s000lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e9/30/LIV-36-488.PMC5063106.pdf
Available at http://www.med-iq.com/ ﬁles/PR/2013/pr11-21-13.html.,Non-OADS,/arxiv_data1/oa_pdf/e9/30/LIV-36-488.PMC5063106.pdf
Available at http://www.deci-sionresources.com/News-and-Events/Press-Releases/Direct- Acting-Antivirals-for-Hepatitis-C-61914.,Non-OADS,/arxiv_data1/oa_pdf/e9/30/LIV-36-488.PMC5063106.pdf
Available at http://www.nice.org.uk/nicemedia/pdf/ cg66niceguideline.pdf Last accessed 1 September 2014.,Non-OADS,/arxiv_data1/oa_pdf/de/59/DME-33-786.PMC5063109.pdf
Available at https://www.diabetes.org.uk/Documents/About%20Us/Statistics/Diabetes-key-stats-guidelines-April2014.pdf Last accessed 1 August 2015.,Non-OADS,/arxiv_data1/oa_pdf/de/59/DME-33-786.PMC5063109.pdf
Available at http://www.biomedcentral.com/1472-6823/14/60 Last accessed 1August 2015.,Non-OADS,/arxiv_data1/oa_pdf/de/59/DME-33-786.PMC5063109.pdf
"ACKNOWLEDGEMENTS OK received research grants from the Ishibashi Yukiko Founda- tion, which had no role in the design or conduct of this research.The authors also thank Inter-Biotech (http://www.inter-biotech.",Non-OADS,/arxiv_data1/oa_pdf/b5/35/CEP-42-1245.PMC5063113.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/00/3a/tcrm-12-1507.PMC5063121.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1507–1515Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1507ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S11470 9 association of medications for lifestyle-related  diseases with reflux esophagitis Daisuke asaoka1 akihito nagahara2 Mariko hojo1 Kenshi Matsumoto1 hiroya Ueyama1 Kohei Matsumoto1 Kentaro izumi1 Tsutomu Takeda1 hiroyuki Komori1 Y oichi akazawa1 Yuji shimada2 Taro Osada1 sumio Watanabe1 1Department of gastroenterology,   University of Juntendo, school of  Medicine, T okyo, 2Department of  gastroenterology, Juntendo University  shizuoka hospital, shizuoka, JapanBackground:  Because of a change in lifestyle, especially adoption of westernized eating habits,  lifestyle-related diseases have become increasingly prevalent.",Non-OADS,/arxiv_data1/oa_pdf/00/3a/tcrm-12-1507.PMC5063121.pdf
"Consequently, there is an increase in national cost of medical care, which  highlights that preventive therapy for lifestyle-related diseases are very important.4Correspondence: Daisuke asaoka Department of gastroenterology,  Juntendo University school of  Medicine, 2-1-1, hongo, Bunkyo-ku,  Tokyo 113-8421, Japan Tel +81 3 3813 3111 Fax +81 3 3813 8862 email daisuke@juntendo.ac.j p Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Asaoka et al Running head recto: Medications of lifestyle-related diseases and reflux esophagitis DOI: http://dx.doi.org/10.2147/TCRM.S114709",Non-OADS,/arxiv_data1/oa_pdf/00/3a/tcrm-12-1507.PMC5063121.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/00/3a/tcrm-12-1507.PMC5063121.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/00/3a/tcrm-12-1507.PMC5063121.pdf
"No consistent pattern was observed for changes in total SHS score when analyzed by early-escape status (Supple- mentary Table 1, available on the Arthritis Care & Researchweb site at http://onlinelibrary.wiley.com/doi/10.1002/acr.",OADS,/arxiv_data1/oa_pdf/f3/41/ACR-67-1739.PMC5063124.pdf
"The proportions of patients with anACR20 or ACR50 response tended to be numerically lowerfor patients who were positive for antibodies to ustekinu- mab compared with those who were negative (Supple- mentary Table 4, available on the Arthritis Care & Research web site at http://onlinelibrary.wiley.com/doi/ 10.1002/acr.22645/abstract); similar results were observed for PASI75 and PASI90 (Supplementary Table 5).",Non-OADS,/arxiv_data1/oa_pdf/f3/41/ACR-67-1739.PMC5063124.pdf
Available at: http://www.nasa.gov/columbia/home/CAIB_V ol1.html.,Non-OADS,/arxiv_data1/oa_pdf/6e/6b/JEP-22-267.PMC5063127.pdf
Available at: https://www.ismp.org/newsletters/acutecare/articles/20070531.asp (last accessed 30 September 2015).,Non-OADS,/arxiv_data1/oa_pdf/6e/6b/JEP-22-267.PMC5063127.pdf
"(2014) http://www.who.int/ malaria/publications/world_malaria_report_2014/en/ Wright, G.J., and Rayner, J.C. (2014) Plasmodium falciparum erythrocyte invasion: combining function with immuneevasion.",Non-OADS,/arxiv_data1/oa_pdf/33/51/CMI-18-573.PMC5063132.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/80/b1/prom-7-157.PMC5063133.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/80/b1/prom-7-157.PMC5063133.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Patient Related Outcome Measures 2016:7 157–171Patient Related Outcome Measures Dovepress submit your manuscript | www.dovepress.com Dovepress 157 Review open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PROM.S102198 Measuring medicine-related experiences from the  patient perspective: a systematic review Barbra Katusiime1 Sarah Corlett1 Joanne Reeve2 Janet Krska1 1Medway School of Pharmacy, The  Universities of Kent and Greenwich,   Chatham, Maritime, Kent, UK;   2warwick Medical School, University  of warwick, Coventry, UKBackground: There is an increasing drive to measure and so improve patients’ experiences  and outcomes of health care.",Non-OADS,/arxiv_data1/oa_pdf/80/b1/prom-7-157.PMC5063133.pdf
"2Correspondence: Barbra Katusiime Medway School of Pharmacy, The Universities of Kent and Greenwich, Central Avenue, Chatham Maritime, Chatham Me4 4TB, UKTel +44 1634 20 2920email bk231@kent.ac.ukJournal name: Patient Related Outcome Measures Article Designation: ReviewY ear: 2016V olume: 7Running head verso: Katusiime et alRunning head recto: Measuring medicine-related experiencesDOI: http://dx.doi.org/10.2147/PROM.S102198",Non-OADS,/arxiv_data1/oa_pdf/80/b1/prom-7-157.PMC5063133.pdf
Avail-able from: http://www.rpharms.com/promoting-pharmacy-pdfs/helping-patients-make-the-most-of-their-medicines.pdf.,Non-OADS,/arxiv_data1/oa_pdf/80/b1/prom-7-157.PMC5063133.pdf
Available from: http://www.england.nhs.uk/2013/05/02/med-opt/.,Non-OADS,/arxiv_data1/oa_pdf/80/b1/prom-7-157.PMC5063133.pdf
Available from: http://www.winsteps.com/winman/reliability.htm.,Non-OADS,/arxiv_data1/oa_pdf/80/b1/prom-7-157.PMC5063133.pdf
"Patient Related Outcome Measures 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Patient Related Outcome Measures Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/patient-related-outcome-measures-journalPatient Related Outcome Measures is an international, peer-reviewed,  open access journal focusing on treatment outcomes specifically relevant to patients.",Non-OADS,/arxiv_data1/oa_pdf/80/b1/prom-7-157.PMC5063133.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/80/b1/prom-7-157.PMC5063133.pdf
Available from URL: https://docs.google.com/viewer?a =v&pid= sites&srcid =ZGVmYXVsdGRvbWFpbnx0aGVpcGFxfGd4OjE0NDgxMDk3NDU1Y WRlZTM.Accesssed30October2015.,Non-OADS,/arxiv_data1/oa_pdf/ee/19/DOM-18-196.PMC5063138.pdf
Available: http://www.epa.gov/oppbppd1/ biopesticides/pips/bt_brad.htm[7July2015].,OADS,/arxiv_data1/oa_pdf/a5/15/PS-72-837.PMC5063140.pdf
Available at http://www.fda.gov/down- loads/Drugs/Guidances/ucm071624.pdf Accessed 12 November 2014.,Non-OADS,/arxiv_data1/oa_pdf/89/bc/DME-33-497.PMC5063147.pdf
Available at: http://www.ich.org/ﬁleadmin/Public_Web_Site/ICH_ Products/Guidelines/Efﬁcacy/E6/E6_R1_Guideline.pdf.,Non-OADS,/arxiv_data1/oa_pdf/89/bc/DME-33-497.PMC5063147.pdf
Available from URL: https://www.medicines.org.uk/emc/medicine/29493Accessed10July2015.,Non-OADS,/arxiv_data1/oa_pdf/de/8a/DOM-18-40.PMC5063148.pdf
Supportin gInformat ionforthisarticle isavailab leontheWWW under http://dx.doi.or g/10.10 02/cmdc.20 1500467.,Non-OADS,/arxiv_data1/oa_pdf/f4/e2/CMDC-11-928.PMC5063151.pdf
"Parsippany, NJ: Daiichi Sankyo, Inc. http://dsi.com/prescribing-information- portlet/getPIContent?productName ¼Benicar&inline ¼true.",Non-OADS,/arxiv_data1/oa_pdf/a9/d1/JCPH-56-484.PMC5063153.pdf
URL: http://www.nzma.org.nz/journal/118-1211/1345/ 15.,Non-OADS,/arxiv_data1/oa_pdf/c3/1b/OSP4-1-067.PMC5063157.pdf
Available from: http://www.health.govt.nz/system/files/ocuments/publications/new-zealand-health-survey-annual-up-date-2012-13-dec13-v2.pdf (accessed 16 October 2015).,Non-OADS,/arxiv_data1/oa_pdf/c3/1b/OSP4-1-067.PMC5063157.pdf
Available from: http://www.health.govt.nz/system/files/documents/publications/methodology-report.pdf(accessed 16 October 2015).,Non-OADS,/arxiv_data1/oa_pdf/c3/1b/OSP4-1-067.PMC5063157.pdf
Available from: http://www.otago.ac.nz/wellington/otago020348.pdf (accessed 16 October 2015).,Non-OADS,/arxiv_data1/oa_pdf/c3/1b/OSP4-1-067.PMC5063157.pdf
Body mass index cut offs to define thinness in children and adolescents: international survey.BMJ 2007; 335: 194. doi: http://dx.doi.org/10.1136/ bmj.39238.399444.55 25.,Non-OADS,/arxiv_data1/oa_pdf/c3/1b/OSP4-1-067.PMC5063157.pdf
Available from: http://alcohol.org.nz/help-advice/advice-on-alco-hol/low-risk-alcohol-drinking-advice (accessed 16 October 2015).,Non-OADS,/arxiv_data1/oa_pdf/c3/1b/OSP4-1-067.PMC5063157.pdf
"Patient growth was assessedthrough standard deviation scores for height and weight,defined as Zscores (obtained from the US Centers for Disease Control and Prevention Growth Charts at http://www.cdc.gov/growthcharts), measuring the distance from the populationmean in units of standard deviations.",OADS,/arxiv_data1/oa_pdf/8e/c3/ANA-78-929.PMC5063160.pdf
Available at: http://www.nytimes.com/2015/03/21/business/breast-milk-products-commercialization.html(Accessed 25 March 2015).,Non-OADS,/arxiv_data1/oa_pdf/a9/6d/MCN-12-278.PMC5063162.pdf
Available at: http://breastfeeding.sph.unc.edu/what-we-do/programs-and-initiatives/tools-for-%20action-donor-human-milk-banking/ (Accessed 15 June 2015).,Non-OADS,/arxiv_data1/oa_pdf/a9/6d/MCN-12-278.PMC5063162.pdf
Available at: http://www.surgeongeneral.gov.,Non-OADS,/arxiv_data1/oa_pdf/a9/6d/MCN-12-278.PMC5063162.pdf
"World Health Organization (2014) Comprehensive implemen- tation plan on maternal, infant and young child nutrition.Available at: http://www.who.int/nutrition/publications/CIP_document/en/ (Accessed 25 March 2015).",Non-OADS,/arxiv_data1/oa_pdf/a9/6d/MCN-12-278.PMC5063162.pdf
Available at: http://www.nccn.org/professionals/physician_gls/pdf/ head-and-neck.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3e/47/HED-38-E1625.PMC5063170.pdf
Available at: http://www.nccn.org/profes-sionals/biomarkers/content/.,Non-OADS,/arxiv_data1/oa_pdf/3e/47/HED-38-E1625.PMC5063170.pdf
"EMA/95098/2010, http://www.encepp.eu/standards_and_guidances (Accessed 10 October 2014).",Non-OADS,/arxiv_data1/oa_pdf/2a/e9/PDS-25-215.PMC5063172.pdf
"Provisional annual data for routine cohort as submitted by PCTs for ﬁrst, second and third dose vaccine coverage by 31 August 2012, https://www.gov.uk/government/uploads/system/uploads/attachment_data/ ﬁle/244479/HPV_AnnualVaccineUptake 2011-2012.pdf (A ccessed 15 July 2014) 16.",Non-OADS,/arxiv_data1/oa_pdf/2a/e9/PDS-25-215.PMC5063172.pdf
2014. http://www.accessdata.fda.gov/ drugsatfda_docs/label/2012/125370s016lbl.pdf 6.,Non-OADS,/arxiv_data1/oa_pdf/aa/ed/CPDD-5-208.PMC5063175.pdf
"Visit http://onlinelibrary.wiley.com/doi/10.1111/os .12202/suppinfo References 1.Ganz R, Klaue K, Vinh TS, Mast JW.",Non-OADS,/arxiv_data1/oa_pdf/a2/45/OS-7-375.PMC5063177.pdf
Medical Education 2015: 49: 1263 –1271 doi: 10.1111/medu.12882 Discuss ideas arising from the article at http://www.mededuc.com discuss.,Non-OADS,/arxiv_data1/oa_pdf/ea/50/MEDU-49-1263.PMC5063180.pdf
http://www.asit.org.,Non-OADS,/arxiv_data1/oa_pdf/ea/50/MEDU-49-1263.PMC5063180.pdf
"London, 2012. http://www.aagbi.org/sites/default/ﬁles/ checking_anaesthetic_equipment_2012.pdf (accessed 07/07/2015).",Non-OADS,/arxiv_data1/oa_pdf/93/bd/ANAE-71-85.PMC5063182.pdf
"London, 2011. http://www.rcoa.ac.uk/news-and-bulletin/rcoa-news-and-statements/paa-supervision -and-limitation-of-scope-of-practice-may (accessed 24/05/15).",Non-OADS,/arxiv_data1/oa_pdf/93/bd/ANAE-71-85.PMC5063182.pdf
http://www.ra-uk.org/index.php/guidelines-standards/5-detail/274-supervision-statement (accessed 07/09/15).,Non-OADS,/arxiv_data1/oa_pdf/93/bd/ANAE-71-85.PMC5063182.pdf
"London: Association of Anaesthetists of Great Britain & Ireland, 2014. http://www.aagbi.org/sites/ default/ﬁles/Fatigue%20Guideline%20web.pdf (accessed 07/ 07/2015).",Non-OADS,/arxiv_data1/oa_pdf/93/bd/ANAE-71-85.PMC5063182.pdf
The Working Time Regulations 1998. http://www.legislation.,Non-OADS,/arxiv_data1/oa_pdf/93/bd/ANAE-71-85.PMC5063182.pdf
"London, 2011. http://www.aagbi.org/sit es/default/ﬁles/Capnographyaagbi090711AJH%5B1%5D_1.pdf (accessed 24/04/15).",Non-OADS,/arxiv_data1/oa_pdf/93/bd/ANAE-71-85.PMC5063182.pdf
"London, 2013. http://www.aagbi.org/sites/de- fault/ﬁles/immediate_post-anaesthesia_recovery_2013.pdf(accessed 10/05/15).",Non-OADS,/arxiv_data1/oa_pdf/93/bd/ANAE-71-85.PMC5063182.pdf
"London: Academy of Medical Royal Colleges, 2013. http://www.aomrc.org.uk/ doc_view/9737-safe-sedation-practice-for-healthcare-procedur es-standards-and-guidance (accessed 11/05/15).",Non-OADS,/arxiv_data1/oa_pdf/93/bd/ANAE-71-85.PMC5063182.pdf
"London, 2009. http://www.aagbi.org/sites/default/ﬁles/interhospital09.pdf (accessed 24/04/15).",Non-OADS,/arxiv_data1/oa_pdf/93/bd/ANAE-71-85.PMC5063182.pdf
"Depth of anaesthesia monitors –Bispectral Index (BIS), E-Entropy and Narcotrend-Compact M. NICE diagnostics guidance [DG6], 2012. http://www.nice.org.uk/guidance/dg6 (accessed 26/04/15).",Non-OADS,/arxiv_data1/oa_pdf/93/bd/ANAE-71-85.PMC5063182.pdf
http://www.webcitation.,Non-OADS,/arxiv_data1/oa_pdf/79/40/ADD-111-420.PMC5063184.pdf
org/6cPIS69B8 (Archived at: http://www.webcitation.org/6cPIS69B8) 12.,Non-OADS,/arxiv_data1/oa_pdf/79/40/ADD-111-420.PMC5063184.pdf
Available at: http://www.pewresearch.org/fact-tank/2014/01/15/pew-re- search-increases-share-of-inte rviews-conducted-by-cellphone/ (accessed 19 October 2015).,Non-OADS,/arxiv_data1/oa_pdf/79/40/ADD-111-420.PMC5063184.pdf
http://www.webcitation.org/6cPIpm4Vl (Archived at: http://www.webcitation.org/6cPIpm4Vl).,Non-OADS,/arxiv_data1/oa_pdf/79/40/ADD-111-420.PMC5063184.pdf
"ONL: outer nuclear layer; OS: outer segment; black circle: optic nerve head; red lines: vessels; S: superior; I: inferior; N: nasal; T: temporal.Source: refs 32, 72, 94, and 112–127; http://www.cvrl.org/database/text/intros/introdens.htm © 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/1c/46/PATH-238-300.PMC5063185.pdf
"2016;21(3):165-170 http://dx.doi.org/10.3746/pnf.2016.21.3.165 pISSN 2287-1098 ㆍeISSN 2287-8602 Received 29 February 2016; Accepted 18 August 2016; Published online 30 September 2016 Correspondence to Hyunjung Lim, Tel: +82-31-201-2343, E-mail: hjlim@khu.ac.kr Copyright © 2016 by The Korean Society of Food Science and Nutrition.",Non-OADS,/arxiv_data1/oa_pdf/5a/a0/pnfs-21-165.PMC5063200.pdf
http://www.rda.go.kr/board/board.do?mode=view&prg- Id=day_farmprmninfoEntry&dataNo=100000448466 (ac-cessed August 2013).,Non-OADS,/arxiv_data1/oa_pdf/5a/a0/pnfs-21-165.PMC5063200.pdf
"2016;21(3):171-180 http://dx.doi.org/10.3746/pnf.2016.21.3.171 pISSN 2287-1098 ㆍeISSN 2287-8602 Received 7 April 2016; Accepted 27 July 2016; Published online 30 September 2016 Correspondence to Shanmugam M. Jeyakumar, Tel: +91-040-2719-7341, E-mail: smjkumar@gmail.com Copyright © 2016 by The Korean Society of Food Science and Nutrition.",Non-OADS,/arxiv_data1/oa_pdf/ec/75/pnfs-21-171.PMC5063201.pdf
"2016;21(3):181-186 http://dx.doi.org/10.3746/pnf.2016.21.3.181 pISSN 2287-1098 ㆍeISSN 2287-8602 Received 14 April 2016; Accepted 16 August 2016; Published online 30 September 2016 Correspondence to Ji-Sook Han, Tel: +82-51-510-2836, E-mail: hanjs@pusan.ac.kr Copyright © 2016 by The Korean Society of Food Science and Nutrition.",Non-OADS,/arxiv_data1/oa_pdf/02/6e/pnfs-21-181.PMC5063202.pdf
"2016;21(3):187-196 http://dx.doi.org/10.3746/pnf.2016.21.3.187 pISSN 2287-1098 ㆍeISSN 2287-8602 Received 17 June 2016; Accepted 12 August 2016; Published online 30 September 2016 Correspondence to Kwontack Hwang, Tel: +82-62-970-0174, E-mail: hwangskt@nambu.ac.kr *These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/9e/35/pnfs-21-187.PMC5063203.pdf
"2016;21(3):197-201 http://dx.doi.org/10.3746/pnf.2016.21.3.197 pISSN 2287-1098 ㆍeISSN 2287-8602 Received 15 March 2016; Accepted 27 June 2016; Published online 30 September 2016 Correspondence to Don Haeng Lee, Tel: +82-32-890-1181, E-mail: ldh@inha.ac.kr*These authors equally contributed to this work.",Non-OADS,/arxiv_data1/oa_pdf/04/69/pnfs-21-197.PMC5063204.pdf
"2016;21(3):202-207 http://dx.doi.org/10.3746/pnf.2016.21.3.202 pISSN 2287-1098 ㆍeISSN 2287-8602 Received 29 June 2016; Accepted 23 August 2016; Published online 30 September 2016 Correspondence to Yangha Kim, Tel: +82-2-3277-3101, E-mail: yhmoon@ewha.ac.kr Copyright © 2016 by The Korean Society of Food Science and Nutrition.",Non-OADS,/arxiv_data1/oa_pdf/af/41/pnfs-21-202.PMC5063205.pdf
"2016;21(3):208-220 http://dx.doi.org/10.3746/pnf.2016.21.3.208 pISSN 2287-1098 ㆍeISSN 2287-8602 Received 8 June 2016; Accepted 10 July 2016; Published online 30 September 2016 Correspondence to Jae Sue Choi, Tel: +82-51-629-5845, E-mail: choijs@pknu.ac.kr Copyright © 2016 by The Korean Society of Food Science and Nutrition.",Non-OADS,/arxiv_data1/oa_pdf/48/27/pnfs-21-208.PMC5063206.pdf
"2016;21(3):221-226 http://dx.doi.org/10.3746/pnf.2016.21.3.221 pISSN 2287-1098 ㆍeISSN 2287-8602 Received 10 May 2016; Accepted 7 July 2016; Published online 30 September 2016 Correspondence to Jong-Sang Kim, Tel: +82-53-950-5752, E-mail: vision@knu.ac.kr Copyright © 2016 by The Korean Society of Food Science and Nutrition.",Non-OADS,/arxiv_data1/oa_pdf/06/aa/pnfs-21-221.PMC5063207.pdf
"2016;21(3):227-235 http://dx.doi.org/10.3746/pnf.2016.21.3.227 pISSN 2287-1098 ㆍeISSN 2287-8602 Received 16 February 2016; Accepted 23 June 2016; Published online 30 September 2016 Correspondence to Gyo-Nam Kim, Tel: +82-55-249-6330, E-mail: gnkim@kyungnam.ac.kr Copyright © 2016 by The Korean Society of Food Science and Nutrition.",Non-OADS,/arxiv_data1/oa_pdf/95/34/pnfs-21-227.PMC5063208.pdf
"2016;21(3):236-244 http://dx.doi.org/10.3746/pnf.2016.21.3.236 pISSN 2287-1098 ㆍeISSN 2287-8602 Received 8 April 2016; Accepted 22 June 2016; Published online 30 September 2016 Correspondence to Young-Je Cho, Tel: +82-53-950-7755, E-mail: yjcho@knu.ac.kr Copyright © 2016 by The Korean Society of Food Science and Nutrition.",Non-OADS,/arxiv_data1/oa_pdf/ed/0c/pnfs-21-236.PMC5063209.pdf
"2016;21(3):245-254 http://dx.doi.org/10.3746/pnf.2016.21.3.245 pISSN 2287-1098 ㆍeISSN 2287-8602 Received 31 May 2016; Accepted 21 August 2016; Published online 30 September 2016 Correspondence to SangGuan You, Tel: +82-33-640-2853, E-mail: umyousg@gwnu.ac.kr Copyright © 2016 by The Korean Society of Food Science and Nutrition.",Non-OADS,/arxiv_data1/oa_pdf/c9/67/pnfs-21-245.PMC5063210.pdf
"2016;21(3):255-262 http://dx.doi.org/10.3746/pnf.2016.21.3.255 pISSN 2287-1098 ㆍeISSN 2287-8602 Received 15 June 2016; Accepted 1 August 2016; Published online 30 September 2016 Correspondence to Eun-Sun Hwang, Tel: +82-31-670-5182, E-mail: ehwang@hknu.ac.kr Copyright © 2016 by The Korean Society of Food Science and Nutrition.",Non-OADS,/arxiv_data1/oa_pdf/b9/ea/pnfs-21-255.PMC5063211.pdf
"2016;21(3):263-270 http://dx.doi.org/10.3746/pnf.2016.21.3.263 pISSN 2287-1098 ㆍeISSN 2287-8602 Received 1 June 2016; Accepted 21 June 2016; Published online 30 September 2016 Correspondence to Ji-Sang Kim, Tel: +82-55-249-2185, E-mail: jisangkim@kyungnam.ac.kr Copyright © 2016 by The Korean Society of Food Science and Nutrition.",Non-OADS,/arxiv_data1/oa_pdf/0b/87/pnfs-21-263.PMC5063212.pdf
"2016;21(3):271-280 http://dx.doi.org/10.3746/pnf.2016.21.3.271 pISSN 2287-1098 ㆍeISSN 2287-8602 Received 31 March 2016; Accepted 5 June 2016; Published online 30 September 2016 Correspondence to Gi-Hyung Ryu, Tel: +82-41-330-1484, E-mail: ghryu@kongju.ac.kr Copyright © 2016 by The Korean Society of Food Science and Nutrition.",Non-OADS,/arxiv_data1/oa_pdf/83/d1/pnfs-21-271.PMC5063213.pdf
"2016;21(3):281-288 http://dx.doi.org/10.3746/pnf.2016.21.3.281 pISSN 2287-1098 ㆍeISSN 2287-8602Research Note Received 15 March 2016; Accepted 13 June 2016; Published online 30 September 2016 Correspondence to Sang-Min Lee, Tel: +82-33-640-2414, E-mail: smlee@gwnu.ac.kr Copyright © 2016 by The Korean Society of Food Science and Nutrition.",Non-OADS,/arxiv_data1/oa_pdf/27/7a/pnfs-21-281.PMC5063214.pdf
"2016;21(3):289-295 http://dx.doi.org/10.3746/pnf.2016.21.3.289 pISSN 2287-1098 ㆍeISSN 2287-8602Research Note Received 21 June 2016; Accepted 22 August 2016; Published online 30 September 2016 Correspondence to Soon-Taek Hong, Tel: +82-42-821-7876, E-mail: hongst@cnu.ac.kr Copyright © 2016 by The Korean Society of Food Science and Nutrition.",Non-OADS,/arxiv_data1/oa_pdf/4f/04/pnfs-21-289.PMC5063215.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3c/dd/main.PMC5063217.pdf
Osteoblasts express the chemokine CXCL12 whereas theContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2016.03.007 2212-1374/ &2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/3c/dd/main.PMC5063217.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3c/dd/main.PMC5063217.pdf
"Evidence demonstrates that CAFs recruit monocytes mostly through CCL2-CCR2 in breast cancer and mel- anoma, and CD68 þmacrophages through CXCL14 in prostateContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2016.03.008 2212-1374/ &2016 Published by Elsevier GmbH.",Non-OADS,/arxiv_data1/oa_pdf/b8/ec/main.PMC5063218.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/ec/main.PMC5063218.pdf
"24 (2013) 384 –390, http://dx.doi.org/10.1093/ annonc/mds333 .",Non-OADS,/arxiv_data1/oa_pdf/b8/ec/main.PMC5063218.pdf
"14 (2008) 518 –527, http://dx.doi.org/10.1038/nm1764 .",Non-OADS,/arxiv_data1/oa_pdf/b8/ec/main.PMC5063218.pdf
"24 (2013) 179 –185, http://dx.doi.org/10.1093/annonc/mds246 .",Non-OADS,/arxiv_data1/oa_pdf/b8/ec/main.PMC5063218.pdf
"Thomas, et al., Progression of genotype-speci ﬁc oral cancer leads to senescence of cancer- associated ﬁbroblasts and is mediated by oxidative stress and TGF-β, Carci- nogenesis 34 (2013) 1286 –1295, http://dx.doi.org/10.1093/carcin/bgt035 .",Non-OADS,/arxiv_data1/oa_pdf/b8/ec/main.PMC5063218.pdf
"4 (2014) 62, http://dx.doi.org/10.3389/ fonc.2014.00062 .",Non-OADS,/arxiv_data1/oa_pdf/b8/ec/main.PMC5063218.pdf
"25 (2014) 33 –46,http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/b8/ec/main.PMC5063218.pdf
"319 (2013) 1596 –1603, http://dx.doi.org/ 10.1016/j.yexcr.2013.03.022 .",Non-OADS,/arxiv_data1/oa_pdf/b8/ec/main.PMC5063218.pdf
doi: 〈https://doi.org/10.1007/s10555-011-9340-x 〉.,Non-OADS,/arxiv_data1/oa_pdf/b8/ec/main.PMC5063218.pdf
"Erler, et al., Matrix crosslinking forces tumor progression by enhancing integrin signaling, Cell139 (2009) 891 –906, http://dx.doi.org/10.1016/j.cell.2009.10.027 .",OADS,/arxiv_data1/oa_pdf/b8/ec/main.PMC5063218.pdf
"15 (2014) 786 –801, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/b8/ec/main.PMC5063218.pdf
"18 (2012) 148 –152, http://dx.doi.org/10.1038/nm.2574 .",Non-OADS,/arxiv_data1/oa_pdf/b8/ec/main.PMC5063218.pdf
"29 (2015) 70 –76,http://dx.doi.org/10.1002/jbt.21669 .",Non-OADS,/arxiv_data1/oa_pdf/b8/ec/main.PMC5063218.pdf
"(2015) , http://dx.doi.org/10.1016/j.addr.2015.07.007 .",OADS,/arxiv_data1/oa_pdf/b8/ec/main.PMC5063218.pdf
"Cancer 130 (2012) 40 –47, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/b8/ec/main.PMC5063218.pdf
"Nabet, B. Xu, Y. Qiu, T. Yoon, et al., Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways, Cell 159 (2014) 499 –513, http://dx.doi.org/10.1016/j.cell.2014.09.051 .",OADS,/arxiv_data1/oa_pdf/b8/ec/main.PMC5063218.pdf
"16 (2015) 1671 –1681, http://dx.doi.org/10.1080/ 15384047.2015.1071742 .",Non-OADS,/arxiv_data1/oa_pdf/b8/ec/main.PMC5063218.pdf
"Cancer 11 (2011) 411 –425, http://dx.doi.org/10.1038/nrc3055 .",Non-OADS,/arxiv_data1/oa_pdf/b8/ec/main.PMC5063218.pdf
"Wen, E. Brogi, et al., Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma, Cell 154 (2013) 1060 –1073, http://dx.doi.org/10.1016/j.cell.2013.07.036 .",OADS,/arxiv_data1/oa_pdf/b8/ec/main.PMC5063218.pdf
"10 (2012) 494 –503, http://dx.doi.org/10.1158/1541-7786.",Non-OADS,/arxiv_data1/oa_pdf/b8/ec/main.PMC5063218.pdf
38 (1996) 241 –246 http://www.ncbi.nlm.nih.gov/ pubmed/8974787 .,Non-OADS,/arxiv_data1/oa_pdf/b8/ec/main.PMC5063218.pdf
"O ’Connor- McCourt, et al., Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone, Oncogene 28 (2009) 1005 –1015, http://dx.doi.org/10.1038/onc.2008.454 .P.",Non-OADS,/arxiv_data1/oa_pdf/b8/ec/main.PMC5063218.pdf
This has generated new insights into the cellular andContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2016.05.004 2212-1374/ &2016 Published by Elsevier GmbH.,OADS,/arxiv_data1/oa_pdf/f1/13/main.PMC5063219.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f1/13/main.PMC5063219.pdf
"References [1] S. Nik-Zainal, et al., Landscape of somatic mutations in 560 breast cancer whole-genome sequences, Nature (2016) http://dx.doi.org/10.1038/ nature17676 .",Non-OADS,/arxiv_data1/oa_pdf/f1/13/main.PMC5063219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/df/75/main.PMC5063220.pdf
Bone metastasis induced by CaSR The heterodimeric G-protein coupled CaSR is the most im- portant receptor on the cell surface for detecting extracellularContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2016.06.004 2212-1374/ &2016 Published by Elsevier GmbH.,Non-OADS,/arxiv_data1/oa_pdf/df/75/main.PMC5063220.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: AKT, AKT8 virus oncogene cellular homolog; BMP's, bone mor- phogenetic proteins; cAMP, cyclic adenosine monophosphate; CaSR, calcium-sen- sing receptor; COPD, chronic obstructive pulmonary disease; ERK, extracellularsignal-regulated kinase; ET-1, endothelin-1; FGF, ﬁbroblast growth factor; IGF, in- sulin-like growth factor; JNK, jun N-terminal kinase; MAPK, mitogen-activatedprotein kinase; M-CSF, macrophage colony-stimulating factor; PDGF, platelet-de-rived growth factor; PGE-2, prostaglandin E-2; PKA, protein kinase A; PLC, phos-pholipase C; PSA, prostate speci ﬁc antigen; PTEN, phosphatase and tensin homolog deleted on chromosome 10; PTHrP, parathyroid hormone-related protein; RANK, receptor activator of NF- κB; RANKL, receptor activator of NF- κB ligand; SK3, small conductance calcium-activated potassium channel 3; TGF β, transforming growth factor beta; TRP, transient receptor potential nCorresponding author.",Non-OADS,/arxiv_data1/oa_pdf/df/75/main.PMC5063220.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/12/main.PMC5063221.pdf
Such discrepanciesContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2016.02.007 2212-1374/ &2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b8/12/main.PMC5063221.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/12/main.PMC5063221.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e5/bb/main.PMC5063223.pdf
These opposite stromal responses suggest that different types of cancers adopt distinct strategies toContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2016.04.002 2212-1374/ &2016 Published by Elsevier GmbH.,Non-OADS,/arxiv_data1/oa_pdf/e5/bb/main.PMC5063223.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e5/bb/main.PMC5063223.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/0f/main.PMC5063225.pdf
We and others have recently reviewed the role of TAMs in each of the metastatic steps [11 –13].Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2016.03.004 2212-1374/ &2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/50/0f/main.PMC5063225.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/0f/main.PMC5063225.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/3c/main.PMC5063226.pdf
These conditions are associated with higher cancer recurrence and reduced survival in women withContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2016.03.003 2212-1374/ &2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/bd/3c/main.PMC5063226.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/3c/main.PMC5063226.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c3/78/main.PMC5063227.pdf
"Traditionally,Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2016.03.009 2212-1374/ &2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c3/78/main.PMC5063227.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c3/78/main.PMC5063227.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cd/b1/main.PMC5063228.pdf
This review highlights thesigniﬁcance of vascular niches during skeletal metastases and discusses the potential therapeutic interventions for targeting the vascular niche.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2016.04.003 2212-1374/ &2016 Published by Elsevier GmbH.,Non-OADS,/arxiv_data1/oa_pdf/cd/b1/main.PMC5063228.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cd/b1/main.PMC5063228.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/6a/main.PMC5063229.pdf
DTC dormancy in the HSC niche The concept of a dormancy supportive/permissive micro- environment in the bone marrow is an increasingly important and complex area of investigation in clinical oncology due to theContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2016.02.005 2212-1374/ &2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/09/6a/main.PMC5063229.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/6a/main.PMC5063229.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4d/66/main.PMC5063254.pdf
"Given the importance of the ECM in directing almost all cellular behaviour, it is not too surprising that altered ECM deposition, synthesis and post-translational modi ﬁcation leads to a dis- organised mesh with differing properties and results in diseasesContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2016.04.001 2212-1374/ &2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/4d/66/main.PMC5063254.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).☆Funding: AG: Breast Cancer Now; JTE: Novo Nordisk Foundation Hallas Møller Stipend; TRC: BRIC.,Non-OADS,/arxiv_data1/oa_pdf/4d/66/main.PMC5063254.pdf
"Additionally, these variants include a number of single nucleotide polymorphisms (SNPs), and the distribution of SNPsContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2016.07.001 1880-4276/ &2016 Japanese Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/9a/5e/main.PMC5063257.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Arrhythmia 32 (2016) 313 –314,Non-OADS,/arxiv_data1/oa_pdf/9a/5e/main.PMC5063257.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/47/main.PMC5063258.pdf
This isContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2016.02.009 1880-4276/ &2016 Japanese Heart Rhythm Society.,Non-OADS,/arxiv_data1/oa_pdf/46/47/main.PMC5063258.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorresponding author.,Non-OADS,/arxiv_data1/oa_pdf/46/47/main.PMC5063258.pdf
http://dx.doi.org/10.1113/JP271573 .G.,Non-OADS,/arxiv_data1/oa_pdf/46/47/main.PMC5063258.pdf
http://dx.doi.org/ 10.1016/j.joa.2015.11.003 .,OADS,/arxiv_data1/oa_pdf/46/47/main.PMC5063258.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/82/7a/main.PMC5063259.pdf
422Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2016.07.012 1880-4276/ &2016 Japanese Heart Rhythm Society.,Non-OADS,/arxiv_data1/oa_pdf/82/7a/main.PMC5063259.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorresponding author at: Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital , and National Taiwan University College of Medicine, Taipei, Taiwan.",Non-OADS,/arxiv_data1/oa_pdf/82/7a/main.PMC5063259.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/53/c6/main.PMC5063260.pdf
379Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2015.11.009 1880-4276/ &2016 Japanese Heart Rhythm Society.,Non-OADS,/arxiv_data1/oa_pdf/53/c6/main.PMC5063260.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorrespondence to: 800 Rose Street, MS508, Lexington, KY 40536, USA.",Non-OADS,/arxiv_data1/oa_pdf/53/c6/main.PMC5063260.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/4c/main.PMC5063261.pdf
357Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2015.09.009 1880-4276/ &2015 Japanese Heart Rhythm Society.,Non-OADS,/arxiv_data1/oa_pdf/03/4c/main.PMC5063261.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorresponding author.,Non-OADS,/arxiv_data1/oa_pdf/03/4c/main.PMC5063261.pdf
http://dx.doi.org/ 10.1161/CIRCEP.115.003098 .,Non-OADS,/arxiv_data1/oa_pdf/03/4c/main.PMC5063261.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c7/a2/main.PMC5063262.pdf
394Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2015.12.009 1880-4276/ &2016 Japanese Heart Rhythm Society.,Non-OADS,/arxiv_data1/oa_pdf/c7/a2/main.PMC5063262.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: ARVD/C, arrhythmogenic right ventricular dysplasia/cardiomyopathy; BrS, Brugada syndrome; CHD, coronary heart disease; CPVT, catecholaminerg ic polymorphic ventricular tachycardia; DCM, dilated cardiomyopathy; GWAS, genome wide association study; HCM, hypertrophic cardiomyopathy; HF, h eart failure; ICD, implantable cardioverter de ﬁbrillator; NGS, next generation sequencing; LQTS, long QT syndrome; SCD, sudden cardiac death; VA, ventricular arrhythmia; VF, ventricular ﬁbrillation; WES, whole exome sequencing nTel.",Non-OADS,/arxiv_data1/oa_pdf/c7/a2/main.PMC5063262.pdf
"The ARVD/C Genetic Variants Database is currently available online ( http://www.arvcdatabase.info/ ), and summarizes ARVD/C- associated variants and their pathogenesis [75].",OADS,/arxiv_data1/oa_pdf/c7/a2/main.PMC5063262.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/b8/main.PMC5063263.pdf
"LQTS is attributed to mutations in genes that encode ion channels or their regulatory proteins responsible for the proper repolarization of cardiomyocytes [1–3],Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2015.10.005 1880-4276/ &2015 Japanese Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/f8/b8/main.PMC5063263.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: LQTS, long QT syndrome; HERG, human-ether-a-go-go-related gene; HS, heat shock; HSP, heat shock protein; HSF, heat shock factor; GGA, geranyl geranyl acetone nCorrespondence to: Division of Regenerative Medicine and Therapeutics, Tottori University Graduate School of Medical Science, 36-1 Nishi-cho, Yonago, Tottori 683-8504, Japan.",Non-OADS,/arxiv_data1/oa_pdf/f8/b8/main.PMC5063263.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.joa.2015.10.005 .,OADS,/arxiv_data1/oa_pdf/f8/b8/main.PMC5063263.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e6/2b/main.PMC5063264.pdf
"The death can occur at all ages, andContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2015.09.010 1880-4276/ &2015 Japanese Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/e6/2b/main.PMC5063264.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorresponding author at: Agnes Ginges Centre for Molecular Cardiology, Centenary Institute, Locked Bag 6, Newtown, NSW 2042, Australia.",Non-OADS,/arxiv_data1/oa_pdf/e6/2b/main.PMC5063264.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.joa.2015.09.010 .,OADS,/arxiv_data1/oa_pdf/e6/2b/main.PMC5063264.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/7e/main.PMC5063265.pdf
"A recent consensus report recommended thatcatheter ablation of VT or a triggering focus of VF should be con-sidered as a class IIa indication in patients with VT/VF storm whenadequate operator experience is available, although, presumably,Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2016.01.011 1880-4276/ &2016 Japanese Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/af/7e/main.PMC5063265.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorrespondence to: Cardiovascular Division, Institute of Clinical Medicine, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, Ibaraki 305-8575, Japan.",Non-OADS,/arxiv_data1/oa_pdf/af/7e/main.PMC5063265.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8d/fa/main.PMC5063266.pdf
"However, the relationship of electrolyte changes andContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2015.09.001 1880-4276/ &2015 Japanese Heart Rhythm Society.",OADS,/arxiv_data1/oa_pdf/8d/fa/main.PMC5063266.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: BrS, total Brugada Syndrome; BrS-D, patients who took anti- arrhythmic drugs; BrS-ND, patients who did not take anti-arrhythmic drugs; SCD,sudden cardiac death; K þ, potassium; ANS, autonomic nervous system; ICD, implantable cardioverter-de ﬁbrillator; O 2 peak , peak oxygen consumption; ECG, electrocardiogram; RER, respiratory exchange ratio; HR, heart rate; HRV, heart ratevariability; HRR, heart rate recovery; VF, ventricular ﬁbrillation; VT, ventricular tachycardia; SDNN, standard deviation of all normal sinus RR intervals; RMSSD, thesquare root of the mean of the sum of the squares of differences between adjacent normal to normal intervals; LF, low frequency; HF, high frequency; CHO, carbohydrate.",Non-OADS,/arxiv_data1/oa_pdf/8d/fa/main.PMC5063266.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.joa.2015.09.001 .R.,OADS,/arxiv_data1/oa_pdf/8d/fa/main.PMC5063266.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c6/a8/main.PMC5063267.pdf
"Traditionally, the major clinical indications for left cardiac sympathetic denervation (LCSD) are ß-blocker intolerance or refractoriness, high risk of sudden death with ß-blocker treatment (despite the patient being asymptomatic), frequent ICD shocks, orContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2015.08.002 1880-4276/ &2015 Japanese Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/c6/a8/main.PMC5063267.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nTel.,Non-OADS,/arxiv_data1/oa_pdf/c6/a8/main.PMC5063267.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/a0/main.PMC5063268.pdf
Molecular genetic studies have revealed that congenital LQTS is linked to mutations in genes encoding subunits of cardiac ionchannels or adapter proteins that modify the channel functions.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2015.12.006 1880-4276/ &2016 Japanese Heart Rhythm Society.,Non-OADS,/arxiv_data1/oa_pdf/4f/a0/main.PMC5063268.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorresponding author at: Department of Pharmacology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, 710061 Xi 'an, China.",Non-OADS,/arxiv_data1/oa_pdf/4f/a0/main.PMC5063268.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.or g/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/6c/main.PMC5063269.pdf
Introduction Catecholaminergic polymorphic ventricular tachycardia (CPVT) is induced by emotional stress or exercise in patients without organic heart disease and may be polymorphic or bidirectionalContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2015.09.008 1880-4276/ &2015 Japanese Heart Rhythm Society.,Non-OADS,/arxiv_data1/oa_pdf/03/6c/main.PMC5063269.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nTel.,Non-OADS,/arxiv_data1/oa_pdf/03/6c/main.PMC5063269.pdf
"J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge$,$$ Charles Antzelevitch, PhD, FHRSa,n, Gan-Xin Yan, MD, PhDb, Michael J. Ackerman, MD, PhDc, Martin Borggrefe, MDd, Domenico Corrado, MD, PhDe, Jihong Guo, MDf, Ihor Gussak, MD, PhDg, Can Hasdemir, MDh, Minoru Horie, MDi, Heikki Huikuri, MDj, Changsheng Ma, MDk, Hiroshi Morita, MD, PhDl, Gi-Byoung Nam, MD, PhDm, Frederic Sacher, MD, PhDn, Wataru Shimizu, MD, PhDo, Sami Viskin, MDp, Arthur A.M. Wilde, MD, PhD, FHRSq,r aLankenau Institute for Medical Research, Wynnewood, PA, United States bLankenau Medical Center, Wynnewood, PA, United States cDepartments of Cardiovascular Diseases, Pediatrics, and Molecular Pharmacology & Experimental Therapeutics, Divisions of Heart Rhythm Services and Pediatric Cardiology, Windland Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, MN, United States d1st Department of Medicine –Cardiology, University Medical Centre Mannheim, and DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, Mannheim, Germany eDepartment of Cardiac, Thoracic and Vascular Sciences, University of Padua Medical School, Padua, Italy fDivision of Cardiology, Peking University of People 's Hospital, Beijing, China gRutgers University, New Brunswick, NJ, United States hDepartment of Cardiology, Ege University School of Medicine, Izmir, Turkey iShiga University of Medical Sciences, Ohtsu, Shiga, Japan jResearch Unit of Internal Medicine, Medical Research Center, Oulu University Hospital, and University of Oulu, Oulu, Finland kDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, B eijing, China lDepartment of Cardiovascular Therapeutics, Okayama University Graduate School of Medicine, Okayama, Japan mHeart Institute, Asian Medical Center, and Department of Internal Medicine, University of Ulsan College of Medicine Seoul, Seoul, South Korea nBordeaux University Hospital, LIRYC Institute/INSERM 1045, Bordeaux, France oDepartment of Cardiovascular Medicine, Nippon Medical School, Tokyo, Japan pTel-Aviv Sourasky Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel qHeart Center, Department of Clinical and Experimental Cardiology, Academic Medical Center, University of Amsterdam, The Netherlands rJawhara Al-Brahim Centre of Excellence in Research of Hereditary Disorders, Jeddah, Saudi ArabiaContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2016.07.002 1880-4276/ &2016 Japanese Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/f0/88/main.PMC5063270.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).☆Endorsed by the Asia Paci ﬁc Heart Rhythm Society (APHRS), the European Heart Rhythm Association (EHRA), the Heart Rhythm Society (HRS), and the Latin American Society of Cardiac Pacing and Electrophysiology (Sociedad Latinoamericana de Estimulación Cardíaca y Electro ﬁsiología [SOLAECE]).",Non-OADS,/arxiv_data1/oa_pdf/f0/88/main.PMC5063270.pdf
The study appears at the National Institutes of Health website (ClinicalTrials.gov) and can be acces- sed at http://clinicaltrials.gov/ct2/show/ NCT00789165?term_bru gada&rank_2 .,OADS,/arxiv_data1/oa_pdf/f0/88/main.PMC5063270.pdf
http://www.heartrhythmjournal.com/article/S1547-5271(16)30372-1/pdf .,Non-OADS,/arxiv_data1/oa_pdf/f0/88/main.PMC5063270.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/24/0a/main.PMC5063271.pdf
402Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2016.01.006 1880-4276/ &2016 Japanese Heart Rhythm Society.,Non-OADS,/arxiv_data1/oa_pdf/24/0a/main.PMC5063271.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nTel.,Non-OADS,/arxiv_data1/oa_pdf/24/0a/main.PMC5063271.pdf
"To avoid misunderstanding of the detected variants in the ARVC relatedgenes, a comparison of the detected mutations with data forethnically matched controls is needed, for example, the 1000genome study [50] and the ExAC Browser (http://exac.broad- institute.org/).",Non-OADS,/arxiv_data1/oa_pdf/24/0a/main.PMC5063271.pdf
"Pediatr Int 2015 http://dx.doi.org/10.1111/ped.12832 , in press.",OADS,/arxiv_data1/oa_pdf/24/0a/main.PMC5063271.pdf
"Europace 2015 http://dx.doi.org/10.1093/ europace/euv205 , in press.",Non-OADS,/arxiv_data1/oa_pdf/24/0a/main.PMC5063271.pdf
"Mark Estes III, MDl,4, Guilherme Fenelonm,3, Fermin C. Garcia, MDn,3, Maurizio Gasparini, MDo,1, David E. Haines, MD, FHRSp, Jeff S. Healey, MD, MSc, FRCPC, FHRSd, Jodie L. Hurtwitz, MDq,5, Roberto Keegan, MDr,3, Christof Kolb, MDs,1, Karl-Heinz Kuck, MD, FHRSt,1, Germanas Marinskis, MD, FESCu,1, Martino Martinelli, MD, PhDv, Mark McGuire, MBBS, PhDw,2, Luis G. Molina, MD, DScx,3, Ken Okumura, MD, PhDy,2, Alessandro Proclemer, MDz,1, Andrea M. Russo, MD, FHRSaa, Jagmeet P. Singh, MD, DPhil, FHRSab, Charles D. Swerdlow, MD, FHRSac, Wee Siong Teo, MBBS, FHRSad,2, William Uribe, MD, FHRSae,3, Sami Viskin, MDaf,1, Chun-Chieh Wang, MDag,2, Shu Zhang, MDah,2 aCleveland Clinic, Cleveland, OH, United States bCentre Hospitalier Universitaire Trousseau, Tours, France cWaikato Hospital, Hamilton, New Zealand dDepartment of Medicine, Cardiology Division, McMaster University-Population Health Research Institute, Hamilton, Canada eDuke University Medical Center, Durham, NC, United States fGrupo HM Hospitales, Universidad CEU San Pablo, Madrid, Spain gCentro Privado De Cardiologia, Tucuman, Argentina hJohns Hopkins University, Baltimore, MD, United States iServicio de Arritmias, Instituto de Cardiologia Infantil, Montevideo, Uruguay jClinica y Maternidad Suizo Argentina kVirginia Commonwealth University Medical Center, Richmond, VA, United States lNew England Medical Center, Boston, MA, United States mFederal University of Sao Paulo, Sao Paulo, Brazil nHospital of the University of Pennsylvania, Philadelphia, PA, United States oHumanitas Research Hospital, Milan, Italy pWilliam Beaumont Hospital Division of Cardiology, Royal Oak, MI, United States qNorth Texas Heart Center, Dallas, TX, United States rHospital Privado del Sur, Bahia Blanca, Argentina sDeutsches Herzzentrum Munchen, Munich, Germany tAllgemeines Krankenhaus St. Georg, Hamburg, Germany uVilnius University, Clinic of Cardiac and Vascular Diseases, Lithuania vInstituto do Coraçao, Universidade de Sao Paulo, Sao Paulo, Brazil wRoyal Prince Alfred Hospital, Sydney, Australia xMexico ’s National University, Mexico ’s General Hospital, Mexico City, Mexico yHirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan zAzienda Ospedaliero Universitaria S. Maria della Misericordia –Udine, Udine, Italy aaCooper University Hospital, Camden, NJ, United States abMassachusetts General Hospital, Harvard Medical School, Boston, MA, United StatesContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2016.08.001 1880-4276/ &2016 Japanese Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/61/9e/main.PMC5063272.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).DOI of original article: http://dx.doi.org/10.1016/j.joa.2015.12.001Journal of Arrhythmia 32 (2016) 441 –442,Non-OADS,/arxiv_data1/oa_pdf/61/9e/main.PMC5063272.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8d/f5/main.PMC5063273.pdf
"Prevalence of atrial arrhythmias The prevalence of atrial arrhythmias in inherited arrhythmo- genic disorders varies depending on the type of arrhythmia, mode of detection (12-lead electrocardiogram [ECG], Holter monitoring, or implantable cardioverter de ﬁbrillator [ICD] monitoring), and clinical presentation of inherited arrhythmogenic disorders, whichContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2015.11.007 1880-4276/ &2015 Japanese Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/8d/f5/main.PMC5063273.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nTel.,Non-OADS,/arxiv_data1/oa_pdf/8d/f5/main.PMC5063273.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fd/30/ppa-10-2063.PMC5063286.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2063–2072Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2063Study Protocolopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/PPA.S10778 5 Effectiveness of the Health complex Model in  Iranian primary health care reform: the study  protocol Jafar Sadegh tabrizi1 Mostafa Farahbakhsh2 Homayoun Sadeghi- Bazargani3,4 roya Hassanzadeh5 Akram Zakeri6 leili Abedi7 1tabriz Health Services Management  research center, tabriz university  of Medical Sciences, tabriz, Iran;   2research center of Psychiatry &  Behavioral Sciences, tabriz university  of Medical Sciences, tabriz, Iran;   3road traffic Injury research  center, department of Statistics &  Epidemiology, tabriz university of  Medical Sciences, tabriz, Iran; 4WHo   collaborating center on community  Safety Promotion, department of  Public Health Sciences, Karolinska  Institute, Stockholm, Sweden;   5department of Health Services  Management, Iranian center of  Excellence in Health Management,   School of Management and Medical  Informatics, 6National Public  Health Management center, tabriz  university of Medical Sciences,   tabriz, 7department of Statistics  and Epidemiology, Faculty of Health,   Kerman university of Medical  Sciences, Kerman, IranBackground:  Iranian traditional primary health care (PHC) system, although proven to be  successful in some areas in rural populations, suffers major pitfalls in providing PHC services  in urban areas especially the slum urban areas.",Non-OADS,/arxiv_data1/oa_pdf/fd/30/ppa-10-2063.PMC5063286.pdf
"Because of limited resources, high costs,  and low quality of services, politicians and health policy makers are forced to make  changes or replace a new system to meet the people’s needs and improve the satisfac - tion of service providers.3 In 1975, in cooperation with the World Health Organization (WHO), Iran started the  health worker training project in West Azerbaijan Province, and in 1977, the govern - ment adopted PHC as the health service development policy,4,5 such that primary health correspondence: Homayoun Sadeghi- Bazargani Road Traffic Injury Research Center,  department of Statistics & Epidemiology,  tabriz university of Medical Sciences,  Sadeghi Street, Golshahr Square, El Goli  Avenue, tabriz 5167846311, Iran tel +98 9144027218 Email homayoun.sadeghi@gmail.co m Journal name: Patient Preference and Adherence Article Designation: Study Protocol Y ear: 2016 Volume: 10 Running head verso: Tabrizi et al Running head recto: Iranian health care reform: research protocol DOI: http://dx.doi.org/10.2147/PPA.S107785",Non-OADS,/arxiv_data1/oa_pdf/fd/30/ppa-10-2063.PMC5063286.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/fd/30/ppa-10-2063.PMC5063286.pdf
Available from: http://www.who.int/violence_injury_prevention/ road_safety_status/2013/en /.,Non-OADS,/arxiv_data1/oa_pdf/fd/30/ppa-10-2063.PMC5063286.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7e/81/ppa-10-1957.PMC5063289.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1957–1966Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1957OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11738 8 Patient-centeredness and quality management in  Dutch diabetes care organizations after a 1-year  intervention Marjo Je campmans- Kuijpers1 lidwien c lemmens2 caroline A Baan2 guy ehM rutten1 1Julius centre for health sciences  and Primary care, University Medical  centre Utrecht, Utrecht, 2centre  for nutrition, Prevention and health  services, national institute of  Public health and the environment,   Bilthoven, Utrecht, the netherlandsBackground:  More focus on patient-centeredness in care for patients with type 2 diabetes  requests increasing attention to diabetes quality management processes on patient-centeredness  by managers in primary care groups and outpatient clinics.",Non-OADS,/arxiv_data1/oa_pdf/7e/81/ppa-10-1957.PMC5063289.pdf
"Keywords:  diabetes care, patient-centeredness, patient centered, quality management, patient  involvement, self-management support Introduction Over the past 25 years, care for patients with type 2 diabetes has changed from acute  reactive services to regular integrated chronic care management, in recognition of  the changing needs of patients.1 To improve their coping with the disease, a pro-active  attitude of the patients is necessary.2 Moreover, various health care providers are correspondence: Marjo Je campmans- Kuijpers Julius centre for health sciences and  Primary care, University Medical centre  Utrecht, heidelberglaan 100,   3584 cX Utrecht, the netherlands Tel +316 232 959 34 email m.j.e.campmans-kuijpers@ umcutrecht.n l Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Campmans-Kuijpers et al Running head recto: Quality management and patient-centeredness in diabetes care DOI: http://dx.doi.org/10.2147/PPA.S117388",Non-OADS,/arxiv_data1/oa_pdf/7e/81/ppa-10-1957.PMC5063289.pdf
"According to the Dutch law on medical scien - tific research on people, no ethical approval was needed for  this study, because it does not meet the WMO (Wet Medisch  wetenschappelijk Onderzoek) criteria for medical human  scientific research ( https://www.overheid.n l).",Non-OADS,/arxiv_data1/oa_pdf/7e/81/ppa-10-1957.PMC5063289.pdf
Available from: http://www.zelfmanagement.com/zorgverlen - ers/tools-voor-de-zorgverlener /.,Non-OADS,/arxiv_data1/oa_pdf/7e/81/ppa-10-1957.PMC5063289.pdf
Available from:  http://www.meetinstrumentenzorg.nl/Portals/0/bestanden/352_3_N.,Non-OADS,/arxiv_data1/oa_pdf/7e/81/ppa-10-1957.PMC5063289.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/7e/81/ppa-10-1957.PMC5063289.pdf
"Available from: http://www.actieprogrammadia - betes.nl/home/275-multidisciplinaire-richtlijn-over-zelfcontrole-van- bloedglucosewaarde n. Accessed July 15, 2016.",Non-OADS,/arxiv_data1/oa_pdf/7e/81/ppa-10-1957.PMC5063289.pdf
"Available from: http://www.actieprogrammadia - betes.nl/images/stories/downloads/06815_owja_izd-dv.pd f. Accessed  July 15, 2016.",Non-OADS,/arxiv_data1/oa_pdf/7e/81/ppa-10-1957.PMC5063289.pdf
Available  from: http://www.diep.info /.,Non-OADS,/arxiv_data1/oa_pdf/7e/81/ppa-10-1957.PMC5063289.pdf
Available from: https://www.dvn.nl/dvn/ actueel/nieuws/1131 /.,Non-OADS,/arxiv_data1/oa_pdf/7e/81/ppa-10-1957.PMC5063289.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4b/d6/ppa-10-2083.PMC5063292.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2083–2090Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2083Methodologyopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/PPA.S11239 8 Which kind of psychometrics is adequate for  patient satisfaction questionnaires?",Non-OADS,/arxiv_data1/oa_pdf/4b/d6/ppa-10-2083.PMC5063292.pdf
"Like all other measurement instruments, patient satisfaction questionnaires  should be reliable, that is, they should be associated with as little measurement error Correspondence: Uwe Konerding trimberg Research Academy, University  of Bamberg, An der Weberei 5,   d-96045 Bamberg, germany tel +49 951 986 3341 Fax +49 951 986 3390 email uwe.konerding@uni-bamberg.d e Journal name: Patient Preference and Adherence Article Designation: Methodology Y ear: 2016 Volume: 10 Running head verso: Konerding Running head recto: Patient satisfaction DOI: http://dx.doi.org/10.2147/PPA.S112398",Non-OADS,/arxiv_data1/oa_pdf/4b/d6/ppa-10-2083.PMC5063292.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/4b/d6/ppa-10-2083.PMC5063292.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3b/0f/ppa-10-2051.PMC5063293.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2051–2061Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2051OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11172 5 satisfaction with control of systemic lupus  erythematosus and lupus nephritis: physician  and patient perspectives neelufar Mozaffarian1 steve lobosco2 Peng lu3 Adam roughley2 gabriela Alperovich4 1clinical Development, AbbVie inc.,   north chicago, UsA; 2Adelphi real  World ltd., Macclesfield, UK;   3clinical Development, AbbVie inc.,   Worcester, MA, UsA; 4global Medical  Affairs immunology, AbbVie inc.,   Madrid,  spainPurpose:  Patient satisfaction with disease control of systemic lupus erythematosus (SLE) is  an important component of medical management.",Non-OADS,/arxiv_data1/oa_pdf/3b/0f/ppa-10-2051.PMC5063293.pdf
"The prevalence of SLE has been reported to be 53 cases per 100,000  persons in the US,1 although this may be an underestimate due to underdiagnosis of  the disease.2,3 At least one-half of all patients with SLE may experience lupus nephritis  (LN) at some time during their disease course, although this number may be even  higher because autopsy results show some renal involvement in most patients with  SLE.4 LN is a poor prognostic factor and may result in renal dysfunction and increased  morbidity and mortality.correspondence: steve lobosco Adelphi real World ltd., Adelphi Mill,  grimshaw lane, sK10 5JB Bollington,  cheshire, UK Tel +44 1625 577 233 Fax +44 1625 575 853 email steve.lobosco@adelphigroup.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Mozaffarian et al Running head recto: Treatment satisfaction in SLE and lupus nephritis DOI: http://dx.doi.org/10.2147/PPA.S111725",Non-OADS,/arxiv_data1/oa_pdf/3b/0f/ppa-10-2051.PMC5063293.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/3b/0f/ppa-10-2051.PMC5063293.pdf
These γc-cytokines also maintain the reservoir through homeostatic  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f3/9d/nihms820454.PMC5063304.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures and five figures and can be found with this article online at  http://dx.doi.org/10.1016/j.celrep.2016.02.022 .,OADS,/arxiv_data1/oa_pdf/f3/9d/nihms820454.PMC5063304.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).Photoacoustics  4  (2016)  81–82 Contents  lists  available  at  ScienceDirect Photoacoustics journal  homepage:  www.elsevier.com/locate/pacs,Non-OADS,/arxiv_data1/oa_pdf/90/29/main.PMC5063352.pdf
"Glickman,  A.A. Oraevsky,  All-Optical  Optoacoustic  Microscopy  Based  on  Probe  Beam  Deﬂection Technique,  Photoacoustics  4  (2016)  91–101,  doi:http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/90/29/main.PMC5063352.pdf
"[7]  M.  Seeger,  A.  Karlas,  D.  Soliman,  J.  Pelisek,  V.  Ntziachristos,  Multimodal optoacoustic  and  multiphoton  microscopy  of  human  carotid  atheroma, Photoacoustics  4  (2016)  102 –111,  doi:http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/90/29/main.PMC5063352.pdf
"[8]  W.  Liu,  H.F.  Zhang,  Photoacoustic  imaging  of  the  eye:  a  mini  review, Photoacoustics  4  (2016)  112 –123,  doi:http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/90/29/main.PMC5063352.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Photoacoustics  4  (2016)  102 –111 Contents  lists  available  at  ScienceDirect Photoacoustics journal  homepage:  www.else  vie  r.com/locate  /pacs,Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"References [1]  WHO,  2014,  WHO,  The  top  10  causes  of  death,  Fact  Sheet  N/C14310  (Updated  May 2014)  (2014)  http://www.who.int/mediacentre/factsheets/fs310/en/ .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"12  (2003)  237 –248, doi:http://dx.doi.org/10.1016/S1054-8807(03)00072-3 .",OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"1–2,  doi:http://dx.doi.org/10.1017/ CBO9780511544941.002 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"A  report  from  the  Committee  on  Vascular  Lesions  of  the Council  on  Arteriosclerosis,  American  Heart  Association,  Circulation  89  (1994) 2462 –2478,  doi:http://dx.doi.org/10.1161/01.cir.89.5.2462 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"41  (1999)  323 –333,  doi: http://dx.doi.org/10.1016/S0008-6363(98)00322-8 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"Dinsmore,  V.  Fuster,  S.  Glagov,  W.  Insull,  et  al.,  A deﬁnition  of  advanced  types  of  atherosclerotic  lesions  and  a  histological classi ﬁcation  of  atherosclerosis:  a  report  from  the  Committee  on  Vascular Lesions  of  the  Council  on  Arteriosclerosis,  American  Heart  Association, Circulation  92  (1995)  1355 –1374,  doi:http://dx.doi.org/10.1161/01.",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"Relation  of  characteristics  to  degree of  stenosis  in  human  coronary  arteries,  Circulation  94  (1996)  928 –931,  doi: http://dx.doi.org/10.1161/01.CIR.94.5.928 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"Shah,  V.  Fuster,  Coronary  plaque  disruption,  Circulation  92  (1995) 657 –671,  doi:http://dx.doi.org/10.1161/01.CIR.92.3.657 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"Born,  Inﬂuence  of  plaque  conﬁguration  and stress  distribution  on  ﬁssuring  of  coronary  atherosclerotic  plaques,  Lancet  334 (1989)  941 –944,  doi:http://dx.doi.org/10.1016/S0140-6736(89)90953-7 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"19 (1999)  54–58,  doi:http://dx.doi.org/10.1161/01.ATV.19.1.54 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"24  (2009)  439 –445,  doi:http://dx.doi.org/10.1007/ s10103-007-0535-x .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"Krane,  et  al.,  Matrix metalloproteinase-13/collagenase-3  deletion  promotes  collagen accumulation  and  organization  in  mouse  atherosclerotic  plaques,  Circulation 112  (2005)  2708 –2715,  doi:http://dx.doi.org/10.1161/ CIRCULATIONAHA.105.562041 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"91  (2003)  4B–8B,  doi:http://dx.doi.org/10.1016/S0002-9149(02) 03267-8 .M.",OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"16 (2011)  103 –108,  doi:http://dx.doi.org/10.1177/1358863X11402249 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"114  (2014)  1852 –1866,  doi:http://dx.doi.org/10.1161/ CIRCRESAHA.114.302721 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"25  (2005)  2054 –2061,  doi:http://dx.doi.org/10.1161/01.",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"38  (2003) 1241 –1247,  doi:http://dx.doi.org/10.1016/S0741-5214(03)00910-8 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"41  (2004)  54–63,  doi: http://dx.doi.org/10.1159/000076246 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"196  (2002)  887 –896,  doi:http://dx.doi.org/10.1084/jem.20012044 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"197  (2002)  41–49,  doi:http://dx.doi.org/10.1084/ jem.20020945 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"12  (2007)  054008,  doi:http://dx.doi.org/10.1117/ 1.2800337 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"17  (2011)  1680 –1684,  doi:http://dx.doi.org/10.1038/nm.2555 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"57  (2011)  2516 –2526,  doi:http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"Opt.15  (2010) 011107,  doi:http://dx.doi.org/10.1117/1.3280282 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"Folco,  et  al., Indocyanine  green  enables  near-infrared  ﬂuorescence  imaging  of  lipid-rich, Inﬂamed  Atherosclerotic  Plaques  3  (2011)  1–20,  doi:http://dx.doi.org/10.1126/ scitranslmed.3001577.Indocyanine .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"Microdevices  12  (2009)  1–20,  doi:http://dx.doi.org/ 10.1117/1.2795437.Label-free .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"12  (2014) 044005,  doi:http://dx.doi.org/10.1117/1.2772652 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"Express  1  (2010)  59–73,  doi:http://dx.doi.org/10.1364/ BOE.1.000059 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"57  (2011)  2516 –2526,  doi:http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"281 (2008)  1813 –1822,  doi:http://dx.doi.org/10.1016/j.optcom.2007.07.067 .",OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"29  (2009)  1342 –1348,  doi: http://dx.doi.org/10.1161/ATVBAHA.109.189316 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"Ruppert,  et  al., Optoacoustic  detection  of  intra-  and  extracranial  hematomas  in  rats  after  blast injury,  Photoacoustics  2  (2014)  75–80,  doi:http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"Express  16  (2008)  3362 –3367,  doi:http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"Express  18  (2010)  4889 –4897,  doi: http://dx.doi.org/10.1364/OE.18.004889 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"(2015)  1–9,  doi:http://dx.doi.org/10.1038/srep12902 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"19  (2014)  36002,  doi: http://dx.doi.org/10.1117/1.JBO.19.3.036002 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"7  (1998)  27–41,  doi: http://dx.doi.org/10.1109/83.650848 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"(2012)  1–9,  doi:http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"76  (2012)  1274 –1282,  doi:http://dx.doi.org/10.1253/circj.CJ- 11-0768 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"99  (2002)  11014 –11019,  doi:http://dx.doi.org/ 10.1073/pnas.172368799 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"Express  20  (2012)  9551,  doi:http://dx.doi.org/10.1364/oe.20.009551 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"7  (2012)  654 –669,  doi:http://dx.doi.org/10.1038/nprot.2012.009 \rnprot.2012.009  pii.",OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"(2016)  245 –255,  doi:http://dx.doi.org/ 10.1242/jcs.152272 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"110  (2010)  2783 –2794,  doi: http://dx.doi.org/10.1021/cr9002566 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"Interface  3  (2006) 15–35,  doi:http://dx.doi.org/10.1098/rsif.2005.0073 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"41  (1999)  376 –384,  doi:http://dx.doi.org/10.1016/S0008-6363 (98)00321-6 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"[55]  G.  Pasterkamp,  R.  Virmani,  The  erythrocyte:  a  new  player  in  atheromatous  core formation,  Heart  88  (2002)  115 –116,  doi:http://dx.doi.org/10.1136/ heart.88.2.115 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"Imaging  3  (2010)  41–44,  doi:http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
"Express  20  (2012)  25044,  doi:http://dx.doi.org/10.1364/ oe.20.025044 .",Non-OADS,/arxiv_data1/oa_pdf/fb/5f/main.PMC5063356.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Photoacoustics  4  (2016)  91–101 Contents  lists  available  at  ScienceDirect Photoacoustics journal  homepage:  www.elsevier.com/locate/pacs,Non-OADS,/arxiv_data1/oa_pdf/0c/cc/main.PMC5063357.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ae/80/ppa-10-2073.PMC5063358.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2073–2082Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2073OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11472 0 expectation and satisfaction of hiV/AiDs  patients toward the pharmaceutical care  provided at gondar University referral hospital,  northwestern ethiopia: a cross-sectional study Tamrat Befekadu Abebe1 Daniel Asfaw erku2 Begashaw Melaku  gebresillassie1 Kaleab Taye haile3 Abebe Basazn Mekuria4 1Department of clinical Pharmacy,   2Department of Pharmaceutical  chemistry, 3Department of  Pharmaceutics, 4Department  of Pharmacology, school of  Pharmacy, University of gondar,   gondar, ethiopiaPurpose:  Measurements of patient satisfaction help to assess the performance of health service  provision and predict treatment adherence and outcomes.",Non-OADS,/arxiv_data1/oa_pdf/ae/80/ppa-10-2073.PMC5063358.pdf
"Even though HIV/acquired immunodeficiency syndrome (AIDS) remains a  worldwide pandemic, Ethiopia is one of the highly affected Sub-Saharan countries.2,3  In 2014, the national HIV/AIDS prevalence in Ethiopia was 1.14%, and the estimated correspondence: Tamrat Befekadu  Abebe Department of clinical Pharmacy, school  of Pharmacy, University of gondar, lideta  Kebele 16, PO Box 196, gondar, ethiopia Fax +251 58 114 1240 email befekadutamrat@gmail.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Abebe et al Running head recto: Expectation and satisfaction of patients toward pharmaceutical care DOI: http://dx.doi.org/10.2147/PPA.S114720",Non-OADS,/arxiv_data1/oa_pdf/ae/80/ppa-10-2073.PMC5063358.pdf
Available from: http://www.lenus.ie/ hse/handle/10147/43559?locale =ga.,Non-OADS,/arxiv_data1/oa_pdf/ae/80/ppa-10-2073.PMC5063358.pdf
"Available from:  http://www.etharc.or g. Accessed August 20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/ae/80/ppa-10-2073.PMC5063358.pdf
"Available  from: http://www.hst.org.za/sites/default/files/clientguide.pd f. Accessed  April 17, 2014.",Non-OADS,/arxiv_data1/oa_pdf/ae/80/ppa-10-2073.PMC5063358.pdf
"Available from: http://www.afro.who.int/ en/ethiopia/country-programmes/topics/4480-hivaids.htm l. Accessed  August 20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/ae/80/ppa-10-2073.PMC5063358.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/ae/80/ppa-10-2073.PMC5063358.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Photoacoustics  4  (2016)  112–123 Contents  lists  available  at  ScienceDirect Photoacoustics journal  homepage:  www.else  vie  r.com/locate  /pacs,Non-OADS,/arxiv_data1/oa_pdf/36/97/main.PMC5063360.pdf
Putative miR -218-regulated genes were  identified by searching the TargetScan database (http://www.targetscan.org/).,OADS,/arxiv_data1/oa_pdf/2d/f9/ijo-49-05-1870.PMC5063422.pdf
(http://www.fda.gov/) Accessed 22 Apr 2016.,Non-OADS,/arxiv_data1/oa_pdf/63/16/ijo-49-05-1773.PMC5063425.pdf
ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000400001Eosinophils in COPD: why should I care?,Non-OADS,/arxiv_data1/oa_pdf/13/a5/1806-3713-jbpneu-42-04-00237.PMC5063436.pdf
Curr Allergy Asthma Rep.  2015;15(3):509. http://dx.doi.org/10.1007/s11882-014-0509-6 3.,Non-OADS,/arxiv_data1/oa_pdf/13/a5/1806-3713-jbpneu-42-04-00237.PMC5063436.pdf
2015;135(1):63-72. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/13/a5/1806-3713-jbpneu-42-04-00237.PMC5063436.pdf
2015;3(6):435-42. http://dx.doi.org/10.1016/S2213-2600(15)00106-X 8.,OADS,/arxiv_data1/oa_pdf/13/a5/1806-3713-jbpneu-42-04-00237.PMC5063436.pdf
2015;191(4):391-401.  http://dx.doi.org/10.1164/rccm.201410-1935PP 238 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/13/a5/1806-3713-jbpneu-42-04-00237.PMC5063436.pdf
"ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000000161Conglomerate masses Edson Marchiori1,2, Bruno Hochhegger3,4, Gláucia Zanetti2,5 1.",Non-OADS,/arxiv_data1/oa_pdf/93/45/1806-3713-jbpneu-42-04-00239.PMC5063437.pdf
"ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000000225Test for trend: evaluating dose-response  effects in association studies Cecilia Maria Patino1,2, Juliana Carvalho Ferreira2,3 1.",Non-OADS,/arxiv_data1/oa_pdf/80/77/1806-3713-jbpneu-42-04-00240.PMC5063438.pdf
[Epub ahead of print] http://dx.doi.org/10.1016/j.jaci.2016.01.014 2.,Non-OADS,/arxiv_data1/oa_pdf/80/77/1806-3713-jbpneu-42-04-00240.PMC5063438.pdf
http://dx.doi.org/10.2105/ AJPH.2004.059204 3.,Non-OADS,/arxiv_data1/oa_pdf/80/77/1806-3713-jbpneu-42-04-00240.PMC5063438.pdf
"ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562015000000122ABSTRACT Objective:  To determine whether COPD severity correlates with sputum cell counts,  atopy, and asthma.",Non-OADS,/arxiv_data1/oa_pdf/c1/84/1806-3713-jbpneu-42-04-00241.PMC5063439.pdf
2000;356(9240):1480-5. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c1/84/1806-3713-jbpneu-42-04-00241.PMC5063439.pdf
2005;26(5):835-45. http://dx.doi.org/10.1183/09031936.05.0010890 4 5.,Non-OADS,/arxiv_data1/oa_pdf/c1/84/1806-3713-jbpneu-42-04-00241.PMC5063439.pdf
1996;153(2):530-4. http://dx.doi.org/10.1164/ ajrccm.153.2.8564092 6.,Non-OADS,/arxiv_data1/oa_pdf/c1/84/1806-3713-jbpneu-42-04-00241.PMC5063439.pdf
2000;162(4 Pt 1):1355-60.  http://dx.doi.org/10.1164/ajrccm.162.4.9910097 7.,Non-OADS,/arxiv_data1/oa_pdf/c1/84/1806-3713-jbpneu-42-04-00241.PMC5063439.pdf
2012;185(10):1065-72. http://dx.doi.org/10.1164/rccm.201110- 1792OC 8.,Non-OADS,/arxiv_data1/oa_pdf/c1/84/1806-3713-jbpneu-42-04-00241.PMC5063439.pdf
2006;61(2):115-21. http://dx.doi.org/10.1136/thx.2005.040519 9.,Non-OADS,/arxiv_data1/oa_pdf/c1/84/1806-3713-jbpneu-42-04-00241.PMC5063439.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c1/84/1806-3713-jbpneu-42-04-00241.PMC5063439.pdf
"Hamilton, Canada:  Decker 2011:[about 18 p.] Available from: http://www.medicinanet.",Non-OADS,/arxiv_data1/oa_pdf/c1/84/1806-3713-jbpneu-42-04-00241.PMC5063439.pdf
1979;34(4):209-12. http://dx.doi.org/10.1111/j.1398-9995.1979.,Non-OADS,/arxiv_data1/oa_pdf/c1/84/1806-3713-jbpneu-42-04-00241.PMC5063439.pdf
1997;52(6):498-501. http://dx.doi.org/10.1136/thx.52.6.498 16.,Non-OADS,/arxiv_data1/oa_pdf/c1/84/1806-3713-jbpneu-42-04-00241.PMC5063439.pdf
http://dx.doi.org/10.1378/chest.121.5_suppl.121S 18.,Non-OADS,/arxiv_data1/oa_pdf/c1/84/1806-3713-jbpneu-42-04-00241.PMC5063439.pdf
2000;162(6):2152-8. http://dx.doi.org/10.1164/ajrccm.162.6.2003112 20.,Non-OADS,/arxiv_data1/oa_pdf/c1/84/1806-3713-jbpneu-42-04-00241.PMC5063439.pdf
2011;56(2): 298- 304. http://dx.doi.org/10.1016/j.cyto.2011.07.010 22.,OADS,/arxiv_data1/oa_pdf/c1/84/1806-3713-jbpneu-42-04-00241.PMC5063439.pdf
http://dx.doi.org/10.1378/chest.121.5_suppl.160S 24.,Non-OADS,/arxiv_data1/oa_pdf/c1/84/1806-3713-jbpneu-42-04-00241.PMC5063439.pdf
2006;174(1):6-14.  http://dx.doi.org/10.1164/rccm.200510-1659PP 25.,Non-OADS,/arxiv_data1/oa_pdf/c1/84/1806-3713-jbpneu-42-04-00241.PMC5063439.pdf
1999;115(3):697-702. http://dx.doi.org/10.1378/chest.115.3.697 246 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/c1/84/1806-3713-jbpneu-42-04-00241.PMC5063439.pdf
2007;12(3):317- 9. http://dx.doi.org/10.1111/j.1440-1843.2007.01082.x 29.,Non-OADS,/arxiv_data1/oa_pdf/c1/84/1806-3713-jbpneu-42-04-00241.PMC5063439.pdf
2013;39(3):296-305. http://dx.doi.org/10.1590/S1806- 37132013000300006 30.,Non-OADS,/arxiv_data1/oa_pdf/c1/84/1806-3713-jbpneu-42-04-00241.PMC5063439.pdf
1996;9(10):1989-94. http://dx.doi.org/10.1183/0903193 6.96.09101989 31.,Non-OADS,/arxiv_data1/oa_pdf/c1/84/1806-3713-jbpneu-42-04-00241.PMC5063439.pdf
1999;160(6):1869-74. http://dx.doi.org/10.1164/ ajrccm.160.6.9811041 247 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/c1/84/1806-3713-jbpneu-42-04-00241.PMC5063439.pdf
ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562015000000079J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/40/99/1806-3713-jbpneu-42-04-00248.PMC5063440.pdf
2000;117(4):1049-54. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/40/99/1806-3713-jbpneu-42-04-00248.PMC5063440.pdf
2014;271(1):  291-300. http://dx.doi.org/10.1148/radiol.13131265 6.,Non-OADS,/arxiv_data1/oa_pdf/40/99/1806-3713-jbpneu-42-04-00248.PMC5063440.pdf
2008;133(1):264-70. http://dx.doi.org/10.1378/chest.06-1735 7.,Non-OADS,/arxiv_data1/oa_pdf/40/99/1806-3713-jbpneu-42-04-00248.PMC5063440.pdf
2011;37(4):902- 10. http://dx.doi.org/10.1183/09031936.00075310 8.,Non-OADS,/arxiv_data1/oa_pdf/40/99/1806-3713-jbpneu-42-04-00248.PMC5063440.pdf
2004;126(3):959-65. http://dx.doi.org/10.1378/chest.126.3.959 9.,Non-OADS,/arxiv_data1/oa_pdf/40/99/1806-3713-jbpneu-42-04-00248.PMC5063440.pdf
2010;31(1):49-63. http://dx.doi.org/10.1016/j.ccm.2009.08.003 11.,OADS,/arxiv_data1/oa_pdf/40/99/1806-3713-jbpneu-42-04-00248.PMC5063440.pdf
2014;50(5):166-71. http://dx.doi.org/10.1016/j.arbr.2014.03.014 12.,OADS,/arxiv_data1/oa_pdf/40/99/1806-3713-jbpneu-42-04-00248.PMC5063440.pdf
2013;39(2):226-37.http://dx.doi.org/10.1590/S1806- 37132013000200015 13.,Non-OADS,/arxiv_data1/oa_pdf/40/99/1806-3713-jbpneu-42-04-00248.PMC5063440.pdf
2011;105(11):1704-11.  http://dx.doi.org/10.1016/j.rmed.2011.08.008 14.,OADS,/arxiv_data1/oa_pdf/40/99/1806-3713-jbpneu-42-04-00248.PMC5063440.pdf
2002;20(4):972-4. http://dx.doi.org/ 10.1183/09031936.02.00032001 15.,Non-OADS,/arxiv_data1/oa_pdf/40/99/1806-3713-jbpneu-42-04-00248.PMC5063440.pdf
2005;128(5):3551-7.  http://dx.doi.org/10.1378/chest.128.5.3551 16.,Non-OADS,/arxiv_data1/oa_pdf/40/99/1806-3713-jbpneu-42-04-00248.PMC5063440.pdf
2011;37(4):902- 10. http://dx.doi.org/10.1183/09031936.00075310 17.,Non-OADS,/arxiv_data1/oa_pdf/40/99/1806-3713-jbpneu-42-04-00248.PMC5063440.pdf
2009;14(6):859-64. http://dx.doi.org/10.1111/j.1440- 1843.2009.01585.x 18.,Non-OADS,/arxiv_data1/oa_pdf/40/99/1806-3713-jbpneu-42-04-00248.PMC5063440.pdf
2006;129(1):147-50.  http://dx.doi.org/10.1378/chest.129.1.147 253 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/40/99/1806-3713-jbpneu-42-04-00248.PMC5063440.pdf
ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562015000000241ABSTRACT Objective:  To investigate the correlation between respiratory syncytial viral load and  length of hospitalization in infants with acute wheezing episodes.,Non-OADS,/arxiv_data1/oa_pdf/d9/3e/1806-3713-jbpneu-42-04-00261.PMC5063442.pdf
2002;39(7):649-58. http://dx.doi.org/10.1081/JAS- 120014930 3.,Non-OADS,/arxiv_data1/oa_pdf/d9/3e/1806-3713-jbpneu-42-04-00261.PMC5063442.pdf
"2011;87(4):307-13. http://dx.doi.org/10.2223/JPED.2100 5. da Silva ER, Pitrez MC, Arruda E, Mattiello R, Sarria EE, de Paula FE, et al.",OADS,/arxiv_data1/oa_pdf/d9/3e/1806-3713-jbpneu-42-04-00261.PMC5063442.pdf
2013;13:41. http://dx.doi.org/10.1186/1471- 2334-13-41 6.,Non-OADS,/arxiv_data1/oa_pdf/d9/3e/1806-3713-jbpneu-42-04-00261.PMC5063442.pdf
http://dx.doi.org/10.1097/INF.0b013e3181c2a212 7.,Non-OADS,/arxiv_data1/oa_pdf/d9/3e/1806-3713-jbpneu-42-04-00261.PMC5063442.pdf
2008;27(3):213-7. http://dx.doi.org/10.1097/INF.0b013e31815b4935 8.,Non-OADS,/arxiv_data1/oa_pdf/d9/3e/1806-3713-jbpneu-42-04-00261.PMC5063442.pdf
2009;98(1):123-6. http://dx.doi.org/10.1111/j.1651- 2227.2008.01023.x 9.,Non-OADS,/arxiv_data1/oa_pdf/d9/3e/1806-3713-jbpneu-42-04-00261.PMC5063442.pdf
2007;79(12):1951-8. http://dx.doi.org/10.1002/jmv.21026 11.,Non-OADS,/arxiv_data1/oa_pdf/d9/3e/1806-3713-jbpneu-42-04-00261.PMC5063442.pdf
2008;62(4):382-8.  http://dx.doi.org/10.1016/j.diagmicrobio.2008.08.00212.,OADS,/arxiv_data1/oa_pdf/d9/3e/1806-3713-jbpneu-42-04-00261.PMC5063442.pdf
2005;9(2):156-61. http://dx.doi.org/10.1590/S1413-86702005000200006 13.,Non-OADS,/arxiv_data1/oa_pdf/d9/3e/1806-3713-jbpneu-42-04-00261.PMC5063442.pdf
2012;6(1):71-7. http://dx.doi.org/10.1111/j.1750-2659.2011.00265.x 14.,Non-OADS,/arxiv_data1/oa_pdf/d9/3e/1806-3713-jbpneu-42-04-00261.PMC5063442.pdf
2008;80(4):716-23. http://dx.doi.org/10.1002/jmv.21108 15.,Non-OADS,/arxiv_data1/oa_pdf/d9/3e/1806-3713-jbpneu-42-04-00261.PMC5063442.pdf
2015;87(8):1276-84. http://dx.doi.org/10.1002/jmv.24111 17.,Non-OADS,/arxiv_data1/oa_pdf/d9/3e/1806-3713-jbpneu-42-04-00261.PMC5063442.pdf
2015;211(10):1550-9. http://dx.doi.org/10.1093/infdis/jiu658 265 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/d9/3e/1806-3713-jbpneu-42-04-00261.PMC5063442.pdf
"ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562015000000243ABSTRACT Objective:  To translate and perform a cross-cultural adaptation of the Snoring, Tiredness,  Observed apnea, high blood Pressure, Body mass index, Age, Neck circumference,  and Gender (STOP-Bang) questionnaire so that it can be used as a screening tool for  the diagnosis of obstructive sleep apnea in Brazil.",Non-OADS,/arxiv_data1/oa_pdf/96/69/1806-3713-jbpneu-42-04-00266.PMC5063443.pdf
http://dx.doi.org/10.4172/2325-9639.1000121 2.,Non-OADS,/arxiv_data1/oa_pdf/96/69/1806-3713-jbpneu-42-04-00266.PMC5063443.pdf
2012;108(5):768-75. http://dx.doi.org/10.1093/ bja/aes022 3.,Non-OADS,/arxiv_data1/oa_pdf/96/69/1806-3713-jbpneu-42-04-00266.PMC5063443.pdf
1994; 150(5 Pt 1):1279-85. http://dx.doi.org/10.1164/ ajrccm.150.5.7952553 8.,Non-OADS,/arxiv_data1/oa_pdf/96/69/1806-3713-jbpneu-42-04-00266.PMC5063443.pdf
1994;150(3):735-41.  http://dx.doi.org/10.1164/ajrccm.150.3.8087345 9.,Non-OADS,/arxiv_data1/oa_pdf/96/69/1806-3713-jbpneu-42-04-00266.PMC5063443.pdf
1991;115(5):356-9. http://dx.doi.org/10.7326/0003-4819-115-5-356 11.,Non-OADS,/arxiv_data1/oa_pdf/96/69/1806-3713-jbpneu-42-04-00266.PMC5063443.pdf
2010;57(5):423-38. http://dx.doi.org/10.1007/s12630-010-9280-x 12.,Non-OADS,/arxiv_data1/oa_pdf/96/69/1806-3713-jbpneu-42-04-00266.PMC5063443.pdf
2015;21(2):61-8. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/96/69/1806-3713-jbpneu-42-04-00266.PMC5063443.pdf
"Curr Opin Anaesthesiol, 2009;22(3):405- 11. http://dx.doi.org/10.1097/ACO.0b013e32832a96e2 14.",Non-OADS,/arxiv_data1/oa_pdf/96/69/1806-3713-jbpneu-42-04-00266.PMC5063443.pdf
2008;108(5):812-21. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/96/69/1806-3713-jbpneu-42-04-00266.PMC5063443.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/96/69/1806-3713-jbpneu-42-04-00266.PMC5063443.pdf
2010;136(10):1020-4. http://dx.doi.org/10.1001/ archoto.2010.1020 17.,Non-OADS,/arxiv_data1/oa_pdf/96/69/1806-3713-jbpneu-42-04-00266.PMC5063443.pdf
2005;8(2):94-104. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/96/69/1806-3713-jbpneu-42-04-00266.PMC5063443.pdf
2000;25(24):3186-91. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/96/69/1806-3713-jbpneu-42-04-00266.PMC5063443.pdf
2014;102(4):364-73. http://dx.doi.org/10.5935/abc.20140032 24.,Non-OADS,/arxiv_data1/oa_pdf/96/69/1806-3713-jbpneu-42-04-00266.PMC5063443.pdf
2005;14(7):1791- 2. http://dx.doi.org/10.1007/s11136-005-5367-1 27.,Non-OADS,/arxiv_data1/oa_pdf/96/69/1806-3713-jbpneu-42-04-00266.PMC5063443.pdf
2014;40(3):213-21. http://dx.doi.org/10.1590/S1806- 37132014000300003 28.,Non-OADS,/arxiv_data1/oa_pdf/96/69/1806-3713-jbpneu-42-04-00266.PMC5063443.pdf
2015;24(8):2025-30. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/96/69/1806-3713-jbpneu-42-04-00266.PMC5063443.pdf
"ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562015000000290ABSTRACT Objective:  T o  e v a l u a t e  t h e  i n fl u e n c e  o f  c h r o n i c  h e a r t  f a i l u r e  ( C H F )  o n  r e s t i n g  l u n g   volumes in patients with COPD, i.e., inspiratory fraction—inspiratory capacity (IC)/TLC— and relative inspiratory reserve—[1 − (end-inspiratory lung volume/TLC)].",Non-OADS,/arxiv_data1/oa_pdf/95/34/1806-3713-jbpneu-42-04-00273.PMC5063444.pdf
2014;35(1):51-69. http://dx.doi.org/10.1016/j.ccm.2013.09.008 3.,OADS,/arxiv_data1/oa_pdf/95/34/1806-3713-jbpneu-42-04-00273.PMC5063444.pdf
2005;171(6):591-7. http://dx.doi.org/10.1164/ rccm.200407-867OC 4.,Non-OADS,/arxiv_data1/oa_pdf/95/34/1806-3713-jbpneu-42-04-00273.PMC5063444.pdf
1998;158(5 Pt  1):1557-65. http://dx.doi.org/10.1164/ajrccm.158.5.9804004 6.,Non-OADS,/arxiv_data1/oa_pdf/95/34/1806-3713-jbpneu-42-04-00273.PMC5063444.pdf
2006;3(2):180-4. http://dx.doi.org/10.1513/pats.200508-093DO 7.,Non-OADS,/arxiv_data1/oa_pdf/95/34/1806-3713-jbpneu-42-04-00273.PMC5063444.pdf
2006;8(7):706-11. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/95/34/1806-3713-jbpneu-42-04-00273.PMC5063444.pdf
Curr Heart  Fail Rep. 2014;11(3):337-46. http://dx.doi.org/10.1007/s11897-014- 0212-x 9.,Non-OADS,/arxiv_data1/oa_pdf/95/34/1806-3713-jbpneu-42-04-00273.PMC5063444.pdf
2014;16(12):1273-82. http://dx.doi.org/10.1002/ejhf.183 10.,Non-OADS,/arxiv_data1/oa_pdf/95/34/1806-3713-jbpneu-42-04-00273.PMC5063444.pdf
2012;2012:952741. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/95/34/1806-3713-jbpneu-42-04-00273.PMC5063444.pdf
2015;189:134-40.  http://dx.doi.org/10.1016/j.ijcard.2015.03.422 13.,OADS,/arxiv_data1/oa_pdf/95/34/1806-3713-jbpneu-42-04-00273.PMC5063444.pdf
1994;44(1):1-8. http://dx.doi.org/10.1016/0167- 5273(94)90060-4 14.,Non-OADS,/arxiv_data1/oa_pdf/95/34/1806-3713-jbpneu-42-04-00273.PMC5063444.pdf
1998;92(12):1321-5. http://dx.doi.org/10.1016/ S0954-6111(98)90136-6 15.,Non-OADS,/arxiv_data1/oa_pdf/95/34/1806-3713-jbpneu-42-04-00273.PMC5063444.pdf
2010;74(3):416-21. http://dx.doi.org/10.1016/j.mehy.2009.09.030 16.,OADS,/arxiv_data1/oa_pdf/95/34/1806-3713-jbpneu-42-04-00273.PMC5063444.pdf
2013;7:35-43. http://dx.doi.org/10.4137/ ccrpm.s12525 17.,Non-OADS,/arxiv_data1/oa_pdf/95/34/1806-3713-jbpneu-42-04-00273.PMC5063444.pdf
2012;18(8):637-44. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/95/34/1806-3713-jbpneu-42-04-00273.PMC5063444.pdf
Influence of heart failure on resting lung volumes in patients with COPD http://dx.doi.org/10.1183/09031936.05.00034805 19.,Non-OADS,/arxiv_data1/oa_pdf/95/34/1806-3713-jbpneu-42-04-00273.PMC5063444.pdf
2005;26(3):511-22. http://dx.doi.org/10.1183/09031936.05 .00035005 20.,Non-OADS,/arxiv_data1/oa_pdf/95/34/1806-3713-jbpneu-42-04-00273.PMC5063444.pdf
1999;32(6):703-17. http://dx.doi.org/10.1590/s0100- 879x1999000600006 21.,Non-OADS,/arxiv_data1/oa_pdf/95/34/1806-3713-jbpneu-42-04-00273.PMC5063444.pdf
2007;33(4):397- 406. http://dx.doi.org/10.1590/S1806-37132007000400008 22.,Non-OADS,/arxiv_data1/oa_pdf/95/34/1806-3713-jbpneu-42-04-00273.PMC5063444.pdf
http://dx.doi.org/10.1378/chest.11-0787 24.,Non-OADS,/arxiv_data1/oa_pdf/95/34/1806-3713-jbpneu-42-04-00273.PMC5063444.pdf
2015 Apr 15;191(8):873-5. http://dx.doi.org/10.1164/ rccm.201501-0084ED 25.,OADS,/arxiv_data1/oa_pdf/95/34/1806-3713-jbpneu-42-04-00273.PMC5063444.pdf
2016;193(3):299-309. http://dx.doi.org/10.1164/rccm.201504- 0841OC 26.,Non-OADS,/arxiv_data1/oa_pdf/95/34/1806-3713-jbpneu-42-04-00273.PMC5063444.pdf
2015;45(2):377-87. http://dx.doi.org/10.1183/09031936.00135514 27.,Non-OADS,/arxiv_data1/oa_pdf/95/34/1806-3713-jbpneu-42-04-00273.PMC5063444.pdf
http://dx.doi.org/10.1164/arrd.1984.129.2P2.S17 28.,OADS,/arxiv_data1/oa_pdf/95/34/1806-3713-jbpneu-42-04-00273.PMC5063444.pdf
1978;40:157- 84. http://dx.doi.org/10.1146/annurev.ph.40.030178.001105 29.,Non-OADS,/arxiv_data1/oa_pdf/95/34/1806-3713-jbpneu-42-04-00273.PMC5063444.pdf
2007;13(2):100-7. http://dx.doi.org/10.1016/j.cardfail.2006.10.018 31.,OADS,/arxiv_data1/oa_pdf/95/34/1806-3713-jbpneu-42-04-00273.PMC5063444.pdf
2011;140(2):461- 8. http://dx.doi.org/10.1378/chest.10-2582 32.,Non-OADS,/arxiv_data1/oa_pdf/95/34/1806-3713-jbpneu-42-04-00273.PMC5063444.pdf
2009;11(2):130-9. http://dx.doi.org/10.1093/eurjhf/hfn013 33.,Non-OADS,/arxiv_data1/oa_pdf/95/34/1806-3713-jbpneu-42-04-00273.PMC5063444.pdf
1976;19(2):109-15. http://dx.doi.org/10.1016/0033-0620(76)90019-0 35.,Non-OADS,/arxiv_data1/oa_pdf/95/34/1806-3713-jbpneu-42-04-00273.PMC5063444.pdf
2000;117(2):321-32. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/95/34/1806-3713-jbpneu-42-04-00273.PMC5063444.pdf
ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562015000000221ABSTRACT Objective:  To identify respiratory symptoms and evaluate lung function in mine workers.,Non-OADS,/arxiv_data1/oa_pdf/8c/ce/1806-3713-jbpneu-42-04-00279.PMC5063445.pdf
2011;7(6):399-404. http://dx.doi.org/10.2113/gselements.7.6.399 2.,Non-OADS,/arxiv_data1/oa_pdf/8c/ce/1806-3713-jbpneu-42-04-00279.PMC5063445.pdf
2004;54(5):304-10. http://dx.doi.org/10.1093/ occmed/kqh073 4.,Non-OADS,/arxiv_data1/oa_pdf/8c/ce/1806-3713-jbpneu-42-04-00279.PMC5063445.pdf
Available from: http://www.ibram.org.br/sites/1300/1382/00004355.,Non-OADS,/arxiv_data1/oa_pdf/8c/ce/1806-3713-jbpneu-42-04-00279.PMC5063445.pdf
1999;5(1):7-28. http://dx.doi.org/10.1590/S0104- 93131999000100001 11.,Non-OADS,/arxiv_data1/oa_pdf/8c/ce/1806-3713-jbpneu-42-04-00279.PMC5063445.pdf
http://dx.doi.org/10.1590/S1806- 37132006000800012 12.,Non-OADS,/arxiv_data1/oa_pdf/8c/ce/1806-3713-jbpneu-42-04-00279.PMC5063445.pdf
2002;137(1):45-61.  http://dx.doi.org/10.1023/A:1015599406550 13.,Non-OADS,/arxiv_data1/oa_pdf/8c/ce/1806-3713-jbpneu-42-04-00279.PMC5063445.pdf
2011;37(1):36-45. http://dx.doi.org/10.1590/S1806- 37132011000100007 14.,Non-OADS,/arxiv_data1/oa_pdf/8c/ce/1806-3713-jbpneu-42-04-00279.PMC5063445.pdf
1991;144(5):1202-18. http://dx.doi.org/10.1164/ajrccm/144.5.1202 15.,Non-OADS,/arxiv_data1/oa_pdf/8c/ce/1806-3713-jbpneu-42-04-00279.PMC5063445.pdf
1981;38(1):1-13. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/ce/1806-3713-jbpneu-42-04-00279.PMC5063445.pdf
1988;137(2):286- 92. http://dx.doi.org/10.1164/ajrccm/137.2.286 26.,Non-OADS,/arxiv_data1/oa_pdf/8c/ce/1806-3713-jbpneu-42-04-00279.PMC5063445.pdf
2000;26(5):245-53. http://dx.doi.Table 4.,OADS,/arxiv_data1/oa_pdf/8c/ce/1806-3713-jbpneu-42-04-00279.PMC5063445.pdf
2002;122(2):721-8. http://dx.doi.org/10.1378/chest.122.2.721 28.,Non-OADS,/arxiv_data1/oa_pdf/8c/ce/1806-3713-jbpneu-42-04-00279.PMC5063445.pdf
2013;18(5):1353-60.  http://dx.doi.org/10.1590/S1413-81232013000500020 30.,Non-OADS,/arxiv_data1/oa_pdf/8c/ce/1806-3713-jbpneu-42-04-00279.PMC5063445.pdf
1989;23(2):98-106.  http://dx.doi.org/10.1590/S0034-89101989000200003 285 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/8c/ce/1806-3713-jbpneu-42-04-00279.PMC5063445.pdf
"ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000000023ABSTRACT We conducted a cross-sectional, retrospective study, characterized by classical and  molecular epidemiology, involving M. tuberculosis  isolates from a regional prison  in southern Brazil.",Non-OADS,/arxiv_data1/oa_pdf/e9/ef/1806-3713-jbpneu-42-04-00286.PMC5063446.pdf
2015;93(4):739-46. http://dx.doi.org/10.4269/ajtmh.15-0166 5.,Non-OADS,/arxiv_data1/oa_pdf/e9/ef/1806-3713-jbpneu-42-04-00286.PMC5063446.pdf
Banco de dados sobre  tuberculose do DATASUS Available from: http://dtr2004.saude.gov.,Non-OADS,/arxiv_data1/oa_pdf/e9/ef/1806-3713-jbpneu-42-04-00286.PMC5063446.pdf
2012;107(7):909-15. http://dx.doi.org/10.1590/S0074- 02762012000700012 8.,Non-OADS,/arxiv_data1/oa_pdf/e9/ef/1806-3713-jbpneu-42-04-00286.PMC5063446.pdf
2006;12(3):186- 91. http://dx.doi.org/10.1089/mdr.2006.12.186 10.,Non-OADS,/arxiv_data1/oa_pdf/e9/ef/1806-3713-jbpneu-42-04-00286.PMC5063446.pdf
Available from: http://www.miru-vntrplus.org/ MIRU/files/MIRU-VNTRtypingmanualv6.pdf 13.,Non-OADS,/arxiv_data1/oa_pdf/e9/ef/1806-3713-jbpneu-42-04-00286.PMC5063446.pdf
Available from:  http://www.miru-vntrplus.org/MIRU/index.faces 14.,Non-OADS,/arxiv_data1/oa_pdf/e9/ef/1806-3713-jbpneu-42-04-00286.PMC5063446.pdf
2012;45(4):491-5. http://dx.doi.org/10.1590/S0037- 86822012005000004 16.,Non-OADS,/arxiv_data1/oa_pdf/e9/ef/1806-3713-jbpneu-42-04-00286.PMC5063446.pdf
2010;105(6):779-85. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e9/ef/1806-3713-jbpneu-42-04-00286.PMC5063446.pdf
2014;18(3):298-301. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e9/ef/1806-3713-jbpneu-42-04-00286.PMC5063446.pdf
2003;37(5):665-72.  http://dx.doi.org/10.1086/377205 20.,Non-OADS,/arxiv_data1/oa_pdf/e9/ef/1806-3713-jbpneu-42-04-00286.PMC5063446.pdf
ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000000145ABSTRACT Smoking is the most preventable and controllable health risk.,Non-OADS,/arxiv_data1/oa_pdf/be/35/1806-3713-jbpneu-42-04-00290.PMC5063447.pdf
Available from: http://www.pneumoimagem.com.br/ noticia_destaque.asp?idnot=175 3.,Non-OADS,/arxiv_data1/oa_pdf/be/35/1806-3713-jbpneu-42-04-00290.PMC5063447.pdf
Available from: https://www.tobaccofreekids.org/content/what_we_do/industry_watch/doj/FinalOpinionSummary.pdf 5.,Non-OADS,/arxiv_data1/oa_pdf/be/35/1806-3713-jbpneu-42-04-00290.PMC5063447.pdf
Available from: http://www1.inca.gov.br/tabagismo 7.,Non-OADS,/arxiv_data1/oa_pdf/be/35/1806-3713-jbpneu-42-04-00290.PMC5063447.pdf
Available from: http://www.inca.gov.br/observatoriotabaco/ 8.,Non-OADS,/arxiv_data1/oa_pdf/be/35/1806-3713-jbpneu-42-04-00290.PMC5063447.pdf
Available from: http://www.actbr.org.br/tabagismo/ 9.,Non-OADS,/arxiv_data1/oa_pdf/be/35/1806-3713-jbpneu-42-04-00290.PMC5063447.pdf
1996;36:597-613. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/35/1806-3713-jbpneu-42-04-00290.PMC5063447.pdf
Available from: http://apps.who.int/iris/bitstream/10665/148114/1/9789241564854_eng.pdf 13.,OADS,/arxiv_data1/oa_pdf/be/35/1806-3713-jbpneu-42-04-00290.PMC5063447.pdf
2009;120(14):1373-9. http://dx.doi.org/10.1161/CIRCULATIONAHA.109.870691 15.,Non-OADS,/arxiv_data1/oa_pdf/be/35/1806-3713-jbpneu-42-04-00290.PMC5063447.pdf
2015;70(3):237-43. http://dx.doi.org/10.1136/thoraxjnl-2014-206438 16.,Non-OADS,/arxiv_data1/oa_pdf/be/35/1806-3713-jbpneu-42-04-00290.PMC5063447.pdf
2015;372(7):631-40. http://dx.doi.org/10.1056/ NEJMsa1407211 17.,Non-OADS,/arxiv_data1/oa_pdf/be/35/1806-3713-jbpneu-42-04-00290.PMC5063447.pdf
Available from: http://www.ensp.fiocruz.br/portal-ensp/informe/site/materia/detalhe/38099 18.,Non-OADS,/arxiv_data1/oa_pdf/be/35/1806-3713-jbpneu-42-04-00290.PMC5063447.pdf
Available from: http://biblioteca.ibge.gov.br/visualizacao/livros/liv94074.pdf 20.,Non-OADS,/arxiv_data1/oa_pdf/be/35/1806-3713-jbpneu-42-04-00290.PMC5063447.pdf
Available from: http://www.ecigarette-politics.com/files/4q14-wells-fargo.pdf 21.,Non-OADS,/arxiv_data1/oa_pdf/be/35/1806-3713-jbpneu-42-04-00290.PMC5063447.pdf
Available from: http://global.tobaccofreekids.org/files/pdfs/en/TAX_Cigarette_affordability_report_en.pdf 23.,Non-OADS,/arxiv_data1/oa_pdf/be/35/1806-3713-jbpneu-42-04-00290.PMC5063447.pdf
Available from: http://bphc.hrsa.gov/ buckets/treatingtobacco.pdf 24.,OADS,/arxiv_data1/oa_pdf/be/35/1806-3713-jbpneu-42-04-00290.PMC5063447.pdf
2008;34(10):845-80. http://dx.doi.org/10.1590/S1806- 37132008001000014 27.,Non-OADS,/arxiv_data1/oa_pdf/be/35/1806-3713-jbpneu-42-04-00290.PMC5063447.pdf
1998;3(1):71-9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/35/1806-3713-jbpneu-42-04-00290.PMC5063447.pdf
2002;166(5):675-9. http://dx.doi.org/10.1164/rccm.2112096 33.,Non-OADS,/arxiv_data1/oa_pdf/be/35/1806-3713-jbpneu-42-04-00290.PMC5063447.pdf
2013;22(127):37-43. http://dx.doi.org/10.1183/09059180.00007212 34.,Non-OADS,/arxiv_data1/oa_pdf/be/35/1806-3713-jbpneu-42-04-00290.PMC5063447.pdf
2007;33(3):282-6. http://dx.doi.org/10.1590/S1806-37132007000300009 35.,Non-OADS,/arxiv_data1/oa_pdf/be/35/1806-3713-jbpneu-42-04-00290.PMC5063447.pdf
2013;1(3):241-50. http://dx.doi.org/10.1016/S2213-2600(13)70063-8 36.,OADS,/arxiv_data1/oa_pdf/be/35/1806-3713-jbpneu-42-04-00290.PMC5063447.pdf
2013;49(8):354-63. http://dx.doi.org/10.1016/j.arbres.2013.02.005 37.,OADS,/arxiv_data1/oa_pdf/be/35/1806-3713-jbpneu-42-04-00290.PMC5063447.pdf
Available from: http://actbr.org.br/uploads/conteudo/721_ Relatorio_Carga_do_tabagismo_Brasil.pdf 38.,Non-OADS,/arxiv_data1/oa_pdf/be/35/1806-3713-jbpneu-42-04-00290.PMC5063447.pdf
"2009;64(5):388-92. http://dx.doi.org/10.1136/thx.2008.102475 39. van Beek EJ, Mirsadraee S, Murchison JT.",OADS,/arxiv_data1/oa_pdf/be/35/1806-3713-jbpneu-42-04-00290.PMC5063447.pdf
2015;7(8):189-93. http://dx.doi.org/10.4329/wjr.v7.i8.189 40.,Non-OADS,/arxiv_data1/oa_pdf/be/35/1806-3713-jbpneu-42-04-00290.PMC5063447.pdf
2009;18(12):3484-9. http://dx.doi.org/10.1158/1055-9965.EPI-09-0895 298 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/be/35/1806-3713-jbpneu-42-04-00290.PMC5063447.pdf
"ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000000073Resistance profile of strains of  Mycobacterium fortuitum  isolated from  clinical specimens Debora Ribeiro de Souza Santos1,2, Maria Cristina Silva Lourenço3,   Fábrice Santana Coelho4, Fernanda Carvalho Queiroz Mello5,   Rafael Silva Duarte6 1.",Non-OADS,/arxiv_data1/oa_pdf/ca/e9/1806-3713-jbpneu-42-04-00299.PMC5063448.pdf
2012;25(3):545- 82. http://dx.doi.org/10.1128/CMR.05030-11 2.,Non-OADS,/arxiv_data1/oa_pdf/ca/e9/1806-3713-jbpneu-42-04-00299.PMC5063448.pdf
2007;175(4):367-416. http://dx.doi.org/10.1164/ rccm.200604-571ST 8.,Non-OADS,/arxiv_data1/oa_pdf/ca/e9/1806-3713-jbpneu-42-04-00299.PMC5063448.pdf
2012;39(3):201- 5. http://dx.doi.org/10.1016/j.ijantimicag.2011.11.014 11.,OADS,/arxiv_data1/oa_pdf/ca/e9/1806-3713-jbpneu-42-04-00299.PMC5063448.pdf
2007;44  Suppl 2:S27-72 http://dx.doi.org/10.1086/511159 301 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/ca/e9/1806-3713-jbpneu-42-04-00299.PMC5063448.pdf
"ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000000134Management of pericardial cyst in the  mediastinum: a single-port approach Dario Amore1, Antonio Mazzella1, Alessandro Izzo2, Antonio Cennamo2,   Fabio Perrotta2 1.",Non-OADS,/arxiv_data1/oa_pdf/09/a6/1806-3713-jbpneu-42-04-00302.PMC5063449.pdf
2004;21(3):269- 72. http://dx.doi.org/10.1111/j.0742-2822.2004.03097.x 2.,Non-OADS,/arxiv_data1/oa_pdf/09/a6/1806-3713-jbpneu-42-04-00302.PMC5063449.pdf
1996;61(1):208-10. http://dx.doi.org/10.1016/0003- 4975(95)00720-2 5.,Non-OADS,/arxiv_data1/oa_pdf/09/a6/1806-3713-jbpneu-42-04-00302.PMC5063449.pdf
ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000000196Not every irreversible airflow obstruction is  COPD José Baddini-Martinez1 1.,Non-OADS,/arxiv_data1/oa_pdf/c5/61/1806-3713-jbpneu-42-04-00304.PMC5063450.pdf
2013;39(4):518-20. http://dx.doi.org/10.1590/S1806-37132013000400017 2.,Non-OADS,/arxiv_data1/oa_pdf/c5/61/1806-3713-jbpneu-42-04-00304.PMC5063450.pdf
1959;14(4):286-99. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/61/1806-3713-jbpneu-42-04-00304.PMC5063450.pdf
Available from: http://goldcopd.org/global-strategy-diagnosis-management- prevention-copd-2016/ 4.,Non-OADS,/arxiv_data1/oa_pdf/c5/61/1806-3713-jbpneu-42-04-00304.PMC5063450.pdf
2015;46(3):622-39. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/61/1806-3713-jbpneu-42-04-00304.PMC5063450.pdf
2011;184(1):57-63. http://dx.doi.org/10.1164/rccm.201101-0021OCChart 1.,Non-OADS,/arxiv_data1/oa_pdf/c5/61/1806-3713-jbpneu-42-04-00304.PMC5063450.pdf
"ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000000099The rapid shallow breathing index as  a predictor of successful mechanical ventilation weaning: clinical utility when calculated from ventilator data Luiz Alberto Forgiarini Junior1, Antonio M. Esquinas2 1.",Non-OADS,/arxiv_data1/oa_pdf/4e/f9/1806-3713-jbpneu-42-04-00306.PMC5063451.pdf
2015;41(6):530-5. http://dx.doi.org/10.1590/S1806-37132015000000077 2.,Non-OADS,/arxiv_data1/oa_pdf/4e/f9/1806-3713-jbpneu-42-04-00306.PMC5063451.pdf
2015;29(1):64-8. http://dx.doi.org/10.1053/j.jvca.2014.06.022 3.,Non-OADS,/arxiv_data1/oa_pdf/4e/f9/1806-3713-jbpneu-42-04-00306.PMC5063451.pdf
2015;41(4):358-64. http://dx.doi.org/10.1590/S1806-37132015000004453J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/4e/f9/1806-3713-jbpneu-42-04-00306.PMC5063451.pdf
"The mRNA expression of CD90 in ovarian cancer was identified from Oncomine database as the criteria of P -value <1E-4, fold change >3, and gene ranking  in the top 10% (https://www.oncomine.org/resource/login.html) (25,26).",OADS,/arxiv_data1/oa_pdf/1c/55/ijo-49-05-1881.PMC5063452.pdf
The correlation  between CD90 expression and post-progression survival in ovarian cancer was analyzed by Kaplan-Meier plotter database (http://kmplot.com/analysis/) (27).,OADS,/arxiv_data1/oa_pdf/1c/55/ijo-49-05-1881.PMC5063452.pdf
"The correlation between DNA copy number and mRNA expression of CD90 in ovarian cancer is identified by cBioPortal database (http://www.cbio - portal.org/) (28,29).",OADS,/arxiv_data1/oa_pdf/1c/55/ijo-49-05-1881.PMC5063452.pdf
"http://dx.doi.org/10.1016/j.stemcr.2016.08.012 SUMMARY Parkinson’s disease (PD) is characterized by the selective loss of dopamine neurons in the substantia nigra; however, the mechanism of neurodegeneration in PD remains unclear.",Non-OADS,/arxiv_data1/oa_pdf/16/13/main.PMC5063469.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/16/13/main.PMC5063469.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, six ﬁgures, and two tables and can be found withthis article online at http://dx.doi.org/10.1016/j.stemcr.2016.",OADS,/arxiv_data1/oa_pdf/16/13/main.PMC5063469.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7f/c9/ndt-12-2521.PMC5063479.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2521–2526Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2521OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11388 0 Screening for attention deficit and hyperactivity  disorder, autism spectrum disorder, and  developmental delay in Taiwanese aboriginal  preschool children hsiang-lin chan1,2,* Wen-sheng liu3–6,* Yi-hsuan hsieh1,2 chiao-Fan lin1,2 Tiing-soon ling2,7 Yu-shu huang1,2 1Department of child Psychiatry,   chang gung Memorial hospital,   2college of Medicine, chang gung  University, Taoyuan, 3Division of  Nephrology, Department of Medicine,   Taipei city hospital, Zhong-Xing  Branch, Taipei, Taiwan; 4school  of Medicine, National Yang-Ming  University, Taipei, Taiwan; 5institute  of environmental and Occupational  health sciences, school of Medicine,   National Yang-Ming University,   Taipei, Taiwan; 6college of science  and engineering, Fu Jen catholic  University, New Taipei city, Taiwan;   7Department of Family Medicine,   chang gung Memorial hospital,   Taoyuan, Taiwan, republic of china *These authors contributed equally  to this workObjectives:  This study aimed to estimate the percentages of attention deficit and hyperactivity  disorder (ADHD) and autism spectrum disorder (ASD) in Taiwanese aboriginal preschool  children.",Non-OADS,/arxiv_data1/oa_pdf/7f/c9/ndt-12-2521.PMC5063479.pdf
"The Australian longitudinal  birth cohort study of urban aboriginal infants reported that 3-year-old Australian  aboriginal children performed better in locomotor and personal–social domains and had  weakness in language, fine motor, and performance skills.1 Jorm et al found a higher  prevalence of behavioral problems in Australian aboriginal children and adolescents  than in nonaboriginal children, according to data collected from parents and caregivers.2  Baydala et al had indicated that ADHD characteristics, including hyperactivity, rapidly  shifting attention, and impulsivity may have offered selective advantage in early  hunter–gatherer society, many of whom were represented by aboriginal populations.3  In their study, a high prevalence of ADHD is reported in Canadian aboriginal children, correspondence: Yu-shu huang Department of child Psychiatry, chang  gung Memorial hospital, No 5, Fusing  street, gueishan Township, Taoyuan  county 333, Taiwan, republic of china Tel +886 3 328 1200 ext 2479 Fax +886 3 328 0267 email yushuhuang1212@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Chan et al Running head recto: ADHD and ASD in Taiwanese aboriginal children DOI: http://dx.doi.org/10.2147/NDT.S113880",Non-OADS,/arxiv_data1/oa_pdf/7f/c9/ndt-12-2521.PMC5063479.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/7f/c9/ndt-12-2521.PMC5063479.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7f/c9/ndt-12-2521.PMC5063479.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/70/10/jpr-9-779.PMC5063480.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/70/10/jpr-9-779.PMC5063480.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 779–785Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  779 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S102696Improvement in pain severity category in clinical  trials of pregabalin  Bruce Parsons1 Charles E Argoff2 Andrew Clair1 Birol Emir1 1Pfizer, New Y ork, NY, USA; 2Albany  Medical Center, Albany, NY,  USABackground: Pregabalin is approved by the US Food and Drug Administration for the treatment  of fibromyalgia (FM), diabetic peripheral neuropathy (DPN), postherpetic neuralgia (PHN),  and neuropathic pain due to spinal cord injury (SCI).",Non-OADS,/arxiv_data1/oa_pdf/70/10/jpr-9-779.PMC5063480.pdf
"1,2 As a result, while Correspondence: Bruce Parsons Pfizer, 235 East 42nd Street, New York, NY 10017, USATel +1 212 573 1649Email bruce.parsons@pfizer.comJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Parsons et alRunning head recto: Pain severity with pregabalinDOI: http://dx.doi.org/10.2147/JPR.S102696",Non-OADS,/arxiv_data1/oa_pdf/70/10/jpr-9-779.PMC5063480.pdf
Available from: http://labeling.pfizer.com/ShowLabel-ing.aspx?id=561.,Non-OADS,/arxiv_data1/oa_pdf/70/10/jpr-9-779.PMC5063480.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT00156078.,Non-OADS,/arxiv_data1/oa_pdf/70/10/jpr-9-779.PMC5063480.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT00143156.,Non-OADS,/arxiv_data1/oa_pdf/70/10/jpr-9-779.PMC5063480.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/70/10/jpr-9-779.PMC5063480.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 785 Pain severity with pregabalin 11.,Non-OADS,/arxiv_data1/oa_pdf/70/10/jpr-9-779.PMC5063480.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f2/f5/ott-9-6065.PMC5063481.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6065–6074OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6065Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S9764 4 New developments in the management of non- small-cell lung cancer, focus on rociletinib: what  went wrong?",Non-OADS,/arxiv_data1/oa_pdf/f2/f5/ott-9-6065.PMC5063481.pdf
"When this glycine is  replaced by either alanine, serine, or cysteine, it results in a distortion of the P-loop, Correspondence: elisa Giovannetti Department of Medical Oncology, vU  University Medical Center, Cancer Center  Amsterdam room 1.54, De Boelelaan 1117,  1081Hv Amsterdam, the Netherlands Tel +31 20 444 2630 Fax +31 20 444 3844 email elisa.giovannetti@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Van Der Steen et al Running head recto: Rociletinib in NSCLC DOI: http://dx.doi.org/10.2147/OTT.S97644 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/f2/f5/ott-9-6065.PMC5063481.pdf
Or use: http://youtu.be/HOKFCbxAwo Ivideo abstract,Non-OADS,/arxiv_data1/oa_pdf/f2/f5/ott-9-6065.PMC5063481.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/f2/f5/ott-9-6065.PMC5063481.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/f5/ott-9-6065.PMC5063481.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8b/94/ott-9-6021.PMC5063482.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6021–6027OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6021Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11634 8 recurrence pattern of squamous cell carcinoma  in the midthoracic esophagus: implications for  the clinical target volume design of postoperative  radiotherapy Xiaoli Wang1,2,* Yijun luo1,2,* Minghuan li2 hongjiang Yan2 Mingping sun2 Tingyong Fan2 1school of Medicine and life  sciences, Jinan University- shandong  academy of Medical sciences, Jinan,   shandong, People’s republic of china;   2Department of radiation Oncology,   shandong cancer hospital and  institute, Jinan, shandong, People’s  republic of china *These authors contributed equally  to this workBackground:  Postoperative radiotherapy has shown positive efficacy in lowering the recurrence  rate and improving the survival rate for patients with esophageal squamous cell carcinoma  (ESCC).",Non-OADS,/arxiv_data1/oa_pdf/8b/94/ott-9-6021.PMC5063482.pdf
"For patients  with locally advanced ESCC, the standard treatment is neoadjuvant chemotherapy or correspondence: Tingyong Fan Department of radiation Oncology,  shandong cancer hospital and institute,  Jiyan road 440, Jinan 250117, shandong  Province, People’s republic of china Tel/fax +86 531 6762 6921 email fanty681105@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Wang et al Running head recto: Recurrence pattern of midthoracic esophagus squamous cell carcinoma DOI: http://dx.doi.org/10.2147/OTT.S116348",Non-OADS,/arxiv_data1/oa_pdf/8b/94/ott-9-6021.PMC5063482.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/8b/94/ott-9-6021.PMC5063482.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8b/94/ott-9-6021.PMC5063482.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/11/0e/lra-9-083.PMC5063483.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/11/0e/lra-9-083.PMC5063483.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Local and Regional Anesthesia 2016:9 83–86Local and Regional Anesthesia Dovepress submit your manuscript | www.dovepress.com Dovepress  83 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LRA.S116102Single-shot lamina thoracic paravertebral block  with ketofol for modified radical mastectomy Ambrose Rukewe1  Oludolapo O Afuwape2  Austin Ugheoke3  Akinola A Fatiregun4 1Department of Anaesthesia &  Critical Care, Faculty of Medicine,   University of Botswana, Gaborone,  Botswana;  2Department of Surgery,   College of Medicine 3Department  of Anaesthesia, University College Hospital, Ibadan,  4World Health  Organisation, Akure, Ondo State,  NigeriaAbstract:  We describe the use of single-shot lamina thoracic paravertebral block (TPVB) with  sedation for a 56-year-old female patient who had modified radical mastectomy with axillary  clearance.",Non-OADS,/arxiv_data1/oa_pdf/11/0e/lra-9-083.PMC5063483.pdf
"Correspondence: Ambrose Rukewe   Department of Anaesthesia & Critical  Care, Faculty of Medicine, University of Botswana, Private Bag 00713, Gaborone, Botswana   Tel +267 7622 6524 Email ambyrukewe@gmail.comJournal name: Local and Regional Anesthesia Article Designation: CASE REPORTY ear: 2016V olume: 9Running head verso: Rukewe et alRunning head recto: Single-shot lamina thoracic paravertebral blockDOI: http://dx.doi.org/10.2147/LRA.S116102",Non-OADS,/arxiv_data1/oa_pdf/11/0e/lra-9-083.PMC5063483.pdf
"Local and Regional Anesthesia 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Local and Regional Anesthesia Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/local-and-regional-anesthesia-journalLocal and Regional Anesthesia is an international, peer-reviewed,  open access journal publishing on the development, pharmacology,  delivery and targeting and clinical use of local and regional anesthetics and  analgesics.",Non-OADS,/arxiv_data1/oa_pdf/11/0e/lra-9-083.PMC5063483.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 86 Rukewe et al References  1.,Non-OADS,/arxiv_data1/oa_pdf/11/0e/lra-9-083.PMC5063483.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/61/65/opth-10-1939.PMC5063484.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1939–1944Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1939Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11515 9 assessment of quality of life in patients with  visual impairments using a new visual function  questionnaire: the VFQ-J11 Tadashi nakano1 Motoko Kawashima2 Y oshimune hiratsuka3 hiroshi Tamura4,5 Koichi Ono6 akira Murakami3 Kazuo Tsubota2 Masakazu Yamada7,8 1Department of Ophthalmology,   Jikei University school of Medicine,   2Department of Ophthalmology,   Keio University school of Medicine,   3Department of Ophthalmology,   Juntendo University graduate  school of Medicine, T okyo,   4Department of Ophthalmology &  Visual sciences, Kyoto University,   5Division of Medical information  T echnology & administration Planning,   Kyoto University hospital, Kyoto,   6Department of Ophthalmology,   Juntendo Tokyo Koto geriatric  Medical Center, 7national institute of  sensory Organs, national hospital  Organization T okyo Medical Center,   8Department of Ophthalmology,   Kyorin University, T okyo, JapanBackground:  The purpose of the present study was to assess the vision-related quality of life  (QOL) of visually impaired patients using the Japanese 11-item National Eye Institute Visual  Function Questionnaire (VFQ-J11).",Non-OADS,/arxiv_data1/oa_pdf/61/65/opth-10-1939.PMC5063484.pdf
"It originally  comprised 51 items and was later shortened to 25 items and 13 optional items that Correspondence: Masakazu Yamada Department of Ophthalmology, Kyorin  University school of Medicine, 6-20-2 shinkawa, Mitaka,  Tokyo 181-8611, Japan Tel +81 422 47 5511 Fax +81 422 44 0674 email yamada@eye-center.or g Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Nakano et al Running head recto: Vision-related QOL assessment in visually impaired patients using VFQ-J11 DOI: http://dx.doi.org/10.2147/OPTH.S115159",Non-OADS,/arxiv_data1/oa_pdf/61/65/opth-10-1939.PMC5063484.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/61/65/opth-10-1939.PMC5063484.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/61/65/opth-10-1939.PMC5063484.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/44/88/opth-10-1953.PMC5063485.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1953–1964Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1953Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10922 2 Clinical, optical coherence tomography, and  fundus autofluorescence findings in patients  with intraocular tumors Daniel samuelsson Monika sznage Karl engelsberg elisabeth Wittström Department of Ophthalmology, lund  University, skane University hospital,   lund, swedenPurpose:  To describe clinical, optical coherence tomography (OCT) and fundus autofluorescence  (FAF) findings in patients with intraocular tumors and determine if OCT and FAF could be  helpful in the differential diagnosis and management of different choroidal tumors.",Non-OADS,/arxiv_data1/oa_pdf/44/88/opth-10-1953.PMC5063485.pdf
"These methods provide qualitative and quantita - tive information about retinal changes that are not only important for the management  of patients with many retinal diseases but also for patients with intraocular tumors.1–3  OCT and FAF imaging, when used together and combined with fundus photography,  fluorescein angiography/indocyanine green angiography (FA/ICG), and ultrasonog - raphy, have been shown to be useful for early tumor diagnosis, monitoring of tumor  growth, and follow-up of the results of therapies.1–11Correspondence: elisabeth Wittström Department of Ophthalmology, lund  University, se-221 85 lund, sweden Tel +46 46 17 68 49 Fax +46 46 17 61 41 email elisabeth.wittstrom@skane.s e Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Samuelsson et al Running head recto: OCT and FAF in patients with intraocular tumors DOI: http://dx.doi.org/10.2147/OPTH.S109222",Non-OADS,/arxiv_data1/oa_pdf/44/88/opth-10-1953.PMC5063485.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/44/88/opth-10-1953.PMC5063485.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/44/88/opth-10-1953.PMC5063485.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/67/76/lra-9-065.PMC5063486.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/67/76/lra-9-065.PMC5063486.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Local and Regional Anesthesia 2016:9 65–81Local and Regional Anesthesia Dovepress submit your manuscript | www.dovepress.com Dovepress  65 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LRA.S109659Regional anesthesia or patient-controlled  analgesia and compartment syndrome   in orthopedic surgical procedures:   a systematic review Elizabeth BS Driscoll1  Ana Hosseinzadeh Maleki2  Leila Jahromi3  Brittany Nelson Hermecz4  Lauren E Nelson5  Imelda L Vetter6  Spencer Evenhuis2  Lee Ann Riesenberg2 1Department of Anesthesiology,   University of T ennessee, Knoxville, TN,   2Department of Anesthesiology and  Perioperative Medicine, University of  Alabama at Birmingham, Birmingham,  AL,  3Department of Biology, Georgia  State University, Atlanta, GA,   4Department of Diagnostic Radiology,   University of Alabama at Birmingham School of Medicine, Birmingham,   5University of South Alabama College  of Medicine, Mobile, 6School of  Health Professions, Lister Hill Library,  University of Alabama at Birmingham,    Birmingham, AL, USAAbstract:  A systematic review of the literature on the use of regional anesthesia (RA) and  patient-controlled analgesia (PCA) was conducted in patients who require orthopedic extremity  procedures to determine whether either analgesic technique contributes to a delayed diagnosis  of compartment syndrome (CS).",Non-OADS,/arxiv_data1/oa_pdf/67/76/lra-9-065.PMC5063486.pdf
"13,21,24 Regional analgesia or regional anesthesia (RA) is often used  to alleviate pain in patients who have had limb injuries or interventions.1,30,31 RA has Correspondence: Elizabeth BS Driscoll   Department of Anesthesiology,  University of Tennessee, U109, 1924 Alcoa Highway, Knoxville,  TN 37920-1511, USA Tel +1 865 305 9220   Fax +1 865 305 9216   Email edriscoll@utmck.eduJournal name: Local and Regional Anesthesia Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Driscoll et alRunning head recto: RA or PCA and compartment syndrome in orthopedic surgical proceduresDOI: http://dx.doi.org/10.2147/LRA.S109659",Non-OADS,/arxiv_data1/oa_pdf/67/76/lra-9-065.PMC5063486.pdf
Available at: https://www.asra.com/content/documents/31513_asra_may2013newsletter.pdf.,Non-OADS,/arxiv_data1/oa_pdf/67/76/lra-9-065.PMC5063486.pdf
Available from: http://www.medicine.ox.ac.uk/ban-dolier/painres/download/whatis/Syst-review.pdf.,Non-OADS,/arxiv_data1/oa_pdf/67/76/lra-9-065.PMC5063486.pdf
"Local and Regional Anesthesia 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Local and Regional Anesthesia Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/local-and-regional-anesthesia-journalLocal and Regional Anesthesia is an international, peer-reviewed,  open access journal publishing on the development, pharmacology,  delivery and targeting and clinical use of local and regional anesthetics and  analgesics.",Non-OADS,/arxiv_data1/oa_pdf/67/76/lra-9-065.PMC5063486.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 81 RA or PCA and compartment syndrome in orthopedic surgical procedures 67.,Non-OADS,/arxiv_data1/oa_pdf/67/76/lra-9-065.PMC5063486.pdf
Available from: http://www.hindawi.com/journals/arp/2011/713281/.,Non-OADS,/arxiv_data1/oa_pdf/67/76/lra-9-065.PMC5063486.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/fc/88/lra-9-059.PMC5063487.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/fc/88/lra-9-059.PMC5063487.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Local and Regional Anesthesia 2016:9 59–64Local and Regional Anesthesia Dovepress submit your manuscript | www.dovepress.com Dovepress  59 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LRA.S115432An electronic surgical order, undertaking patient  education, and obtaining informed consent for  regional analgesia before the day of surgery  reduce block-related delays Brandon S Brooks1  Joydip Barman2  Brent A Ponce3  Alisa Sides4  Thomas R Vetter1 1Department of Anesthesiology and  Perioperative Medicine, 2Department  of Health Care Organization and  Policy, 3Division of Orthopaedic  Surgery, Department of Surgery,  University of Alabama at Birmingham,  Birmingham, AL,  4Community Health  Systems, Franklin, TN, USABackground: Obtaining patient informed consent for a regional analgesia block on the day of  surgery can result in surgical case delays.",Non-OADS,/arxiv_data1/oa_pdf/fc/88/lra-9-059.PMC5063487.pdf
"This can lead to confusion and anxiety Correspondence: Thomas R Vetter   Department of Anesthesiology and  Perioperative Medicine, University of Alabama at Birmingham, 619, 19th Street South, JT862, Birmingham, AL 35249-6810, USA Tel +1 205 934 6501   Fax +1 205 996 7272   Email tvetter@uabmc.eduJournal name: Local and Regional Anesthesia Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Brooks et alRunning head recto: Block consent before day of surgeryDOI: http://dx.doi.org/10.2147/LRA.S115432",Non-OADS,/arxiv_data1/oa_pdf/fc/88/lra-9-059.PMC5063487.pdf
